A0_Samples	A17_Age	A18_Sex	A1_OS	A22_histological_type	A23_Tumor_tissue_site	A2_Event	A6_Stage	A7_Grade	A8_New_Event	A8_New_Event_Time	A8_New_Event_Tissue	A8_New_Event_Type	A9_Cancer_Status	additional_studies	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	bcr_patient_barcode	bcr_patient_uuid	day_of_form_completion	days_to_birth	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	drugs.drug.bcr_drug_barcode	drugs.drug.bcr_drug_uuid	drugs.drug.clinical_trail_drug_classification	drugs.drug.day_of_form_completion	drugs.drug.days_to_drug_therapy_end	drugs.drug.days_to_drug_therapy_start	drugs.drug.drug_name	drugs.drug.measure_of_response	drugs.drug.month_of_form_completion	drugs.drug.number_cycles	drugs.drug.prescribed_dose	drugs.drug.prescribed_dose_units	drugs.drug.regimen_indication	drugs.drug.regimen_indication_notes	drugs.drug.regimen_number	drugs.drug.route_of_administrations.route_of_administration	drugs.drug.therapy_ongoing	drugs.drug.therapy_types.therapy_type	drugs.drug.therapy_types.therapy_type_notes	drugs.drug.total_dose	drugs.drug.total_dose_units	drugs.drug.tx_on_clinical_trial	drugs.drug.year_of_form_completion	eastern_cancer_oncology_group	ethnicity	follow_ups.follow_up.bcr_followup_barcode	follow_ups.follow_up.bcr_followup_uuid	follow_ups.follow_up.day_of_form_completion	follow_ups.follow_up.days_to_death	follow_ups.follow_up.days_to_last_followup	follow_ups.follow_up.eastern_cancer_oncology_group	follow_ups.follow_up.followup_case_report_form_submission_reason	follow_ups.follow_up.followup_treatment_success	follow_ups.follow_up.karnofsky_performance_score	follow_ups.follow_up.lost_follow_up	follow_ups.follow_up.month_of_form_completion	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.additional_radiation_therapy	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_neoplasm_event_type	follow_ups.follow_up.new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	follow_ups.follow_up.new_tumor_events.new_tumor_event.progression_determined_by	follow_ups.follow_up.new_tumor_events.new_tumor_event.progression_determined_by_notes	follow_ups.follow_up.new_tumor_events.new_tumor_event_after_initial_treatment	follow_ups.follow_up.performance_status_scale_timing	follow_ups.follow_up.person_neoplasm_cancer_status	follow_ups.follow_up.postoperative_rx_tx	follow_ups.follow_up.primary_therapy_outcome_success	follow_ups.follow_up.radiation_therapy	follow_ups.follow_up.vital_status	follow_ups.follow_up.year_of_form_completion	gender	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	jewish_origin	karnofsky_performance_score	lymphatic_invasion	month_of_form_completion	neoplasm_histologic_grade	new_tumor_events.new_tumor_event.additional_pharmaceutical_therapy	new_tumor_events.new_tumor_event.additional_radiation_therapy	new_tumor_events.new_tumor_event.days_to_new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.days_to_new_tumor_event_after_initial_treatment	new_tumor_events.new_tumor_event.new_neoplasm_event_type	new_tumor_events.new_tumor_event.new_tumor_event_additional_surgery_procedure	new_tumor_events.new_tumor_event.progression_determined_by	new_tumor_events.new_tumor_event.progression_determined_by_notes	new_tumor_events.new_tumor_event_after_initial_treatment	other_dx	patient_id	performance_status_scale_timing	person_neoplasm_cancer_status	postoperative_rx_tx	primary_therapy_outcome_success	race_list.race	radiation_therapy	radiations.radiation.anatomic_treatment_site	radiations.radiation.bcr_radiation_barcode	radiations.radiation.bcr_radiation_uuid	radiations.radiation.course_number	radiations.radiation.day_of_form_completion	radiations.radiation.days_to_radiation_therapy_end	radiations.radiation.days_to_radiation_therapy_start	radiations.radiation.measure_of_response	radiations.radiation.month_of_form_completion	radiations.radiation.numfractions	radiations.radiation.radiation_dosage	radiations.radiation.radiation_treatment_ongoing	radiations.radiation.radiation_type	radiations.radiation.radiation_type_notes	radiations.radiation.regimen_indication	radiations.radiation.regimen_indication_notes	radiations.radiation.units	radiations.radiation.year_of_form_completion	residual_tumor	stage_event.ann_arbor.b_symptoms	stage_event.ann_arbor.extranodal_involvement	stage_event.clinical_stage	stage_event.gleason_grading.gleason_score	stage_event.gleason_grading.primary_pattern	stage_event.gleason_grading.secondary_pattern	stage_event.gleason_grading.tertiary_pattern	stage_event.igcccg_stage	stage_event.masaoka_stage	stage_event.pathologic_stage	stage_event.psa.days_to_psa	stage_event.psa.psa_value	stage_event.serum_markers	stage_event.system_version	stage_event.tnm_categories.clinical_categories.clinical_M	stage_event.tnm_categories.clinical_categories.clinical_N	stage_event.tnm_categories.clinical_categories.clinical_T	stage_event.tnm_categories.pathologic_categories.pathologic_M	stage_event.tnm_categories.pathologic_categories.pathologic_N	stage_event.tnm_categories.pathologic_categories.pathologic_T	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_residual_disease	tumor_tissue_site	venous_invasion	vital_status	year_of_form_completion	year_of_initial_pathologic_diagnosis
TCGA-04-1361	57	FEMALE	989	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	1	927.0		Recurrence	Not Available		57	Bilateral	TCGA-04-1361	a6aad7f9-8444-4c2f-8e4b-b19fd453544f	26	-20860	Not Applicable	0	989	TCGA-04-1361-D24016;TCGA-04-1361-D24018;TCGA-04-1361-D24014;TCGA-04-1361-D24015;TCGA-04-1361-D24017	a5ce32b9-e2c9-4f51-803d-168a80a2a582;91768e3d-6abe-4398-ace4-98c1559151ec;89aeb2a5-7c9d-4496-aec9-1d616616507c;6e726984-aca5-4ae7-9f92-1984000dac83;259ac9a0-8e2c-4dca-a3cc-21878c2d46e6	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	844;989;844;844;989	53;936;53;53;936	Taxol;Avastin;Taxol;Carboplatin;Doxil	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	12;Not Available;6;6;1	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	1	Not Available	TCGA-04-1361-F24013	015f5756-302f-4344-b865-61515b2151b8	26	Not Applicable	989	1	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	927	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	Not Available	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1361	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	No Macroscopic disease	Ovary	Not Available	Alive	2009	2005
TCGA-13-0890	56	FEMALE	4424	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	4424			TUMOR FREE		56	Bilateral	TCGA-13-0890	ee0a4a13-613e-4c5d-96c3-8083a013702d	25	-20770	Not Applicable	0	2068	TCGA-13-0890-D24684;TCGA-13-0890-D24683	70389c25-6516-4dbe-96a8-657ae7a0c003;2116b411-beb7-44ff-a1b5-1a4a51c0c452	Not Available;Not Available	15;15	235;235	15;15	Paclitaxel;Carboplatin	Not Available;Not Available	4;4	8;8	Not Available;Not Available	mg/m2;AUC	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;5	mg/m2;AUC	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0890-F24682;TCGA-13-0890-F72620	d9c71fdd-8bd6-48a6-a691-7be7c78c0ae1;1E18CD80-EFD5-4566-A22E-FACD41069183	25;30	Not Applicable;Not Applicable	2068;4424	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;Not Available	2;7									Not Available;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	Not Available	2	G3									Not Available	Not Available	0890	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2003
TCGA-13-0764	62	FEMALE	1881	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	272.0		Recurrence	WITH TUMOR		62	Bilateral	TCGA-13-0764	034825d0-e8b7-4ac0-be31-25f6038cb04a	24	-22965	Not Applicable	0	944	TCGA-13-0764-D24557;TCGA-13-0764-D24555;TCGA-13-0764-D24556	443a788f-f890-4d47-bfbc-c7ff8c756087;c5a01cb1-41c5-4db6-9fd2-771187c689da;a86c31d3-6cf3-4966-8fc6-35ef8a155966	Not Available;Not Available;Not Available	16;16;16	160;160;160	76;55;55	Bevacizumab;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	Not Available;6;6	Not Available;Not Available;Not Available	mg/kg;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;IV;IV	NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	15;6;175	mg/kg;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0764-F24554;TCGA-13-0764-F72599	d0beab0f-0202-4c06-8b19-f10a92e8cf28;9E2CA4EB-D25E-41E2-ADFC-F5391EE4E424	24;30	Not Applicable;1881	944;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	272;272	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Partial Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Not Available	ASHKENAZI	80	Not Available	2	G3									Not Available	Not Available	0764	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2006
TCGA-61-2002	46	FEMALE	547	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	547			WITH TUMOR		46	Bilateral	TCGA-61-2002	85bb4987-51e7-40fe-ad59-2aa56754eca9	8	-17115	Not Applicable	0	547	TCGA-61-2002-D28322;TCGA-61-2002-D28324;TCGA-61-2002-D28325;TCGA-61-2002-D28323	d6e3f98a-0305-4a2c-8bea-29b7e39775c5;eb420498-8627-4216-ab0a-82de0025a5ca;258ebe71-34ac-4e7a-8daa-c688b3a646d9;400a7f22-69a2-4b72-84ef-540194cb48b8	Not Available;Not Available;Not Available;Not Available	8;8;8;8	129;563;558;129	24;157;400;24	Paclitaxel;Doxorubicin;Avastin;Carboplatin	Not Available;Not Available;Not Available;Not Available	12;12;12;12	06;14;10;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1668;924;6600;4800	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2002-F28321	7707c515-3224-4835-89c6-76f1f0d0e875	8	Not Applicable	547	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	2002	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	11-20 mm	Ovary	YES	Alive	2009	2008
TCGA-24-2254	66	FEMALE	1736	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	606.0		Recurrence	WITH TUMOR		66	Bilateral	TCGA-24-2254	9af2248a-d86a-4277-93b4-8eba5a39bd3c	19	-24407	1736	0	1736	TCGA-24-2254-D26529;TCGA-24-2254-D26528;TCGA-24-2254-D26525;TCGA-24-2254-D26524;TCGA-24-2254-D26526;TCGA-24-2254-D26527;TCGA-24-2254-D26530	82cbc27a-6761-4f89-b883-f8421831e315;f2497656-b837-4017-8ab0-97d93059374a;a12fb8d1-7f50-472a-800a-53b1adcdb84d;ef5ca1b9-d193-4a6f-bce0-d480174dd9c7;0362e136-d6c8-4db8-93b0-f02785a3ccee;2bf84b24-19c6-4b84-8e8e-c27da4acf2db;384a517f-ad06-41c1-80f4-3469584c01cf	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	19;19;19;19;19;19;19	1112;718;165;165;165;718;1112	984;615;17;17;17;615;984	Gemzar;Carboplatin;Doxil;Taxol;Carboplatin;Taxotere;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2	06;06;08;08;08;06;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16000;2765;233;2717;3000;780;4630	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-24-2254-F26523	096da4d1-b2b5-4325-b786-ed88b37ba349	19	1736	1736	0	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	606	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	2254	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	2003
TCGA-20-0987	61	FEMALE	701	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	442.0		Recurrence	WITH TUMOR		61	Bilateral	TCGA-20-0987	34f285ab-6c31-4865-a0a7-a57af3567df0	23	-22287	701	0	Not Available	TCGA-20-0987-D25519;TCGA-20-0987-D25521;TCGA-20-0987-D25520	94d41e3c-23fc-4a1e-9848-caf6ce4d52bd;9df9ba91-1ad5-4fbb-870b-28792a4a90c0;fff65b98-a78b-436b-bef7-4a4ad0448bcd	Not Available;Not Available;Not Available	16;16;16	Not Available;442;Not Available	91;427;91	Taxol;Topotecan;Carboplatin	Not Available;Not Available;Not Available	3;3;3	06;3;06	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;IV	Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-20-0987-F25518	2c19c195-d623-46e6-9244-dbd3d124989d	23	701	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	442	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0987	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	1-10 mm	Ovary	Not Available	Dead	2009	2004
TCGA-13-1483	61	FEMALE	895	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	297.0		Recurrence	WITH TUMOR		61	Not Available	TCGA-13-1483	611600a6-43ec-4029-9682-cd6d6a3312ec	31	-22342	895	0	895	TCGA-13-1483-D24855;TCGA-13-1483-D24853;TCGA-13-1483-D24854	8cb04ad5-b5e6-4d55-b79c-351194c3821d;2832940e-1830-4d9e-9f3e-33a1d5a213b3;cb6d0c9b-51f7-4bc1-9355-880ec0fa012a	Not Available;Not Available;Not Available	30;30;30	239;176;176	219;35;35	Cisplatin;Carboplatin;Paciltaxel	Not Available;Not Available;Not Available	6;6;6	2;6;6	Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;5;174	mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1483-F24852	0d764ff1-764e-47b7-9bf2-dfd722372daa	31	895	895	Not Available	Not Available	Not Available	60	Not Available	3	YES	NO	Not Available	297	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	60	Not Available	3	G3									Not Available	Not Available	1483	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Dead	2009	2000
TCGA-04-1638	57	FEMALE	1686	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	298.0		Recurrence	TUMOR FREE		57	Not Available	TCGA-04-1638	c75c915f-ef4b-4c19-8ace-995e6c6015fd	2	-20987	1686	0	Not Available	TCGA-04-1638-D24141;TCGA-04-1638-D24142;TCGA-04-1638-D24138;TCGA-04-1638-D24140;TCGA-04-1638-D24137;TCGA-04-1638-D24139	63e4b64e-ff9e-4716-b524-46b22d2fb4de;529c5977-9ad5-40f3-89f3-4b26793a407e;e2445899-ef2f-48ec-b6cf-24b31caa303c;486f4a95-24cd-4047-8ae4-2d0d1bf97c21;07806476-c405-476d-9b26-904d536b25ac;8b200c15-6dc8-468b-b56f-e0d576fc6f0f	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9	Not Available;Not Available;193;Not Available;193;193	346;346;17;346;17;17	Carboplatin;Taxol;Carboplatin;Doxil;Taxol;Gemcitibine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	Not Available;Not Available;08;Not Available;08;08	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;mg;Not Available;mg;mg	RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;IV;Not Available;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;2990;Not Available;968;11400	Not Available;Not Available;mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-04-1638-F24136	9dd72b20-6a99-48af-bd9b-a8890dd66dfd	2	1686	Not Available	0	Not Available	Not Available	Not Available	Not Available	6	YES	YES	Not Available	298	Recurrence	Not Available	Other Method	Biopsy	Not Available	Pre-Adjuvant Therapy	TUMOR FREE	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1638	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Not Available	TCGA-04-1638-R24143	92f73583-da49-4671-b7f8-f77bfccdbb70	Not Available	9	Not Available	614	Not Available	11	Not Available	Not Available	NO	Not Available	Not Applicable	RECURRENCE	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	No Macroscopic disease	Ovary	Not Available	Dead	2009	2002
TCGA-13-1505	63	FEMALE	1998	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1561.0			TUMOR FREE		63	Bilateral	TCGA-13-1505	914f84bf-578b-4f4d-93cb-378228ea58f6	31	-23238	Not Applicable	0	128	TCGA-13-1505-D24940;TCGA-13-1505-D24942;TCGA-13-1505-D24941	ca2b331b-320f-43b9-a347-0998e1b4469f;94940689-a0b6-4a75-8b62-bf52715197cd;6e83f0a3-d305-449d-82f6-7ded7579a9e0	Not Available;Not Available;Not Available	1;1;1	167;167;167	27;27;27	Cisplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available	2;2;2	6;6;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1505-F24939;TCGA-13-1505-F72674	e5c8ba1b-3e68-4637-acf7-695582f4474b;6C29C067-34ED-4365-8FC9-CE3BB34BC94C	31;31	Not Applicable;Not Applicable	128;1998	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;1561	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1505	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-25-1632	68	FEMALE	1799	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	537.0		Recurrence	WITH TUMOR		68	Bilateral	TCGA-25-1632	c435627c-159d-4a6d-a819-30abac24bf4d	2	-24993	1799	0	1732	TCGA-25-1632-D26738;TCGA-25-1632-D26739;TCGA-25-1632-D26740;TCGA-25-1632-D26736;TCGA-25-1632-D26737	c6464d1a-44a2-400e-b1bb-9d4bf8921c3a;4fe0a3f6-7b53-4115-8a2a-7e3d948ed169;da7c4e92-7f80-4302-aed3-833dc33e5ee6;434bcedc-1d40-4be8-8da0-4c711ac644db;48dd2827-21eb-4711-ac76-adb1caa6884d	Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17	200;719;719;200;200	82;566;566;82;82	Carboplatin;Carboplatin;Taxol;Doxil;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	08;08;08;08;08	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1632-F26735	4ba05fe8-8855-4d63-a4a5-e711b36c1ae5	2	1799	1732	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	537	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1632	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-09-2051	42	FEMALE	1919	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	583.0		Recurrence	TUMOR FREE		42	Bilateral	TCGA-09-2051	02594e5e-8751-47c1-9245-90c66984b665	3	-15650	Not Applicable	0	1919	TCGA-09-2051-D24380;TCGA-09-2051-D24374;TCGA-09-2051-D24379;TCGA-09-2051-D24375;TCGA-09-2051-D24376;TCGA-09-2051-D24378;TCGA-09-2051-D24382;TCGA-09-2051-D24377;TCGA-09-2051-D24381	03b1566e-cda5-4842-a3f2-1fc17dfb6148;55db8cf8-429e-4b6e-9511-299e01d1922f;7857ae81-1908-47bc-93a9-072a19062d7a;0f1610c9-8ce0-40e3-881e-0ba904f9038b;aed478ec-3ae2-4c26-9734-8d6a57a957f5;51dd5cd9-1805-42ac-bb7e-e163028eb07e;0d3f88c5-99cb-41b5-b48f-02197c8ac79f;077cc169-cf4a-4177-9f9e-8f14fa534c1c;6fb5e7f5-d6cd-4b93-80cb-7f5e114b6847	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3	1024;155;1024;155;Not Available;941;1698;941;1698	947;8;947;8;191;913;1586;913;1586	Taxol;Carboplatin;Carboplatin;Taxol;Ovarex Study;Taxol;Gemzar;Cisplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11	4;8;4;8;Not Available;2;6;2;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;AUC;Not Available;mg/m2;Not Available;Not Available;mg;Not Available;mg	RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT;OTHER, SPECIFY IN NOTES;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Consolidation Therapy;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;Not Available;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;6;Not Available;175;Not Available;Not Available;1380;Not Available;376	Not Available;AUC;Not Available;mg/m2;Not Available;Not Available;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-2051-F24373	94294882-49ef-4a27-9a2a-03646c87209d	3	Not Applicable	1919	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES;YES	NO;NO	Not Available;875	583;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	YES	11	G3									Not Available	Not Available	2051	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	YES	Alive	2009	2004
TCGA-23-1120	60	FEMALE	130	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	130			Not Available		60	Right	TCGA-23-1120	fdf83fdf-dfbb-4306-9a1b-b4487d18b402	24	-22148	Not Applicable	0	130	TCGA-23-1120-D25717;TCGA-23-1120-D25716	14e5fa9c-6598-4755-8dcf-a2ad8f0253c2;706a2a1b-ec67-4c1e-9588-9ad9b8a629ef	Not Available;Not Available	1;1	146;146	63;63	Paclitaxel;Cisplatin	Not Available;Not Available	4;4	05;05	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IP	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	2090;700	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1120-F25715	1f657a1b-69cb-4138-929b-aecb50c96b69	24	Not Applicable	130	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	Not Available	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	2	G3									Not Available	Not Available	1120	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	NO	Alive	2009	2008
TCGA-24-1424	67	FEMALE	183	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	183			TUMOR FREE		67	Bilateral	TCGA-24-1424	c3e443b9-5dc5-4793-91e3-534f21485268	16	-24545	Not Applicable	0	183	TCGA-24-1424-D25942;TCGA-24-1424-D25943;TCGA-24-1424-D25944	763af0d0-0624-41b1-bd45-20ace6a3e7c8;528aaae9-7fb0-4b0e-a7c6-1492c1d7808f;2d84d139-9b11-4149-96e4-346b15bfdf3e	Not Available;Not Available;Not Available	16;16;16	120;120;120	8;8;8	Carboplatin;Paclitaxel;Docetaxel	Not Available;Not Available;Not Available	4;4;4	06;06;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1441;972;429	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1424-F25941	8c85cbc9-0f48-4310-ab56-f53b981e1ee6	16	Not Applicable	183	Not Available	Not Available	Not Available	Not Available	Not Available	4									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	1424	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-61-2613	73	FEMALE	945	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	358.0		Recurrence	WITH TUMOR		73	Bilateral	TCGA-61-2613	c88502e9-0bc6-47c3-adc4-d98b63c7797b	7	-26779	945	0	945	TCGA-61-2613-D28501;TCGA-61-2613-D28503;TCGA-61-2613-D28502	98cb83b6-f0a2-4cb6-8613-c44af0665952;65037e9d-ec78-4979-b499-010777f95ff1;17da5326-4465-4984-b2f9-5ce7c262d9ca	Not Available;Not Available;Not Available	7;7;7	489;Not Available;489	384;86;384	Taxol;Carboplatin;Carboplatin	Not Available;Not Available;Not Available	9;9;9	5;06;05	235;Not Available;265	mg;Not Available;mg	RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;Not Available;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	TCGA-61-2613-F28500	656e7ee7-60c1-407e-abad-3db1ca8f547c	7	945	945	Not Available	Not Available	Not Available	Not Available	Not Available	9	YES	NO	Not Available	358	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	9	G3									Not Available	Not Available	2613	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	11-20 mm	Ovary	Not Available	Dead	2010	1998
TCGA-23-1114	55	FEMALE	2089	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	634.0		Recurrence	WITH TUMOR		55	Left	TCGA-23-1114	c0c3caab-9277-4a31-a96c-c607e38d5ccc	2	-20409	2089	0	2089	TCGA-23-1114-D25697;TCGA-23-1114-D25694;TCGA-23-1114-D25693;TCGA-23-1114-D25695;TCGA-23-1114-D25687;TCGA-23-1114-D25691;TCGA-23-1114-D25686;TCGA-23-1114-D25689;TCGA-23-1114-D25696;TCGA-23-1114-D25688;TCGA-23-1114-D25692;TCGA-23-1114-D25690	2875ceab-afed-41fe-bc04-f6b7729cd8c1;a1d5312d-e9dc-4357-a3a8-a122efc3e0a4;380c38b7-6850-4e82-8f9f-71a6f23b2d41;114cca0b-8220-4673-b571-a6a051f4e930;2594811e-287f-418e-bf86-1e968be8111e;2a752af9-ba01-4375-96ee-7f936b87f0be;28862da8-6071-4b65-a284-73b03b98866e;5369784c-c259-4b05-979b-d85b3da36f4d;665be94d-c439-4e5c-9f31-6d83d62a544a;e6c36e8f-5244-49fd-b850-7b811204f0e4;93752a4e-b8b2-48e8-a5d1-519882e4cd05;073ba0a0-4d7b-42fa-807f-7bac715d4b88	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;14;14;14;14;14;14;14;14	907;2026;1918;747;182;1425;182;1350;747;1222;1425;1350	865;1985;1741;663;43;1357;43;1324;663;1159;1348;1324	Carboplatin;Topotecan;Doxil;Paclitaxel;Paclitaxel;Carboplatin;Carboplatin;Gemzar;Carboplatin;Docetaxel;Gemzar;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12;12;12	03;06;07;05;06;03;06;02;05;04;03;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	OTHER, SPECIFY IN NOTES;PROGRESSION;RECURRENCE;RECURRENCE;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;OTHER, SPECIFY IN NOTES;RECURRENCE;RECURRENCE;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Consolidation;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Persistent;Not Applicable;Persistent;Not Applicable;Not Applicable;Persistent;Persistent	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1305;20.4;475;1400;Not Available;1190;Not Available;5500;2100;520;9625;260	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1114-F25685	02402e47-4ca1-4879-9d04-12415831d9c0	2	2089	2089	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;634	634;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1114	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	No Macroscopic disease	Ovary	Not Available	Dead	2009	2000
TCGA-23-1030	64	FEMALE	886	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	544.0		Recurrence	TUMOR FREE		64	Left	TCGA-23-1030	cbcf6922-a3c0-43a1-826e-642918b0a635	24	-23416	Not Applicable	0	886	TCGA-23-1030-D25644;TCGA-23-1030-D25647;TCGA-23-1030-D25646;TCGA-23-1030-D25645	0545b759-fc20-4f2e-bdc1-95a8e3b09d84;a30cd254-7973-4765-883d-f4a89c773a88;790576ff-0101-4585-a311-1b60c28a5ea8;d696489a-0cbd-49c2-a070-3d4161baecc2	Not Available;Not Available;Not Available;Not Available	14;14;14;14	767;438;165;165	622;243;62;62	Doxil;Xyotax;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available	12;12;12;12	06;08;06;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	RECURRENCE;OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT	Not Applicable;Consolidation;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	540;2160;2130;5010	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1030-F25643	b97fdad8-b975-4f01-a9ac-cbedb5e7a9b6	24	Not Applicable	886	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	NO;NO	Not Available;544	544;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1030	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	YES	Alive	2009	2006
TCGA-24-1435	57	FEMALE	1324	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	505.0		Recurrence	WITH TUMOR		57	Bilateral	TCGA-24-1435	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	12	-21107	1324	0	1324	TCGA-24-1435-D25998;TCGA-24-1435-D25996;TCGA-24-1435-D26000;TCGA-24-1435-D25997;TCGA-24-1435-D25999;TCGA-24-1435-D25995;TCGA-24-1435-D25994;TCGA-24-1435-D26001;TCGA-24-1435-D26002	cf7b733e-4265-4eab-9822-3974d73a0a34;6094c2cf-43ec-43b8-a9ec-8e21041440e4;2833bed6-7480-43d9-b6d1-4528bb4bc1ac;ceaae508-8082-4f39-b5d5-356e4dba9b75;ceab1fa5-5738-4e60-9100-6e0a1b677193;a4a2e768-8d66-4eef-9a7e-e24397ed1287;b65aacb1-c5bb-431b-b422-9d3a5053f383;11036e12-450c-404f-99fd-492656d8bc80;4308a2a0-1e10-4c84-bc45-6ecfc1e7729b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;15	1126;912;1189;1028;1189;771;149;1266;149	1058;814;1140;944;1140;511;27;1259;27	Taxol;Carboplatin;Gemar;Doxil;Cisplatin;Topotecan;Carboplatin;Topotecan;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5	10;05;03;04;03;13;06;1;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4500;2350;6952;286;263;135.9;3590;9.63;1848	mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1435-F25993	fab88b94-18a9-48a3-b679-10658361d8d8	12	1324	1324	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	505	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	5	G3									Not Available	Not Available	1435	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-13-1501	50	FEMALE	1314	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	392.0		Progression of Disease	WITH TUMOR		50	Bilateral	TCGA-13-1501	561968ce-da9a-4d69-8bc2-bc87b9550f93	31	-18393	Not Applicable	0	999	TCGA-13-1501-D24933;TCGA-13-1501-D24932	168cc04a-b942-44dc-906f-12795c06a1c4;dfd6e676-24dc-4684-8f20-ad1b24c3189c	Not Available;Not Available	29;29	183;183	78;78	Paclitaxel;Carboplatin	Not Available;Not Available	6;6	6;6	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;5	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1501-F24931;TCGA-13-1501-F72651	567ddcdb-f843-4f51-81bc-9074b6b2c0a8;9FD4CF25-9CF4-4E06-91B1-8830FDC5E94F	31;31	Not Applicable;1314	999;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	3;7	YES;Not Available	NO;Not Available	Not Available;Not Available	392;392	Progression of Disease;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Partial Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	3	G3									Not Available	Not Available	1501	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Alive	2009	2006
TCGA-OY-A56P	48	FEMALE	1207	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	1	794.0		Recurrence	WITH TUMOR		48	Right	TCGA-OY-A56P	260723BF-9620-450D-BF31-F3A45543F9DB	4	-17580	Not Applicable	0	802	TCGA-OY-A56P-D40751;TCGA-OY-A56P-D40752	4C69AC4B-5520-421E-ADEF-0F12EB0C0911;002D674C-302E-4EEE-9324-3C912254F7DC	Not Available;Not Available	27;27	160;160	26;26	Taxotere;Carboplatin	Complete Response;Complete Response	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	NOT HISPANIC OR LATINO	TCGA-OY-A56P-F56664	81CEF205-14CE-42CB-8DF5-E36D77C2B390	17	Not Applicable	1207	Not Available	Scheduled Follow-up Submission	Stable Disease	Not Available	NO	2									Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2014	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G3	YES;YES	Not Available;Not Available	Not Available;Not Available	794;794	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Imaging Study	Not Applicable;Not Applicable	YES	No	A56P	Not Available	WITH TUMOR	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			R2	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	YES	NO	OY	1-10 mm	Ovary	NO	Alive	2013	2010
TCGA-24-1563	66	FEMALE	1451	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	396.0		Recurrence	WITH TUMOR		66	Left	TCGA-24-1563	52386f66-2877-4c75-894e-5c1dc03e6ef4	13	-24274	1451	0	1451	TCGA-24-1563-D26252;TCGA-24-1563-D26255;TCGA-24-1563-D26258;TCGA-24-1563-D26256;TCGA-24-1563-D26250;TCGA-24-1563-D26257;TCGA-24-1563-D26251;TCGA-24-1563-D26254;TCGA-24-1563-D26253;TCGA-24-1563-D26249	95408fd7-f755-419a-8146-2263478e1c30;f65e8c56-e88c-4759-8cb6-66183229fcd6;1e096777-3bc5-41f1-94f2-87440512f7e0;0a7b61df-19a5-490f-be5a-3ce579d751d4;bc788a60-417a-421c-8fb6-073e20697b4d;610a8295-344d-4fd1-9716-df116525edf1;dd492ae2-573e-41f7-b671-4cc2cec89e5c;268270d4-d717-41f2-9c43-964163522ded;06e2c625-c9ad-454e-bc58-427688825aeb;d33a7059-08ca-4bb1-b763-fcaade80c979	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;13;13;13	805;1061;1182;1239;144;1402;676;868;868;144	728;889;1087;1183;22;1402;408;812;812;22	Taxol;Carboplatin;Tamoxifen;Topotecan;Taxol;Carboplatin;Topotecan;Doxil;Gemzar;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5	03;08;Not Available;03;06;1;14;03;03;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg/day;mg;mg;mg;mg;mg;mg;mg	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;PO;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1050;3310;20;24.7;1910;459;135;181;2820;3450	mg;mg;mg/day;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1563-F26248	4a3e5d73-58ba-403c-91a7-92653e760093	13	1451	1451	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	396	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1563	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-13-0800	52	FEMALE	2661	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1396.0			TUMOR FREE		52	Bilateral	TCGA-13-0800	390eed6b-50af-48a9-9fd6-3a68a2bbb7f9	25	-19087	Not Applicable	0	247	TCGA-13-0800-D24616;TCGA-13-0800-D24617;TCGA-13-0800-D24618	9a8cf2ea-d928-477e-800a-2201bdeb5b9f;ff5f69d5-3de1-4738-9a02-dbe76765b393;7686a479-629f-4b7f-9af3-a7179af92576	Not Available;Not Available;Not Available	15;15;15	142;142;142	30;30;30	Cisplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0800-F24615;TCGA-13-0800-F72612	217432e2-4489-425f-a6e6-79c90c55f1f9;2BAB540D-033B-48FE-929E-8B36399D71D7	25;30	Not Applicable;Not Applicable	247;2661	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;1396	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0800	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-13-1817	56	FEMALE	1024	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	541.0		Recurrence	WITH TUMOR		56	Bilateral	TCGA-13-1817	8ae56ffc-960c-46c2-bd6c-1dcff33875d0	2	-20771	1024	0	1024	TCGA-13-1817-D24977;TCGA-13-1817-D24975;TCGA-13-1817-D24976;TCGA-13-1817-D24980;TCGA-13-1817-D24978;TCGA-13-1817-D24979	5f052b46-08ee-4244-9beb-91a6f49b3fe1;46c68ad3-9918-4b43-af34-dcf1dc8b88bd;24256629-d9d5-4c58-9dc1-ca8ccdf4f19f;e8666c06-5d87-4aef-a92d-637aa94392bb;5a5172bf-f07f-4e34-980d-1413e248b8dc;3166878d-db0c-4d9b-a45a-9701c30fe271	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;8;8;8	318;122;122;902;594;594	210;7;7;706;552;552	Cisplatin;Carboplatin;Paclitaxel;Liposomal Doxorubicin;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	05;06;06;08;03;03	75;Not Available;176;39;365;176	mg/m2;AUC;mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IP;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;5;Not Available;Not Available;Not Available;Not Available	mg/m2;AUC;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-13-1817-F24974	1dd20852-7a1c-4a36-8d97-64b76e918a0a	2	1024	1024	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;633	541;Not Available	Recurrence;Both Locoregional and Distant Metastasis	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1817	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Dead	2009	2001
TCGA-20-0996	59	FEMALE	2196	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	0	2196			WITH TUMOR		59	Bilateral	TCGA-20-0996	d7f82e34-5b34-4e8c-a0cf-d7561bcea43c	23	-21572	Not Applicable	0	2196	TCGA-20-0996-D25536;TCGA-20-0996-D25534;TCGA-20-0996-D25537;TCGA-20-0996-D25538;TCGA-20-0996-D25535	e552a4cc-5113-447c-b57b-c5b1e8e7d6e3;8250f16b-1184-4fd2-8fee-602539eab355;dc9650af-ba57-4533-a6e1-a7f3c8462f01;6f44cefa-f2d9-45fb-914f-f4ce34d4ec60;0101cf7f-8bad-467b-a24b-7f0843a67403	Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16	590;224;1078;Not Available;224	443;168;616;1106;168	Topotecan;Carboplatin;Liposomal Doxorubicin;Etoposide;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	15;03;13;06;03	Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2;mg;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;IV;PO;PO;IV	Not Available;Not Available;Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	4;Not Available;40;50;175	mg/m2;Not Available;mg/m2;mg;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	0	NOT HISPANIC OR LATINO	TCGA-20-0996-F25533	f8e39cd8-ab2c-4f80-9f2c-0991a4e688e4	23	Not Applicable	2196	0	Not Available	Not Available	Not Available	Not Available	2									Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	2	G2									Not Available	Not Available	0996	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	1-10 mm	Ovary	Not Available	Alive	2009	2001
TCGA-13-0903	42	FEMALE	3887	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	3887			Discrepancy		42	Bilateral	TCGA-13-0903	8783e4b0-2b62-45d5-8cd9-f5a71cc0138e	25	-15705	Not Applicable	0	1441	TCGA-13-0903-D24719;TCGA-13-0903-D24718;TCGA-13-0903-D24721;TCGA-13-0903-D24720	d7ddd098-94ed-4968-8ad0-9a6990826131;d0670488-e31a-49a9-a4ed-1015c0b39e32;8a819232-2e9f-4703-9afd-2238a6314430;7f98152d-4925-437d-a83a-3b9561499e78	Not Available;Not Available;Not Available;Not Available	15;15;16;16	127;127;335;141	22;22;169;22	Paclitaxel;Carboplatin;Cetuximab;Cetuximab	Not Available;Not Available;Not Available;Not Available	4;4;4;4	6;6;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;Not Available;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	1050;Not Available;250;250	mg/m2;Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0903-F24717;TCGA-13-0903-F72624	af4c2496-e373-4d64-bd57-acdf6bfe34ae;86E7DD7F-2CE1-4F7E-A62E-43CB5B91BB8A	25;30	Not Applicable;Not Applicable	1441;3887	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	80;Not Available	Not Available;Not Available	2;7									Not Available;NO	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0903	Pre-Adjuvant Therapy	Discrepancy	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2004
TCGA-23-1113	48	FEMALE	949	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	949			WITH TUMOR		48	Left	TCGA-23-1113	6209e80d-a115-4f8e-bf0d-18461401a1c6	19	-17791	949	0	Not Available	TCGA-23-1113-D25678;TCGA-23-1113-D25681;TCGA-23-1113-D25683;TCGA-23-1113-D25679;TCGA-23-1113-D25680;TCGA-23-1113-D25682	a3b52bce-08d8-456b-8f1e-d68fb5b21ef7;8c3b8e3e-b95c-467c-acdf-7734757cc2e3;0e6ed55a-1671-4de0-92bb-1f511b80c3d6;ad1b6d9d-88c5-4a21-a3d5-485738b49d45;26c1331d-7f91-47a7-996d-d19bdc7a1244;d6010400-23c3-4365-a990-0aa37395b0fa	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27	74;187;873;74;187;253	27;102;253;27;102;225	Carboplatin;Cisplatin;Docetaxel;Paclitaxel;Gemcitabine;Doxorubicin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	3;4;9;3;4;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1650;528;910;870;11282;816	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1113-F25677	8f74e7a1-1849-44b8-8387-31bff5e4bfb7	19	949	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1113	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-61-1736	45	FEMALE	1484	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	764.0		Recurrence	WITH TUMOR		45	Bilateral	TCGA-61-1736	0a2d29de-869a-4dc8-ad11-6ee0d0a3a895	2	-16613	1484	0	1484	TCGA-61-1736-D28178;TCGA-61-1736-D28177;TCGA-61-1736-D28180;TCGA-61-1736-D28176;TCGA-61-1736-D28179	57649c27-8fde-4924-bb6a-36f78d3d965e;0dd45cff-9b04-43bc-862b-62ac6b70880a;6b95b794-0927-46c0-8786-6e66ec7050fc;f0714214-07d4-4c41-9e61-b6470308eea9;4be9230a-4d81-4cd4-a1ba-3f24ad91f5cc	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	138;138;Not Available;Not Available;Not Available	34;34;946;Not Available;Not Available	Carboplatin;Taxol;Doxil;Gemzar;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	06;06;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;PROGRESSION;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;Not Available;Not Available;Not Available	NO;NO;NO;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1736-F28175	dbee91e2-9410-4570-9c69-8e43beb8887d	2	1484	1484	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;812	764;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Excisional Biopsy	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1736	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	YES	Dead	2009	2005
TCGA-04-1367	50	FEMALE	3145	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	2997.0		Progression of Disease	TUMOR FREE		50	Bilateral	TCGA-04-1367	30b8f4cd-9245-4496-a8a8-c3e59093bc0a	2	-18577	Not Applicable	0	2174	TCGA-04-1367-D24054;TCGA-04-1367-D24053	b8e70426-e545-4d98-8d53-6a6b8c355636;d22430b7-f915-4dfb-928c-96aea53a860c	Not Available;Not Available	9;9	199;199	24;24	Carboplatin;Taxol	Not Available;Not Available	11;11	07;07	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	721;1925	mg;mg	Not Available;Not Available	2009;2009	0	NOT HISPANIC OR LATINO	TCGA-04-1367-F24052;TCGA-04-1367-F62486	88ca4e8a-5a13-4da2-909f-cffd1961f4ed;870E6179-46DB-40A7-8130-1AA517FD6454	2;17	Not Applicable;Not Applicable	2174;3145	0;Not Available	Scheduled Follow-up Submission;Scheduled Follow-up Submission	Not Available;Progressive Disease	100;Not Available	Not Available;NO	10;7	None;YES	None;NO	None;Not Available	None;2997	None;Progression of Disease	None;Not Available	None;Molecular Markers	None;Not Applicable	Not Available;NO	Preoperative;Not Available	TUMOR FREE;WITH TUMOR	YES;NO	Complete Remission/Response;Progressive Disease	NO;NO	Alive;Alive	2009;2014	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	100	NO	10	G3									Not Available	Not Available	1367	Preoperative	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	04	No Macroscopic disease	Ovary	NO	Alive	2009	2003
TCGA-13-1500	71	FEMALE	425	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	253.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-13-1500	a285786d-120e-4c88-b48b-8111f4413988	31	-26172	425	0	425	TCGA-13-1500-D24928;TCGA-13-1500-D24929;TCGA-13-1500-D24927	15ffe254-2600-4046-bf65-1dd44c66bad5;f7997b39-d17f-4df6-b167-9f763ba44acb;f6462173-d369-423a-b1fc-560c5243c71d	Not Available;Not Available;Not Available	29;29;29	136;225;136	Not Available;197;Not Available	Paclitaxel;Cisplatin;Carboplatin	Not Available;Not Available;Not Available	6;6;6	6;2;6	Not Available;Not Available;Not Available	Not Available;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IV	NO;NO;Not Available	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;40;Not Available	Not Available;mg/m2;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1500-F24926	4ea742f9-e3d0-493b-bf36-ce751235de74	31	425	425	Not Available	Not Available	Not Available	80	Not Available	3	YES	NO	Not Available	253	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	3	G3									Not Available	Not Available	1500	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	11-20 mm	Ovary	Not Available	Dead	2009	2006
TCGA-13-1489	70	FEMALE	2553	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	806.0		Recurrence	WITH TUMOR		70	Bilateral	TCGA-13-1489	7248cd60-be22-44bc-bc58-f644db0940a2	31	-25768	Not Applicable	0	2521	TCGA-13-1489-D24878;TCGA-13-1489-D24876;TCGA-13-1489-D24877;TCGA-13-1489-D24880;TCGA-13-1489-D24881;TCGA-13-1489-D24882;TCGA-13-1489-D24879	4eb06fd9-31b2-459d-96a0-7315217783c1;b0a011bd-04dc-4e24-b280-6c67dd5f3534;fc5425f7-3273-4bb3-838a-03543f181941;9bc5219c-8085-4ded-b99a-8444532624f6;ee222450-84ac-4896-87a4-a7c4498c0772;9acb3c04-7c91-484b-834b-639ead34a695;4bdd6d3b-c2f3-458e-91ea-4e0678cc20db	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	30;30;30;8;8;8;8	181;272;181;868;1012;1012;868	41;272;41;867;Not Available;Not Available;867	Paclitaxel;Cisplatin;Carboplatin;Paclitaxel;Carboplatin;Taxotere;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;3;3;3;3	7;1;7;1;5;5;1	Not Available;Not Available;Not Available;Not Available;Not Available;60;Not Available	mg/m2;mg/m2;Not Available;Not Available;AUC;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	175;75;6;Not Available;5;Not Available;Not Available	mg/m2;mg/m2;Not Available;Not Available;AUC;mg/m2;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1489-F24875;TCGA-13-1489-F72641	9b9579e6-5cd9-4f4f-b084-67d406cad426;DFAA007F-8C3B-4331-8370-1A7F6E350247	31;30	Not Applicable;2553	2521;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	80;Not Available	Not Available;Not Available	3;7	YES;YES;Not Available	NO;NO;Not Available	Not Available;833;Not Available	806;Not Available;806	Recurrence;Locoregional Disease;Unknown	Not Available;YES;Not Available	Imaging Study;Imaging Study;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	3	G2									Not Available	Not Available	1489	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2002
TCGA-61-1734	52	FEMALE	866	Serous Cystadenocarcinoma	Ovary	Alive	Stage IC	G3	0	866			TUMOR FREE		52	Bilateral	TCGA-61-1734	b5e64bdb-24f1-400d-aaf7-8fda8ab6fd3c	2	-19026	Not Applicable	0	866	TCGA-61-1734-D28172;TCGA-61-1734-D28173	199c76a7-19fe-4f8a-90f0-0064008b434b;14804ed4-485f-4cb9-b2be-ce15222dcfc1	Not Available;Not Available	8;8	158;158	46;46	Taxol;Carboplatin	Not Available;Not Available	12;12	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1734-F28171	2abe1e0f-edaa-4908-b0b4-55626b3eb663	2	Not Applicable	866	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1734	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	YES	Alive	2009	2006
TCGA-13-0727	71	FEMALE	462	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	253.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-13-0727	90f4b65c-cfd4-4066-a5b9-842885c172e2	24	-26185	462	0	462	TCGA-13-0727-D24520;TCGA-13-0727-D24521;TCGA-13-0727-D24522	48326e26-e676-4b3a-a613-5f8398fa1b3a;c84669f2-ec70-49d1-b206-2db206e0976a;85fd0b24-2879-4b9d-af7d-b78feec02170	Not Available;Not Available;Not Available	16;16;16	120;120;267	9;9;230	Carboplatin;Paclitaxel;Femara	Not Available;Not Available;Not Available	4;4;4	6;6;Not Available	Not Available;Not Available;Not Available	Not Available;mg/m2;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;Not Available	Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	Not Available;175;2.5	Not Available;mg/m2;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0727-F24519	c54b18db-aeab-4253-8e80-49aeae62f572	24	462	462	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	253	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0727	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-24-1555	50	FEMALE	2692	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	1577.0		Recurrence	WITH TUMOR		50	Bilateral	TCGA-24-1555	5d36676e-4140-44b5-aa0e-b2af092b7dc0	13	-18404	2692	0	2692	TCGA-24-1555-D26174;TCGA-24-1555-D26175;TCGA-24-1555-D26180;TCGA-24-1555-D26177;TCGA-24-1555-D26182;TCGA-24-1555-D26172;TCGA-24-1555-D26178;TCGA-24-1555-D26173;TCGA-24-1555-D26181;TCGA-24-1555-D26176;TCGA-24-1555-D26179	5bbe4103-b205-4f8a-88e4-ff87713c9481;5cae58de-79d6-40a8-84e3-4d5435b373f1;91c2f17b-0c3a-45d7-b649-490b80802943;9ad7092e-7bb7-47d4-87d0-49c8ac554e44;117ed049-353f-465d-82bb-1ff4b61c6dec;b0e7bfa1-aa6f-4875-a333-1d37969df73a;79c1118b-b324-4d35-bca4-9e7825ae7d64;63def26d-2198-4012-9d2a-e17538649b95;50740da7-ca0d-45d3-b7ca-7fe04e0bfc2d;bc8f5f9c-8a23-44d0-a253-3a6cc0100be1;ffd29f9d-1824-4e15-b2b2-aea9b65e04e0	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;13;13;13;13	1928;2050;2628;2415;Not Available;Not Available;2415;Not Available;Not Available;2050;2628	1563;1959;2506;2262;2635;Not Available;2262;Not Available;2635;1959;2506	Topotecan;Carboplatin;Doxil;Carboplatin;Taxol;Carboplatin;Taxol;Taxol;Carboplatin;Taxol;Gemzar	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;5	16;06;04;08;04;06;08;06;04;06;04	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	RECURRENCE;PROGRESSION;RECURRENCE;RECURRENCE;PROGRESSION;ADJUVANT;RECURRENCE;ADJUVANT;PROGRESSION;PROGRESSION;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-24-1555-F26171	5867b96d-991e-437a-9e0c-b4c7846721ad	13	2692	2692	0	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	1577	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1555	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	Not Available	Ovary	Not Available	Dead	2009	1997
TCGA-57-1994	63	FEMALE	761	Serous Cystadenocarcinoma	Ovary	Alive		Not Available	0	761			Not Available		63	Not Available	TCGA-57-1994	602e2934-223a-44db-8c33-06eb05d72f94	10	-23062	Not Applicable	0	761																								Not Available	Not Available	TCGA-57-1994-F28096	0c4a4165-8e20-496f-b731-9666c8c63d86	10	Not Applicable	761	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	NO	Not Available	NO	Alive	2011	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	Not Available									Not Available	Not Available	1994	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	57	Not Available	Ovary	Not Available	Alive	2011	2004
TCGA-24-1466	74	FEMALE	1373	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	491.0		Recurrence	WITH TUMOR		74	Bilateral	TCGA-24-1466	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	17	-27307	1373	0	1373	TCGA-24-1466-D26032;TCGA-24-1466-D26035;TCGA-24-1466-D26033;TCGA-24-1466-D26030;TCGA-24-1466-D26036;TCGA-24-1466-D26029;TCGA-24-1466-D26031;TCGA-24-1466-D26037;TCGA-24-1466-D26034	95c8c713-2e46-4b1f-ba01-0327f5df424f;7a193f01-5589-49f8-affe-87258ba73206;f173fa84-796d-4b1c-a328-63bc667ded63;c6e44e2b-090b-4e55-bdde-6b44e3a1f501;d560fa78-e2e9-4912-a9de-fefea60898f4;e6de86e0-4434-4398-93ab-507903ddf2e5;565fb3ee-a4c7-4150-a80f-4b2abfcc9bc0;60fd442d-0cea-4420-beb7-74230f801921;da59a6a9-6e33-407b-aaca-6d930603d936	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17;17;17;17;17	680;1216;1020;145;852;145;680;Not Available;1020	483;1081;880;12;670;12;483;1227;880	Carboplatin;Topetecan;Carboplatin;Taxol;Tamoxifen;Carboplatin;Taxol;Tamoxifen;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4;4;4	7;6;6;6;Not Available;6;7;Not Available;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg/day;mg;mg;Not Available;mg	RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;PO;IV;IV;PO;IV	NO;NO;NO;NO;NO;NO;NO;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3820;57.6;3110;1715;20;3502;1904;Not Available;1564	mg;mg;mg;mg;mg/day;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1466-F26028	d74104a4-dfb4-4dfc-b627-ff418aba20ec	17	1373	1373	Not Available	Not Available	Not Available	Not Available	Not Available	4	YES	NO	Not Available	491	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	1466	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1998
TCGA-30-1880	56	FEMALE	1751	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	348.0		Recurrence	WITH TUMOR		56	Bilateral	TCGA-30-1880	bc873b2a-35b7-4365-a2cc-e6a83063556e	2	-20525	1751	0	1751	TCGA-30-1880-D27629;TCGA-30-1880-D27622;TCGA-30-1880-D27625;TCGA-30-1880-D27624;TCGA-30-1880-D27630;TCGA-30-1880-D27627;TCGA-30-1880-D27628;TCGA-30-1880-D27623;TCGA-30-1880-D27626;TCGA-30-1880-D27621;TCGA-30-1880-D27631	13b6227e-71f3-470b-9004-61740ce4ae73;38844241-56d0-4348-bad6-cea1c8676542;cd005c2a-a2f0-4edc-80ae-1a99c144c424;4f399194-c399-49e7-8a36-5be1a8c99795;c3c91988-c02c-4a0a-a97d-2a9642af6acd;85360ccf-2a0a-47ee-83db-5975230aeea8;06ef436c-e8d9-4b26-94f4-70f29686f536;9ac2fa30-2499-46b0-a7fb-bcfb674103ca;b598f971-0c3c-459c-bbc9-82ee2b755e69;628b3fcc-ca45-466b-98fc-54ef1c3a8bea;8eafb3d9-4869-4af0-9a1f-cf55767563cd	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28;28;28;28;28;8	1656;152;823;823;1722;1610;1610;152;1228;497;1722	1642;46;718;718;1660;1400;1400;46;1106;357;1660	CBP501;Carboplatin;Taxol;Carboplatin;Navelbine;Carboplatin;Taxol;Taxol;Gemcitabine;Doxil;Avastin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12;1	Not Available;06;06;06;08;09;09;06;Not Available;06;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;AUC;mg/m2;AUC;mg/m2;AUC;mg/m2;mg/m2;mg/m2;mg/m2;mg/kg	PROGRESSION;ADJUVANT;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;PO	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3.6;5;175;5;20;5;175;175;700;40;10	mg/m2;AUC;mg/m2;AUC;mg/m2;AUC;mg/m2;mg/m2;mg/m2;mg/m2;mg/kg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1880-F27620	12029b34-6b0f-4cd6-bc27-ef536288b467	2	1751	1751	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	348	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1880	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	No Macroscopic disease	Ovary	Not Available	Dead	2009	2001
TCGA-29-1762	59	FEMALE	2634	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	1	1375.0		Recurrence	WITH TUMOR		59	Bilateral	TCGA-29-1762	5495b18a-10ec-427b-83b8-03ef4b587b13	2	-21879	2634	0	2606	TCGA-29-1762-D27322;TCGA-29-1762-D27323;TCGA-29-1762-D27320;TCGA-29-1762-D27318;TCGA-29-1762-D27319;TCGA-29-1762-D27321;TCGA-29-1762-D27317	718474fa-5bd1-47e2-b4f3-1e1d8862e5b6;cd162e63-987c-4f2a-ae65-454519e42da0;0217767c-919b-42cc-9e93-cc15c80a7898;fc15c1dd-7e5f-443e-a5a5-e8bd13e582ee;62ebbf79-daf4-4030-8213-1c06279ced96;70b6d9af-391e-4fec-a670-83101d90add9;41be6bf3-dcfb-4d18-8360-f08247ea6ab4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	30;30;30;30;30;30;30	2488;2555;2229;140;1513;2418;140	2439;2509;2167;7;1387;2255;7	Topotecan HCL;Docetaxel;Doxorubicin HCI Liiposomal;Paclitaxel;Carboplatin;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11	06;03;03;Not Available;06;08;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;Not Available;Not Available;mg;Not Available	RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	60;150;80;Not Available;Not Available;400;Not Available	mg;mg;mg;Not Available;Not Available;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	2	Not Available	TCGA-29-1762-F27316	9362c381-3391-410c-8898-c0797a7bdab2	2	2634	2606	2	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	1375	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1762	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Dead	2009	1998
TCGA-24-1928	77	FEMALE	336	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	70.0		Recurrence	WITH TUMOR		77	Bilateral	TCGA-24-1928	b45c543a-40d9-423a-a7fa-98e4b325b487	15	-28126	336	0	336	TCGA-24-1928-D26406;TCGA-24-1928-D26408;TCGA-24-1928-D26404;TCGA-24-1928-D26407;TCGA-24-1928-D26405	bd6a4fde-5afb-48cc-a6cd-6538eb9a0726;f968a12b-04f3-4647-a29c-b5af2d7f610a;84aa9ced-7dc3-4ffe-88f5-66e7f23074ad;c759afb6-7464-4e2e-ba2c-560abc41b8d8;e3a4fc7d-f026-495c-ba6e-a47f284cbba8	Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15	226;Discrepancy;126;282;126	156;327;14;254;14	Taxotere;Etoposide;Taxol;Doxil;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	04;01;06;02;06	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg	RECURRENCE;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;PO;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	560;1200;1130;138;537	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-1928-F26403	144f8c7e-e805-4c4c-92ff-e14d57b79a60	15	336	336	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	70	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1928	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	11-20 mm	Ovary	Not Available	Dead	2010	1998
TCGA-23-2072	58	FEMALE	759	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	476.0		Recurrence	WITH TUMOR		58	Right	TCGA-23-2072	1592af8e-8d11-4325-8a2b-e0c690b15b58	18	-21523	759	0	Not Available	TCGA-23-2072-D25761;TCGA-23-2072-D25759;TCGA-23-2072-D25760;TCGA-23-2072-D25758	ac71f616-6349-4cdd-aee1-9e7df89acd4a;7fde5afb-c211-4558-a45f-0bfc5aeb3791;f58539f9-5158-4d42-8b4c-701c651a0c41;0eb5afce-60e8-4797-9672-a84ced84dbdb	Not Available;Not Available;Not Available;Not Available	18;18;18;18	571;151;620;151	571;26;579;26	Doxil;Taxol;Gemzar;Carboplatin	Not Available;Not Available;Not Available;Not Available	11;11;11;11	01;07;04;07	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	64;1890;6280;3325	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-2072-F25757	3bba6ccf-5cb0-46d4-b223-f5e07789ada6	18	759	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES	NO	Not Available	476	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	Not Available	11	G3									Not Available	Not Available	2072	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	>20 mm	Ovary	Not Available	Dead	2009	2000
TCGA-13-1512	49	FEMALE	442	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	427.0			Not Available		49	Bilateral	TCGA-13-1512	82093ed9-a3c8-4e34-931f-4ec7ae745711	31	-18134	Not Applicable	0	94	TCGA-13-1512-D24972;TCGA-13-1512-D24971	ff3734cb-1218-44b6-9238-000101ea4d25;7bfa8188-46df-46ec-8f64-73d2c54f71b4	Not Available;Not Available	29;29	94;94	73;73	Paclitaxel;Carboplatin	Not Available;Not Available	6;6	2;2	Not Available;Not Available	mg/m2;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;700	mg/m2;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1512-F24970;TCGA-13-1512-F72681	440d2b6f-c84d-4658-b921-7d114ea5c138;E62AFE2C-3688-4D2B-BF63-05A8319B0AFA	31;31	Not Applicable;Not Applicable	94;442	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;427	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	Not Available;WITH TUMOR	YES;Not Available	Not Available;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	60	Not Available	3	G3									Not Available	Not Available	1512	Pre-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-13-0921	72	FEMALE	1483	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1483			TUMOR FREE		72	Bilateral	TCGA-13-0921	31b997dd-aaea-4003-a64d-11d3e19b0bbc	25	-26606	Not Applicable	0	141	TCGA-13-0921-D24779;TCGA-13-0921-D24780	63fc0d14-1978-464b-b001-b72b7cc526f7;fa9ca8bd-dc3a-44e7-8853-e0d8147cb914	Not Available;Not Available	16;16	140;140	35;35	Cisplatin;Paclitaxel	Not Available;Not Available	4;4	6;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IV;IP;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0921-F24778;TCGA-13-0921-F72634	cf7eb88e-6c76-400b-8ad2-7e85d16f6fcc;7F676671-5968-4115-98B2-C27DEF2D15B1	25;30	Not Applicable;1483	141;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	Not Available;Not Available	Not Available;Not Available	2;7									Not Available;Unknown	Not Available;Not Available	TUMOR FREE;Unknown	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0921	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-24-1474	57	FEMALE	676	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	332.0		Recurrence	WITH TUMOR		57	Left	TCGA-24-1474	d7b3156d-672a-4a55-868d-9ca6a09fcb0f	13	-20902	676	0	676	TCGA-24-1474-D26077;TCGA-24-1474-D26075;TCGA-24-1474-D26076;TCGA-24-1474-D26074;TCGA-24-1474-D26078	2a00f718-f1e2-4eff-bc7f-5b77b5f35bc2;bfeee902-a018-4e6e-bb1d-38e6dfa8586a;eecac960-1b19-4854-beb4-ab67384cee3a;df02a6f7-9b82-42f2-acf8-938d8e6af6f3;a604ab2b-1244-4582-aeb7-42765d3a9923	Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13	635;123;431;123;635	454;18;350;18;454	Gemzar;Taxol;Topotecan;Carboplatin;Doxil	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	07;06;05;06;07	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg	PROGRESSION;ADJUVANT;RECURRENCE;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	2365;1962;57;4050;302	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1474-F26073	76d29b08-30df-4efc-8cba-1bd4d4935300	13	676	676	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	332	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1474	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-29-1785	55	FEMALE	1104	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	473.0		Recurrence	Not Available		55	Right	TCGA-29-1785	1aea3c25-d2bc-4ff5-bc27-32e939944e9d	2	-20417	1104	0	1053	TCGA-29-1785-D27443;TCGA-29-1785-D27446;TCGA-29-1785-D27445;TCGA-29-1785-D27449;TCGA-29-1785-D27448;TCGA-29-1785-D27444;TCGA-29-1785-D27447	698a373b-5699-474a-b8d6-fdd85307ffa6;c431ed1c-ba8d-41fc-b6a4-f5e5a1fbc579;331fce9e-ac3e-4a38-99a9-35704d71d5e4;8111da34-a2c8-4258-aff6-c9d64b6c2e16;2004f10c-78e9-4a30-aaeb-be371007890c;ec9873e2-600a-4805-bc39-ff9d81e7fef3;f00119e6-143f-459d-8b3a-d340fd6169a6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2	73;496;156;612;612;156;496	51;496;94;521;521;94;496	Carboplatin;Carboplatin;Paciltaxel;Docetaxel;Carboplatin;Carboplatin;Paciltaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11	02;01;04;05;05;04;01	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	610;560;300;110;610;610;330	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-29-1785-F27442	17f78a1a-2ea9-4f63-8106-86672d28f6df	2	1104	1053	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	473	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	Not Available	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1785	Post-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Dead	2009	2006
TCGA-29-1784	55	FEMALE	163	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	163			TUMOR FREE		55	Right	TCGA-29-1784	23d32627-9fd2-4312-bcda-ee7409e3983f	2	-20210	Not Applicable	0	163	TCGA-29-1784-D27439;TCGA-29-1784-D27438;TCGA-29-1784-D27440;TCGA-29-1784-D27437	ca6a7ec0-5ee5-4be8-a942-9b86ff67a8b2;14115b3c-a38c-47f2-84e9-b36340c5c238;f607cd30-cc09-4356-b447-bf0f45cbb16c;a7ddfd0e-e8fd-4f46-898d-db041e8123b7	Not Available;Not Available;Not Available;Not Available	10;10;10;10	59;17;24;136	59;17;23;17	Paclitaxel; Albumin-Bount;Paclitaxel;Gemcitabine HCI;Carboplatin	Not Available;Not Available;Not Available;Not Available	12;12;12;12	01;01;01;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	300;270;2480;3330	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	0	Not Available	TCGA-29-1784-F27436	28926cc4-ceb1-40d1-b84d-c2e9bcb874e6	2	Not Applicable	163	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1784	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	No Macroscopic disease	Ovary	Not Available	Alive	2009	2009
TCGA-13-0717	54	FEMALE	748	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	294.0		Recurrence	WITH TUMOR		54	Bilateral	TCGA-13-0717	3867e193-c82f-4693-9b32-bac76b5f4d06	24	-20042	748	0	748	TCGA-13-0717-D24495;TCGA-13-0717-D24496	01973948-9206-4968-b05a-8b19e465ef65;3a6a17e8-3079-4667-be37-f8a1adc186e1	Not Available;Not Available	15;15	182;182	9;9	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	8;8	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0717-F24494	e6fab168-c489-442f-82ab-85ef871f703d	24	748	748	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	294	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0717	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Dead	2009	2000
TCGA-13-1409	73	FEMALE	1742	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	690.0			WITH TUMOR		73	Not Available	TCGA-13-1409	18e0e996-8f23-4f53-94a5-dde38b550863	20	-26836	Not Applicable	0	208	TCGA-13-1409-D24819;TCGA-13-1409-D24820	fdbbf073-c52a-4972-b714-ec92cf255e88;532deb83-2d9a-4d0c-a56a-1eeec028d682	Not Available;Not Available	30;30	Not Available;Not Available	94;94	Carboplatin;Paclitaxel	Not Available;Not Available	6;6	6;6	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	5;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1409-F24818;TCGA-13-1409-F72660	581da1f9-2a0c-42d4-953b-7a311eeacbb6;9D019620-151B-4004-9B02-F9AFBC121F16	20;31	Not Applicable;1742	208;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;690	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Not Available;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	60	Not Available	3	G3									Not Available	Not Available	1409	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-29-1763	43	FEMALE	2032	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G2	1	428.0		Recurrence	WITH TUMOR		43	Bilateral	TCGA-29-1763	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	2	-16021	Not Applicable	0	2032	TCGA-29-1763-D27326;TCGA-29-1763-D27327;TCGA-29-1763-D27334;TCGA-29-1763-D27328;TCGA-29-1763-D27332;TCGA-29-1763-D27333;TCGA-29-1763-D27335;TCGA-29-1763-D27331;TCGA-29-1763-D27330;TCGA-29-1763-D27329	cb9f2119-7302-400b-83e8-3f5ad57235a0;09bda96f-0f13-49ee-acb6-2d6f13f554c5;413c6676-1d15-45d6-9312-3ef011666f04;0edd2650-9330-4381-8830-33e36ca5e4a2;feb62c19-c331-439f-937c-9067cac1f748;8b5415a7-cf18-4683-aff5-dab81c1097a6;0fddbda9-cca7-4024-8e3a-f946b424ef6d;14e4248a-479b-4a23-9689-768e0c095441;f931a981-978e-4332-8125-5f615bb61706;643648fe-7469-4eba-8a99-020867cbdb1a	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;7;7;7;7;7;7;7;7	100;100;2252;579;1839;2126;2161;1376;1367;1325	15;15;2189;450;1727;2049;2049;1346;1346;1283	Carboplatin;Paclitaxel;Carboplatin;Carboplatin;Paclitaxel;Doxil;Bevacizumab;Paclitaxel;Carboplatin;Gemcitabine HCL	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;4;4;4;4;4;4;4;4	05;05;03;06;06;04;Not Available;03;02;04	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;AUC;mg;mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;Not Available;IV;IV;IV	NO;NO;YES;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3175;1645;6;675;350;80;1000;350;435;2000	mg;mg;AUC;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-29-1763-F27325	5ab2d1a0-ed91-44b1-97ec-51a9f633cbea	2	Not Applicable	2032	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	YES;YES	Not Available;1868	428;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Other Method;Other Method	Biopsy;Biopsy	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1763	Other	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available	Local Recurrence	TCGA-29-1763-R27336	4299f8fb-8407-4ec5-8aae-7a93350b199d	Not Available	3	1979	1948	Not Available	6	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Alive	2009	2004
TCGA-25-1322	62	FEMALE	91	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	91			WITH TUMOR		62	Bilateral	TCGA-25-1322	b520aae5-65a6-4b27-bc2a-10b02c7b1aeb	27	-22646	91	0	91	TCGA-25-1322-D26678;TCGA-25-1322-D26677	1a388ff5-ebda-4497-83dc-d0d6d3229810;739c8ffc-668b-4118-a7a3-5e7bf16ec133	Not Available;Not Available	27;27	91;91	30;30	Carbo;Taxol	Not Available;Not Available	3;3	3;3	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1322-F26676	841d1973-7063-4915-bfcc-de4685a2372d	27	91	91	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1322	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	>20 mm	Ovary	Not Available	Dead	2009	2001
TCGA-25-1635	71	FEMALE	1583	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	614.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-25-1635	bc2591b0-65d7-48c3-a5cc-783f67b65869	2	-26200	1583	0	1558	TCGA-25-1635-D26758;TCGA-25-1635-D26757;TCGA-25-1635-D26761;TCGA-25-1635-D26759;TCGA-25-1635-D26760	6c145dd3-1953-43e8-8e9d-9837ebbe110c;f2c02abe-3a05-4bc0-914c-48f367820dfa;71ad95f2-916c-4bfe-8f65-738b7c70f090;cedc0d74-6848-4ad4-b8b1-73046c2b6d83;c428925d-3fb6-46e7-87a4-90747d2e33b9	Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17	233;233;741;233;741	24;24;614;24;614	Gemzar;Taxol;Taxol;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	8;08;4;8;4	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1635-F26756	ba5104ee-89a9-455e-bff2-e4f3bec0a20b	2	1583	1558	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	614	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1635	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-13-1495	60	FEMALE	2749	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	977.0		Recurrence	WITH TUMOR		60	Bilateral	TCGA-13-1495	74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7	31	-22046	Not Applicable	0	1498	TCGA-13-1495-D24899;TCGA-13-1495-D24901;TCGA-13-1495-D24900;TCGA-13-1495-D24898;TCGA-13-1495-D24902	19c672b1-5c6a-4562-80fb-a01df80b0337;cbd8492b-b71f-43ef-aaa8-7902407ef2a8;5b1848c8-8f23-471a-9171-95fd53eac209;878063e7-b796-4aa4-aecb-55060d6028ab;ef97d8d6-aea8-42de-9b62-054e1106d2ae	Not Available;Not Available;Not Available;Not Available;Not Available	29;29;29;29;29	140;119;548;140;224	21;21;231;21;147	Paclitaxel;Cetuximab;Paclitaxel;Carboplatin;Cetuximab	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	6;Not Available;12;6;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available	175;250;175;6;250	mg/m2;mg/m2;mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1495-F24897;TCGA-13-1495-F72645	ff28eb04-b270-4a74-9b59-fcdc531eaeaf;5691E281-AC17-493B-9BD9-30E563655424	31;31	Not Applicable;2749	1498;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	80;Not Available	Not Available;Not Available	3;7	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;984;Not Available	977;Not Available;977	Recurrence;Both Locoregional and Distant Metastasis;Unknown	Not Available;YES;Not Available	Imaging Study;Imaging Study;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;Unknown	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	3	G2									Not Available	Not Available	1495	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2004
TCGA-29-1775	51	FEMALE	376	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	1	341.0		Recurrence	WITH TUMOR		51	Bilateral	TCGA-29-1775	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	2	-18943	Not Applicable	0	376	TCGA-29-1775-D27399;TCGA-29-1775-D27400;TCGA-29-1775-D27401;TCGA-29-1775-D27402;TCGA-29-1775-D27406;TCGA-29-1775-D27403;TCGA-29-1775-D27405;TCGA-29-1775-D27404;TCGA-29-1775-D27407	39863e9b-48dc-497d-bc6f-7ddaf6d74979;3d88301d-c73c-4314-b25e-8d6c5c85050d;d81cc8d4-ee3e-44c2-9775-1336cc2c23a5;ac4fe03f-ca40-4a24-96fe-592c7547f834;2eb3063c-17a4-467e-8041-172da15d04d5;a1f3b59c-bbe7-4421-a1b4-a70684037a52;fa8fc828-6c75-47d5-927d-86af2fa3cfb2;4e0514c2-918e-49ce-b00d-fda19f334ef1;0754f353-8c2d-477a-aa6c-ebb7d3191088	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;10;10;10;10;10;10	166;166;320;432;604;355;467;377;576	29;29;114;355;576;355;397;377;530	Paclitaxel;Carboplatin;Bevacizumab vs Placebo;Cisplatin;Doxil;Paclitaxel;Gemcitabine HCL;Taxotere;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;5;5;5;5;5;5	06;06;10;04;02;01;05;01;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg/m2;mg/m2;Not Available;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;PROGRESSION;RECURRENCE;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IP;IV;IV;IV;IV;Not Available	NO;NO;NO;NO;YES;NO;NO;NO;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2040;4290;11694;100;40;Not Available;1600;120;20	mg;mg;mg;mg/m2;mg/m2;Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-29-1775-F27398	5beb42b4-f148-4115-849e-6d5be911a460	2	Not Applicable	376	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;341	341;Not Available	Recurrence;Locoregional Disease	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1775	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-09-2050	65	FEMALE	2163	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIA	G2	0	2163			TUMOR FREE		65	Bilateral	TCGA-09-2050	3c037acf-f453-4513-a6dd-129163ddde2a	3	-23987	Not Applicable	0	2163	TCGA-09-2050-D24371;TCGA-09-2050-D24369;TCGA-09-2050-D24368;TCGA-09-2050-D24370	1d6971b6-36e2-45af-a856-314033ffc348;a5f02758-3d64-4485-9264-696da62d12f0;8b49a093-29ac-43b2-afe1-29b764d8040c;e8e55844-54ae-4eaa-870f-879d2fc1fc3c	Not Available;Not Available;Not Available;Not Available	3;3;3;3	110;25;25;110	47;5;5;47	Taxotere;Taxol;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available	11;11;11;11	4;2;2;4	Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;AUC;AUC	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	60;175;6;6	mg/m2;mg/m2;AUC;AUC	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-2050-F24367	d376dd7b-c6c2-4e3b-88ce-db3121b2f006	3	Not Applicable	2163	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	11	G2									Not Available	Not Available	2050	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2003
TCGA-13-0760	63	FEMALE	351	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	351			Not Available		63	Bilateral	TCGA-13-0760	d8d13aa4-45d5-4e1a-a6cf-895bdf05e7b2	24	-23036	351	0	351																								Not Available	NOT HISPANIC OR LATINO	TCGA-13-0760-F24543	3203ab30-8200-473e-ac09-004d20628514	24	351	351	Not Available	Not Available	Not Available	80	Not Available	2									Not Available	Pre-Adjuvant Therapy	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	80	Not Available	2	G3									Not Available	Not Available	0760	Pre-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Dead	2009	2006
TCGA-10-0933	77	FEMALE	446	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	356.0		Recurrence	WITH TUMOR		77	Bilateral	TCGA-10-0933	9446e349-71e6-455a-aa8f-53ec96597146	6	-28433	446	0	356	TCGA-10-0933-D24456;TCGA-10-0933-D24455	89e0dd01-e64f-44ab-b287-379aa1c62a89;40b513c9-3e2c-434c-84bc-b79ca9ae8c0e	Not Available;Not Available	18;18	132;132	20;20	Carboplatin;Taxol	Not Available;Not Available	3;3	06;06	Not Available;Not Available	mg/m2;mg/m2	OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Adjuvant and Recurrence;Adjuvant and Recurrence	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	2160;1740	mg/m2;mg/m2	Not Available;Not Available	2009;2009	1	NOT HISPANIC OR LATINO	TCGA-10-0933-F24454	4cddfc2f-91c2-4d1b-959e-a407436f1faf	6	446	356	1	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	356	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0933	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	No Macroscopic disease	Ovary	Not Available	Dead	2009	2003
TCGA-24-1431	67	FEMALE	583	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	199.0		Recurrence	WITH TUMOR		67	Bilateral	TCGA-24-1431	384170fc-e8be-426a-a54e-bf1ca61f2986	12	-24758	583	0	583	TCGA-24-1431-D25978;TCGA-24-1431-D25979;TCGA-24-1431-D25980;TCGA-24-1431-D25981;TCGA-24-1431-D25982	f75d63b3-e5e9-4e08-a119-43aa095dec60;e647deaf-bd3a-46ee-929f-aec2930b59d4;bb8a8867-a1b4-46fb-8c6d-fb1b8f31fcfe;e6f0b81a-42c2-40cb-b3a4-e2fa19737f34;db569566-3e65-423b-89ee-f96f8dd2ae9d	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	147;147;308;Not Available;Not Available	42;42;262;Not Available;329	Carboplatin;Taxol;Topotecan;Taxotere;Doxil	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	06;06;03;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1431-F25977	d6b3e869-46dd-40c8-ad63-998478c5b806	12	567	583	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	199	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	5	G3									Not Available	Not Available	1431	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-09-1665	73	FEMALE	1266	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	468.0		Recurrence	WITH TUMOR		73	Left	TCGA-09-1665	9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d	2	-27010	1266	0	Not Available	TCGA-09-1665-D24273;TCGA-09-1665-D24276;TCGA-09-1665-D24275;TCGA-09-1665-D24274	8c2c993d-40cd-4027-9569-1b033b7edd54;b1ed85a0-eac9-4666-ab39-010c1399d205;8d2d4b4c-596d-42a2-9e4b-0e7b2fee3958;37f4416a-9d1d-4c7d-877e-7871f2b85168	Not Available;Not Available;Not Available;Not Available	5;5;5;5	208;483;1022;208	33;400;917;33	Taxol;Tamoxifen;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available	8;8;8;8	6;Not Available;6;6	Not Available;Not Available;Not Available;Not Available	mg/m2;Not Available;AUC;AUC	ADJUVANT;RECURRENCE;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV	NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	175;Not Available;6;6	mg/m2;Not Available;AUC;AUC	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1665-F24272	85d0d258-5285-40e6-bfd7-45c246449c8e	2	1266	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	YES	Not Available	468	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G2									Not Available	Not Available	1665	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-09-1665-R24277	c227e9cc-5a7d-45a2-a868-101ae1ef3aab	Not Available	5	792	778	Not Available	8	Not Available	Not Available	NO	Not Available	Not Applicable	PROGRESSION	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	YES	Dead	2009	2002
TCGA-24-0975	58	FEMALE	663	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	663			WITH TUMOR		58	Bilateral	TCGA-24-0975	6a57948c-0dc5-4ea2-8043-380f26763752	9	-21417	663	0	663	TCGA-24-0975-D25865;TCGA-24-0975-D25866;TCGA-24-0975-D25863;TCGA-24-0975-D25867;TCGA-24-0975-D25862;TCGA-24-0975-D25864	fbde8509-b99c-4069-86ea-638a3eff0d8d;afafd8b8-0b8c-4e45-944e-df82466920bf;f67062fb-a896-4c7b-adab-2bfedbaf34cf;e255c05a-03e0-47a8-a3bc-064fe0d4449b;b6206599-e812-43db-8625-fdd6a2142a9c;441ae864-4ce1-43eb-8f2c-3783269ca89b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9	Not Available;611;Not Available;611;Not Available;Not Available	22;Not Available;22;Not Available;22;22	Doxil;Topotecan;Paclitaxel;Navelbine;Carboplatin;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	2;3;8;3;8;2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-0975-F25861	fc2f81ab-fa8a-47f3-a537-77a64d2c2bff	9	663	663	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0975	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-24-0975-R25868	0ff29145-a460-4150-a863-1b8d8c40d89a	Not Available	9	576	564	Not Available	3	10	3000	NO	EXTERNAL BEAM	Not Applicable	OTHER, SPECIFY IN NOTES	Progression, Recurrence	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2004
TCGA-04-1644	48	FEMALE	1487	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	634.0		Progression of Disease	WITH TUMOR		48	Bilateral	TCGA-04-1644	6f592f17-e00b-4d04-a45b-d9d4cf4c3075	2	-17725	1487	0	Not Available	TCGA-04-1644-D24148;TCGA-04-1644-D24150;TCGA-04-1644-D24146;TCGA-04-1644-D24147;TCGA-04-1644-D24149	0b27b41b-630b-4780-8962-d7d2890b1b49;a5117a44-5eff-422c-a7ef-6a64aa046c04;e34aab47-56e3-467c-b3d8-57873b04644f;394ae296-dd59-40da-afdb-8a8fd220616a;bea9d9ec-f88f-4bae-9fe3-59b8569c7439	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	221;Not Available;120;221;Not Available	113;661;17;17;661	Paclitaxel;Navelbine;Gemcitabine;Carboplatin;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	04;Not Available;04;08;Not Available	300;Not Available;2704;Not Available;Not Available	mg;Not Available;mg;AUC;Not Available	ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	1208;Not Available;12432;6;Not Available	mg;Not Available;mg;AUC;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	1	NOT HISPANIC OR LATINO	TCGA-04-1644-F24145	28f1bf15-8aeb-478c-83b4-d19d4437ca7f	2	1487	Not Available	1	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	634	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1644	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	>20 mm	Ovary	Not Available	Dead	2009	2002
TCGA-13-1412	41	FEMALE	984	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	409.0			TUMOR FREE		41	Bilateral	TCGA-13-1412	44493c23-82e9-4d9f-8e3c-7b3f9ae44970	20	-15119	Not Applicable	0	162	TCGA-13-1412-D24834;TCGA-13-1412-D24833;TCGA-13-1412-D24836;TCGA-13-1412-D24837;TCGA-13-1412-D24835	8b14d588-2044-4f90-9a23-edda2259f27a;0a3e9870-60d6-4529-9570-b86361452929;2f960c5b-fc96-4100-91d5-62689dac2d2b;e8f007f4-1cc1-4eea-8b14-300ff06a3b8a;65181bc8-d203-458a-9869-e6c89c79a77b	Not Available;Not Available;Not Available;Not Available;Not Available	30;30;1;1;1	121;121;205;205;205	37;37;156;156;156	Paclitaxel;Carboplatin;Paclitaxel;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;2;2;2	5;5;3;3;3	Not Available;Not Available;135;60;75	mg/m2;Not Available;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IP;IP	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	175;5;Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1412-F24832;TCGA-13-1412-F72669	a831a5dd-ab90-4720-9a9d-91228986100a;5857F9CC-1A66-4E21-8E2E-E6FDD504F2A5	20;31	Not Applicable;984	162;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;409	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	3	G3									Not Available	Not Available	1412	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-24-2038	68	FEMALE	1354	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIA	GB	1	1169.0		Recurrence	WITH TUMOR		68	Right	TCGA-24-2038	17181157-c9e2-4bd6-8653-f5dce56f9053	19	-24957	1354	0	1354	TCGA-24-2038-D26521;TCGA-24-2038-D26520;TCGA-24-2038-D26519	58c875e5-4f1d-46f3-bc72-100d4df55821;a072c4d8-69e2-471b-8007-4a211bafee54;d15be7f1-44d9-45a2-aebb-c743ee12a8fe	Not Available;Not Available;Not Available	19;19;19	1352;1352;1254	1268;1268;1212	Carboplatin;Taxol;Topotecan	Not Available;Not Available;Not Available	2;2;2	05;05;02	Not Available;Not Available;Not Available	mg;mg;mg	PROGRESSION;PROGRESSION;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	2345;1407;35.2	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	TCGA-24-2038-F26518	8fc55409-dfdb-43de-bd4e-9d1f31594ccc	19	1354	1354	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	NO;NO	Not Available;1183	1169;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	NO	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	GB									Not Available	Not Available	2038	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	2000
TCGA-VG-A8LO	55	FEMALE	24	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	GB	0	24			WITH TUMOR		55	Right	TCGA-VG-A8LO	8628F1B2-3763-4BA9-A375-083874BB18F2	25	-20274	24	0	Not Available	TCGA-VG-A8LO-D60809;TCGA-VG-A8LO-D60817	FC9C6E78-2625-4BFD-879D-1E1FFFD56E85;036051C3-A9BB-4A8E-B1F9-DC9174E397E2	Not Available;Not Available	26;26	8;8	8;8	paclitaxel;Carboplatin	Unknown;Unknown	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	4	NOT HISPANIC OR LATINO																												FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Not Applicable	Excisional Biopsy	Not Available	50	Unknown	3	GB									NO	No	A8LO	Other	WITH TUMOR	YES	Not Applicable	BLACK OR AFRICAN AMERICAN	NO																			R2	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	YES	NO	VG	>20 mm	Ovary	Unknown	Dead	2014	2013
TCGA-13-2057	59	FEMALE	2434	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	897.0			TUMOR FREE		59	Bilateral	TCGA-13-2057	56c4bd48-ab15-4b49-ae2f-968653052b50	1	-21554	Not Applicable	0	433	TCGA-13-2057-D24991;TCGA-13-2057-D24990	37eff60b-6903-445a-b8ed-588e9df2f112;413048b1-1b7c-4cb7-a8f3-47cc291c18a9	Not Available;Not Available	1;1	159;159	51;51	Paclitaxel;Carboplatin	Not Available;Not Available	2;2	6;6	Not Available;Not Available	mg/m2;AUC	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;5	mg/m2;AUC	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-13-2057-F24989;TCGA-13-2057-F72682	23aa1dcb-47f5-4846-9390-de68cc075309;445565CB-8EF6-45C8-8574-37927DD06D6E	1;31	Not Applicable;Not Applicable	433;2434	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	60;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;897	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2010;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	60	Not Available	2	G3									Not Available	Not Available	2057	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2010	2008
TCGA-13-0730	71	FEMALE	542	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	542			Not Available		71	Bilateral	TCGA-13-0730	2ebb738c-4829-4720-931a-96c0fd117e2a	24	-26086	542	0	Not Available																								Not Available	NOT HISPANIC OR LATINO	TCGA-13-0730-F60695	CD6AEFB1-0800-4A90-9E3B-4248FD561A3B	17	542	Not Available	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	6									Unknown	Not Available	Unknown	Not Available	Unknown	Unknown	Dead	2014	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0730	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Dead	2009	2003
TCGA-29-1691	51	FEMALE	1470	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	613.0		Recurrence	WITH TUMOR		51	Bilateral	TCGA-29-1691	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	2	-18664	1470	0	1435	TCGA-29-1691-D27150;TCGA-29-1691-D27149;TCGA-29-1691-D27155;TCGA-29-1691-D27152;TCGA-29-1691-D27154;TCGA-29-1691-D27156;TCGA-29-1691-D27151;TCGA-29-1691-D27157;TCGA-29-1691-D27153	af52351f-2a65-4bab-8bf4-573d7d8c7298;5981636e-0c5c-47af-832a-7eb7e79b6129;877c785c-7487-4730-b800-ec7ca6a067f5;75e41a0f-d235-4fb2-bf9f-34dc7fff8807;a5cf93f1-4cc5-4e17-bfaf-4fa8c64efbb5;af8df55a-1129-4a08-ac99-6b6e6328d6ed;3c9233cf-e2f4-4c15-835e-c8f00dafb4a7;56c9442e-1bb2-4585-8583-da00a67982b0;3cf322bf-45f6-4d30-896a-5a44d2a27e15	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;16;16;16;16;16;16;16	137;137;1353;868;Not Available;1353;868;Not Available;Not Available	Not Available;Not Available;1233;654;988;1233;654;988;868	Paclitaxel;Cisplatin;Cytoxan;Paclitaxel;Doxil;Carboplatin;Carboplatin;Megace (oral);Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;2;2;2;2;2;2;2	06;06;Not Available;06;Not Available;Not Available;06;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;mg/m2;Not Available;Not Available;AUC;Not Available;Not Available	ADJUVANT;ADJUVANT;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IP;IV;IP;IV;IP;IV;IP;IV;IP;IV;PO;IP;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;175;Not Available;Not Available;5;Not Available;Not Available	Not Available;Not Available;Not Available;mg/m2;Not Available;Not Available;AUC;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-29-1691-F27148	cd9c0017-f19f-4f93-983c-3b4f58156aed	2	1470	1435	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;624	613;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1691	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Dead	2009	1995
TCGA-29-1698	53	FEMALE	2078	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	181.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-29-1698	18d21132-a795-4551-83ba-66483de423a2	2	-19611	Not Applicable	0	2078	TCGA-29-1698-D27228;TCGA-29-1698-D27229;TCGA-29-1698-D27236;TCGA-29-1698-D27239;TCGA-29-1698-D27235;TCGA-29-1698-D27232;TCGA-29-1698-D27231;TCGA-29-1698-D27233;TCGA-29-1698-D27240;TCGA-29-1698-D27230;TCGA-29-1698-D27234;TCGA-29-1698-D27237;TCGA-29-1698-D27238	d19d3315-e66f-4c1a-ac23-98bece9f387a;b9c29270-ee60-4e30-a093-5f075678c76a;a7599369-16cc-498d-a785-820ab146b2f3;f5e6d97b-a6dc-4699-8440-cfe1999a7c59;9c5d0db2-99d5-41ba-b046-73bcf1606509;61b62b7a-751e-47c8-952b-ae69e732b57f;67b7d4d3-f5ae-4f94-854b-bd9759d9535e;4515594c-0c88-4d51-80b8-5b339a8c5f5f;ac7e4095-4661-4ea2-bd92-532cd8fe44c8;6ad63dbf-f942-4b8a-bf8f-e7dd53d68606;9879c952-a90b-4770-80e8-145d5b666e53;649ad6e9-fc1e-4d4b-a6f7-c658c687eaf9;2ebf8390-c1f5-4b22-ae80-22ec2332c195	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;9;9;9;9;9;9;9;9;9;9;9	237;237;1972;1419;1783;1566;853;1349;1580;909;1587;2028;2245	8;8;1811;328;1615;1321;741;1321;1524;741;1580;1986;2051	Carboplatin;Paclitaxel;Paclitaxel;Tamoxifen;Doxil;Gemcitabine HCL;Docetaxel;Carboplatin;Avastin (Bevacizumab);Carboplatin;Toptecan;Docetaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;4;4;4;4;4;4;4;4;4;4;4	09;09;17;Not Available;07;06;07;02;Not Available;05;01;03;08	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;AUC	ADJUVANT;ADJUVANT;PROGRESSION;RECURRENCE;PROGRESSION;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;Not Available;IV;IV;IV;IV;Not Available;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5600;2603;100;20;68;1020;53;510;600;570;5;100;5	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;AUC	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-29-1698-F27227	3f529423-5e1c-423a-82d2-6b60842e06f5	2	Not Applicable	2078	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;181	181;Not Available	Recurrence;Locoregional Disease	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1698	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Alive	2009	2004
TCGA-24-1616	56	FEMALE	1163	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	405.0		Recurrence	WITH TUMOR		56	Bilateral	TCGA-24-1616	5d7027f5-60a0-47ab-a79d-667c9acc0e54	13	-20785	1163	0	1163	TCGA-24-1616-D26320;TCGA-24-1616-D26323;TCGA-24-1616-D26316;TCGA-24-1616-D26317;TCGA-24-1616-D26319;TCGA-24-1616-D26322;TCGA-24-1616-D26318;TCGA-24-1616-D26321	6e2e7642-c775-4c35-9930-1c443468a918;b2d785f8-6f1a-4971-8ce9-822f6d1f7270;0c8429b0-fc35-4b1c-80fb-413423b37379;0800291c-aa44-4757-aa71-a9006dfb1af0;92f77834-4053-4145-a116-5dcec0326efd;b0f49dab-9394-4ad9-b5f8-091f90596108;2346b95a-8b34-41a1-9489-cea42c9c5fd2;668a90a6-760c-44f1-b6b0-791749668e43	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;13	Not Available;Not Available;165;165;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;18;18;Not Available;Not Available;Not Available;Not Available	Carboplatin;Cisplatin;Carboplatin;Taxol;Doxil;Gemzar;Topotecan;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5	Not Available;Not Available;08;08;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1616-F26315	127c2b96-0ba3-4db7-8de7-af44da6aa3df	13	1163	1163	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	405	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1616	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-10-0935	68	FEMALE	1078	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1078			WITH TUMOR		68	Bilateral	TCGA-10-0935	48f8afa8-7712-4428-b0d0-d8c3340504b6	6	-25098	1078	0	1078	TCGA-10-0935-D24463;TCGA-10-0935-D24464	3b5b164a-2480-499e-94a3-b17eb309ddc5;8871014c-27c2-4cef-aeb0-58c025e2b10e	Not Available;Not Available	18;18	34;34	34;34	Taxol;Carboplatin	Not Available;Not Available	3;3	1;1	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	240;385	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-10-0935-F24462	74b6de98-2a0e-4043-994a-8903a06b781e	6	1078	1078	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	0935	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	1-10 mm	Ovary	YES	Dead	2009	2003
TCGA-20-1683	65	FEMALE	772	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	618.0		Recurrence	TUMOR FREE		65	Right	TCGA-20-1683	ac2e88ff-8b1e-4691-9a96-5a581f98d827	2	-24006	Not Applicable	0	772	TCGA-20-1683-D25545;TCGA-20-1683-D25546;TCGA-20-1683-D25547	224f8ff6-5ded-405b-b206-521b0ae15315;7175a7a2-ccb7-4926-88d0-fac1af5a4ba7;350300e1-643d-4b95-90bb-307cc8934f29	Not Available;Not Available;Not Available	27;27;27	135;135;Not Available	17;17;618	Carboplatin;Taxol;Tamoxifen	Not Available;Not Available;Not Available	7;7;7	06;06;Not Available	Not Available;Not Available;Not Available	AUC;mg/m2;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;Not Available	NO;NO;YES	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	6;175;20	AUC;mg/m2;mg	Not Available;Not Available;Not Available	2009;2009;2009	0	NOT HISPANIC OR LATINO	TCGA-20-1683-F25544	bbb59b9b-39a7-4e23-89cd-1c5b0514362a	2	Not Applicable	772	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	618	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1683	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	No Macroscopic disease	Ovary	Not Available	Alive	2009	2007
TCGA-13-0885	70	FEMALE	3388	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	3388			Not Available		70	Left	TCGA-13-0885	2a924999-1fbf-470a-97bd-fd2276a9a366	25	-25763	Not Applicable	0	2780	TCGA-13-0885-D24661;TCGA-13-0885-D24660;TCGA-13-0885-D24659	30bfb060-bc43-4205-a472-4139381c0c69;2786c1cb-0952-4c59-b515-77c3a5c35742;1b109abf-497f-455d-b2cd-afb4f953f287	Not Available;Not Available;Not Available	15;15;15	208;110;110	Not Available;6;6	Cisplatin;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available	4;4;4	3;6;6	Not Available;Not Available;Not Available	Not Available;mg/m2;AUC	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;175;5	Not Available;mg/m2;AUC	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0885-F24658;TCGA-13-0885-F72616	dc9ec5ec-5e34-40f1-baef-f0a594f2a4cb;08B199AD-606F-4267-AA79-6F4CB9CFB532	25;30	Not Applicable;Not Applicable	2780;3388	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	80;Not Available	Not Available;Not Available	2;7									Not Available;Unknown	Pre-Adjuvant Therapy;Not Available	Not Available;Unknown	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	2	G3									Not Available	Not Available	0885	Pre-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	11-20 mm	Ovary	Not Available	Alive	2009	2000
TCGA-04-1648	57	FEMALE	871	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	412.0		Recurrence	Not Available		57	Not Available	TCGA-04-1648	cddce77f-21e6-4124-9f03-96fb5ca7cefa	2	-21113	871	0	Not Available	TCGA-04-1648-D24161;TCGA-04-1648-D24163;TCGA-04-1648-D24160;TCGA-04-1648-D24166;TCGA-04-1648-D24165;TCGA-04-1648-D24162;TCGA-04-1648-D24164	0d18b847-2e08-45dc-a2c3-d387fe57031e;d0bd5f53-352e-4300-b4c2-58609d888103;1a700a0d-2529-42d5-9117-dceea252ad8a;a9fefaaf-f2d3-453b-82df-f333775b8ca0;1f937eb0-6773-48b1-925f-54a58b003fbd;09efef17-deb9-41ff-ab69-d9567c390137;cd9ed497-a263-4fda-99ef-74b1f4916798	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10;10	149;Not Available;149;Not Available;Not Available;149;Not Available	3;247;3;247;247;3;247	Carboplatin;Doxil;Gemcitibine;Avastin;Taxotere;Taxol;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11	08;Not Available;08;Not Available;Not Available;08;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;Not Available;mg;mg;Not Available	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;Not Available;Not Available;IV;Not Available	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5140;40;23296;Not Available;129;2544;Not Available	mg;mg;mg;Not Available;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-04-1648-F24159	00200545-63d3-450e-82a8-e6edc4048449	2	871	Not Available	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	412	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Pre-Adjuvant Therapy	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1648	Pre-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-09-2044	77	FEMALE	186	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIB	G3	0	186			TUMOR FREE		77	Right	TCGA-09-2044	7d03ddb6-f3fe-4b50-8bba-514aa65e7d0e	2	-28231	Not Applicable	0	186	TCGA-09-2044-D24335;TCGA-09-2044-D24336	47992e98-d20a-4eaa-8d9a-e0098cf2e22a;21ab3e49-5209-4617-af8c-1c957d3616a7	Not Available;Not Available	2;2	151;151	32;32	Carboplatin;Taxol	Not Available;Not Available	11;11	6;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-2044-F24334	ec42f6f2-8d69-40be-a123-4b0a090af2d2	2	Not Applicable	186	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	11	G3									Not Available	Not Available	2044	Not Available	TUMOR FREE	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2009
TCGA-23-1121	51	FEMALE	194	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	194			Not Available		51	Left	TCGA-23-1121	81005bae-686a-4598-8994-49d90ebac56f	24	-18983	Not Applicable	0	194	TCGA-23-1121-D25721;TCGA-23-1121-D25722;TCGA-23-1121-D25720	a4055b6b-966f-49eb-b54e-58851bea490d;41650c19-fb75-4a26-81cf-84c3d503fbf8;6533e40b-a0cb-48bf-96f6-65d01afb4d7f	Not Available;Not Available;Not Available	7;7;7	194;152;194	31;53;31	Taxol;Avastin;Carboplatin	Not Available;Not Available;Not Available	7;7;7	06;04;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1362;2400;3135	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1121-F25719	dd6b393a-53e8-4bcd-a130-effa676d9a02	24	Not Applicable	194	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1121	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-13-1496	65	FEMALE	129	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	129			Not Available		65	Bilateral	TCGA-13-1496	e5a329ec-e50e-4786-901d-b58474f8ea65	31	-23993	129	0	129	TCGA-13-1496-D24905;TCGA-13-1496-D24906	42c8232f-dc83-4025-a957-1c121f960780;b3f86e9e-52c6-40f6-88cf-521bae342105	Not Available;Not Available	29;29	33;33	33;33	Carboplatin;Paclitaxel	Not Available;Not Available	6;6	1;1	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	6;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1496-F24904	8df03585-7754-4f4b-a868-bfb88530f053	31	129	129	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1496	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Dead	2009	2004
TCGA-61-1914	65	FEMALE	1722	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1674.0		Recurrence	WITH TUMOR		65	Bilateral	TCGA-61-1914	8e1b8811-1eb2-4337-852c-c19eaa0ee418	1	-23850	Not Applicable	0	1722	TCGA-61-1914-D28275;TCGA-61-1914-D28278;TCGA-61-1914-D28274;TCGA-61-1914-D28277;TCGA-61-1914-D28276	40a2d81b-7bf7-4f8e-a283-d44999b5d6ce;6d844227-9edb-4c02-bd47-494f8080a17f;6f5663c3-61f6-4e8c-b0d0-f89618d07922;b2513645-c71d-4268-bb2e-b6543d55e1b3;6ffd14a7-cd33-4aa5-af00-b98302635493	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4	193;1673;193;1871;1871	22;1155;22;1753;1753	Carboplatin;Tamoxifen;Taxol;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	08;Not Available;08;06;06	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	3360;1030;2400;2580;1890	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-61-1914-F28273	bf92b598-521f-46b7-a2e9-92a747d5177f	1	Not Applicable	1722	Not Available	Not Available	Not Available	Not Available	Not Available	10	YES;YES	NO;NO	Not Available;1702	1674;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	10	G3									Not Available	Not Available	1914	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	>20 mm	Ovary	YES	Alive	2009	2003
TCGA-23-2641	85	FEMALE	84	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	84			Not Available		85	Left	TCGA-23-2641	49e5ee61-a1c9-4038-84ac-92683e573a65	9	-31232	Not Applicable	0	84																								Not Available	NOT HISPANIC OR LATINO	TCGA-23-2641-F25810	a0a46d22-1029-40b7-b01c-a0d2322c130b	9	Not Applicable	84	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	2641	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-23-1032	73	FEMALE	84	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	84			WITH TUMOR		73	Right	TCGA-23-1032	d1976840-35f7-4423-8458-12fb32a52b33	23	-26715	84	0	68																								Not Available	NOT HISPANIC OR LATINO	TCGA-23-1032-F25659	22b559e9-5e92-444d-93ca-0d357461bd74	23	84	68	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	1032	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-23-1029	46	FEMALE	268	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	268			TUMOR FREE		46	Right	TCGA-23-1029	4d71dd15-cd01-4dae-ad70-6dc325140207	2	-16889	Not Applicable	0	268	TCGA-23-1029-D25641;TCGA-23-1029-D25640	5f098756-c714-43d6-b097-9d2dae9f2152;eb833ce3-8f8b-4694-b538-a8d573f473d0	Not Available;Not Available	12;12	78;78	30;30	Paciltaxel;Cisplatin	Not Available;Not Available	8;8	03;03	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IV;IP;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1212;375	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1029-F25639	b21097d0-d714-4e0c-a8b9-fecac7ce4111	2	Not Applicable	268	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1029	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Alive	2009	2007
TCGA-04-1332	70	FEMALE	1247	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	393.0		Recurrence	WITH TUMOR		70	Bilateral	TCGA-04-1332	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	26	-25786	1247	0	1247	TCGA-04-1332-D23919;TCGA-04-1332-D23916;TCGA-04-1332-D23914;TCGA-04-1332-D23912;TCGA-04-1332-D23917;TCGA-04-1332-D23913;TCGA-04-1332-D23915;TCGA-04-1332-D23920;TCGA-04-1332-D23918;TCGA-04-1332-D23922;TCGA-04-1332-D23921	648e9735-7f2e-4d75-b997-4165f16e33f4;9872734c-4308-4239-a327-badc002227f5;66a262b2-950e-462d-a399-affebbfd0761;a5ef9119-338a-4e6c-a55d-9898611a296a;7fb06145-71d2-4719-b919-ce42f9a236b2;eaa50f60-2e69-4f97-b316-7f7b4d6ad0e7;3cceae8f-8fbc-4d20-bc2d-aff4a747632f;a815049a-3d7b-4507-ac73-9c01557671f5;45d7a0a0-7a94-413c-840e-d265aa8e32b3;8ae61fa8-4a16-4bb1-aa64-344b42cfd9aa;9938439e-42e6-45d7-b1c8-df2a25fd6afe	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	30;30;30;30;30;30;30;30;30;22;22	179;1155;1063;Not Available;1155;Not Available;1063;179;1216;606;606	28;1094;971;Not Available;1094;Not Available;971;28;1155;424;424	Topotecan/Carboplatin;Cisplatin;Carboplatin;Gemcitabine;Taxotere;Doxil;Taxotere;Taxol/Carboplatin;Doxil;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11;2;2	4;2;3;7;2;7;3;4;3;6;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;IV;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2010;2010	1	NOT HISPANIC OR LATINO	TCGA-04-1332-F23911	10d96c4f-798d-4db3-95ce-0ba9beacfc5f	26	1247	Not Available	1	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	393	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G3									Not Available	Not Available	1332	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-61-2110	56	FEMALE	1354	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	Not Available	1	213.0		Recurrence	WITH TUMOR		56	Bilateral	TCGA-61-2110	88180134-710f-46ea-9b06-5e5d860d6d9f	4	-20718	1354	0	1354	TCGA-61-2110-D28459;TCGA-61-2110-D28457;TCGA-61-2110-D28458;TCGA-61-2110-D28462;TCGA-61-2110-D28463;TCGA-61-2110-D28460;TCGA-61-2110-D28461;TCGA-61-2110-D28464	cf284d67-59f2-44d4-ac77-0aaaa1a593e9;e104ed61-6ac7-4c6c-ad84-389d00289ed8;2b91b2c6-dd7b-4b55-a31e-a5d0b54914e4;83713042-6ff6-4fb5-af9f-d052de0e9ef4;59347194-a069-4b01-830f-b2a17362f69d;b7c2bc59-6246-44da-afb4-445792bf317e;106ff996-b75a-4830-a231-a7812b2ba5bc;22c34e90-e390-42af-afe8-975c0b18cac9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4;4	770;161;161;1239;1354;930;1089;356	661;20;20;1089;459;774;979;244	Topotecan;Carboplatin;Taxol;Gemzar;Tamoxifen;Carbplatin;Doxil;IL 2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12	05;06;06;05;Not Available;06;05;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;Not Available	RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE;PROGRESSION;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;PO;IV;IV;IP	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;2970;1620;12640;10;3900;315;16	mg;mg;mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2110-F28456	47c8d668-e766-409d-b4bd-eb05a7befb17	4	1354	1354	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES;YES	YES;YES	Not Available;213	213;Not Available	Recurrence;Metastatic	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	12	Not Available									Not Available	Not Available	2110	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence	TCGA-61-2110-R28465	0a8ee0e7-6928-425c-9669-747c96e6ee7d	Not Available	7	Not Available	1263	Not Available	12	02	0600	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	Not Available	Dead	2009	1998
TCGA-61-1917	60	FEMALE	1321	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G3	0	1321			Not Available		60	Bilateral	TCGA-61-1917	87cdf9a8-0579-4d3e-b4df-0f8eef63d7f4	30	-21972	1321	0	1321	TCGA-61-1917-D28293;TCGA-61-1917-D28291;TCGA-61-1917-D28292	8bc7ad9c-d6f6-4863-863b-8d9a79d97ca5;77081d9f-b721-4405-931e-35b61c21871b;e7226494-66f0-4f59-8453-395e4e996045	Not Available;Not Available;Not Available	30;30;30	Not Available;Not Available;Not Available	19;19;19	Taxol;Gemzar;Carboplatin	Not Available;Not Available;Not Available	11;11;11	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1917-F28290	a316538e-69fd-4b85-86e5-e43c4aeab4e4	30	1321	1321	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	Not Available	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	11	G3									Not Available	Not Available	1917	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	NO	Dead	2009	2002
TCGA-30-1860	58	FEMALE	1366	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	397.0		Recurrence	WITH TUMOR		58	Bilateral	TCGA-30-1860	563853a2-9ac2-48be-adf3-1e547ee2b274	2	-21406	1366	0	1366	TCGA-30-1860-D27584;TCGA-30-1860-D27587;TCGA-30-1860-D27586;TCGA-30-1860-D27581;TCGA-30-1860-D27583;TCGA-30-1860-D27588;TCGA-30-1860-D27585;TCGA-30-1860-D27582;TCGA-30-1860-D27589	d3ce4085-ca82-4143-ad0b-ec81ff9f2ea9;cf6521d0-a099-4672-b87c-60626cb8ac54;3abc00eb-e2d3-4427-8aa4-b023be30b7dd;3329995b-440d-44b0-bae0-188b798ee53c;2b1e50e4-2b3e-4287-9fb3-c53cce0cb15f;6f7e67db-f301-47f1-a6f6-e0f3af86bd09;2b258497-1982-434d-8908-7f2d70f63de5;0f428947-8a45-4e60-a43e-7772159e8841;078a36dd-f808-4f61-bea3-655803dd03ab	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28;28;28;8	915;1069;957;561;207;1246;915;207;1246	744;994;915;413;22;1191;744;22;1191	Carboplatin;Taxol;Topotecan;Doxil;Taxol;Navelbine;Gemcitabine;Carboplatin;Avastin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;1	06;12;06;03;07;05;06;07;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	AUC;mg/m2;mg/m2;mg;mg/m2;mg/m2;mg/m2;AUC;mg/kg	PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;PO	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;70;4;40;175;15;750;5;10	AUC;mg/m2;mg/m2;mg;mg/m2;mg/m2;mg/m2;AUC;mg/kg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2010	Not Available	HISPANIC OR LATINO	TCGA-30-1860-F27580	1893088c-1c0b-4d3c-bf14-c89f641b604e	2	1366	1366	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	YES;YES	Not Available;974	397;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1860	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-30-1860-R27590	10498612-21cb-499f-9a2d-701e15d53eac	Not Available	28	1055	1006	Not Available	12	25	4500	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	>20 mm	Ovary	NO	Dead	2009	2002
TCGA-04-1530	68	FEMALE	3622	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	350.0		Recurrence	WITH TUMOR		68	Bilateral	TCGA-04-1530	42b3dfa3-152f-4ab7-ac9f-988c7f473bea	2	-25013	3622	0	Not Available	TCGA-04-1530-D24105;TCGA-04-1530-D24107;TCGA-04-1530-D24106;TCGA-04-1530-D24108	00ca66ba-5726-4770-97c9-3cdcb1322fe4;e53d3505-76db-4d22-a0e5-968e706f3e0e;b92c8c57-7fe6-4ada-b32c-ec7b254b1c1c;e9327dc6-1775-4aff-bce4-b32ea0f465bd	Not Available;Not Available;Not Available;Not Available	9;9;9;9	153;550;153;550	43;382;43;382	Taxol;Taxol;Cisplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available	11;11;11;11	06;06;06;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1218;1200;678;2490	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-04-1530-F24104	ad540bc7-095f-4f96-ad41-0981da3fcb0e	2	3622	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;350	350;Not Available	Recurrence;Locoregional Disease	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1530	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	NO	Dead	2009	1995
TCGA-61-1995	43	FEMALE	61	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	61			WITH TUMOR		43	Bilateral	TCGA-61-1995	931738a7-4b5b-46dc-b69f-72600862d8af	8	-16016	Not Applicable	0	61	TCGA-61-1995-D28304;TCGA-61-1995-D28303	5b457183-3195-43d4-8c3e-f244c641648d;154a83f9-1655-45ff-9961-44cd5d6992a7	Not Available;Not Available	8;8	132;132	67;67	Taxol;Cisplatin	Not Available;Not Available	12;12	04;04	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IV;IP;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1311;3202	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1995-F28302	23cec1cb-18f5-4261-bb98-4a4260f7306c	8	Not Applicable	61	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	1995	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Alive	2009	2009
TCGA-04-1336	55	FEMALE	1495	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	0	1495			TUMOR FREE		55	Bilateral	TCGA-04-1336	538acb2a-c4ca-4656-a91c-841a42dbf15f	11	-20271	Not Applicable	0	1495	TCGA-04-1336-D23927;TCGA-04-1336-D23929;TCGA-04-1336-D23928	65f9a9bb-2580-4922-9912-38341e2c039d;bb1ccca2-c7cd-4696-954c-4014fc47e1fc;6232e1fe-6d5b-497e-bb28-aee09a3a7df5	Not Available;Not Available;Not Available	17;17;17	144;542;144	50;179;50	Taxotere;Taxotere;Carboplatin	Not Available;Not Available;Not Available	11;11;11	06;Not Available;06	Not Available;Not Available;Not Available	mg/m2;mg/m2;AUC	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;75;6	mg/m2;mg/m2;AUC	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-04-1336-F23926	12a042d9-c0ed-4d91-bdd8-41e8aefd19ee	26	Not Applicable	1495	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	5	G3									Not Available	Not Available	1336	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	No Macroscopic disease	Ovary	Not Available	Alive	2009	2005
TCGA-13-0720	48	FEMALE	1355	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	292.0		Recurrence	WITH TUMOR		48	Bilateral	TCGA-13-0720	0d23fa5b-95f8-4626-a4d2-c72ad3cc553b	24	-17799	1355	0	1355	TCGA-13-0720-D24499;TCGA-13-0720-D24500;TCGA-13-0720-D24501	aaffa8ca-1eab-4ffc-89bb-6445124f34b8;a2017b37-9590-4aff-83e9-ec7eca6ee91e;aea4d94c-bf50-4440-a9a6-8e32d97645af	Not Available;Not Available;Not Available	15;15;20	180;180;292	7;7;239	Carboplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	8;8;7	Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5;175;560	Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0720-F24498	7da47e49-e807-4f7f-834c-1ade13aca50c	24	1355	1355	Not Available	Not Available	Not Available	80	Not Available	2	YES	NO	Not Available	292	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0720	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-25-1877	81	FEMALE	730	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	549.0		Recurrence	WITH TUMOR		81	Left	TCGA-25-1877	077079c3-6877-467b-b9cc-5c650aae4f07	2	-29615	730	0	549	TCGA-25-1877-D26776;TCGA-25-1877-D26775;TCGA-25-1877-D26777	cd38b202-c4a0-40bb-87e0-14323d353670;1db2e824-9247-48e7-8fde-e1f15f8e6b2b;aa853d2b-f944-48a8-acdb-816b629fa09c	Not Available;Not Available;Not Available	20;20;20	Not Available;Not Available;Not Available	31;Not Available;31	Cytoxan;Taxol;Carboplatin	Not Available;Not Available;Not Available	11;11;11	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1877-F26774	be06d351-8800-477e-ba18-249a66a7fa24	2	730	549	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	549	Recurrence	Not Available	Not Available	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1877	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	1993
TCGA-23-1024	52	FEMALE	468	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	468			TUMOR FREE		52	Right	TCGA-23-1024	8ac6ce06-ab50-4ab4-a469-9f8bf01be963	24	-19052	Not Applicable	0	468	TCGA-23-1024-D25607;TCGA-23-1024-D25606;TCGA-23-1024-D25605;TCGA-23-1024-D25608	39c2c36e-c470-48f1-82a2-9f358d3e5957;0a45720d-954b-4382-b052-f73401d543ce;ad2ca791-17ad-4489-b546-ffff653fff09;4aa79340-215b-4e20-98be-676cd4c8f2e8	Not Available;Not Available;Not Available;Not Available	27;27;27;27	304;304;529;304	13;13;224;13	Cisplatin;Paclitaxel;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available	3;3;3;3	6;6;12;6	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT	Not Applicable;Not Applicable;Consolidation;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IP;IV;IP	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	776;1608;2556;541	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1024-F25604	3e1241b4-c16c-4299-b793-b22309184b85	24	Not Applicable	468	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	Not Available	2	G3									Not Available	Not Available	1024	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Alive	2009	2007
TCGA-23-1021	45	FEMALE	1446	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1			Locoregional Disease	WITH TUMOR		45	Right	TCGA-23-1021	b923ac70-70ea-4a82-8466-46350c5803bf	24	-16484	1446	0	1446	TCGA-23-1021-D25570;TCGA-23-1021-D25569;TCGA-23-1021-D25571;TCGA-23-1021-D25568;TCGA-23-1021-D25573;TCGA-23-1021-D25574;TCGA-23-1021-D25572	f3d78a9b-08ea-4aa8-9cb5-677b67207783;ba314cd4-e2a6-4f5a-9104-137cd1e29ba7;9ade7aa5-18d8-4919-ae99-2a73732ba30e;ade37eb4-02de-42c7-8d26-fad6a3398a00;3fd43153-5bdf-45ff-8eef-1bdc764b40ba;9c425509-cbf7-43a5-8830-f4f4f75459f7;c20a16f7-cfb8-421e-8951-fbc938aaa1b2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1;1	693;119;861;119;1380;1408;1331	526;14;722;14;1352;1408;1226	Gemcitabine;Paclitaxel;Topotecan;Carboplatin;Vinorelbine;Doxorubicin;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4	5;6;6;6;2;1;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	OTHER, SPECIFY IN NOTES;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION	Persistence;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6061;2100;60;2880;50;25;2540	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1021-F25567	deff0c2e-9b3e-4181-97d6-13ddfc9f115a	24	1446	1446	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	1181	Not Available	Locoregional Disease	YES	Not Available	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1021	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	>20 mm	Ovary	YES	Dead	2009	2004
TCGA-61-1918	45	FEMALE	479	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	413.0		Recurrence	WITH TUMOR		45	Bilateral	TCGA-61-1918	3491d67a-4f83-4f67-8085-bbb9fe942be5	30	-16689	479	0	479	TCGA-61-1918-D28298;TCGA-61-1918-D28297;TCGA-61-1918-D28296	9c8afc14-2d7e-4c8e-a376-8e012320308d;a042ee9d-a58b-4d21-9b66-936fdf07b954;c63c99b6-fa3c-4a93-9fd6-6e95ef6aad5c	Not Available;Not Available;Not Available	30;30;30	146;146;146	9;9;9	Gemcitibine;Taxol;Carboplatin	Not Available;Not Available;Not Available	11;11;11	6;6;6	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	15616;2179;4686	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1918-F28295	f5f189d5-ceda-430f-996d-dbd6cdbb24a2	30	479	479	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES	NO	Not Available	413	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	11	G3									Not Available	Not Available	1918	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	YES	Dead	2009	2002
TCGA-61-2016	51	FEMALE	36	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	36			WITH TUMOR		51	Bilateral	TCGA-61-2016	512de609-757b-42be-8b30-c414f71af422	8	-18788	36	0	Not Available																								Not Available	NOT HISPANIC OR LATINO	TCGA-61-2016-F28357	991e4692-11e2-4ff7-9ca7-f07af311826f	8	36	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	2016	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	YES	Dead	2009	2006
TCGA-31-1951	58	FEMALE	684	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	659.0		Recurrence	WITH TUMOR		58	Left	TCGA-31-1951	b0839f46-8c82-4619-be3d-c857a1759463	4	-21352	Not Applicable	0	684	TCGA-31-1951-D27694;TCGA-31-1951-D27696;TCGA-31-1951-D27693;TCGA-31-1951-D27695	657dd0b8-f79b-44b4-9847-db5ac8eed2ea;bf9312cc-d8a3-4719-b7bf-b516ea90cadd;c56143b7-c7a5-4bbd-86fc-83ffbd920fc5;5334b5e4-7145-488e-a753-00c01b6c049d	Not Available;Not Available;Not Available;Not Available	4;4;4;4	482;146;482;146	328;41;328;41	Liposomal Doxorubicin;Paclitaxel;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available	1;1;1;1	06;06;06;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	240;1260;3600;3600	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-31-1951-F27692	b880add7-cdf8-492c-86f5-a1f8cbcdd513	4	Not Applicable	684	Not Available	Not Available	Not Available	Not Available	Not Available	1	YES	NO	Not Available	659	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	1	G3									Not Available	Not Available	1951	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	31	No Macroscopic disease	Ovary	YES	Alive	2010	2007
TCGA-36-1581	63	FEMALE	751	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G3	1	702.0		Recurrence	WITH TUMOR		63	Left	TCGA-36-1581	ef5e85cf-2d82-4d52-a02c-fed5c76e4cec	2	-23272	Not Applicable	0	751	TCGA-36-1581-D27894;TCGA-36-1581-D27895	ea9b943e-fd52-4668-bfd9-333776986799;56016835-05a9-40f2-92ca-42c4583f66c4	Not Available;Not Available	15;15	141;141	29;29	Carboplatin;Paclitaxel	Not Available;Not Available	1;1	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	4639;2313	mg;mg	Not Available;Not Available	2010;2010	0	Not Available	TCGA-36-1581-F27893	434514f8-04e5-4ec5-a694-0216e535fd97	2	Not Applicable	751	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	702	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1581	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	No Macroscopic disease	Ovary	Not Available	Alive	2009	2007
TCGA-36-2542	59	FEMALE	657	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	0	657			TUMOR FREE		59	Bilateral	TCGA-36-2542	7aadc24b-3de2-478f-b9e5-aca44424f514	18	-21902	Not Applicable	0	657	TCGA-36-2542-D27943;TCGA-36-2542-D27944	c15888a5-ada4-4d21-bda0-cac3f969bd25;fb87fce9-8378-400b-913d-98bf43261971	Not Available;Not Available	18;18	152;159	25;25	Carboplatin;Paclitaxel	Not Available;Not Available	8;8	06;06	540;77	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3240;1345	mg;mg	Not Available;Not Available	2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-36-2542-F27942	a439d861-b6a1-45a9-a2d7-f3cd9c2603e0	18	Not Applicable	657	Not Available	Not Available	Not Available	Not Available	Not Available	8									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2542	Not Available	TUMOR FREE	Not Available	Not Available	ASIAN	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	1-10 mm	Ovary	Not Available	Alive	2010	2008
TCGA-29-1704	61	FEMALE	1587	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	568.0		Recurrence	WITH TUMOR		61	Bilateral	TCGA-29-1704	8e7f1c74-7cb3-43c0-b07c-bf69b780053f	2	-22511	Not Applicable	0	1587	TCGA-29-1704-D27275;TCGA-29-1704-D27270;TCGA-29-1704-D27272;TCGA-29-1704-D27271;TCGA-29-1704-D27274;TCGA-29-1704-D27273;TCGA-29-1704-D27276	6e65321e-a2c2-438b-bdff-716ffd3b90ac;4a020b5d-1ba8-4996-a204-5c0b373e2693;68023b00-a088-44b2-8aed-3c723e70c172;05c70827-4563-4f78-b419-5a8d88b695fe;3a06f6c4-c0c7-4806-a597-21b86570feb4;1225fcb2-265b-417c-9401-e86d350027a4;21531b27-b04c-4716-b054-832e9646f84e	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3	1587;169;775;169;1300;775;1587	1566;21;642;21;1188;642;1566	Taxotere;carboplatin;Carboplatin;Paclitaxel;Doxil;Paclitaxel;Bevacizumab	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3	03;06;06;06;05;06;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;AUC;mg;mg/m2;mg;mg;mg	RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;Not Available	YES;NO;NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	70;4;485;135;70;230;1100	mg;AUC;mg;mg/m2;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-29-1704-F27269	23a71c94-1e87-4ba8-ae02-bde47265ccdf	2	Not Applicable	1587	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	YES;YES	Not Available;608	568;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Other Method;Other Method	CT;CT	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1704	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence	TCGA-29-1704-R27277	133adbf7-0275-4a02-8bb4-5ec6f14e1ad9	Not Available	3	964	930	Not Available	3	20	3500	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2010	R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	11-20 mm	Ovary	Not Available	Alive	2009	2005
TCGA-24-1423	61	FEMALE	190	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	190			TUMOR FREE		61	Bilateral	TCGA-24-1423	f64ebc7f-0e5a-42b4-af57-6cdb90d24f90	16	-22281	Not Applicable	0	190	TCGA-24-1423-D25939;TCGA-24-1423-D25937;TCGA-24-1423-D25938	69287a5a-8ebe-4dbd-b3aa-2c81832c098b;dfa0c377-ef42-4909-977c-58d6c1d64fe9;cf137e40-7f33-415e-834a-da9dfb583a3c	Not Available;Not Available;Not Available	16;16;16	151;151;151	21;21;21	Paclitaxel;Doxorubicin;Cisplatin	Not Available;Not Available;Not Available	4;4;4	07;07;07	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1703;477;532	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1423-F25936	2c5edeaa-427c-44b6-893c-797f75cdd9a8	16	Not Applicable	190	Not Available	Not Available	Not Available	Not Available	Not Available	4									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	4	G3									Not Available	Not Available	1423	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-24-2020	67	FEMALE	4624	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	723.0		Recurrence	WITH TUMOR		67	Bilateral	TCGA-24-2020	e20ea417-7296-4da8-9fdb-71cd1f45153a	1	-24682	4624	0	4624	TCGA-24-2020-D26438;TCGA-24-2020-D26436;TCGA-24-2020-D26437;TCGA-24-2020-D26439;TCGA-24-2020-D26435;TCGA-24-2020-D26433;TCGA-24-2020-D26434;TCGA-24-2020-D26440;TCGA-24-2020-D26432	16ff8ab0-dc3b-4e6e-83fe-68792b53fed2;aa45d459-df46-4429-a1eb-c4b7b073ebfd;da54104e-edf3-496d-9bb4-0a3e21627587;19d878df-30b8-4dd0-8ac9-22b938ca4021;4a4c8d77-7b48-4d12-91cd-d84d72ab935a;329ca615-a2d4-49ba-bb76-8766d1c58663;7aa60143-74ad-4409-a132-ccd6e17d4473;940f4776-0977-4739-bfab-c2d2ea68f56f;af49fe20-8feb-40e3-bd7f-02304f1d85f4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1;1;1;1	2085;940;1555;2298;940;414;414;2757;176	1905;745;1381;2235;745;274;274;2593;44	Doxil;Taxol;Topotecan;Taxol;Carboplatin;Taxol;Carboplatin;Carboplatin;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3	07;08;07;3;08;07;07;06;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;Not Available;mg	RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;Not Available;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	504;3024;77;1225;2496;1836;2013;Not Available;1032	mg;mg;mg;mg;mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2020-F26431	a3abbfc8-e286-4861-8709-fbe623ad55c4	1	4624	4624	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	723	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2020	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	1994
TCGA-13-0757	71	FEMALE	340	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	293.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-13-0757	2c69f3a4-c26c-4fbb-a1c0-b1f57554c43a	24	-25999	340	0	340	TCGA-13-0757-D24535;TCGA-13-0757-D24536;TCGA-13-0757-D24537	694dc262-613f-40fe-b735-58df6a8f7c5c;d9c850b0-6889-4a82-94f5-deeab734157d;e9908539-10a7-4295-b517-eaa029f112b2	Not Available;Not Available;Not Available	15;15;16	153;154;267	36;36;211	Paclitaxel;Carboplatin;Cisplatin	Not Available;Not Available;Not Available	4;4;4	6;6;3	Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	135;Not Available;Not Available	mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0757-F24534	b853f249-6500-468b-b059-179d7b1f5628	24	340	340	Not Available	Not Available	Not Available	60	Not Available	2	YES	NO	Not Available	293	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	60	Not Available	2	G3									Not Available	Not Available	0757	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2005
TCGA-24-1548	57	FEMALE	493	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	207.0		Recurrence	WITH TUMOR		57	Bilateral	TCGA-24-1548	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	2	-20945	493	0	493	TCGA-24-1548-D26103;TCGA-24-1548-D26108;TCGA-24-1548-D26106;TCGA-24-1548-D26104;TCGA-24-1548-D26107;TCGA-24-1548-D26102;TCGA-24-1548-D26105;TCGA-24-1548-D26109;TCGA-24-1548-D26110;TCGA-24-1548-D26111	aeccb39c-034f-423f-ae71-332c7ac802aa;f51b5aad-7380-4d3e-894d-a8addb1a7404;6839976c-7816-4663-8ed7-41c9acf7ae7a;73e950cc-b96f-4ae2-8983-c7c368a066b6;89cd8691-38f2-4991-86dd-3e97bde5b0a1;82b896d7-b3b2-420c-b7aa-bb20459cf97c;b8403ea4-d3d0-4ac1-982d-8b6fc8f73f25;4530176e-75d6-434b-8d76-b4de9496cde5;e6eb5a6a-9561-4c32-9425-50299638e15e;1d635a63-88f6-4118-aede-37e239476d22	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28;28;28;29;29	123;443;327;242;443;123;242;488;123;123	6;351;272;221;351;6;221;475;6;6	Carboplatin;Navelbine;Doxil;Topotecan;Gemcitabine;Taxol;Cisplatin;Taxol;Taxol;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7;7;7;7	06;Not Available;03;02;Not Available;06;02;03;6;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;mg;mg;Not Available;mg;mg;mg;mg;mg	ADJUVANT;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;ADJUVANT;RECURRENCE;PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4790;Not Available;197;10;Not Available;1750;250;360;1750;4790	mg;Not Available;mg;mg;Not Available;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1548-F26101	f784a2bc-8872-4f2a-ad6e-6a270a01e198	2	493	493	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	207	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1548	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1997
TCGA-04-1542	52	FEMALE	2561	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G2	1	1020.0		Recurrence	WITH TUMOR		52	Bilateral	TCGA-04-1542	0c1a2e7d-e7e4-481e-a012-ef214c444497	2	-19263	2561	0	Not Available	TCGA-04-1542-D24119;TCGA-04-1542-D24126;TCGA-04-1542-D24120;TCGA-04-1542-D24124;TCGA-04-1542-D24133;TCGA-04-1542-D24123;TCGA-04-1542-D24130;TCGA-04-1542-D24131;TCGA-04-1542-D24121;TCGA-04-1542-D24129;TCGA-04-1542-D24127;TCGA-04-1542-D24128;TCGA-04-1542-D24134;TCGA-04-1542-D24132;TCGA-04-1542-D24122;TCGA-04-1542-D24125	ba72049a-201d-41b9-8de5-836bdcfffe5d;232608ab-c0eb-4ce7-b90f-500736a7b355;d5500c2d-df88-43c8-bcff-c3a415ef606f;20d4ef39-b4e4-4099-87b4-3c1ae4e8ede7;98ae57ba-9add-4fe6-9fb3-bce9ae6a5669;f22e4162-0e7a-4685-a9f9-f8c7c4413fb7;1b6278b2-3735-4dbc-b72c-c3a0de8b231b;ae31010e-271a-4578-8b6b-af308af8c194;957ad38f-b0eb-459a-a8d6-fe69e4ceb3ed;19692f61-2cbc-49a2-b4ec-8dc55dad3507;11a6fcf9-f217-42ef-92df-6290ee4740ac;89467124-049b-4810-abf9-b2d8d9346378;96845b6d-fb8b-448e-a46d-fddd67417df7;59897436-39f7-4492-9b3c-b9785fb4da51;2bb98c0b-c301-4b4c-a529-767fd0eb9e36;39b4a282-57ca-433c-b064-947aee07c02b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	24;24;24;24;24;24;24;24;24;24;24;24;24;24;24;24	167;1781;167;1487;2512;1294;2176;2268;167;2176;1781;2106;2512;2328;1294;1529	2;1564;2;1322;2328;1051;2115;2207;2;2115;1564;1993;2328;2268;1051;1501	Paclitaxel;Gemcitabine;Carbplatin;Paclitaxel;Gemcitabine;Carboplatin;Avastin;Carboplatin;Gemcitabine;Docetaxel;Cisplatin;Avastin;Avastin;Doxorubicin;Paclitaxel;Doxil	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11;11;11;11;11;11;11;11	08;11;08;06;09;12;04;03;08;04;11;06;09;03;12;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;AUC;mg;mg;AUC;mg;AUC;mg;mg;mg;mg;mg;mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;Not Available;Not Available;Not Available;Not Available;Not Available;IV;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2534;32496;5;122.1;28756;5;4875;5;17378;124.15;11299.9;7398;2870;343;4004;159	mg;mg;AUC;mg;mg;AUC;mg;AUC;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-04-1542-F24118	6c66cb68-4c55-4a8a-9241-99a2f36bc6fd	2	2561	Not Available	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	1020	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G2									Not Available	Not Available	1542	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-61-2611	40	FEMALE	483	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	383.0		Recurrence	WITH TUMOR		40	Bilateral	TCGA-61-2611	499645bd-e33e-4f89-8526-50460e8bb884	7	-14782	483	0	483	TCGA-61-2611-D28492;TCGA-61-2611-D28493;TCGA-61-2611-D28494	34666b3b-f332-478f-9e6c-b0f883bb1244;7bd1c9d0-0ad8-486c-9554-76f86e0b5519;b44534f8-de06-4bb5-9592-2d22bb4537a9	Not Available;Not Available;Not Available	7;7;7	402;316;316	402;66;66	Doxorubicin HCI Lipsome;Carboplatin;Taxol	Not Available;Not Available;Not Available	9;9;9	1;06;06	10;800;265	mg;mg;mg	RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	TCGA-61-2611-F28491	10f574ef-ba1d-4b3e-ba11-343fcadafa31	7	483	483	Not Available	Not Available	Not Available	Not Available	Not Available	9	YES;YES	NO;NO	Not Available;383	383;Not Available	Recurrence;Locoregional Disease	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	9	G3									Not Available	Not Available	2611	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Dead	2010	2008
TCGA-3P-A9WA	55	FEMALE	420	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIB	G3	0	420			TUMOR FREE		55	Left	TCGA-3P-A9WA	E35B2813-427E-4E83-95F6-4F0281F42A59	29	-20211	Not Applicable	0	243	TCGA-3P-A9WA-D60123;TCGA-3P-A9WA-D60124	CBB9DB6A-C8A4-465E-8180-0CE8BB362721;ADC8FFC1-7FE3-4DBB-A041-FC4CD4F35B60	Not Available;Not Available	29;29	212;212	92;92	Taxol;Paraplatin	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	Not Evaluated	NOT HISPANIC OR LATINO	TCGA-3P-A9WA-F67273	C711B68A-CDCB-4FDC-A287-F34D57A37C2F	4	Not Applicable	420	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	11									NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2014	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8440/3	C56.9	YES	Dilatation and Curettage, Polypectomy	Other method, specify:	Not Available	100	Unknown	5	G3									Not Available	Yes, History of Synchronous/Bilateral Malignancy	A9WA	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			RX	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	YES	NO	3P	Not Available	Ovary	Unknown	Alive	2014	2013
TCGA-24-1471	60	FEMALE	36	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	36			Not Available		60	Left	TCGA-24-1471	ceb19678-b453-4529-b6cb-d02f9cb101b4	13	-22081	Not Applicable	0	36	TCGA-24-1471-D26070;TCGA-24-1471-D26071	9214c29b-a67f-4762-9ca0-9297a0bad8ac;789f5290-ddbc-4a16-8398-ab5cb498b563	Not Available;Not Available	24;24	Not Available;Not Available	Not Available;Not Available	Not Available;GOG 218	Not Available;Not Available	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Chemotherapy;Targeted Molecular therapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-24-1471-F26069	4a48ca18-4453-402f-b1b1-f98c79a2793e	13	Not Applicable	36	Not Available	Not Available	Not Available	Not Available	Not Available	5									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	5	G3									Not Available	Not Available	1471	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Alive	2009	2009
TCGA-61-1901	65	FEMALE	347	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	329.0		Progression of Disease	WITH TUMOR		65	Bilateral	TCGA-61-1901	7a75d318-b301-4f77-a97f-4d6784d27216	1	-24042	347	0	347	TCGA-61-1901-D28228;TCGA-61-1901-D28227	4b2e65d9-beef-462d-9820-6aa8c06bf8c1;f89a19a1-eb39-4031-9043-3ea9fd7fe6cf	Not Available;Not Available	4;4	294;294	28;28	Carboplatin;Taxotere	Not Available;Not Available	12;12	08;08	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3941;2098	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1901-F28226	ba0241ae-e66a-4fa9-8fb4-310aca8c7c68	1	347	347	Not Available	Not Available	Not Available	Not Available	Not Available	10	YES	YES	Not Available	329	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	YES	10	G3									Not Available	Not Available	1901	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-61-1901-R28229	6f60dfdd-ff7c-4d73-aaa8-ec7de28d6af3	Not Available	4	337	330	Not Available	12	07	2100	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	YES	Dead	2009	2008
TCGA-23-2078	66	FEMALE	2661	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	2661			TUMOR FREE		66	Bilateral	TCGA-23-2078	ebe677e6-94b6-45be-a58d-eaae4cf63d12	20	-24223	Not Applicable	0	2661	TCGA-23-2078-D25772;TCGA-23-2078-D25773	e275dc2a-fe10-41d0-9a98-fe92de858ab9;3bbb5d6b-af79-42f3-a412-3ae01a8b6bb0	Not Available;Not Available	20;20	149;149	35;35	Carboplatin;Taxol	Not Available;Not Available	11;11	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3240;1980	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-2078-F25771	a7bc8fe5-86cb-4da0-a383-0be6d1f16c49	20	Not Applicable	2661	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	YES	11	G3									Not Available	Not Available	2078	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	No Macroscopic disease	Ovary	YES	Alive	2009	2001
TCGA-23-1124	62	FEMALE	1768	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	641.0		Recurrence	WITH TUMOR		62	Left	TCGA-23-1124	8a6d2ce3-cc57-451b-9b07-8263782aa23f	19	-23005	1768	0	Not Available	TCGA-23-1124-D25741;TCGA-23-1124-D25744;TCGA-23-1124-D25742;TCGA-23-1124-D25745;TCGA-23-1124-D25740;TCGA-23-1124-D25743	df58a615-2cd0-4768-855e-d920caff4cbe;ac2cb5f8-306a-4e7e-b2cf-e9e8e84ea8fd;d72e12a2-1524-4f1e-ab4e-108fffef106a;d94c08b1-d8f5-480f-bae4-b7239957cdf4;4285dc70-1dda-45e9-b520-d7704bfb61ba;4575fc46-e77a-4c7e-b1bc-351538c08b00	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27	872;1510;1286;1566;197;1342	676;1363;1070;1538;19;1307	Gemcitabine;Doxorubicin;Paclitaxel;Topotecan;Carboplatin;Vinorelbine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	18;6;11;4;9;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	RECURRENCE;PROGRESSION;RECURRENCE;PROGRESSION;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18000;390;3080;12;4950;180	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-23-1124-F25739	c90aa1d1-772f-417c-b113-a6161625f250	19	1768	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	NO;NO	Not Available;644	641;Not Available	Recurrence;Metastatic	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1124	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	No Macroscopic disease	Ovary	YES	Dead	2009	1999
TCGA-10-0928	71	FEMALE	563	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	563			WITH TUMOR		71	Bilateral	TCGA-10-0928	29d26e7e-f4ae-4476-9a3f-27d5ec2ccb8a	6	-26066	563	0	563																								0	Not Available	TCGA-10-0928-F24430	c87807df-3345-4970-807a-a338040b2c38	6	563	563	0	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G3									Not Available	Not Available	0928	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	1-10 mm	Ovary	NO	Dead	2009	2000
TCGA-25-1320	65	FEMALE	1155	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	424.0		Recurrence	WITH TUMOR		65	Bilateral	TCGA-25-1320	46395c3d-5e51-477f-946e-e58b87cc7baa	27	-24018	1155	0	1124	TCGA-25-1320-D26666;TCGA-25-1320-D26665;TCGA-25-1320-D26667;TCGA-25-1320-D26668	32ce5448-ce5a-4626-ae66-c2f43005976b;ace5ad75-8cc5-441f-80ff-875333731b1c;5c3d0e22-0362-45b8-9daf-27c853cebc0f;4494b225-32ae-457c-add4-f6ee7654acec	Not Available;Not Available;Not Available;Not Available	27;27;27;27	181;181;181;607	28;28;28;424	Carbo;Taxol;Topotecan;Doxil	Not Available;Not Available;Not Available;Not Available	3;3;3;3	8;8;8;7	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	Not Available;NO;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1320-F26664	96391cfa-b15a-41b8-9967-3af1db0693fc	27	1155	1124	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	424	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1320	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-10-0937	44	FEMALE	608	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	235.0		Recurrence	WITH TUMOR		44	Bilateral	TCGA-10-0937	a5030259-cf9c-4a58-8710-b9da8ee59320	6	-16222	608	0	460	TCGA-10-0937-D24478;TCGA-10-0937-D24481;TCGA-10-0937-D24477;TCGA-10-0937-D24480;TCGA-10-0937-D24479	64cba306-01c8-4412-9e49-95d131594683;b7a1dace-94aa-4b2e-9b21-8887a767f9b0;db74055c-a84f-449b-82f1-9108f0ff89c0;f638ea11-a654-4755-af37-e67ded7c0ca7;985bd058-ab32-48c3-b123-43ac7e98ac1a	Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18	146;451;146;Not Available;296	33;Not Available;33;346;244	Carboplatin;Gemcitabine;Taxol;Topotecan;Doxil	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	06;3;06;1;06	Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	3990;4176;1980;21;140	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	0	Not Available	TCGA-10-0937-F24476	33721cd1-5029-49c4-bc36-64ee90e76df1	6	608	460	0	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	235	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0937	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	1-10 mm	Ovary	Not Available	Dead	2009	2005
TCGA-24-2024	72	FEMALE	1769	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	421.0		Recurrence	WITH TUMOR		72	Bilateral	TCGA-24-2024	0a48873a-092a-4b25-822b-b0b3c18c08a8	26	-26476	1769	0	1769	TCGA-24-2024-D26452;TCGA-24-2024-D26454;TCGA-24-2024-D26453;TCGA-24-2024-D26451	a14ae0bf-eabb-413b-8ff0-8caa2797bc01;b6880a72-50bd-41c7-b4b8-360e632eb75c;38b75d0f-1ca9-4064-b1e6-b5137f0d86bf;0b41e156-a9cb-47a8-9417-eade393e92ee	Not Available;Not Available;Not Available;Not Available	26;26;26;15	120;568;568;120	10;456;456;10	Carboplatin;Taxol;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available	2;2;2;3	06;06;06;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3348;2444;3533;1573	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2024-F26450	ea9bc46b-5020-4f83-98a5-bb896df3f040	26	1769	1769	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	NO;NO	Not Available;419	421;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Molecular Markers;Molecular Markers	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	2024	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	1994
TCGA-36-2547	64	FEMALE	624	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	624			Not Available		64	Left	TCGA-36-2547	5e447cbc-9bc9-4e1a-9b43-06cf619e5aa9	18	-23706	Not Applicable	0	624	TCGA-36-2547-D27959;TCGA-36-2547-D27960	2d0f8024-f78a-4818-b9a7-2f78a52624a2;88a8157c-ca8d-494c-ab8d-de85bb90d7c1	Not Available;Not Available	18;18	Not Available;Not Available	42;42	Carboplatin;Pacliltaxel	Not Available;Not Available	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IP;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-36-2547-F27958	2debace6-a790-48a8-a169-ca0f12294b4c	18	Not Applicable	624	Not Available	Not Available	Not Available	Not Available	Not Available	8									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2547	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	No Macroscopic disease	Ovary	Not Available	Alive	2010	2008
TCGA-31-1956	60	FEMALE	1342	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	1			Locoregional Disease	WITH TUMOR		60	Left	TCGA-31-1956	e1158102-06f2-47bb-9fe0-49b57f070755	19	-22100	Not Applicable	0	1342	TCGA-31-1956-D27712;TCGA-31-1956-D27713	d3e74b41-1369-48f8-a1ad-767692bd830f;5cc90a67-38af-4ca7-a5cf-9c7676f0cb0b	Not Available;Not Available	19;19	188;188	34;34	Carboplatin;Paclitaxel	Not Available;Not Available	10;10	07;07	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5150;1590	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-31-1956-F27711	97da6eb3-ae55-4f66-af96-3a0332182595	19	Not Applicable	1342	Not Available	Not Available	Not Available	Not Available	Not Available	10	YES	NO	119	Not Available	Locoregional Disease	YES	Not Available	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	10	G3									Not Available	Not Available	1956	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	31	Not Available	Ovary	NO	Alive	2009	2005
TCGA-23-1123	59	FEMALE	1018	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1018			WITH TUMOR		59	Left	TCGA-23-1123	60cce7ac-d27d-44a6-9873-ecf91da5e906	24	-21552	1018	0	Not Available	TCGA-23-1123-D25735;TCGA-23-1123-D25737;TCGA-23-1123-D25736;TCGA-23-1123-D25734	ca5ac43f-2f1e-4180-9c04-2d70675ebbda;800b81f9-0925-43c9-b017-0e9c8fa28a33;3348bc4e-bbef-480d-81d3-aa751f366dd9;d80cf2a4-4284-404d-a4d6-72fc39b01dff	Not Available;Not Available;Not Available;Not Available	1;1;1;1	250;894;599;250	7;812;452;7	Paclitaxel;Topotecan;Doxorubicin;Carboplatin	Not Available;Not Available;Not Available;Not Available	4;4;4;4	8;3;6;8	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;ADJUVANT	Not Applicable;Persistence;Persistence;Not Applicable	Not Available;Not Available;Not Available;Not Available	Other (specify below);Other (specify below);Not Available;Other (specify below)	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	2000;39.9;456;4800	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1123-F25733	c472da3f-a91f-41a5-b7e9-345a90ed3ada	24	1018	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1123	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	11-20 mm	Ovary	Not Available	Dead	2009	1998
TCGA-29-2425	60	FEMALE	1977	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	1	1577.0		Progression of Disease	TUMOR FREE		60	Not Available	TCGA-29-2425	40635bf3-d8ba-4833-b623-547e55e5d07e	9	-22089	Not Applicable	0	1977	TCGA-29-2425-D27464;TCGA-29-2425-D27465;TCGA-29-2425-D27466;TCGA-29-2425-D27468;TCGA-29-2425-D27463;TCGA-29-2425-D27467	7db78a21-3be4-499a-a7bc-fff049921c40;bb6485f6-0925-462b-b098-086512a78e90;b1c41005-66fb-4b61-bb72-9a2dde69f06d;a11754f7-bc64-44fb-b4ba-049a4f6f9766;68120a6b-d428-4644-a08d-39d0d8635aa4;b173f7f4-e6ed-49dc-bf99-a3d7a213801b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9	1696;202;97;1696;1696;202	1584;10;10;1584;1584;119	Carboplatin;Carboplatin;Gemzar;Bevacizumab;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2	06;06;04;Not Available;06;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	AUC;AUC;mg/m2;mg/m2;mg/m2;mg/m2	PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;Not Available;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;6;1000;15;175;175	AUC;AUC;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-29-2425-F27462	dbe47bcc-3e28-4fec-95cf-f4363c17e184	9	Not Applicable	1977	0	Not Available	Not Available	Not Available	Not Available	2	YES;YES	NO;NO	Not Available;1024	1577;Not Available	Progression of Disease;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	2	G2									Not Available	Not Available	2425	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Alive	2010	2004
TCGA-13-0919	52	FEMALE	2571	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	2571			TUMOR FREE		52	Bilateral	TCGA-13-0919	45957be6-e4df-4245-acf8-39dfc118ee19	25	-19337	Not Applicable	0	453	TCGA-13-0919-D24772;TCGA-13-0919-D24773	943463ed-59a4-44d1-a1fe-cd706824fe1f;53980a2d-3250-4d22-951c-af3ecf5572e7	Not Available;Not Available	16;16	160;160	42;42	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	6;6	Not Available;Not Available	AUC;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	5;175	AUC;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0919-F24771;TCGA-13-0919-F72632	f48b87bd-e3fb-4c13-a59d-3aba2fbf2585;E63E879C-A38A-4316-8AF1-B387294B3964	25;30	Not Applicable;Not Applicable	453;2571	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	80;Not Available	Not Available;Not Available	2;7									Not Available;NO	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0919	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2007
TCGA-61-2000	67	FEMALE	441	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	339.0		Recurrence	WITH TUMOR		67	Bilateral	TCGA-61-2000	29949b65-2913-4c86-bbd7-b85c5df6f15e	8	-24723	Not Applicable	0	441	TCGA-61-2000-D28319;TCGA-61-2000-D28315;TCGA-61-2000-D28314;TCGA-61-2000-D28317;TCGA-61-2000-D28313;TCGA-61-2000-D28316;TCGA-61-2000-D28312;TCGA-61-2000-D28318	c8caf399-a8ff-4dc9-8b74-2708050e41c0;d8595da8-5331-4069-8b2c-8ce6f92b1d33;de3a38db-115b-4578-b4ca-1a70e152bc86;a7437859-e26f-4182-a68e-d71bb725f774;f41bfb1f-715c-488a-8c23-0547b7a39613;f43225b8-2247-4397-90fb-8ac91e6a7806;01c66404-139e-49b4-880f-f7fc97c53c34;b473a7f5-5323-4b38-b6ec-4f105fe01e5c	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8;8	588;231;231;491;231;491;231;588	525;28;28;420;28;420;28;525	Taxol;Taxol;CCDP;Oxaliplatin;Taxol;Docetaxel;Carboplatin;Avastin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12	09;06;06;04;09;04;3;04	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IV;IP;IV;IP;IV;IP;IV;IP;IV;IP;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	855;390;720;367;2130;508;1905;3780	mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2000-F28311	e1ec40cf-3f01-42e9-859f-d16e3aaff23e	8	Not Applicable	441	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES;YES	NO;NO	Not Available;381	339;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	2000	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	YES	Alive	2009	2008
TCGA-13-1482	52	FEMALE	1877	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	1	602.0		Recurrence	WITH TUMOR		52	Not Available	TCGA-13-1482	f3af727e-b592-4828-94f5-22008666cf8c	31	-19178	1877	0	1877	TCGA-13-1482-D24850;TCGA-13-1482-D24849	0b9deb4b-3ed0-4350-bfc1-daadb62afa14;15515ea8-488a-4962-8719-11b9d4bda728	Not Available;Not Available	30;30	152;152	33;33	Paciltaxel;Carboplatin	Not Available;Not Available	6;6	6;6	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;5	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1482-F24848	6827f11a-2b5c-4f30-9223-474c514708e6	31	1877	1877	Not Available	Not Available	Not Available	80	Not Available	3	YES	NO	Not Available	602	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	3	G2									Not Available	Not Available	1482	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Dead	2009	2000
TCGA-04-1346	73	FEMALE	1993	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	0	1993			TUMOR FREE		73	Bilateral	TCGA-04-1346	25a0a9e6-4f5b-45d8-8f34-abfd31d5ff1b	26	-26865	Not Applicable	0	1993																								Not Available	NOT HISPANIC OR LATINO	TCGA-04-1346-F23959	da328292-e520-498b-aaaa-60337d841505	26	Not Applicable	1993	Not Available	Not Available	Not Available	100	Not Available	3									Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	100	YES	3	G2									Not Available	Not Available	1346	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	Not Available	Alive	2009	2003
TCGA-29-1702	84	FEMALE	728	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	286.0		Recurrence	WITH TUMOR		84	Right	TCGA-29-1702	0e1598d8-cbe5-4113-95f1-4bcda061239b	2	-30910	728	0	568	TCGA-29-1702-D27250;TCGA-29-1702-D27251;TCGA-29-1702-D27252;TCGA-29-1702-D27253	9cbffc31-fc40-4166-b1b8-601d6f9fa089;8929ea04-1247-4be3-aecc-300064ec7a3b;0722dd17-afea-443f-a0cb-14c6334919b9;475e241e-06ea-4bd8-a562-92e47214f991	Not Available;Not Available;Not Available;Not Available	18;18;20;20	199;Not Available;Not Available;Not Available	Not Available;Not Available;376;466	Carboplatin;Paclitaxel;Doxil;Topotecan	Not Available;Not Available;Not Available;Not Available	12;12;4;4	6;Not Available;Not Available;02	Not Available;Not Available;Not Available;Not Available	AUC;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	6;Not Available;Not Available;Not Available	AUC;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010	1	Not Available	TCGA-29-1702-F27249	a69603c0-0756-4367-a239-b419edfc8130	2	728	568	1	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	286	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1702	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Dead	2009	2005
TCGA-04-1331	78	FEMALE	1336	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	459.0		Recurrence	WITH TUMOR		78	Bilateral	TCGA-04-1331	6d10d4ee-6331-4bba-93bc-a7b64cc0b22a	26	-28848	1336	0	1224	TCGA-04-1331-D23907;TCGA-04-1331-D23909;TCGA-04-1331-D23908	f4aaacc4-22bc-4b11-9987-42a72560fe95;8248d776-145a-4301-8d69-09567aedcf3d;0debc4f0-665e-47b4-880c-d732d3897ea2	Not Available;Not Available;Not Available	10;10;10	169;498;169	36;481;36	Taxol;Velcade;Carboplatin	Not Available;Not Available;Not Available	11;11;11	06;Not Available;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;IV	NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available	1650;4.4;455	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-04-1331-F23906	301b373d-8abe-471e-8805-51bcf72a4fc2	26	1336	1224	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	459	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	1331	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	NO	Dead	2009	2004
TCGA-04-1536	60	FEMALE	885	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	498.0		Recurrence	WITH TUMOR		60	Bilateral	TCGA-04-1536	1fe19c6b-71d0-4b07-923b-74ea32210db0	3	-21939	885	0	Not Available	TCGA-04-1536-D24111;TCGA-04-1536-D24115;TCGA-04-1536-D24114;TCGA-04-1536-D24113;TCGA-04-1536-D24116;TCGA-04-1536-D24112	4c9cdf72-d881-4079-bec6-5453fe89239d;efdac1c1-cacb-45e9-8da2-5c9209fcda54;feed8215-093e-4fb3-a54c-38013eb6625f;57161b96-b564-4d9b-89ff-30dc8dee32c8;b895268f-eb7a-4293-9f10-6dbaea5fd999;049090d1-2734-4c0c-b1f1-d7fe561af4c8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9	232;Not Available;Not Available;232;Not Available;232	36;518;518;36;518;36	Carboplatin;Doxil;Carboplatin;Doxil;Taxotere;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	08;Not Available;Not Available;08;Not Available;08	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;mg;Not Available;mg	ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;Not Available;IV;Not Available;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3360;Not Available;Not Available;188;Not Available;2125	mg;Not Available;Not Available;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-04-1536-F24110	d2bb276e-782a-46a9-bbef-889f1b28b446	3	885	Not Available	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	498	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1536	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-13-0923	74	FEMALE	2547	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1719.0			TUMOR FREE		74	Right	TCGA-13-0923	378f7ea2-86b4-4072-80b8-e12d67193106	25	-27081	Not Applicable	0	195	TCGA-13-0923-D24783;TCGA-13-0923-D24785;TCGA-13-0923-D24784	942a1a6d-f1f2-4550-bab2-8cdbe1bcdea0;b303f13f-01de-4e5a-8fe1-c7ef1b52fe06;26beddad-f96d-4695-b753-f76cf0f72aeb	Not Available;Not Available;Not Available	15;15;15	151;151;151	39;39;39	Cisplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;60;135	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0923-F24782;TCGA-13-0923-F72635	490be56a-1798-44b3-9506-10b9657852fa;F8E53537-3FD8-4EDB-8B88-242BBD058BCD	25;30	Not Applicable;Not Applicable	195;2547	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;1719	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0923	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-61-2101	55	FEMALE	1688	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	0	1688			WITH TUMOR		55	Bilateral	TCGA-61-2101	5d1a54fe-e0df-4c17-b623-b649a136dc82	7	-20287	1688	0	Not Available	TCGA-61-2101-D28423;TCGA-61-2101-D28425;TCGA-61-2101-D28429;TCGA-61-2101-D28433;TCGA-61-2101-D28432;TCGA-61-2101-D28430;TCGA-61-2101-D28424;TCGA-61-2101-D28427;TCGA-61-2101-D28431;TCGA-61-2101-D28426;TCGA-61-2101-D28434;TCGA-61-2101-D28428	48ba6dc6-f632-4dce-b86d-ff727f1251b3;a9ae8b0a-2427-4bb0-82c6-ee9668363f5f;f557ab9d-8841-415f-a81a-2986f12eb545;b3ae2276-2ab9-4b82-bc5e-83f7143af1ea;bb3e3e24-b6db-4a5c-ae01-b27ab1c1628c;a0365ba7-19d8-4ea4-9b7a-ce9c9cf90d23;a17b6920-5a05-4657-a3ee-1dafc0f723e7;119e9ed1-a261-483a-a7bf-34bcece33123;ad0029f1-24b5-490c-b5e2-56e03495b8a3;395d5771-ffed-491a-baa5-f715fb8fbd06;e2b74437-6a3e-4db1-ba77-7c66df176fc0;22a24cee-77c5-423e-b0fa-2fadedc64e6d	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7;7;7;7;7;7	117;221;Not Available;Not Available;Not Available;Not Available;117;Not Available;Not Available;221;Not Available;Not Available	2;152;1103;1251;1220;1159;2;733;1190;152;1129;733	Taxol;Taxol;Doxil;VP 16;Doxil;Hexalen;Cisplatin;Gemcitabine;Gemzar;Carboplatin;IL 12;Hexalin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12;12;12	06;04;Not Available;Not Available;Not Available;Not Available;06;Not Available;Not Available;04;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;Not Available;Not Available;Not Available;Not Available;mg;mg;Not Available;mg;mg/kg;mg	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;Not Available;Not Available;Not Available;Not Available;IV;Not Available;Not Available;IV;IP;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1800;1200;Not Available;Not Available;Not Available;Not Available;762;1420;Not Available;3050;300;800	mg;mg;Not Available;Not Available;Not Available;Not Available;mg;mg;Not Available;mg;mg/kg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	0	NOT HISPANIC OR LATINO	TCGA-61-2101-F28422	d25c7ceb-de04-4a5b-87e1-8c217938de7d	7	1688	Not Available	0	Not Available	Not Available	100	Not Available	12									Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	100	Not Available	12	G2									Not Available	Not Available	2101	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence;Primary Tumor Field	TCGA-61-2101-R28435;TCGA-61-2101-R28436	2e12c990-cd4b-46fc-a84c-c6f3478884e1;bce41480-77eb-4e42-be71-741a6ce4caed	Not Available;Not Available	7;7	1327;1327	1309;1319	Not Available;Not Available	12;12	02;07	600;1960	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	PALLIATIVE;PALLIATIVE	Not Available;Not Available	cGy;cGy	2009;2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	11-20 mm	Ovary	Not Available	Dead	2009	1999
TCGA-42-2582	49	FEMALE	1447	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	616.0		Recurrence	WITH TUMOR		49	Bilateral	TCGA-42-2582	7922df77-f09a-488c-a1be-58646ceb9b3e	3	-17961	Not Applicable	0	435	TCGA-42-2582-D28029;TCGA-42-2582-D28031;TCGA-42-2582-D28028;TCGA-42-2582-D28030;TCGA-42-2582-D28818;TCGA-42-2582-D28819;TCGA-42-2582-D31446	cb3e3212-e23f-4b37-9f42-93c5ee99a980;dfdd0a09-cbbb-4dcb-9cc5-cefebd224b34;55f15f39-17c5-4aa3-9a39-bab6794e69f5;c19b14c4-4aae-4c87-bf43-e31418a4506b;495ec0d8-ca4e-4ef2-af6c-2f5ee7b212fc;f7f05050-c2e8-4fa4-8768-ce2a34d3835e;44CFCC79-0825-468C-84A0-5E1288307CF4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;18;18;2	Not Available;36;184;185;560;682;955	232;36;57;37;232;640;800	Taxol;Taxol;Taxotere;Cisplatin;Taxol;Cisplatin;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Stable Disease	6;6;6;6;5;5;5	7;1;6;7;06;03;Not Available	240;325;135;180;242;180;Not Available	mg;mg;mg;mg;mg;mg;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;02;03;Not Available	IV;IV;IV;IP;IV;IP;Not Available	YES;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1440;325;945;1260;1453;540;Not Available	mg;mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;NO	2010;2010;2010;2010;2011;2011;2012	1	NOT HISPANIC OR LATINO	TCGA-42-2582-F28027;TCGA-42-2582-F28812;TCGA-42-2582-F34655;TCGA-42-2582-F34657	eabede43-353b-4c49-bf74-35f7d76ef33d;50a689bd-b234-4bbe-a9ae-c0cfadb1a842;70638D89-1FBF-4A94-A6FC-242ED16A6937;099527CD-4D0D-4C42-A39C-5A80120ABFA4	3;18;18;18	Not Applicable;Not Applicable;1447;1447	435;792;Not Available;Not Available	1;1;Not Available;Not Available	Not Available;Not Available;Additional New Tumor Event;Additional New Tumor Event	Not Available;Not Available;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;NO;NO	6;5;3;3	None;YES;YES;YES;YES;YES;YES	None;NO;NO;YES;YES;YES;YES	None;Not Available;616;Not Available;Not Available;Not Available;Not Available	None;616;Not Available;1073;1073;1179;1179	None;Recurrence;Metastatic;Progression of Disease;Unknown;Progression of Disease;Unknown	None;Not Available;YES;Not Available;Not Available;Not Available;Not Available	None;Imaging Study;Imaging Study;Imaging Study;Imaging Study;Imaging Study;Imaging Study	None;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;YES;YES	Not Available;Post-Adjuvant Therapy;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES	Stable Disease;Stable Disease;Stable Disease;Stable Disease	NO;NO;NO;NO	Alive;Alive;Dead;Dead	2010;2011;2013;2013	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	YES	6	G3									Not Available	Not Available	2582	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	42	No Macroscopic disease	Ovary	Not Available	Alive	2010	2009
TCGA-29-2434	52	FEMALE	349	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	349			TUMOR FREE		52	Left	TCGA-29-2434	cb090048-9af1-489d-9ebe-7efaa3dc4e85	7	-18997	Not Applicable	0	349	TCGA-29-2434-D27508;TCGA-29-2434-D27507;TCGA-29-2434-D27506	266546a4-d823-480b-9c84-a8b4ae413205;052789d2-36ee-41a4-8bc3-b6bfa7a2f87b;269dc635-745c-4959-aef6-d92e348c7080	Not Available;Not Available;Not Available	7;7;7	140;134;134	35;28;28	Paclitaxel;Cisplatin;Paclitaxel	Not Available;Not Available;Not Available	6;6;6	05;06;06	100;100;135	mg;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg;mg/m2;mg/m2	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	HISPANIC OR LATINO	TCGA-29-2434-F27505	7f29f50c-d1c4-4c15-a139-611db85c9ea8	7	Not Applicable	349	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	2434	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	No Macroscopic disease	Ovary	Not Available	Alive	2010	2009
TCGA-04-1370	52	FEMALE	1824	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	1824			Not Available		52	Bilateral	TCGA-04-1370	7e6cdbc7-26a7-44f2-96fa-094738cbccae	12	-19329	Not Applicable	0	1824	TCGA-04-1370-D24063;TCGA-04-1370-D24064	83f67477-8b87-4f45-b848-4f793508c589;643a2e01-ac72-408c-b5cb-c8de74fe6c58	Not Available;Not Available	12;12	200;200	8;8	Paclitaxel;Carboplatin	Not Available;Not Available	8;8	08;08	315;528	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	2520;5320	mg;mg	Not Available;Not Available	2010;2010	1	Not Available	TCGA-04-1370-F24062	51c21a91-4729-46db-9a19-2b5383585fcd	12	Not Applicable	1824	1	Not Available	Not Available	Not Available	Not Available	8									Not Available	Pre-Adjuvant Therapy	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	1370	Pre-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Alive	2010	2004
TCGA-29-1697	62	FEMALE	949	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	500.0		Recurrence	WITH TUMOR		62	Bilateral	TCGA-29-1697	42ebd30b-175e-4ece-a806-e55cb7e40e96	2	-22933	949	0	949	TCGA-29-1697-D27218;TCGA-29-1697-D27217;TCGA-29-1697-D27219;TCGA-29-1697-D27223;TCGA-29-1697-D27224;TCGA-29-1697-D27221;TCGA-29-1697-D27220;TCGA-29-1697-D27225;TCGA-29-1697-D27222	d5003891-7fb6-49cf-a9d9-e8c42ce205f6;2defdb44-07c7-4c6f-989c-522e938522e5;08e36e3c-04d0-4eb9-82d4-db345de17ba7;71741cc7-cf5c-4722-83bf-365852338e29;54c4ffc2-7da7-44bc-b3f3-c4ec287b03d4;b1d90209-3eef-4785-bbe2-df492af098b4;cc1a9ed1-7a73-4ac6-af71-62aaef17faab;4bbdb89d-adc9-4248-a03d-a57515745d82;0454b893-307a-4c01-8b81-3973f8a22e54	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;7;7;7;7;7;7	91;182;182;899;934;664;535;927;843	28;28;111;878;927;552;510;927;780	Gemcitabine;Carboplatin;Paclitaxel;Carboplatin;Topotecan HCL;Carboplatin;Docetaxel;Bevacizumab;Doxorubicin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;4;4;4;4;4;4	04;07;04;02;02;06;04;Not Available;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;Not Available;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11184;4512;1246;574;5.2;574;54;650;70	mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2010;2010;2010;2010;2010;2010	1	Not Available	TCGA-29-1697-F27216	9c6b4033-ddba-482d-a15c-ea455d16687e	2	949	949	1	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	500	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1697	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Dead	2009	2003
TCGA-WR-A838	72	FEMALE	304	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	245.0		Progression of Disease	WITH TUMOR		72	Right	TCGA-WR-A838	B8023162-5E82-40E6-AD8C-8ACF81821F01	6	-26418	Not Applicable	0	245	TCGA-WR-A838-D57160;TCGA-WR-A838-D66186	392FF296-622C-4E06-8938-686004A62D8D;CCE11CBD-98D9-43FB-99E6-8770D1782337	Not Available;Not Available	3;3	92;92	30;30	Carboplatin;Taxol	Clinical Progressive Disease;Clinical Progressive Disease	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2014;2014	1	NOT HISPANIC OR LATINO	TCGA-WR-A838-F66184	31A49E6E-CA78-4FD3-AE74-242CC21A8774	3	304	Not Available	Not Available	Scheduled Follow-up Submission	Progressive Disease	Not Available	NO	10	Not Available	Not Available	Not Available	245	Progression of Disease	Not Available	Not Available	Not Applicable	NO	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2014	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3	YES;YES	NO;NO	Not Available;Not Available	245;245	Progression of Disease;Unknown	Not Available;Not Available	Imaging Study;Imaging Study	Not Applicable;Not Applicable	YES	No	A838	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	BLACK OR AFRICAN AMERICAN	NO																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	WR	Not Available	Ovary	YES	Alive	2014	2013
TCGA-59-2372	73	FEMALE	1363	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	0	1363			Not Available		73	Bilateral	TCGA-59-2372	5d8abed4-62b3-4e17-a8ce-9f6028e97103	12	Not Available	1363	0	Not Available	TCGA-59-2372-D28120;TCGA-59-2372-D28121	791be596-c56b-401b-8e73-0067dcd7484f;ae86c082-8c04-4078-bd1e-b303705819cd	Not Available;Not Available	15;15	Not Available;Not Available	Not Available;Not Available	Carboplatin;Taxol	Not Available;Not Available	3;3	4;4	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-59-2372-F28119	775d5554-2b75-4382-9f09-177790839905	12	1363	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	2	G2									Not Available	Not Available	2372	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	59	No Macroscopic disease	Ovary	NO	Dead	2010	2005
TCGA-13-0758	60	FEMALE	346	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	212.0		Progression of Disease	WITH TUMOR		60	Bilateral	TCGA-13-0758	514aa64e-a58d-48c2-aff9-498604cc11d6	24	-22088	346	0	346	TCGA-13-0758-D24540;TCGA-13-0758-D24541	052c2082-e91f-4ae5-9471-90fa513e2975;34cc047c-282b-4d98-b8d6-e0dcd9ab5ee9	Not Available;Not Available	17;17	161;161	14;14	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	8;8	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	6;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0758-F24539	5574373d-18ca-42bc-a604-5803d33e993b	24	346	346	Not Available	Not Available	Not Available	60	Not Available	2	YES	NO	Not Available	212	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	60	Not Available	2	G3									Not Available	Not Available	0758	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2005
TCGA-13-0888	78	FEMALE	2811	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	2811			TUMOR FREE		78	Right	TCGA-13-0888	6cf9f872-2e59-45cf-bb5e-ebd7fa1b3caf	25	-28498	Not Applicable	0	2141	TCGA-13-0888-D24674;TCGA-13-0888-D24676;TCGA-13-0888-D24675	6ff16be4-ef53-4e2d-b800-e9fe11910306;e70b84ff-49ff-42fb-ae5c-18c3c1a22aa4;31c8aef7-cb07-4117-983a-0544b208f1d7	Not Available;Not Available;Not Available	16;16;16	232;Not Available;232	54;253;54	Carboplatin;Femara;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	8;Not Available;8	Not Available;Not Available;Not Available	Not Available;mg;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;IV	NO;YES;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;mg;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0888-F24673;TCGA-13-0888-F72618	5da77845-7980-438e-b5bb-94e293431a72;44FEA357-3287-44B8-BBAD-734044D397EF	25;30	Not Applicable;2811	2141;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	80;Not Available	Not Available;Not Available	2;7									Not Available;NO	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Discrepancy;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0888	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2003
TCGA-09-0369	56	FEMALE	1082	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	274.0		Recurrence	WITH TUMOR		56	Left	TCGA-09-0369	1d9893c8-0de3-4b07-b0ba-a53019b23eb4	4	-20705	1082	0	Not Available	TCGA-09-0369-D24222;TCGA-09-0369-D24221;TCGA-09-0369-D24218;TCGA-09-0369-D24219;TCGA-09-0369-D24220;TCGA-09-0369-D24223;TCGA-09-0369-D24224	bbdd7a4d-fef2-4c8c-861b-13a0f7078f3b;8f85510a-6960-4611-95c3-22de367928af;aeffde3e-f5d7-46b9-98da-ec10ec9ca0ef;ac05217b-40a7-4a8c-9ff0-2fb4526a9f18;5e712ef4-3b95-4cfb-913c-1440d7767ee5;7d37f03d-f6d7-4a69-a9da-8e6830441fa9;a3c40628-cd5c-49dd-98f3-eed3e9460b59	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27;27	99;99;74;74;78;298;446	99;99;8;8;78;298;310	gemcitabine;Carbo;Carbo;taxol;Taxotere;doxil;topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3	1;1;4;4;1;1;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;Not Available;Not Available;mg/m2;mg;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1000;Not Available;Not Available;175;80;40;Not Available	mg/m2;Not Available;Not Available;mg/m2;mg;mg/m2;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-0369-F24217	1df2523e-6d80-4fbd-b56a-101649dd493a	4	1082	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;326	274;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	0369	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	YES	Dead	2009	2003
TCGA-25-1321	65	FEMALE	1033	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	454.0		Recurrence	WITH TUMOR		65	Bilateral	TCGA-25-1321	6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d	27	-23987	1033	0	1033	TCGA-25-1321-D26672;TCGA-25-1321-D26674;TCGA-25-1321-D26671;TCGA-25-1321-D26673	fbb96ad3-036d-4338-b798-0b952467b432;0a92e43c-03a4-49b0-8988-d565ab0f53b8;b6642ab9-ddb0-47d9-847b-edf5d7ad4a7a;00fdffad-a9ac-447b-b494-d4c6acc9a1e4	Not Available;Not Available;Not Available;Not Available	27;27;27;27	181;498;181;181	28;454;28;28	Gemzar;Topotecan;Carbo;Taxol	Not Available;Not Available;Not Available;Not Available	3;3;3;3	8;2;8;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	0	NOT HISPANIC OR LATINO	TCGA-25-1321-F26670	06fca474-4b69-4a35-8807-ee9385ccd71c	27	1033	1033	0	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;638	454;Not Available	Recurrence;Metastatic	Not Available;Not Available	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1321	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	No Macroscopic disease	Ovary	Not Available	Dead	2009	2001
TCGA-24-1845	42	FEMALE	116	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	116			Not Available		42	Bilateral	TCGA-24-1845	a782352e-c4bb-4c3e-ba82-456a47c3689a	2	-15599	Not Applicable	0	116	TCGA-24-1845-D26342;TCGA-24-1845-D26341;TCGA-24-1845-D26344;TCGA-24-1845-D26343	bd50326e-286b-406c-93da-ac4a34f33bb0;648e66f9-bb04-47e6-b0b3-5924e9d57a16;3eb57026-ad81-47df-b3f8-c4a97364c200;83aed886-8165-445f-9927-bd928274d9fe	Not Available;Not Available;Not Available;Not Available	24;24;24;24	123;123;123;123	72;72;72;72	Doxetaxel;Carboplatin;Pacliatxel;Cisplatin	Not Available;Not Available;Not Available;Not Available	8;8;8;8	06;06;06;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV;IP;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	603;1169;118;469	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1845-F26340	589f82e0-f528-49ec-ab57-8efff59e192c	2	Not Applicable	116	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1845	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-25-1626	65	FEMALE	518	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	318.0		Recurrence	WITH TUMOR		65	Right	TCGA-25-1626	662d77d1-1a43-427a-813b-e11edd30868e	2	-23932	518	0	481	TCGA-25-1626-D26720;TCGA-25-1626-D26718;TCGA-25-1626-D26717;TCGA-25-1626-D26719	65255dd7-ebe5-4226-aa16-7268117cf88c;e35ee48a-e2ed-46c0-bc8d-99b1952ba6c4;41ec1a22-9d13-48f6-a366-98d7ba9b6812;be7f9a79-ee48-4e2c-a58a-f9c54237084e	Not Available;Not Available;Not Available;Not Available	15;15;15;15	319;208;208;208	319;21;21;21	Doxil;Carboplatin;Taxol;Gemzar	Not Available;Not Available;Not Available;Not Available	6;6;6;6	1;7;7;7	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	RECURRENCE;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1626-F26716	827174ff-d45f-4226-80a0-df0bcc8d9f66	2	518	481	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	318	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1626	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	>20 mm	Ovary	Not Available	Dead	2009	2006
TCGA-13-0792	40	FEMALE	3602	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	816.0		Recurrence	WITH TUMOR		40	Bilateral	TCGA-13-0792	c11cae7e-91cd-4470-a9d8-188a4f6b8fa1	24	-14729	Not Applicable	0	1117	TCGA-13-0792-D24589;TCGA-13-0792-D24590;TCGA-13-0792-D24591	4c5d66cb-f9d3-4438-944a-a84abe10f840;f047d3e4-be77-443e-a63f-a9ed378a2787;c684d9ec-477e-4668-af2d-69f602efaefb	Not Available;Not Available;Not Available	16;16;16	160;160;160	34;34;34	Cisplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP	Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;135;60	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0792-F24588;TCGA-13-0792-F72605	1b6ba623-902c-40fa-bd13-a9e55cf9d4b0;560D983E-450E-48CD-899E-C3B02E89C5DF	24;30	Not Applicable;Not Applicable	1117;3602	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	816;816	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0792	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2005
TCGA-25-1625	66	FEMALE	840	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	526.0		Recurrence	WITH TUMOR		66	Bilateral	TCGA-25-1625	88d61634-913c-435a-8d25-e019c8dab7da	2	-24298	840	0	548	TCGA-25-1625-D26714;TCGA-25-1625-D26713	3eac29d8-a7d5-4c20-be59-87f846c18e02;cf67ac82-70f1-4f1e-bff1-f4e1f59f7bc0	Not Available;Not Available	15;15	Not Available;Not Available	Not Available;Not Available	Carboplatin;Taxol	Not Available;Not Available	6;6	08;08	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1625-F26712	08af2828-7b39-4fa2-b029-1131f1b50b8d	2	840	548	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;545	526;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1625	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2006
TCGA-23-1119	64	FEMALE	3953	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	3378.0		Recurrence	TUMOR FREE		64	Left	TCGA-23-1119	2dfd8a0e-e642-49b3-abd7-f0334927eebb	27	-23686	Not Applicable	0	3953	TCGA-23-1119-D25712;TCGA-23-1119-D25713	f137b469-6105-4631-9476-7318dfa0df61;d66ab420-e93b-4d8a-9414-c8439da9c270	Not Available;Not Available	27;27	3494;125	3389;18	Carboplatin;Carboplatin	Not Available;Not Available	3;3	6;6	Not Available;Not Available	mg;mg	RECURRENCE;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	2230;2700	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1119-F25711	ad69caa2-16b6-43a8-aa18-1569f9bd7522	27	Not Applicable	3953	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;3378	3378;Not Available	Recurrence;Metastatic	Not Available;YES	Other Method;Other Method	Biopsy;Biopsy	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	1119	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	YES	Alive	2009	1997
TCGA-29-1711	45	FEMALE	1053	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	0	1053			TUMOR FREE		45	Bilateral	TCGA-29-1711	f58e49fc-9641-4b46-be4c-766445ec70a3	2	-16485	Not Applicable	0	1053	TCGA-29-1711-D27310;TCGA-29-1711-D27309;TCGA-29-1711-D27308	5006a879-35cd-40f4-959a-d7c4ac2e9da4;c10283d7-f31a-4930-b91d-e81e88307348;403d3536-f161-4d82-81c6-8c42ccda444c	Not Available;Not Available;Not Available	13;13;13	234;136;136	30;30;30	Bevacizumab;Oxaliplatin;Docetaxel	Not Available;Not Available;Not Available	11;11;11	Not Available;06;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;IV;IV	NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1863;170;150	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	0	Not Available	TCGA-29-1711-F27307	764f8125-40f5-4183-8365-5d97c30cbdf0	2	Not Applicable	1053	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1711	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	No Macroscopic disease	Ovary	Not Available	Alive	2009	2006
TCGA-29-2436	36	FEMALE	297	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	0	297			TUMOR FREE		36	Bilateral	TCGA-29-2436	295231ab-477b-4077-a368-db34f867102c	7	-13346	Not Applicable	0	297	TCGA-29-2436-D27515;TCGA-29-2436-D27516	5061e9ad-2cf6-4dd3-970c-57ce41b37689;906d31f6-1d9e-4baf-a9b5-2cb038fe599e	Not Available;Not Available	7;7	191;191	17;17	Paclitaxel;Carboplatin	Not Available;Not Available	6;6	06;06	275;870	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1406;5220	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-29-2436-F27514	1d73fbe8-7e0f-4030-a6ac-73851d305020	7	Not Applicable	297	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	2436	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	YES	Alive	2010	2009
TCGA-24-2033	87	FEMALE	562	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	351.0		Recurrence	WITH TUMOR		87	Bilateral	TCGA-24-2033	872d2922-7292-4681-adb7-d3b267eccbe7	15	-31977	562	0	562	TCGA-24-2033-D26492;TCGA-24-2033-D26494;TCGA-24-2033-D26493;TCGA-24-2033-D26491	cf9d8857-7237-4caf-99e5-a79b8fd29421;c32ae140-edf1-44da-b2ae-3eee3ef19553;3b90cc85-3ff1-4f51-abf7-8d2c3554bda3;ef87003d-e997-422d-84af-6d400d8d9cc9	Not Available;Not Available;Not Available;Not Available	15;15;15;15	232;Not Available;400;232	38;471;358;38	Taxol;Hexalen;Topotecan;Carboplatin 6th	Not Available;Not Available;Not Available;Not Available	3;3;3;3	10;Not Available;03;10	Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;mg	ADJUVANT;PROGRESSION;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;PO;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	2940;Not Available;Not Available;3020	mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2033-F26490	803d2c06-fa19-4069-8e38-943eb8afc387	15	562	562	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	351	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2033	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1995
TCGA-23-2643	74	FEMALE	143	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	143			TUMOR FREE		74	Right	TCGA-23-2643	5554a003-da6f-4ddf-9f05-6785987ac46c	9	-27093	Not Applicable	0	143	TCGA-23-2643-D25815;TCGA-23-2643-D25816;TCGA-23-2643-D25814;TCGA-23-2643-D25813	37da2899-93db-4757-9940-479746754dac;b22c0d76-80d5-40aa-bb10-9ddc9571a9fa;25aaccf8-7a6f-441b-9938-b771bec4e3e8;25e8bdc4-321f-4b54-993e-cb26be058f73	Not Available;Not Available;Not Available;Not Available	9;9;9;9	24;24;129;129	24;24;45;45	Taxol;Carboplatin;Cisplatin;Taxol	Not Available;Not Available;Not Available;Not Available	12;12;12;12	01;01;05;05	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV;IP;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	294;373;610;1295	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-2643-F25812	0a29aa5b-6fa4-47e6-88bf-d5463886261d	9	Not Applicable	143	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	12	G3									Not Available	Not Available	2643	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-13-1484	62	FEMALE	3785	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	497.0		Recurrence	WITH TUMOR		62	Not Available	TCGA-13-1484	ead71c90-cc5e-42ce-8754-c3cf15a41134	31	-22698	Not Applicable	0	2982	TCGA-13-1484-D24858;TCGA-13-1484-D24859	63c40a83-cb68-4b71-9d6a-b78c6e0f4bf5;28c061b0-19ec-4c30-b351-4b54731b4d8a	Not Available;Not Available	30;30	191;191	86;86	Carboplatin;Paclitaxel	Not Available;Not Available	6;6	6;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1484-F24857;TCGA-13-1484-F72640	30eccca8-a390-4c88-bffa-de7070c2fed6;C39BAF1F-585B-45B2-B555-EA37EF74F5CA	31;30	Not Applicable;3785	2982;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	3;7	YES;Not Available	NO;Not Available	Not Available;Not Available	497;497	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Preoperative;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	80	Not Available	3	G3									Not Available	Not Available	1484	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2000
TCGA-09-1668	57	FEMALE	1684	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	1684			WITH TUMOR		57	Right	TCGA-09-1668	0e475b3d-be3c-431a-ab12-5a867ea8f6cd	2	-20972	Not Applicable	0	1684	TCGA-09-1668-D24303;TCGA-09-1668-D24301;TCGA-09-1668-D24302	fb1e1df5-88fc-4470-8a14-b8e52cb01d91;d03e27fc-0655-4ff0-b02f-aa7941ea73f5;e5afb655-15ff-4e6d-8a65-2427d238370e	Not Available;Not Available;Not Available	6;6;6	135;320;135	31;151;31	Taxotere;Taxotere;Carboplatin	Not Available;Not Available;Not Available	8;8;8	6;9;6	Not Available;Not Available;Not Available	mg;mg/m2;mg	ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT	Not Applicable;Not Available;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	120;60;480	mg;mg/m2;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1668-F24300	4c6e3ed8-1d30-4366-96fc-60bfa0104dfd	2	Not Applicable	1684	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1668	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	Not Available	Ovary	NO	Alive	2009	2004
TCGA-59-2355	58	FEMALE	65	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	65			WITH TUMOR		58	Right	TCGA-59-2355	708eec28-2348-4e15-b98c-8c6f9d057b1e	29	Not Available	65	0	Not Available	TCGA-59-2355-D28112;TCGA-59-2355-D28113	a484b2da-a6d7-403b-b76e-17312504bdbc;90eccdfc-050e-473d-854a-6bd75e253a13	Not Available;Not Available	31;31	Not Available;Not Available	Not Available;Not Available	Carboplatin;Taxol	Not Available;Not Available	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-59-2355-F28111	395e39dd-fe65-4c7c-ae0d-6065c0217d5f	29	65	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1									Not Available	Not Available	WITH TUMOR	YES	Not Available	Not Available	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	1	G3									Not Available	Not Available	2355	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	59	>20 mm	Ovary	Not Available	Dead	2010	2006
TCGA-24-1923	51	FEMALE	690	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	343.0		Recurrence	WITH TUMOR		51	Bilateral	TCGA-24-1923	8449955f-42d9-46f6-919a-5cc5d59e6284	19	-18628	690	0	690	TCGA-24-1923-D26380;TCGA-24-1923-D26383;TCGA-24-1923-D26381;TCGA-24-1923-D26382;TCGA-24-1923-D26384	6472b85a-ce8f-4dd6-b255-8d215538af3f;dd656b25-2f04-4167-937f-f3d8b4434a9c;ea59cc77-d039-49f3-9ebc-8a903228c266;8c315697-557b-4e11-9d30-223d743a4782;aa10be72-fe56-4ef3-9a71-3abf202da29c	Not Available;Not Available;Not Available;Not Available;Not Available	19;19;19;19;4	233;Not Available;233;233;Not Available	35;383;35;35;Not Available	carboplatin;Topotecan;Taxol;Doxil;GOG182	Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;6	08;Not Available;3;4;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;Not Available	NO;NO;NO;NO;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-1923-F26379	a490cc6b-d715-4c9e-8039-8508af334257	19	690	690	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	343	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1923	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	2001
TCGA-24-1847	45	FEMALE	343	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	343			TUMOR FREE		45	Bilateral	TCGA-24-1847	21966708-4e66-4211-add0-f1515b09e362	2	-16529	Not Applicable	0	343	TCGA-24-1847-D26351;TCGA-24-1847-D26353;TCGA-24-1847-D26352	1b6a9f6f-1592-436b-800f-4e4d1a19ba98;c4a831bf-4848-4384-ba02-f802c9f681c4;d01c128c-796e-4aa3-9939-631fc9179bbc	Not Available;Not Available;Not Available	24;24;24	143;143;143	28;28;28	Taxotere;Taxol;Ciplastin	Not Available;Not Available;Not Available	7;7;7	6;6;6	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	733;687;862	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1847-F26350	a302ccb0-5b86-4a6a-8121-fdf54689c24c	2	Not Applicable	343	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Excisional Biopsy	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1847	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-25-2396	71	FEMALE	92	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	92			Not Available		71	Bilateral	TCGA-25-2396	6264e699-d40b-4ebc-b443-0a0edcb220dc	5	-26145	92	0	92																								Not Available	NOT HISPANIC OR LATINO	TCGA-25-2396-F26808	b232044d-3dba-49c2-93ae-c83e8d7469ef	5	92	92	Not Available	Not Available	Not Available	Not Available	Not Available	1									Not Available	Not Available	Not Available	Not Available	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2396	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	No Macroscopic disease	Ovary	Not Available	Dead	2010	2004
TCGA-29-2428	58	FEMALE	1372	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	1372			TUMOR FREE		58	Left	TCGA-29-2428	b0585c7a-7205-4dac-9d54-6da89674accb	8	-21392	Not Applicable	0	1372	TCGA-29-2428-D27479;TCGA-29-2428-D27480	0f7b6d8e-68b1-42e2-8242-af4bf9964970;a0dae621-3815-4b2a-8364-e19198be75ac	Not Available;Not Available	8;8	141;141	18;18	Carboplatin;Paclitaxel	Not Available;Not Available	2;2	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IV;IP;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	670;280	mg;mg	Not Available;Not Available	2010;2010	0	Not Available	TCGA-29-2428-F27478	1aae8af8-d856-4054-bdcd-5cd78895a694	8	Not Applicable	1372	0	Not Available	Not Available	Not Available	Not Available	2									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	2428	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Alive	2010	2005
TCGA-61-2614	71	FEMALE	262	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	38.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-61-2614	09643c0d-efdb-46b4-94df-018bd6134a88	7	-26142	262	0	262																								Not Available	Not Available	TCGA-61-2614-F28505	6f9863a6-5596-41d2-8532-fbac794ef1c6	7	262	262	Not Available	Not Available	Not Available	Not Available	Not Available	9	YES;YES	NO;NO	Not Available;38	38;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	NO	Stable Disease	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	9	G3									Not Available	Not Available	2614	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Dead	2010	2007
TCGA-61-1895	52	FEMALE	44	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	0	44			TUMOR FREE		52	Bilateral	TCGA-61-1895	0dd95368-0713-45f0-84f4-c91af9cbba74	1	-19060	Not Applicable	0	44	TCGA-61-1895-D28214;TCGA-61-1895-D28215	509215c0-2874-4032-a07f-fe9216ced5a7;8ef7db20-0617-45f6-90ae-fe393e156f93	Not Available;Not Available	4;4	156;156	44;44	Carboplatin;Taxotere	Not Available;Not Available	12;12	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3780;400	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1895-F28213	c1f746b4-ff13-496d-a9f5-5ffabca2bff5	1	Not Applicable	44	Not Available	Not Available	Not Available	Not Available	Not Available	10									Not Available	Not Available	TUMOR FREE	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	10	G3									Not Available	Not Available	1895	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	YES	Alive	2009	2009
TCGA-24-1104	56	FEMALE	1933	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	959.0		Recurrence	WITH TUMOR		56	Left	TCGA-24-1104	f9f44f86-10c7-4473-b156-5afbfa9a2ad0	9	-20527	1933	0	1933	TCGA-24-1104-D25836;TCGA-24-1104-D25837;TCGA-24-1104-D25835;TCGA-24-1104-D25838;TCGA-24-1104-D25839;TCGA-24-1104-D25840;TCGA-24-1104-D25841	e9de231f-ab26-4ed6-af61-fa3e6e1173f7;b446a898-1eae-4f20-88d0-55fafab04fa8;49a7aa0b-ee9a-451f-bbc4-1b6de517ec0e;d48553ab-2f2b-4708-8d43-fdd995fa330c;3bcc4b9b-c529-4706-845d-5c82f0e81e9a;3a12c164-e3cd-4312-ba87-6320222e0dbc;8d708e6e-b456-4878-9446-dad3734222aa	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;27;1;1;1	1589;175;175;175;1113;1113;1876	1526;30;30;30;1001;1001;1858	Doxil;Cisplatin;Paclitaxel;Carboplatin;Taxol;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;2;2;2	3;6;6;6;6;6;2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	RECURRENCE;ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	190;250;1518;2007;1800;402;438	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2010;2010;2010	Not Available	Not Available	TCGA-24-1104-F25834	e919193f-c3a5-4dc0-b6ce-3c6d7f1a727e	9	1933	1933	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	YES	Not Available	959	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1104	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-24-1104-R25842	bdf8fde3-3d66-4c7f-b088-22bddec5aad5	Not Available	9	Not Available	969	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	RECURRENCE	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2009	2001
TCGA-09-2055	48	FEMALE	819	Serous Cystadenocarcinoma	Ovary	Alive	Stage IC	G3	0	819			TUMOR FREE		48	Left	TCGA-09-2055	838778c3-0b33-4fc5-97fc-5da163475485	2	-17545	Not Applicable	0	819	TCGA-09-2055-D24397;TCGA-09-2055-D24396	49441fe6-198e-43c3-ba65-b1575d1075ab;71b4da94-56ba-47a7-9cbe-e33ec42f2095	Not Available;Not Available	2;2	189;189	5;5	Taxol;Carboplatin	Not Available;Not Available	11;11	6;6	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;Not Available	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-2055-F24395	fac2d6fc-13cf-49fc-9201-6997dd4cb7a0	2	Not Applicable	819	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	11	G3									Not Available	Not Available	2055	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2007
TCGA-04-1364	61	FEMALE	1024	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	288.0		Recurrence	WITH TUMOR		61	Bilateral	TCGA-04-1364	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	26	-22294	1024	0	Not Available	TCGA-04-1364-D24032;TCGA-04-1364-D24039;TCGA-04-1364-D24037;TCGA-04-1364-D24041;TCGA-04-1364-D24038;TCGA-04-1364-D24040;TCGA-04-1364-D24029;TCGA-04-1364-D24035;TCGA-04-1364-D24036;TCGA-04-1364-D24034;TCGA-04-1364-D24031;TCGA-04-1364-D24042;TCGA-04-1364-D24030;TCGA-04-1364-D24033	eb6c4302-3a07-4fcb-8131-2be34065fe88;58df2207-1cb7-402e-a01c-df9b30e13cf7;6c9294a5-491a-4587-95ab-ce1f11c1ae91;a745b383-07f8-4eb1-a64a-7e8f7858561b;421f933a-52e6-42f5-b837-55b2362f589e;ee3416d9-a24f-4ec5-b710-a57166eaebd4;abbdcb69-6108-40d7-8c23-69271ce2bda5;ee5c2bae-8c4c-4a1d-bf59-b3c1d4357b7c;a0a50587-aad9-4b1d-8206-694d37745750;58851b60-22dc-4a9d-85fe-338ed52e93b4;82444910-d44e-4470-a279-958e2467a045;eebd6dca-fb4f-448b-8c96-5f8f94f48847;6ec6788e-d27f-4b70-8e0d-8a863c19a3f6;f0840d96-e4ac-4cb5-bb8c-37f30ae5fbce	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	24;24;24;24;24;24;24;24;24;24;24;24;24;24	188;827;462;949;827;857;584;370;462;310;188;949;188;310	35;615;401;919;615;857;462;341;401;279;35;919;35;279	Doxil;Avastin;Cisplatin;Docetaxel;5F4 Leucovorin;RBBX 01;Etoposide;Hexalen;Gemcitabine;Navelbine;Paclitaxel;Carboplatin;Carboplatin;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11;11;11;11;11;11	07;14;02;02;14;1;05;2;02;02;07;2;07;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;AUC;AUC;mg	ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;IV;Not Available;IV;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	235;1860;240;260;7000;8.5;10500;1400;6400;198;2408;5;5;19.8	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;AUC;AUC;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	1	NOT HISPANIC OR LATINO	TCGA-04-1364-F24028	4a04d83d-7ae1-45e0-81a1-55960afdf90b	26	1024	Not Available	1	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	288	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G3									Not Available	Not Available	1364	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-29-1688	39	FEMALE	2400	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	184.0		Recurrence	WITH TUMOR		39	Bilateral	TCGA-29-1688	05019013-7ea5-4905-ac79-901146ba2ee2	2	-14574	2400	0	2400	TCGA-29-1688-D27125;TCGA-29-1688-D27126;TCGA-29-1688-D27134;TCGA-29-1688-D27138;TCGA-29-1688-D27139;TCGA-29-1688-D27128;TCGA-29-1688-D27137;TCGA-29-1688-D27131;TCGA-29-1688-D27129;TCGA-29-1688-D27135;TCGA-29-1688-D27130;TCGA-29-1688-D27132;TCGA-29-1688-D27136;TCGA-29-1688-D27127;TCGA-29-1688-D27133	7f10efbe-1ac7-4b34-8a8f-d2018c500d2a;f7096fd1-a75b-40ad-908c-dcdb17d5cd01;a72dc90d-76a7-464f-a6b5-1e6e5248cb0e;79bc99cb-f7b0-44ea-9611-2552e156242c;51e458fd-2614-41e5-9f4b-779a7d8ebbee;62430697-e553-49a9-a8fe-953be4c87a64;c7d13c51-ca4e-4da5-bf9b-2509804ed7e5;568adf68-a27f-4f9c-944c-b128bdc775b2;82e60918-c339-44fc-a5e8-d2e1ac77bd14;8b78391e-9f51-426d-91ab-a34a0f7efd4a;c7147c57-ad18-4e46-91b1-41247eacbe8a;a3c745b9-c5ed-42e9-bac6-15d75ede0e8e;f168b196-edb1-49f3-9196-eb9e7332f9ab;553498e9-4fe2-45d7-9580-0ced2aa9ffba;2ff9881a-ae13-4df7-acf6-5ec75660419f	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;16;16;16;16;16;16;16;16;16;16;16;16;16	Not Available;Not Available;Not Available;2395;2395;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;1719;Not Available;Not Available;197;1900;Not Available;743;Not Available;743;Not Available;1900;197;Not Available	Cisplatin;Cytoxan;Taxotere;Carboplatin;Cytoxan;Etoposide;Paclitaxel;Oral Etoposide;Carboplatin;Hexalen;Cytoxan;Topotecan;Carboplatin;Cisplatin;Etoposide	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;2;2;2;2;2;2;2;2;2;2;2;2;2	Not Available;Not Available;06;Not Available;Not Available;06;Not Available;03;06;Not Available;06;Not Available;Not Available;06;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;mg/m2;Not Available;Not Available;Not Available;Not Available;Not Available;AUC;Not Available;Not Available	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IP;IV;IP;IV;IP;IV;IP;IV;IP;IV;PO;IP;IV;IP;IV;IP;IV;IP;IV;IP;IV;IP;IV;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;175;Not Available;Not Available;Not Available;Not Available;Not Available;5;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;mg/m2;Not Available;Not Available;Not Available;Not Available;Not Available;AUC;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-29-1688-F27124	eb9c7a54-595c-42ce-bf50-83f92050181d	2	2400	2400	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	YES;YES	Not Available;184	184;Not Available	Recurrence;Locoregional Disease	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1688	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-29-1688-R27140	a18091de-1597-462f-abbe-05f595f2f50e	Not Available	3	Not Available	2235	Not Available	6	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	Not Available	Ovary	YES	Dead	2009	1992
TCGA-61-1899	81	FEMALE	256	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	256			TUMOR FREE		81	Left	TCGA-61-1899	35b1bb47-b32b-4acd-8e5e-fe6bd56c0289	1	-29692	Not Applicable	0	256	TCGA-61-1899-D28219;TCGA-61-1899-D28218	e0d17430-bc63-44d6-894d-4b001467cc7a;6194d641-aa69-41e2-8f81-acbf267cc1df	Not Available;Not Available	4;4	159;159	52;52	Taxol;Carbplatin	Not Available;Not Available	12;12	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1104;2220	mg;mg	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-61-1899-F28217	7eb2e429-e0c5-4482-9210-7a48a331c602	1	Not Applicable	256	Not Available	Not Available	Not Available	Not Available	Not Available	10									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	10	G3									Not Available	Not Available	1899	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	NO	Alive	2009	2008
TCGA-23-1117	42	FEMALE	1013	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	418.0		Recurrence	WITH TUMOR		42	Left	TCGA-23-1117	a88b7e66-5f12-4023-a7e2-fcfbd1f25977	19	-15690	1013	0	Not Available	TCGA-23-1117-D25703;TCGA-23-1117-D25702;TCGA-23-1117-D25705;TCGA-23-1117-D25701;TCGA-23-1117-D25704;TCGA-23-1117-D25700;TCGA-23-1117-D25706	647f8f33-378a-47c3-8cda-37dbc04a7c54;bffb1d3e-6bc8-472c-b3b6-2b072e107ea2;53b2ce95-0ac5-4e1b-af64-9a769cdc3df6;df44bbcd-995d-4b79-9bee-e364bb571dcd;d5b2da86-8889-4e99-b890-64d403e5e8d3;ae227383-099e-44a2-8398-ba4aa5c804eb;044d289f-4ad5-4e9f-9e5a-373407bd5892	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27;11	863;757;993;624;928;294;928	781;712;951;459;890;22;890	Cisplatin;Cyclophosphamide;Gemcitabine;Topotecan;Docetaxel;Carboplatin;Herceptin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;1	5;3;4;8;5;11;05	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	600;3450;3960;92;280;6470;600	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2010	Not Available	Not Available	TCGA-23-1117-F25699	7a1fbb0f-3052-4169-b736-a2ad807a71ec	19	1013	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	NO;NO	Not Available;438	418;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Other Method;Other Method	Biopsy;Biopsy	Not Available	Not Available	WITH TUMOR	NO	Complete Remission/Response	YES	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1117	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	YES	Dead	2009	1998
TCGA-13-0714	55	FEMALE	189	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	110.0		Progression of Disease	WITH TUMOR		55	Bilateral	TCGA-13-0714	1e14f098-17b2-4f54-8e4f-e38088008df7	24	-20109	189	0	189	TCGA-13-0714-D24492;TCGA-13-0714-D24490;TCGA-13-0714-D24491	e54432b5-99df-4c39-b995-647542102aaf;8ca3dedd-47ab-4034-aab2-6050c4600c4a;9d443d74-433e-4f6f-8591-4a482fc81098	Not Available;Not Available;Not Available	15;15;15	Not Available;Not Available;Not Available	12;12;12	Gemcitabine;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	4;4;4	Not Available;Not Available;Not Available	Not Available;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;PO;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;5;175	Not Available;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0714-F24489	7fe913a4-d022-4890-a2a8-82c1b9c72755	24	189	189	Not Available	Not Available	Not Available	80	Not Available	2	YES	NO	Not Available	110	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	2	G3									Not Available	Not Available	0714	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-13-1481	76	FEMALE	2648	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	0	2648			TUMOR FREE		76	Right	TCGA-13-1481	c5355491-e1e8-46a4-a05e-bafcaf2e7459	31	-27898	2648	0	2648	TCGA-13-1481-D24846;TCGA-13-1481-D24844;TCGA-13-1481-D24845	f88e48af-f598-4236-bf59-a343851c2d7c;82353d99-0371-47d6-90a3-c012f8fad803;799031c3-47c1-4f36-a30d-e518b4c11298	Not Available;Not Available;Not Available	30;30;30	242;131;131	198;11;11	Cisplatin;Paciltaxel;Carboplatin	Not Available;Not Available;Not Available	6;6;6	3;6;6	Not Available;Not Available;Not Available	Not Available;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;175;5	Not Available;mg/m2;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1481-F24843	ad6484b6-fb62-4ffe-a5f7-0728b7654d8e	31	2648	2648	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G2									Not Available	Not Available	1481	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-24-1557	49	FEMALE	1213	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	447.0		Progression of Disease	WITH TUMOR		49	Bilateral	TCGA-24-1557	7dcc809b-e33a-4453-b92a-c00786f48cb0	2	-17943	1213	0	1213	TCGA-24-1557-D26198;TCGA-24-1557-D26207;TCGA-24-1557-D26200;TCGA-24-1557-D26203;TCGA-24-1557-D26202;TCGA-24-1557-D26205;TCGA-24-1557-D26197;TCGA-24-1557-D26199;TCGA-24-1557-D26206;TCGA-24-1557-D26208;TCGA-24-1557-D26210;TCGA-24-1557-D26196;TCGA-24-1557-D26195;TCGA-24-1557-D26201;TCGA-24-1557-D26204;TCGA-24-1557-D26209	debe84cc-e3d6-4000-a882-d98d3c8a6ba4;ba3ef76c-2125-4d51-9389-53fbe45038ce;e57199e1-666f-4ecf-bb4b-4ea3ddd7b2f1;baf86572-a1d7-42d3-aeaf-8d2fa5a4b4ee;df63e12d-81ee-4689-a57a-d0e15aac56bc;c9831383-8169-4c19-a7ad-fc3cc27c0a65;c496b3e4-ce90-4e94-9a46-55bb27442fe7;52dafb0c-43cf-4792-8ac6-5c637bc5b87d;7dbeeb29-0d9a-4b2f-91ea-d8d37e26e1f0;1cc3aa32-4736-449f-ac47-a04687665f87;a3727227-4be8-4f2a-af72-e123a4b9fa28;64f69477-8db0-43cf-9bac-2ae1b6f59698;386a4c8c-a9a8-45a8-b364-458ce1968c66;9b12afd7-4c83-4a87-acfa-6bdb3ac8bc09;522480c7-725f-40d4-86d9-911d47a79860;6680f2b7-6970-4e51-a357-8755f0d0e451	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28;28;28;28;28;28;28;28;28;28;28	347;1069;445;727;623;1008;281;445;1008;1154;873;281;281;623;798;1154	300;1027;368;644;462;875;27;368;875;1090;765;27;27;462;754;1090	Topotecan;Taxotere;Doxil;Taxol;Carboplatin;Cisplatin;Topotecan;Gemzar;Gemzar;Taxol;Not Available;Carboplatin;Taxol;Taxol;Topotecan;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7;7;7;7;7;7;7;7;7;7	03;03;03;04;08;07;4;03;07;04;Not Available;12;8;08;03;04	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available;mg;mg;mg;mg;mg	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PALLIATIVE;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;Not Available;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	32.4;424;175;1300;5350;670;14.7;10980;12240;1300;Not Available;6250;3392;2600;45.5;2315	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1557-F26194	300786cc-f4e9-45c3-8987-c78cb62f21ea	2	1213	1213	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	447	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1557	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2009	2000
TCGA-09-2053	72	FEMALE	1209	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	1209			TUMOR FREE		72	Left	TCGA-09-2053	ea605be2-6578-4e01-8ec3-bbd84c0b7f1d	2	-26433	Not Applicable	0	1209	TCGA-09-2053-D24385;TCGA-09-2053-D24386	d711d5ea-2290-411c-afa5-ab30773d3e11;e2e0c1ed-9af3-414e-b5e4-b993d4ebf97f	Not Available;Not Available	2;2	138;138	34;34	Carboplatin;Taxol	Not Available;Not Available	11;11	6;6	Not Available;Not Available	AUC;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	6;175	AUC;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-2053-F24384	634220c4-f1be-44e0-b294-0277c24ff97d	2	Not Applicable	1209	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	11	G3									Not Available	Not Available	2053	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2005
TCGA-36-2543	85	FEMALE	68	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	27.0		Progression of Disease	WITH TUMOR		85	Bilateral	TCGA-36-2543	73b63d07-0c1d-4bf2-bf11-b183e090e200	18	-31211	68	0	68																								3	Not Available	TCGA-36-2543-F27946	39b21e93-385a-47bc-b804-7db98b08fde2	18	68	68	3	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	27	Progression of Disease	Not Available	Not Available	Not Applicable	Not Available	Other	WITH TUMOR	NO	Progressive Disease	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2543	Other	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	Not Available	Dead	2010	2008
TCGA-31-1953	52	FEMALE	204	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	70.0		Recurrence	WITH TUMOR		52	Bilateral	TCGA-31-1953	61feee94-3ac9-42fe-aaa3-dc6a3efe563c	20	-19064	Not Applicable	0	204	TCGA-31-1953-D27700;TCGA-31-1953-D27702;TCGA-31-1953-D27701;TCGA-31-1953-D27699	ece15379-890e-4d24-8c23-a9bd4dcd8e46;eb1db586-968a-445e-87e4-81609c8cc5e2;c46dae01-314c-4890-b522-e1446a0f2223;87f2114d-3ed1-418a-b563-c4a1efdd6c0f	Not Available;Not Available;Not Available;Not Available	20;20;20;20	65;Not Available;Not Available;65	23;100;100;23	Paciltaxel;Paciltaxle;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available	10;10;10;10	03;Not Available;Not Available;03	Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;mg	ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;YES;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	840;Not Available;Not Available;1350	mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	1	NOT HISPANIC OR LATINO	TCGA-31-1953-F27698	0b48f22b-fc99-4647-bd44-0e2a250c6d91	20	Not Applicable	204	1	Not Available	Not Available	Not Available	Not Available	10	YES	NO	Not Available	70	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	10	G3									Not Available	Not Available	1953	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	31	Not Available	Ovary	NO	Alive	2009	2008
TCGA-61-1733	71	FEMALE	967	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	175.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-61-1733	04ecaf38-0232-4dcd-9242-308a22cc1331	2	-26180	Not Applicable	0	967	TCGA-61-1733-D28166;TCGA-61-1733-D28169;TCGA-61-1733-D28167;TCGA-61-1733-D28164;TCGA-61-1733-D28168;TCGA-61-1733-D28165	3d4bc96f-852a-4613-af54-9a451e00749f;54936660-8150-4378-bb3a-200680460618;9cb8b2cf-4118-4be9-bfb9-b27a645a9d44;c5f1a4ae-9989-4347-8a0a-d1afa03088c0;62907e81-bc0a-4302-9897-8d0b0a0fa75e;b774d231-1124-433a-818f-ba0a853908d0	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4	372;625;625;127;625;127	231;484;484;22;484;22	Doxil;Taxotere;Taxol;Carboplatin;Cisplatin;Docetaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12	06;06;06;06;06;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IV;IP;IV;IV;IP;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	482;582;390;3924;720;638	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-61-1733-F28163	a342a16c-6eba-4ab9-9688-f1b9f952ac7f	2	Not Applicable	967	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;175	175;Not Available	Recurrence;Metastatic	Not Available;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1733	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	YES	Alive	2009	2006
TCGA-04-1349	69	FEMALE	656	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	428.0		Recurrence	WITH TUMOR		69	Bilateral	TCGA-04-1349	4b930a10-4b12-4428-84f9-3255b4a3bc4f	26	-25213	656	0	Not Available	TCGA-04-1349-D23983;TCGA-04-1349-D23986;TCGA-04-1349-D23985;TCGA-04-1349-D23979;TCGA-04-1349-D23981;TCGA-04-1349-D23980;TCGA-04-1349-D23984;TCGA-04-1349-D23982;TCGA-04-1349-D23978	b6b0b86f-0a20-4b17-a137-0d361563e1e3;4ed4f655-53b4-4a3c-9f0d-68d03e0be4e4;657f0e7d-e78a-426c-877e-5ffe76061984;dbb69d58-12bc-4b08-b033-f6445d45d0b2;19d1b2b2-e7da-44e6-8eff-02c8438a5e16;e6584537-e4b7-40ac-8cd8-6e6329a6a620;1d5f70a4-4277-456b-8425-78630a4842fe;eb24d9d8-a70b-43e2-af7b-199124d06a41;21e672d6-60ea-4ba5-a90a-3d8d33c0197d	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10;10;10;10	373;Not Available;373;653;653;653;373;653;653	1;Not Available;1;436;436;436;1;436;436	Cisplatin;Avastin;Paclitaxel;Cisplatin;Paclitaxel;Cisplatin;Paclitaxel;Cytoxan;Doxil	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11	12;Not Available;12;8;8;8;12;8;8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/kg;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV;IP;IP;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	75;5;135;75;60;60;175;750;30	mg/m2;mg/kg;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-04-1349-F23977	989bb706-37f0-4425-9e52-384c66da23cb	26	656	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	428	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	1349	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	Not Available	Dead	2009	2004
TCGA-04-1335	60	FEMALE	55	Serous Cystadenocarcinoma	Ovary	Dead	Stage IB	G2	0	55			WITH TUMOR		60	Bilateral	TCGA-04-1335	ab3dbbbe-eed6-4a35-a505-1815225e86c9	26	-21963	55	0	Not Available																								Not Available	NOT HISPANIC OR LATINO	TCGA-04-1335-F23924	3b638854-eea9-42f7-a790-93ea3d17bd9d	26	55	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Preoperative	WITH TUMOR	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G2									Not Available	Not Available	1335	Preoperative	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	NO	Dead	2009	2005
TCGA-30-1862	65	FEMALE	186	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	0	186			WITH TUMOR		65	Not Available	TCGA-30-1862	58f5a54e-de50-4cca-afa1-cc331d8b3479	2	-23895	186	0	186																								Not Available	NOT HISPANIC OR LATINO	TCGA-30-1862-F27593	98838264-1d26-43dc-a7f7-7d0b7a0e956b	2	186	186	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G2									Not Available	Not Available	1862	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	>20 mm	Ovary	Not Available	Dead	2009	2003
TCGA-04-1655	49	FEMALE	1380	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G2	1	819.0		Recurrence	Not Available		49	Bilateral	TCGA-04-1655	f8a5547f-f1bc-4c01-8b68-25b5ee0caeab	2	-17988	1380	0	Not Available	TCGA-04-1655-D24192;TCGA-04-1655-D24194;TCGA-04-1655-D24196;TCGA-04-1655-D24195;TCGA-04-1655-D24193	0fc35dff-0325-4013-8faa-f9338450f776;d6ee6177-9651-4002-8886-321a006ddb09;6af7c96d-fd92-4419-89f8-4a3f81291128;31f9f5de-7d10-4be7-922a-486e53358208;6554c537-7883-461c-a2bc-e5d5cff12e2f	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9	139;139;Not Available;Not Available;139	34;34;839;184;34	Taxol;Taxol;Carboplatin;Taxol;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	06;06;Not Available;Not Available;06	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;Not Available;Not Available;mg	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IV;IV;IV;IP;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	1288;574;Not Available;Not Available;953	mg;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	0	Not Available	TCGA-04-1655-F24191	6fdc0964-ba27-42bc-bb14-ff4240c2b90e	2	1380	Not Available	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	819	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Pre-Adjuvant Therapy	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1655	Pre-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	No Macroscopic disease	Ovary	Not Available	Dead	2009	1999
TCGA-24-0970	63	FEMALE	354	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	280.0		Recurrence	WITH TUMOR		63	Bilateral	TCGA-24-0970	95e58015-a7c0-4bdc-bf64-7617d24d0784	9	-23276	354	0	354	TCGA-24-0970-D25873;TCGA-24-0970-D25872;TCGA-24-0970-D25871	426b35b9-eeab-4015-898d-f5a50d3c5f6e;3d5f98c0-fb1e-4647-aa0f-4e9ab61b6d8b;e1f3db9f-1bfe-4fca-8fb6-d17d4ae824fa	Not Available;Not Available;Not Available	9;9;9	314;314;314	25;25;25	Doxil;Carboplatin;Taxol	Not Available;Not Available;Not Available	3;3;3	08;08;08	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	Not Available;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	152;3840;1980	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-0970-F25870	cbaaeb30-6a61-4f76-b5fa-b61833e4fdf2	9	354	354	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	280	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	Not Available	YES	3	G3									Not Available	Not Available	0970	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2009	2005
TCGA-10-0927	65	FEMALE	2490	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	1001.0		Recurrence	WITH TUMOR		65	Bilateral	TCGA-10-0927	933dbfbd-4697-403e-bd73-c17cb300c94b	6	-23982	2490	0	2478	TCGA-10-0927-D24424;TCGA-10-0927-D24428;TCGA-10-0927-D24426;TCGA-10-0927-D24423;TCGA-10-0927-D24421;TCGA-10-0927-D24422;TCGA-10-0927-D24425;TCGA-10-0927-D24427	f5b4eecf-392c-4dc2-b6b4-84147f8d78a8;e99dde4c-fd87-4c00-8d67-dcd6cb912a64;5543938e-67eb-414c-a80d-dcb113ce7c6e;6efe15d8-13aa-4760-8bfb-dadb529205f0;8a17dc93-4b32-40e2-8134-94b2aa680461;6f9c873b-a61c-4074-abaf-03124c45be22;3d37f28e-e854-4a31-a7f1-407e7c128dba;3c8fee69-6a99-4182-8581-b545e14c58a2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18;18;18;18	1686;1640;2302;1301;121;121;1910;2463	1601;1336;1938;1017;9;9;1686;2330	Arimidex;Tamoxifen;Doxil;Carboplatin;Taxol;Carboplatin;Taxol;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3	10;Not Available;10;10;6;6;10;10	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Progression and Recurrence;Progression and Recurrence;Progression and Recurrence;Progression and Recurrence;Not Applicable;Not Applicable;Progression and Recurrence;Progression and Recurrence	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	Not Available;NO;NO;NO;Not Available;NO;Not Available;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	60;12000;845;5400;1800;2940;2320;9920	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	HISPANIC OR LATINO	TCGA-10-0927-F24420	086690da-aa4d-4658-a679-f871fa293b7c	6	2490	2478	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	1001	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G2									Not Available	Not Available	0927	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-36-1568	52	FEMALE	875	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	548.0		Recurrence	WITH TUMOR		52	Bilateral	TCGA-36-1568	de548bdd-14ca-486b-bd16-a6fbdd5b50d2	2	-19311	Not Applicable	0	875	TCGA-36-1568-D27851;TCGA-36-1568-D27853;TCGA-36-1568-D27852	2a3f80b3-6a80-4ee7-9c35-29309d21d631;178044bb-7b27-4a53-b3d0-6e8a5a9352c3;9d38e2ae-a6be-479e-9c79-8865a90a7eb5	Not Available;Not Available;Not Available	15;15;15	737;123;123	624;10;10	Liposomal Doxorubicin;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available	1;1;1	05;05;05	Not Available;Not Available;Not Available	mg;mg;mg	PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	286;1257;2610	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	TCGA-36-1568-F27850	8050daa1-0821-4b10-9f7e-13838a72c862	2	Not Applicable	875	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	548	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1568	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	Not Available	Ovary	Not Available	Alive	2009	2007
TCGA-24-1103	50	FEMALE	1646	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	678.0		Recurrence	WITH TUMOR		50	Bilateral	TCGA-24-1103	f34aa3b6-e966-49c6-bc55-130545772c53	9	-18583	1646	0	1646	TCGA-24-1103-D25826;TCGA-24-1103-D25827;TCGA-24-1103-D25828;TCGA-24-1103-D25825;TCGA-24-1103-D25829;TCGA-24-1103-D25830;TCGA-24-1103-D25832;TCGA-24-1103-D25831	5c3acf57-141b-4ce6-91fe-581490c243ba;22f59aba-f17a-4a62-99f6-f823663235f8;31b255dd-31d7-4ed8-933f-d460bb56c52e;f44476cf-cc04-42d3-bb41-71b9b94dd313;ded5f911-f2be-4407-8843-973d988ec6b2;23789e95-afa2-45e4-863c-265228e4944c;e6d71b0b-52f3-46bb-9928-e8313c172b61;ba9a1f08-8120-426b-8d9e-75de1729a6ff	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;27;1;1;1	910;910;1127;127;127;1127;Not Available;Not Available	694;694;1016;19;19;1016;1625;1625	Topotecan;Navelbine;Taxotere;Taxol;Carboplatin;Carboplatin;Carboplatin;Taxotere	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;2;2;2	9;9;6;6;6;6;1;1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IP;IP	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	43.2;816;756;1920;2210;2322;347;130	mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2010;2010;2010	Not Available	Not Available	TCGA-24-1103-F25824	37eac75a-a99b-46ea-ab5f-172ea3b9cbb4	9	1646	1646	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	678	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1103	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-24-1430	68	FEMALE	863	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	449.0		Recurrence	WITH TUMOR		68	Bilateral	TCGA-24-1430	3018efe7-13a1-47ae-a726-8fc967c73841	12	-24939	863	0	863	TCGA-24-1430-D25974;TCGA-24-1430-D25968;TCGA-24-1430-D25971;TCGA-24-1430-D25973;TCGA-24-1430-D25970;TCGA-24-1430-D25969;TCGA-24-1430-D25972;TCGA-24-1430-D25975;TCGA-24-1430-D25967	a3db39b6-eb97-47a8-8e64-cb0d8de8ffab;4630dd23-dba3-4101-8d84-62b9fd51dfa3;bafc8e9f-3310-409a-9129-50f29f23b38d;26fd89d8-c384-4c27-8f76-e8fa42667511;cbaf76a6-ae77-42d5-8ff7-fdc31b7a31bb;ada775a9-b4ec-43c5-bf11-7533cd8667cd;3194f6fd-af01-4f55-ba85-50eb0bd7af8e;2a8e83d3-0e03-4a92-ac3d-9db1c4104de4;574ea0f6-0c98-43ed-a8c7-3bf90f81ae70	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12	841;106;624;769;547;106;769;841;106	804;22;568;652;463;22;652;804;22	Doxil;Taxol;Doxil;Carboplatin;Topotecan;Amitostine;Taxol;Gomzar;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5	1.5;06;03;05;05;06;05;1.5;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg	PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;RECURRENCE;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	81;1252;177;1960;44.88;5301;128;5150;539	mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009	1	Not Available	TCGA-24-1430-F25966	a1fbfc62-641e-41cd-bebb-0044b8433a52	12	863	863	1	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	449	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1430	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2009	2000
TCGA-30-1856	56	FEMALE	477	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	220.0		Recurrence	WITH TUMOR		56	Bilateral	TCGA-30-1856	91a6f311-c758-4e40-9abb-cc0f6584b9c9	2	-20626	477	0	477	TCGA-30-1856-D27554;TCGA-30-1856-D27556;TCGA-30-1856-D27559;TCGA-30-1856-D27553;TCGA-30-1856-D27560;TCGA-30-1856-D27555;TCGA-30-1856-D27558;TCGA-30-1856-D27557;TCGA-30-1856-D27561;TCGA-30-1856-D27562	8b99703a-2b37-485b-9c5b-9fd8cf793f2a;17d3f156-81fa-443c-9bcd-8c5a72174dbb;c66732af-f355-40df-a6b3-4993bb55a8f7;06847472-6031-4f11-a05b-a66e4c119973;c580c4e7-0a42-4ca4-b24f-43a2ca827d00;1df9a4b7-edff-4838-abd5-cb77b22ee5a5;9d9e6ff1-26ab-4620-9423-bc250e900e29;7f66f918-6c82-4943-a08a-9ce8dee928ec;76cc12ec-df1b-4744-aea9-228dca5926e0;4f34558c-9912-4486-8df5-f0a6fcc95fb1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;23;23;23;23;23;23;23	195;195;462;195;462;195;300;195;462;Not Available	17;17;339;17;339;17;272;17;339;230	Carboplatin;Adriamycin;Doxil;Paclitaxel;Navelbine;Gemcitabine;Taxotere;Topotecan;CPT 11;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9;9;9;9	09;09;01;09;01;09;04;09;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;Not Available;mg/m2;mg	ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;PO	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;Not Available;30;175;20;1000;30;Not Available;50;40	Not Available;Not Available;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;Not Available;mg/m2;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1856-F27552	6fe31f68-f93f-403c-9363-e526f881bc11	2	477	477	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;224	220;Not Available	Recurrence;Locoregional Disease	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1856	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	NO	Dead	2009	2001
TCGA-24-2293	47	FEMALE	506	Serous Cystadenocarcinoma	Omentum	Dead		G3	0	506			Not Available		47	Right	TCGA-24-2293	bdd792e7-d75f-4aa3-b38e-f0708e112075	26	-17235	506	0	506	TCGA-24-2293-D26599;TCGA-24-2293-D26600;TCGA-24-2293-D26602;TCGA-24-2293-D26603;TCGA-24-2293-D26601	259222b7-aa56-4b27-b5c1-a167efcc5a05;478b2750-e834-4ab0-9745-79e4791c52ea;c370ef42-66a2-4812-a7b2-c1a6cfdf941d;a3d3ee41-2df1-443f-afc8-12b8d71bb04f;8050a129-6bfa-4037-8fe8-a5b254002a76	Not Available;Not Available;Not Available;Not Available;Not Available	26;26;26;26;26	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Carboplatin;Taxol;Etoposide;Carboplatin;Melphalan	Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2	06;06;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2293-F26598	65ef94b1-f432-43af-b82b-79eda4ec62be	26	506	506	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	Not Available	YES	Partial Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8441/3	C48.1	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	2293	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Omentum	Not Available	Dead	2010	1995
TCGA-24-1846	45	FEMALE	133	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	133			Not Available		45	Bilateral	TCGA-24-1846	67f526f1-def5-43b4-bc89-154baae190fc	2	-16534	Not Applicable	0	133	TCGA-24-1846-D26347;TCGA-24-1846-D26348	b64016e1-72c8-4a3b-8f11-3dc2a09dd64b;f815ee22-1cf2-484f-a4bf-7ee83a32679e	Not Available;Not Available	24;24	175;175	43;43	Carboplatin;Paclitaxel	Not Available;Not Available	8;8	05;05	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3800;1173	mg;mg	Not Available;Not Available	2009;2009	1	Not Available	TCGA-24-1846-F26346	e73b1ede-abff-4032-af69-0c538317414f	2	Not Applicable	133	1	Not Available	Not Available	Not Available	Not Available	6									Not Available	Other	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1846	Other	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-13-A5FU	60	FEMALE	256	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	256			WITH TUMOR		60	Bilateral	TCGA-13-A5FU	0F7AC6CA-7806-4B2A-9D37-94FF74FCD010	26	-22256	256	0	Not Available	TCGA-13-A5FU-D43573;TCGA-13-A5FU-D43574	84B42869-00D9-41FA-BB29-C17DB74E66C9;A3157A7F-920B-484C-A9B4-BF6C78BC2CFE	Not Available;Not Available	26;26	182;182	35;35	Carboplatin;Paclitaxel	Partial Response;Partial Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Evaluated																												FEMALE	Serous Cystadenocarcinoma	No	C48.0	8441/3	C48.0	YES	Not Applicable	Tumor resection	Not Available	50	Unknown	5	G3									NO	No	A5FU	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			R2	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	13	1-10 mm	Ovary	Unknown	Dead	2013	2009
TCGA-04-1353	64	FEMALE	16	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	Not Available	0	16			Not Available		64	Not Available	TCGA-04-1353	cddbac56-2861-46a5-98a3-df32ab69d5da	19	-23611	Not Applicable	0	16																								Unknown	NOT HISPANIC OR LATINO	TCGA-04-1353-F65201	825C57A6-B8EF-4C2B-B4A3-D081332802BA	19	Not Applicable	16	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	NO	9									Unknown	Not Available	Unknown	Not Available	Not Available	Not Available	Alive	2014	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Not Available	Not Available	Not Available	Not Available	9	Not Available									Not Available	No	1353	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	04	Not Available	Ovary	Not Available	Alive	2014	2003
TCGA-24-1565	74	FEMALE	312	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	145.0		Recurrence	WITH TUMOR		74	Bilateral	TCGA-24-1565	cf1e86ec-4bcb-403c-831b-d67bddef14eb	13	-27048	312	0	312	TCGA-24-1565-D26275;TCGA-24-1565-D26277;TCGA-24-1565-D26276	f520e210-c6e9-48c9-bbff-f257cb97ba74;43054d58-b335-4d70-a5db-42959006cfc5;00f13539-fd47-4c29-96ff-381d74b856a4	Not Available;Not Available;Not Available	13;13;13	123;Not Available;123	39;178;39	Taxol;Topotecan;Cisplatin	Not Available;Not Available;Not Available	5;5;5	06;Not Available;06	Not Available;Not Available;Not Available	mg;Not Available;mg	ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1389;Not Available;774	mg;Not Available;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1565-F26274	213a13f2-5a06-4c77-ba1e-0a5fe7281956	13	312	312	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	145	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	5	G3									Not Available	Not Available	1565	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1997
TCGA-23-2081	49	FEMALE	2342	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1			Locoregional Disease	WITH TUMOR		49	Bilateral	TCGA-23-2081	41178cbc-db73-4007-b5d8-febebf7f578d	20	-18162	2342	0	Not Available	TCGA-23-2081-D25782;TCGA-23-2081-D25791;TCGA-23-2081-D25793;TCGA-23-2081-D25792;TCGA-23-2081-D25784;TCGA-23-2081-D25786;TCGA-23-2081-D25789;TCGA-23-2081-D25788;TCGA-23-2081-D25790;TCGA-23-2081-D25785;TCGA-23-2081-D25783;TCGA-23-2081-D25787	9ac0d608-4f98-4a24-a71d-73e2428d160c;fe9683d7-e2d6-4136-92ea-1d6d51fd5023;903e47f3-51cb-44cf-8d4b-104edf2dd63e;03beed10-8066-4b0d-9003-4ba326eb7011;a9f3cb5e-4bf8-4810-9a1e-f310588bff21;0c4ca03d-0418-47da-bbaf-216d3a8d39cb;87be1e88-31e9-48b0-aa2f-4159d6917c71;3274a846-11f3-4a57-a950-f5115fa188a2;98483a68-d8fc-4b86-a0e5-51e3715b1bcf;6b335083-5754-47d9-8591-2910cb2ad861;c9566413-8e08-47c1-8a4f-527b3da46ef9;498bccb4-7600-48cd-b1dd-3c8c80fb6b6b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	20;20;20;20;20;20;20;20;20;20;20;20	Discrepancy;1948;2173;1948;173;418;1154;960;1154;173;Discrepancy;960	Discrepancy;1790;2070;1790;16;331;988;939;988;16;Discrepancy;939	Avastin;Gemzar;AMG 706;Cisplatin;Paclitaxel;Doxil;Cisplatin;Carboplatin;Gemzar;Carboplatin;Paclitaxel;Taxotere	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11;11;11;11	03;11;11;11;08;04;08;02;08;08;03;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	OTHER, SPECIFY IN NOTES;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;OTHER, SPECIFY IN NOTES;RECURRENCE	Persistent;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Persistent;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;PO;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1750;13200;1325;660;2480;280;1020;1400;20400;4400;300;290	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-2081-F25781	3bed5a01-64cb-41cf-9ed8-4d91eecc4adf	20	2342	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES	NO	250	Not Available	Locoregional Disease	YES	Not Available	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	YES	11	G3									Not Available	Not Available	2081	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-61-2003	53	FEMALE	122	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	0	122			WITH TUMOR		53	Bilateral	TCGA-61-2003	33dc48d8-2e01-482b-944c-ac10da727ec9	8	-19605	Not Applicable	0	122	TCGA-61-2003-D28332;TCGA-61-2003-D28328;TCGA-61-2003-D28331;TCGA-61-2003-D28330;TCGA-61-2003-D28329	682e5459-eee9-47d4-aa3f-b5543a57a9c5;548a0b5e-a665-40db-864c-7a990f366c0d;c055893d-8966-4aca-8d83-54c687fa097f;08a1b811-658b-474d-8e5c-6b15e313b88e;1de90898-a17b-4157-9573-4a8049004b10	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	Not Available;121;Not Available;121;121	122;52;122;52;52	Carboplatin;Carboplatin;Gemcitabine;Taxol;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;IP;IV;Not Available;IV;IP	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2003-F28327	b31360a4-1e89-4989-a36b-11f5e8817b5d	8	Not Applicable	122	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	YES	12	G2									Not Available	Not Available	2003	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Alive	2009	2008
TCGA-23-1116	83	FEMALE	592	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	286.0		Recurrence	Not Available		83	Left	TCGA-23-1116	70fe08bd-a0b4-4a88-b82e-813b176f8e40	20	-30464	Not Applicable	0	139	TCGA-23-1116-D25749;TCGA-23-1116-D25748;TCGA-23-1116-D25750;TCGA-23-1116-D25751	fdcbd10e-6a29-44af-a6d3-0ae779462f28;cebb3b12-fd0f-4d3d-836e-9a2f550a8a89;ca70e5a7-b898-44a8-a40a-56f5788f613d;aadd8f4f-1254-476b-ae3f-6c120a36477e	Not Available;Not Available;Not Available;Not Available	1;1;14;14	187;187;418;418	19;19;306;306	Paclitaxel;Carboplatin;Carboplatin;Gemzar	Not Available;Not Available;Not Available;Not Available	4;4;12;12	06;06;06;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IP;IV;IV;IV	Not Available;Not Available;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1746;2100;1530;11028	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1116-F25747;TCGA-23-1116-F72416	e5378114-5a3c-43f3-9de2-0e3a86b3c462;AA13B064-F5F9-4296-8413-407B773E8B77	20;26	Not Applicable;592	139;Not Available	Not Available;Not Available	Not Available;Additional New Tumor Event	Not Available;Progressive Disease	Not Available;Not Available	Not Available;NO	2;6	None;YES;YES	None;NO;NO	None;Not Available;Not Available	None;286;286	None;Recurrence;Unknown	None;Not Available;Not Available	None;Not Available;Not Available	None;Not Applicable;Not Applicable	Not Available;YES	Not Available;Not Available	Not Available;WITH TUMOR	YES;YES	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	YES	2	G3									Not Available	Not Available	1116	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	>20 mm	Ovary	YES	Alive	2009	2008
TCGA-23-1107	59	FEMALE	9	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	9			WITH TUMOR		59	Left	TCGA-23-1107	acb7ec56-8a47-495f-a11b-2c9fb5d8fe95	19	-21561	9	0	Not Available																								Not Available	NOT HISPANIC OR LATINO	TCGA-23-1107-F25661	83880442-ee2e-4ba6-a679-94c04b632568	19	9	9	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	1107	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	>20 mm	Ovary	Not Available	Dead	2009	1999
TCGA-25-1328	38	FEMALE	2009	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	244.0		Recurrence	WITH TUMOR		38	Bilateral	TCGA-25-1328	79fd602b-3e8e-4353-aa78-4f5f170b607d	27	-13911	2009	0	1979	TCGA-25-1328-D26699;TCGA-25-1328-D26702;TCGA-25-1328-D26700;TCGA-25-1328-D26703;TCGA-25-1328-D26701	35af06d0-1470-4bcc-b7de-b72f7bf5a4e4;c713fc4f-e804-4cde-9a55-e2302007534c;7cf22dc8-eab8-40af-919b-502e16d6da2a;2bf527ee-a751-4f97-ae92-5d1509de4d83;74b4f735-4e91-4cc1-b586-2b6debf758be	Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27	395;214;395;214;395	275;30;275;30;275	Topotecan;Taxol;Cytoxan;Carbo;Carbo	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1328-F26698	9b2cf6b3-c423-4721-90b4-ae9c1fb5c92f	27	2009	1979	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;244	244;Not Available	Recurrence;Locoregional Disease	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1328	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-24-1852	55	FEMALE	2201	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	1009.0		Recurrence	WITH TUMOR		55	Bilateral	TCGA-24-1852	d48fff14-9413-40a7-a09c-41f12bbe0aa9	2	-20390	2201	0	2201	TCGA-24-1852-D26370;TCGA-24-1852-D26364;TCGA-24-1852-D26366;TCGA-24-1852-D26368;TCGA-24-1852-D26367;TCGA-24-1852-D26369;TCGA-24-1852-D26365;TCGA-24-1852-D26371	e7eb9218-249e-49ad-b914-a39276408ee6;4fbaa045-8c1a-4562-8a14-027c36c47dc8;41abc427-0a0a-417c-bdac-62964cd28fc6;2daf9300-1112-4263-8c24-998de2e397b3;df90f7fb-b62b-48db-af5d-7c531637e2c2;416cb486-e33c-42e3-a36f-a9a39252ecd5;55c0ae4e-b446-4d4c-b6f0-4e29ecf218c0;f16113a4-2994-442f-a585-2f7a08d53101	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	26;26;26;26;26;26;26;26	1709;128;1040;1255;1255;1558;128;1709	Not Available;6;1010;1071;1071;1497;6;Not Available	Doxil;Carboplatin;Topotecan;Taxol;Carboplatin;Taxotere;Taxol;Gemzar	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2;2	06;06;02;09;09;02;06;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	RECURRENCE;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;PO;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-1852-F26363	86a11d6f-67e3-45ae-a719-41592e845a39	2	2201	2201	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;1211	1009;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1852	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1997
TCGA-24-1425	45	FEMALE	181	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	181			TUMOR FREE		45	Bilateral	TCGA-24-1425	b120b701-c194-43d7-a491-3206fac38ec1	12	-16764	Not Applicable	0	181	TCGA-24-1425-D25947;TCGA-24-1425-D25948;TCGA-24-1425-D25949	def339b3-1e0a-4329-aaae-7a397dcd76a1;4e000e93-7c9c-430e-803d-b235fa58d076;96ca010b-3b93-4206-8972-2599cf9895cd	Not Available;Not Available;Not Available	12;12;12	145;145;145	27;27;27	Taxotere;Carboplatin;Taxol	Not Available;Not Available;Not Available	5;5;5	06;06;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	832;5065;553	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	0	Not Available	TCGA-24-1425-F25946	4a3aabd7-413a-42fe-a1dd-5af7e3935ec3	12	Not Applicable	181	0	Not Available	Not Available	Not Available	Not Available	5									Not Available	Other	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1425	Other	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-31-1946	30	FEMALE	918	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	664.0		Recurrence	WITH TUMOR		30	Bilateral	TCGA-31-1946	da274941-3edd-420b-9262-bbd959923c67	20	-11146	Not Applicable	0	918	TCGA-31-1946-D27682;TCGA-31-1946-D27681;TCGA-31-1946-D27685;TCGA-31-1946-D27684;TCGA-31-1946-D27680;TCGA-31-1946-D27683;TCGA-31-1946-D27686	56f9a0bb-a46c-40eb-95a8-194c7567a88b;1686102f-3307-402f-ba68-dfff1343b060;87e7d1d3-165b-4969-bce1-1a00f13eec10;67ffe7ae-da38-4393-8271-545d0259f6ff;67422b5d-9481-47cc-850b-68769f0c75d5;6a769fec-2edb-4b44-910d-e1d49d42c7ce;870e5a5d-f290-492a-b282-4171aac9f5d4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	20;20;20;20;20;20;20	148;43;743;743;43;148;828	64;22;687;687;22;64;771	Gemcitabine;Paciltaxel;Carboplatin;Liosomal Docorubicin;Carboplatin;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10;10	04;02;03;03;02;04;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Unable to tolerate Liposomal Doxorobicin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12000;260;180;144;1400;2200;1500	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-31-1946-F27679	5a829c07-1749-4281-9d01-caab3b1caf7c	20	Not Applicable	918	Not Available	Not Available	Not Available	Not Available	Not Available	10	YES	NO	Not Available	664	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	10	G3									Not Available	Not Available	1946	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	31	No Macroscopic disease	Ovary	YES	Alive	2009	2006
TCGA-09-1661	75	FEMALE	1169	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1169			WITH TUMOR		75	Right	TCGA-09-1661	f8e9d538-7291-4fe7-b3f2-d01676a027f9	2	-27486	1169	0	Not Available	TCGA-09-1661-D24236;TCGA-09-1661-D24238;TCGA-09-1661-D24239;TCGA-09-1661-D24235;TCGA-09-1661-D24237;TCGA-09-1661-D24240;TCGA-09-1661-D24234;TCGA-09-1661-D24241	7c35797f-19d1-480c-8bce-2040e341c6ae;e2248b7d-7614-4bcd-9650-8067047dc92b;2fc710fc-85e0-4df2-af3e-6f41158143a7;31c1fcf0-7c88-43b9-96db-a52d39cf4245;d01e89cf-f3a7-44d6-b16c-f81b8627cf14;d4c5014f-8791-4723-8b70-cade55f5cbde;6599ea24-89a7-4494-b817-2e31333dbd26;360588ef-c280-4c8f-af28-5a16924646e3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5	165;766;940;165;709;1052;332;641	58;758;828;58;641;1017;213;498	Taxol;Gemcitabine;Taxol;Carboplatin;Carboplatin;Taxotere;Doxil;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8;8	6;1;17;6;4;5;4;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg/m2;mg/m2;mg;Not Available;mg/m2;mg/m2;mg	ADJUVANT;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;ADJUVANT;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Not Applicable;Not Available;Not Available;Not Applicable;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	135;800;70;192;6;30;40;20	mg;mg/m2;mg/m2;mg;Not Available;mg/m2;mg/m2;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1661-F24233	9763f5ee-7f9a-4e7b-8fd1-98ce241e0d5f	2	1169	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1661	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	1-10 mm	Ovary	NO	Dead	2009	2000
TCGA-61-2009	65	FEMALE	1212	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	101.0		Recurrence	WITH TUMOR		65	Bilateral	TCGA-61-2009	ae914f23-87b9-4169-a7f7-a3483078c902	8	-23772	Not Applicable	0	1212	TCGA-61-2009-D28343;TCGA-61-2009-D28346;TCGA-61-2009-D28350;TCGA-61-2009-D28345;TCGA-61-2009-D28342;TCGA-61-2009-D28348;TCGA-61-2009-D28349;TCGA-61-2009-D28347;TCGA-61-2009-D28344	d23924cf-bfbe-491c-857d-ee0725112933;fb931ec9-877c-411a-b75f-07a07fd3afd4;9d9b6e91-c5ec-4d50-b8fc-c27068ee4470;3ff0898b-635f-4c55-b7d9-beb06c6248c8;fd4307f9-d370-43de-9bb1-aa5a096b8295;ef2747cc-31fe-4893-8aab-d084a7b528c2;60906890-5f6c-494d-8601-e9967fafa145;a6d772c2-aeae-48ee-9e3e-c9357345c653;6d2c40c5-e1e8-4083-a77d-24b61b62bef7	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8;8;8	83;295;Not Available;295;83;1003;1126;1003;295	41;120;658;120;41;839;1100;839;120	Carboplatin;Taxol;Tamoxifen;Cisplatin;Taxol;Docetaxel;Doxil;Oxaliplatin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12	06;07;Not Available;07;06;07;04;07;07	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;Not Available;mg;mg;mg;mg;mg;mg	ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IV;Not Available;IP;IV;IV;IP;IV;IV;IP;IV;IP;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1545;490;Not Available;635;778;658;304;987;1200	mg;mg;Not Available;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2009-F28341	fc604495-213e-4fd9-bf0b-968863d4f36d	8	Not Applicable	1212	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES;YES	NO;NO	Not Available;819	101;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	2009	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	11-20 mm	Ovary	YES	Alive	2009	2006
TCGA-25-1329	76	FEMALE	457	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	457			Not Available		76	Bilateral	TCGA-25-1329	955c80be-53df-4565-9303-a7abf96a2f81	27	-28093	457	0	90																								Not Available	NOT HISPANIC OR LATINO	TCGA-25-1329-F26705	f1c2ba9f-692a-4e14-a1ff-b522f182598b	27	457	90	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	Not Available	YES	Not Available	Not Available	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1329	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	11-20 mm	Ovary	Not Available	Dead	2009	2002
TCGA-13-0726	55	FEMALE	949	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	GX	1	392.0		Recurrence	WITH TUMOR		55	Bilateral	TCGA-13-0726	32960bc7-839a-42c5-9460-3917fa578ffc	24	-20134	949	0	946	TCGA-13-0726-D24517;TCGA-13-0726-D24516	9297737f-6669-4c71-858d-095117428338;f8476d0c-e091-4678-a588-e33fdb388ee4	Not Available;Not Available	16;16	169;169	29;29	Paclitaxel;Carboplatin	Not Available;Not Available	4;4	7;7	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	175;Not Available	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0726-F24515	b95035b9-c865-4fe8-88c3-f5723ea3ad15	24	949	946	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	392	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	GX									Not Available	Not Available	0726	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-04-1338	78	FEMALE	1418	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	380.0		Recurrence	WITH TUMOR		78	Bilateral	TCGA-04-1338	31872f6a-d225-4f91-b38d-4505d19e406c	14	-28789	Not Applicable	0	1418	TCGA-04-1338-D23934;TCGA-04-1338-D23937;TCGA-04-1338-D23938;TCGA-04-1338-D23935;TCGA-04-1338-D23936	3852b927-d887-4d24-a04b-a490d8104764;303cbcd2-da20-448e-9b83-9469a2068fe8;7df91b7d-ebc2-4b72-9e60-d401fb168d18;99006d2c-78d0-433d-93c0-11361212d049;c40ba7f9-061d-493a-b88e-70b482fdb3be	Not Available;Not Available;Not Available;Not Available;Not Available	24;24;24;24;24	201;627;Not Available;201;510	0;597;627;0;415	Carboplatin;Gemcitabine;Tamoxifen;Taxol;Docetaxel	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	08;1;Not Available;8;6	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg;mg;Not Available;mg	ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;IV;IV;Not Available;IV	NO;NO;YES;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;800;10;Not Available;812	Not Available;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	1	NOT HISPANIC OR LATINO	TCGA-04-1338-F23933	a1d5c870-53e2-4dcf-91b7-2edaf75e8168	26	Not Applicable	1418	1	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	380	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	7	G3									Not Available	Not Available	1338	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Alive	2009	2005
TCGA-20-0990	74	FEMALE	789	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	871.0		Recurrence	WITH TUMOR		74	Bilateral	TCGA-20-0990	c9524775-6b50-4793-8858-24b6a6d3e4e6	23	-27170	Not Applicable	0	789	TCGA-20-0990-D25527;TCGA-20-0990-D25528;TCGA-20-0990-D25524;TCGA-20-0990-D25525;TCGA-20-0990-D25526	122c2ea5-7803-4149-88c4-b8601e1a2511;15ac365e-4f23-4eaf-aa92-f6b2dfaec21d;e4109126-8bb8-4994-b2c0-26b5599e62ca;00c73916-b074-4f01-8663-a17d24d71686;b8c952b4-928b-4ceb-b655-5db68e4da13c	Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16	1174;1174;236;236;999	1034;1034;116;116;901	Carboplatin;Liposomal Doxorubican;Carboplatin;Paclitaxil;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	06;06;06;06;05	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg/m2;mg	RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	Not Available;Not Available;Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	320;47;480;175;1240	mg;mg;mg;mg/m2;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	1	NOT HISPANIC OR LATINO	TCGA-20-0990-F25523	c08304fa-042d-4a64-a8c1-165686740dd1	23	Not Applicable	789	1	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	871	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0990	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	Not Available	Ovary	Not Available	Alive	2009	2005
TCGA-61-2096	56	FEMALE	1776	Serous Cystadenocarcinoma	Ovary	Alive	Stage IC	G2	1	421.0		Recurrence	TUMOR FREE		56	Right	TCGA-61-2096	6beaa1cb-a9f1-4127-898c-7aff2273788e	7	-20663	Not Applicable	0	1776	TCGA-61-2096-D28400;TCGA-61-2096-D28405;TCGA-61-2096-D28403;TCGA-61-2096-D28408;TCGA-61-2096-D28404;TCGA-61-2096-D28402;TCGA-61-2096-D28399;TCGA-61-2096-D28406;TCGA-61-2096-D28401;TCGA-61-2096-D28407;TCGA-61-2096-D28411;TCGA-61-2096-D28409;TCGA-61-2096-D28410	747e5765-384f-47e1-b3e6-cb03b2421b71;bddc4142-e4c3-4aca-a2af-b3fd121af417;6d4dc7be-241f-4118-bcfc-23669a4aa990;4c55795f-5c4d-4e31-8f40-261d3e5b4ebd;0194e725-95cb-4433-a529-83ed2c8d8982;9421779f-251f-47b0-b58b-f6a909449e5b;7d5010dc-37d5-47a1-a188-bb9fc40715d6;32b36471-32ff-40be-8198-66ce4f3ce473;0ce482e8-1b48-4a3b-aba4-5e06a663f25c;3d15ee97-366f-4c71-9465-e207cf22ffdc;105b962c-185f-43a2-a308-d39d139bae04;9e834075-0f48-4e0a-a791-c91c65803a6d;70f500bc-f3f6-4f06-83c6-f6a96bfed24c	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7;7;7;7;9;9;9	79;1372;988;2010;1156;544;79;1372;544;2010;642;642;642	29;1191;916;1723;1059;474;29;1191;474;1723;Not Available;Not Available;Not Available	Taxol;Gemcitabine;Carboplatin;Avastin;Taxol;Taxol;Carboplatin;Carboplatin;Carboplatin;Topotecan;Cyclophosphamide;Topotecan;Melphalon	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12;2;2;2	03;06;03;04;05;04;03;06;04;04;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	645;9450;1230;5320;1876;1296;1440;1430;2200;43.2;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2010;2010;2010	Not Available	Not Available	TCGA-61-2096-F28398	fe500f96-37c9-445e-9e91-ca55df7e2783	7	Not Applicable	1776	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES	NO	Not Available	421	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	TUMOR FREE	YES	Progressive Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	12	G2									Not Available	Not Available	2096	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	Not Available	Alive	2009	2003
TCGA-13-1494	43	FEMALE	2856	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	693.0		Recurrence	WITH TUMOR		43	Bilateral	TCGA-13-1494	f50ee039-1da9-43d9-ac01-657ec77a7f32	31	-15993	Not Applicable	0	1162	TCGA-13-1494-D24895;TCGA-13-1494-D24894	4e2bfc0a-008f-4a5d-b555-4fa7ecb07882;cd1fa5ad-5986-444a-ad95-2f307d5700c4	Not Available;Not Available	30;30	182;182	Not Available;Not Available	Paclitaxel;Carboplatin	Not Available;Not Available	6;6	6;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1494-F24893;TCGA-13-1494-F72644	0ddc7119-70bd-4d8b-985a-0fbe4758e999;010AF80F-1855-45A3-8EFC-9414DFE3C3D1	31;31	Not Applicable;2856	1162;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	Not Available;Not Available	Not Available;Not Available	3;7	YES;YES;Not Available	NO;NO;Not Available	Not Available;767;Not Available	693;Not Available;693	Recurrence;Metastatic;Unknown	Not Available;YES;Not Available	Imaging Study;Imaging Study;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;Unknown	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1494	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2004
TCGA-61-1919	58	FEMALE	1161	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	439.0		Recurrence	Not Available		58	Bilateral	TCGA-61-1919	ce871097-a6e9-4139-897e-642ee24ee123	30	-21199	1161	0	1161																								Not Available	NOT HISPANIC OR LATINO	TCGA-61-1919-F28300	32f30aa0-9c9e-4a94-8b29-558fb4a1029f	30	1161	1161	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES;YES	NO;NO	Not Available;438	439;Not Available	Recurrence;Metastatic	Not Available;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	Not Available	Not Available	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	11	G2									Not Available	Not Available	1919	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	Not Available	Dead	2009	2001
TCGA-61-1724	47	FEMALE	637	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1			Locoregional Disease	WITH TUMOR		47	Bilateral	TCGA-61-1724	2ae65a06-df0f-4de1-a536-537cae0cc260	2	-17168	637	0	637	TCGA-61-1724-D28138;TCGA-61-1724-D28140;TCGA-61-1724-D28136;TCGA-61-1724-D28137;TCGA-61-1724-D28139;TCGA-61-1724-D28141	5a48d2d4-f2f1-4169-aa5f-c07f1a4897e3;cd8e9c06-c812-47cd-be39-6f65386c41ef;6af00c2d-d0db-4f4b-8bcf-05807748460e;17389b1d-4f26-4ea4-9e25-44de0d1f6504;10ae53d3-cf86-4d27-acc9-b14b417c38e9;01418efe-a192-41b4-b329-40e650144015	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;514;287;Not Available;368;608	Carboplatin;Taxotere;Cisplatin;Gemcitabine;Doxil;Gemzar	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;IP;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1724-F28135	81734ce6-1983-4b83-a2ac-394d263fefb0	2	637	637	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	187	Not Available	Locoregional Disease	YES	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1724	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	YES	Dead	2009	2007
TCGA-23-1111	63	FEMALE	98	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	98			Not Available		63	Right	TCGA-23-1111	6b2a9f9a-fe96-4311-a330-925c4ad36fe7	2	-23171	Not Applicable	0	98	TCGA-23-1111-D25674;TCGA-23-1111-D25675;TCGA-23-1111-D25673	23d2be25-9d1f-4e0d-a2cd-ce35c16e2cd9;5b8a8e00-e4be-4a14-a676-a1e13668a596;47ac4877-04ba-4b1e-8cd0-abbe3e23f2e2	Not Available;Not Available;Not Available	12;12;12	129;129;129	45;24;24	Investigal drug Avastin;Carboplatin;Taxol	Not Available;Not Available;Not Available	8;8;8	05;06;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5850;3389;1860	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-23-1111-F25672	5e8299c1-4db5-4867-afc7-db96e4f3fe68	2	Not Applicable	98	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1111	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-13-0791	58	FEMALE	1224	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	281.0		Recurrence	WITH TUMOR		58	Bilateral	TCGA-13-0791	90118207-8f11-4784-ac1b-0deec2e7af3a	24	-21380	Not Applicable	0	1184	TCGA-13-0791-D24581;TCGA-13-0791-D24580;TCGA-13-0791-D24582;TCGA-13-0791-D24585;TCGA-13-0791-D24586;TCGA-13-0791-D24583;TCGA-13-0791-D24584	4bbea2bf-9e76-4eb8-943a-c8261c1e3d4b;710705ec-cf9c-48b3-ba3e-231fd550abdc;379ea08d-75c7-4d5b-98f6-81fab2e749e8;75a48310-4c7b-4d7e-aeba-64a599ee42e4;ae155608-caaf-401f-9b84-046e87854d2c;0e93df1a-7811-43d7-ad40-d83f7e680672;ad968ce1-3353-45e4-a7c6-d061d40f6126	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;8;8;8;8	141;141;281;780;829;449;640	36;36;213;654;794;302;479	Paclitaxel;Carboplatin;Paclitaxel;Gemcitabine;Carboplatin;Liposomal Doxorubicin;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;3;3;3;3	6;6;4;12;2;6;19	Not Available;Not Available;Not Available;800;Not Available;40;3	mg/m2;Not Available;mg/m2;mg/m2;AUC;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	Not Available;Not Available;Not Available;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	175;Not Available;135;Not Available;4;Not Available;Not Available	mg/m2;Not Available;mg/m2;mg/m2;AUC;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0791-F24579;TCGA-13-0791-F72604	93d82464-ef0e-4d3e-b324-86b1b2e7b05c;F17EB102-471B-4D9A-8283-118007CC21E9	24;30	Not Applicable;1224	1184;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	281;281	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0791	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2005
TCGA-24-1545	69	FEMALE	1746	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	861.0		Recurrence	WITH TUMOR		69	Bilateral	TCGA-24-1545	f2ec64f5-a414-4c34-99c7-d59bc4e831e0	2	-25460	1746	0	1746	TCGA-24-1545-D26089;TCGA-24-1545-D26093;TCGA-24-1545-D26094;TCGA-24-1545-D26091;TCGA-24-1545-D26090;TCGA-24-1545-D26092;TCGA-24-1545-D26095	55f6d8ae-116b-4664-9b7c-dbdb2cccac10;e4f6dcef-e36c-4d69-973e-66292bb6d9c3;7eae83cf-f8b8-4002-aaa2-c10132f7fdf4;bca3bc2d-ed36-41e0-afc3-d899ba451903;63fb1c9b-e07e-4a55-a88e-be3534fd87fc;47004f32-ba26-4d9c-be14-611ebf3f5dd9;f2c12ae2-10b5-4066-b8c4-2538743a8fff	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27;27	285;1169;1169;951;285;1028;1238	14;1056;1056;867;14;973;1203	Taxol;Taxol;Carboplatin;Topotecan;Carboplatin;Doxil;Navelbine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7	10;06;06;05;10;03;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;PROGRESSION;PROGRESSION;RECURRENCE;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2520;1476;3068;42;5750;165;215	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-24-1545-F26088	84f70a51-070e-4649-8a9e-df72b6b5e095	2	1746	1746	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	861	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1545	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2009	1997
TCGA-13-2065	71	FEMALE	1993	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	946.0			TUMOR FREE		71	Bilateral	TCGA-13-2065	8d1dcf21-efd3-4fbe-ad44-f43a19239383	2	-25973	Not Applicable	0	266	TCGA-13-2065-D25016;TCGA-13-2065-D25014;TCGA-13-2065-D25015	4cd10442-1ec3-49c9-8ec3-a564919e8276;ec1c37f5-42f6-4a57-b90c-b4ffad895817;9d325c18-026c-4f04-80c4-bf1ce79b67ad	Not Available;Not Available;Not Available	2;2;2	68;141;141	16;89;89	Carboplatin;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available	2;2;2	3;3;3	Not Available;Not Available;Not Available	AUC;AUC;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5;5;Not Available	AUC;AUC;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	TCGA-13-2065-F25013;TCGA-13-2065-F72688	85387f59-4a1c-40e5-b5fb-1c151e51ee15;D90678EA-18DA-4C5D-A807-C5ECBCA0B291	2;31	Not Applicable;Not Applicable	266;1993	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	Not Available;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;946	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2010;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	2065	Not Available	TUMOR FREE	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2010	2009
TCGA-09-1667	61	FEMALE	1882	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G2	1	460.0		Recurrence	WITH TUMOR		61	Bilateral	TCGA-09-1667	32d4d200-1fdf-44ed-b81f-1954a9c93926	2	-22306	Not Applicable	0	1882	TCGA-09-1667-D24295;TCGA-09-1667-D24294;TCGA-09-1667-D24297;TCGA-09-1667-D24296;TCGA-09-1667-D24293	44e0c058-2dad-42aa-a59f-80335409f7a2;75fe69a4-be66-4430-83bb-26c8e6fc4e3a;28bcdda1-2d1e-46f9-bc34-8e22d90fe9c1;40335523-102a-49a1-b4d4-7909d043b53f;7128aad9-cd3e-493b-bbfd-7280aae2574f	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	685;118;1135;1875;118	559;7;1135;820;7	Carboplatin;Taxol;Carboplatin;Doxil;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	5;6;1;20;6	Not Available;Not Available;Not Available;Not Available;Not Available	AUC;mg/m2;AUC;mg/m2;AUC	RECURRENCE;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	6;175;6;40;6	AUC;mg/m2;AUC;mg/m2;AUC	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1667-F24292	8bed668f-c2de-4768-9bb9-ff8adf3d84e3	2	Not Applicable	1882	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	YES;YES	Not Available;511	460;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G2									Not Available	Not Available	1667	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence	TCGA-09-1667-R24298	6929c2c5-1340-4667-a59f-ba92f9c89d11	Not Available	3	1552	1539	Not Available	6	10	3000	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2004
TCGA-24-1850	72	FEMALE	168	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	168			TUMOR FREE		72	Bilateral	TCGA-24-1850	b6b607cd-67b8-4c04-a212-a4e8c0743f05	2	-26369	Not Applicable	0	168	TCGA-24-1850-D26360;TCGA-24-1850-D26361	f7c53c2b-1b5d-48ce-9a74-26affe5d69ee;2be1a502-15f0-4f43-b7ec-c94679b5e0d4	Not Available;Not Available	24;24	138;138	34;34	Carboplatin;Taxotere	Not Available;Not Available	8;8	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3138;706	mg;mg	Not Available;Not Available	2009;2009	0	Not Available	TCGA-24-1850-F26359	1345a9a2-a18f-418a-94bf-ec8ab20404b7	2	Not Applicable	168	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1850	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-23-1109	62	FEMALE	1562	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	987.0		Recurrence	WITH TUMOR		62	Right	TCGA-23-1109	7c466a5f-a6b4-4d1a-a0f5-ddcd7ef90ff1	19	-23002	1562	0	1562																								Not Available	NOT HISPANIC OR LATINO	TCGA-23-1109-F25663	bf98d383-003d-451a-b7fa-7986df387d5c	19	1562	1562	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	YES;YES	Not Available;987	987;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	1109	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence	TCGA-23-1109-R25664	9294a1c2-8b3a-40e0-8112-1dd01671610e	Not Available	7	1433	1392	Not Available	7	30	5500	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-04-1351	76	FEMALE	1991	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	1	1658.0		Recurrence	TUMOR FREE		76	Not Available	TCGA-04-1351	12b032ed-ff92-4bfe-b980-eb273ae8ae17	26	-28045	Not Applicable	0	1991	TCGA-04-1351-D24002;TCGA-04-1351-D24003	a7c3ad1f-4d37-4b3e-9b47-d4ec008b2874;b6d20430-8f48-46d9-876a-65ed5004e96e	Not Available;Not Available	23;23	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;RECURRENCE	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-04-1351-F24001	32e5fadb-7231-48fb-b1fe-54e0acf09411	26	Not Applicable	1991	Not Available	Not Available	Not Available	100	Not Available	3	YES	NO	Not Available	1658	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	100	Not Available	3	G2									Not Available	Not Available	1351	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	Not Available	Alive	2009	2004
TCGA-25-1325	77	FEMALE	976	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	976			Not Available		77	Left	TCGA-25-1325	9471bc5e-18da-4356-bb0f-c78edd35ff99	27	-28183	976	0	976																								Not Available	NOT HISPANIC OR LATINO	TCGA-25-1325-F26689	f831163a-bda9-4cae-bb8a-0f303a988a52	27	976	976	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	Not Available	Not Available	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1325	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	>20 mm	Ovary	Not Available	Dead	2009	2002
TCGA-24-2295	69	FEMALE	1007	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	281.0		Recurrence	WITH TUMOR		69	Right	TCGA-24-2295	7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1	5	-25416	1007	0	1007	TCGA-24-2295-D26606;TCGA-24-2295-D26607;TCGA-24-2295-D26609;TCGA-24-2295-D26608;TCGA-24-2295-D26610	4b24ec33-656b-4372-8c85-24b7baf3e849;def7542e-56d7-45d4-ab76-bbf9b8045491;fa744431-dc45-47a0-aeef-bfff1ee692fc;f6b1b0fe-2b75-479a-a270-6363001de556;b5f3da82-9a24-4265-b713-fc348932d319	Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5	133;133;868;Not Available;Not Available	6;6;Not Available;Not Available;895	Taxol;Carboplatin;Carboplatin;Taxotere;VP 16	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4	07;07;14;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;PO	NO;NO;NO;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	1591;3737;2874;Not Available;Not Available	mg;mg;mg;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2295-F26605	695ad248-871c-4957-b597-9f1f0d08470e	5	1007	1007	Not Available	Not Available	Not Available	Not Available	Not Available	4	YES	NO	Not Available	281	Recurrence	Not Available	First Seen At Further Surgery	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	4	G3									Not Available	Not Available	2295	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1995
TCGA-29-1699	57	FEMALE	1106	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1106			Not Available		57	Bilateral	TCGA-29-1699	fe0e3851-d8cb-4533-9536-b4826cd25f87	2	-21130	1106	0	16																								1	Not Available	TCGA-29-1699-F41729	E35B9DF2-19B1-4DDB-BFE2-9C7D7E028D9E	20	1106	Not Available	Not Available	Not Available	Progressive Disease	Not Available	Not Available	8									NO	Not Available	Not Available	Not Available	Not Available	Not Available	Dead	2013	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1699	Preoperative	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Dead	2009	2004
TCGA-61-1998	48	FEMALE	168	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	168			WITH TUMOR		48	Bilateral	TCGA-61-1998	565d06a1-3640-4274-8fb3-8cad7e578876	8	-17855	Not Applicable	0	168	TCGA-61-1998-D28307;TCGA-61-1998-D28308;TCGA-61-1998-D28309	bf3290fb-d43f-40f0-b67f-584975a56c14;32b34fbe-8dba-4a98-8abb-fdabf73ff607;d1901164-9c69-4aa7-bfc2-bf9a93581e24	Not Available;Not Available;Not Available	8;8;8	77;Not Available;Not Available	10;52;52	Cisplatin;Carboplatin;Taxol	Not Available;Not Available;Not Available	12;12;12	02;06;06	Not Available;Not Available;Not Available	mg;AUC;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;YES;YES	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	188;6;175	mg;AUC;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1998-F28306	0d0da8b8-e9f8-4dbb-9a7f-ff76d2dc734f	8	Not Applicable	168	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	1998	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Alive	2009	2009
TCGA-23-1031	60	FEMALE	575	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	575			WITH TUMOR		60	Left	TCGA-23-1031	c7c3fe4a-327a-4b7e-a259-989b72971209	23	-22225	575	0	575	TCGA-23-1031-D25653;TCGA-23-1031-D25656;TCGA-23-1031-D25651;TCGA-23-1031-D25655;TCGA-23-1031-D25652;TCGA-23-1031-D25654;TCGA-23-1031-D25657;TCGA-23-1031-D25650	d9844a5a-51b3-43da-b153-53e40564a073;7ac6d001-2bdb-4e6a-863d-a72c506dfd1c;9be966b3-0747-412f-a979-39238e9d9e22;57796331-d5b0-4b3d-9544-405b027f6373;ae37b6fb-a4cb-4003-b9e4-6cbc3d5ef1b2;285fafde-48f2-415b-bf55-b7e7ef4e6253;a876fbfc-b6f9-425c-9f99-8581d9c760ab;6c520881-7f90-4327-848b-639e34dda8b9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27;27;27	446;477;166;485;321;446;555;166	341;460;26;460;265;341;541;26	Gemcitabine;Xeloda;Paclitaxel;Docetaxel;Doxorubicin;Cisplatin;Topotecan;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3	11;2;7;2;3;11;2;7	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;Not Available	ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;PO;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16500;1000;2305;280;225;715;11.4;Not Available	mg;mg;mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1031-F25649	2c5cf608-bf49-4d20-9963-e592a4b39096	23	575	575	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	Not Available	2	G3									Not Available	Not Available	1031	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-61-1915	50	FEMALE	2061	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G3	0	2061			TUMOR FREE		50	Bilateral	TCGA-61-1915	0adadf17-c4b6-48b0-a326-21450de3e144	1	-18424	Not Applicable	0	2061	TCGA-61-1915-D28282;TCGA-61-1915-D28281	04be4ceb-917f-4055-b536-a529442dfbcf;4bd27c43-6a47-4962-a865-7fbad514b6d9	Not Available;Not Available	4;4	143;143	25;25	Carboplatin;Taxol	Not Available;Not Available	12;12	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3300;1560	mg;mg	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-61-1915-F28280	b7206aa3-0932-424c-b730-59730aa0c46c	1	Not Applicable	2061	Not Available	Not Available	Not Available	Not Available	Not Available	10									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	10	G3									Not Available	Not Available	1915	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	YES	Alive	2009	2003
TCGA-24-2288	70	FEMALE	25	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	25			WITH TUMOR		70	Bilateral	TCGA-24-2288	28ed2d42-5b4c-4bca-b2b2-6b2a6d3c42cf	19	-25831	25	0	25	TCGA-24-2288-D26575;TCGA-24-2288-D26576	a60ba99a-bb6f-4c5d-a38b-cb3218c5aeed;f9e65bb5-d987-4920-ba32-65526fa41a72	Not Available;Not Available	19;19	21;21	21;21	Taxol;Carboplatin	Not Available;Not Available	2;2	01;01	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	350;600	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-24-2288-F26574	b0b53cfc-c2f6-45cc-bd58-f3412c058ea3	19	25	25	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	2288	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1999
TCGA-57-1585	57	FEMALE	53	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	53			WITH TUMOR		57	Bilateral	TCGA-57-1585	5ed14506-f69a-4da8-9965-72d3270b9f72	2	-20862	53	0	53	TCGA-57-1585-D28078;TCGA-57-1585-D28077	e291cd52-9ae7-45f5-a0bd-fc522f30f01b;81bf2efd-8318-47a1-9950-fbc7a075cf68	Not Available;Not Available	28;28	53;53	18;18	Taxol;Carboplatin	Not Available;Not Available	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-57-1585-F28076	80632215-5601-43af-ad21-18fba962496e	2	53	53	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1585	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	57	11-20 mm	Ovary	YES	Dead	2009	2007
TCGA-59-2354	63	FEMALE	1046	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	462.0		Progression of Disease	WITH TUMOR		63	Left	TCGA-59-2354	d7925dfc-18ce-46ab-a47b-9d06eacc96d0	29	Not Available	1046	0	Not Available	TCGA-59-2354-D28109;TCGA-59-2354-D28108	a31debf1-cc26-497d-8434-113fc8930b99;efd422e2-ed42-4926-ac5f-947cb1a6f888	Not Available;Not Available	31;31	Not Available;Not Available	Not Available;Not Available	Not Available;Carboplatin	Not Available;Not Available	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	RECURRENCE;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-59-2354-F28107	43712126-05c8-4734-8834-ceeb5a6f0ffe	29	1046	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	YES	NO	Not Available	462	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	Not Available	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	1	G3									Not Available	Not Available	2354	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	59	1-10 mm	Ovary	Not Available	Dead	2010	2005
TCGA-25-2392	75	FEMALE	31	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	31			Not Available		75	Bilateral	TCGA-25-2392	7413c891-f74e-456f-bc70-69c83fb53c70	5	-27667	31	0	31																								Not Available	NOT HISPANIC OR LATINO	TCGA-25-2392-F26801	d9ebef02-cd9d-4ec0-851a-3192d9744cd5	5	31	31	Not Available	Not Available	Not Available	Not Available	Not Available	1									Not Available	Not Available	Not Available	NO	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2392	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	11-20 mm	Ovary	Not Available	Dead	2010	2003
TCGA-30-1866	61	FEMALE	1114	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	1	285.0		Recurrence	WITH TUMOR		61	Bilateral	TCGA-30-1866	cbc7f427-5f7b-4267-ad56-055d8880a4cc	2	-22562	1114	0	1114	TCGA-30-1866-D27603;TCGA-30-1866-D27599;TCGA-30-1866-D27601;TCGA-30-1866-D27596;TCGA-30-1866-D27600;TCGA-30-1866-D27602;TCGA-30-1866-D27598;TCGA-30-1866-D27597	e1c6ebe7-8c5c-4199-a06f-ab66088a058b;c64a880a-85be-42d3-8378-642a1f1dce7f;e9f71e7a-9032-4e6d-8906-57b4fa5f37b8;898a6998-0b59-4803-ba74-26e008181c0e;41f27513-1242-4061-a85b-c2884f60a85c;70f90115-e87d-47e9-bf4f-7456761ae58e;6b21b434-6af0-431c-90dd-0fc0118ede26;42b5deb5-1f12-40c6-b3c9-532ec204c50a	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28;28;28	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;126;126	Not Available;Not Available;Not Available;265;Not Available;Not Available;19;19	Taxol;Carboplatin;Topotecan;Doxil;Gemcitabine;Gemcitabine;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12	Not Available;08;Not Available;06;08;Not Available;06;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1866-F27595	105fdc97-99c0-4fb1-ae9d-4361199bbfc9	2	1114	1114	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;285	285;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1866	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-13-0805	57	FEMALE	1074	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	177.0		Progression of Disease	WITH TUMOR		57	Bilateral	TCGA-13-0805	2a3a6222-f477-4198-ab9e-cdf527c1a6cf	25	-21014	1074	0	1073	TCGA-13-0805-D24639;TCGA-13-0805-D24640	bb8c4793-e6e0-4827-ba78-fcd2a9e25910;77384840-9b33-4f4c-9b08-37d02ec121b7	Not Available;Not Available	15;15	151;151	17;17	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	6;6	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0805-F24638	83b411a0-6a00-4c33-a14a-243c680e9403	25	1074	1073	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	177	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0805	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2005
TCGA-13-1485	48	FEMALE	629	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	1	170.0		Progression of Disease	WITH TUMOR		48	Bilateral	TCGA-13-1485	49bfd0fe-48ce-49db-9f76-ce2310410950	31	-17642	629	0	629	TCGA-13-1485-D24862;TCGA-13-1485-D24863	0c370900-9664-4345-ae5e-9ff4c8de205e;9ca66b5d-b2d7-4ed3-91d7-e0a0cc34922a	Not Available;Not Available	30;30	149;149	45;45	Carboplatin;Paciltaxel	Not Available;Not Available	6;6	6;6	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1485-F24861	c541cbcc-09ee-4152-b710-60d9f09f384d	31	629	629	Not Available	Not Available	Not Available	80	Not Available	3	YES	NO	Not Available	170	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	80	Not Available	3	G2									Not Available	Not Available	1485	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-10-0930	70	FEMALE	1040	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	680.0		Recurrence	WITH TUMOR		70	Left	TCGA-10-0930	99f1ae02-86ec-4d93-8cd4-650bf6f02c10	6	-25737	1040	0	1011	TCGA-10-0930-D24434;TCGA-10-0930-D24438;TCGA-10-0930-D24436;TCGA-10-0930-D24433;TCGA-10-0930-D24437;TCGA-10-0930-D24435	bfd5b64b-62d5-4c17-8783-e6dbbf799d03;07366f75-ef12-4507-a120-de282ff35bb7;9e40afd1-1f30-4db6-9986-40cd5b982b0f;5c3e10dc-5d6b-4948-ba8b-4ac663d8e8db;548ef658-969a-490c-9410-cf5e38504c2a;d0b6b8e2-d04f-4bac-9938-6ce9760f5018	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18;18	124;Discrepancy;736;124;838;736	8;Discrepancy;694;8;782;694	Carboplatin;Tamoxifen;Carbo;Taxol;Doxil;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	06;Not Available;03;06;03;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;Not Available;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2520;2400;250;1800;210;810	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-10-0930-F24432	7e161c2d-e784-4e5e-927a-f8aceb86f854	6	1040	1011	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	680	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0930	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-23-1026	45	FEMALE	816	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	797.0		Recurrence	WITH TUMOR		45	Left	TCGA-23-1026	c6ede8ae-881c-47a0-a0ef-745ed4b7764a	23	-16442	Not Applicable	0	816	TCGA-23-1026-D25613;TCGA-23-1026-D25611;TCGA-23-1026-D25612;TCGA-23-1026-D25614	98eca7c8-8f45-43b4-806f-193aba7901b6;5e32312e-6a0d-4e28-a91e-b186be5f1c1c;8eb2970b-6005-448d-b3aa-a1ebcc49df1f;3b5456ab-a33b-4cbf-b0e9-6958219b0063	Not Available;Not Available;Not Available;Not Available	1;1;1;1	936;108;108;936	866;7;7;866	Gemcitabine;Carboplatin;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available;Not Available	4;4;4;4	05;06;06;05	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IV;IV;IP;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	5648;3420;1560;520	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1026-F25610	adc0c0f8-0f93-40af-862a-f2efc4dd6cf1	23	Not Applicable	816	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	NO;NO	Not Available;816	797;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	1026	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Alive	2009	2004
TCGA-24-1428	50	FEMALE	529	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	448.0		Recurrence	WITH TUMOR		50	Left	TCGA-24-1428	9c744ff8-1cde-4176-b6d7-0ab62bf42620	16	-18306	Not Applicable	0	529	TCGA-24-1428-D25962;TCGA-24-1428-D25963;TCGA-24-1428-D25961;TCGA-24-1428-D25964	b79259a9-f490-4eb8-b109-250dc9b3e2bb;5548e7d7-b1dd-43fa-8ccc-db41342a5281;d43e79be-c0cc-4f9b-9631-fbaebe20de3a;acd19c02-f634-4947-b1d5-33ce6ddcd4f5	Not Available;Not Available;Not Available;Not Available	16;16;16;11	130;130;130;508	46;46;46;466	Cisplatin;Paclitaxel;Docetaxel;Carbplatin	Not Available;Not Available;Not Available;Not Available	4;4;4;6	6;6;6;03	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	900;600;780;1519	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2010	Not Available	Not Available	TCGA-24-1428-F25960	51f0a185-1a9f-486d-ae86-8816f919f682	16	Not Applicable	529	Not Available	Not Available	Not Available	Not Available	Not Available	4	YES	NO	Not Available	448	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	1428	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-13-2071	63	FEMALE	773	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	322.0			TUMOR FREE		63	Bilateral	TCGA-13-2071	0d15e5aa-2483-4f81-973a-ff469296c911	1	-23367	Not Applicable	0	191	TCGA-13-2071-D25023;TCGA-13-2071-D25024	35bbcd97-398d-453a-a49d-0e9a5d097a8b;de33c7f9-63e7-415d-9648-7c5dc597446e	Not Available;Not Available	1;1	146;146	41;41	Carboplatin;Paclitaxel	Not Available;Not Available	2;2	6;6	Not Available;Not Available	mg;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	mg;mg/m2	Not Available;Not Available	2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-2071-F25022;TCGA-13-2071-F72689	557458c9-a795-4c0c-bd75-106debd147c0;612CD70B-9F6A-486B-9DA7-ECA4801953BA	1;31	Not Applicable;773	191;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;322	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2010;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	2	G3									Not Available	Not Available	2071	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2010	2009
TCGA-61-1906	55	FEMALE	1038	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	236.0		Recurrence	WITH TUMOR		55	Bilateral	TCGA-61-1906	f553e953-6464-421f-8933-26ca82cb79d3	1	-20378	1038	0	1038	TCGA-61-1906-D28248;TCGA-61-1906-D28241;TCGA-61-1906-D28242;TCGA-61-1906-D28247;TCGA-61-1906-D28243;TCGA-61-1906-D28245;TCGA-61-1906-D28244;TCGA-61-1906-D28246	08069844-2b07-4cb9-ba89-13dc8ef3efcc;ad137f25-8a5c-497a-a23c-cc32c105dbf9;3df3ef68-bd63-40f3-8aac-cda81634d52e;256a66da-facb-406a-b470-479d7de669f4;bc864245-d830-48e2-b862-7ee8c983f05d;d096b01e-2201-4d76-8e34-adaf4f8cd7f9;f5a0e7fc-c6ea-43b4-89f5-f51891c4f550;10f0eb71-7ac1-4247-ac2f-0c1943154b96	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4;4	1038;153;153;1038;321;484;391;484	489;27;27;489;279;400;335;400	Carboplatin;Carboplatin;Taxol;Taxol;Topotecan;Gemzar;Doxil;Avastin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12	10;06;06;10;02;04;03;04	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	AUC;AUC;mg;mg;mg;mg;mg;mg	RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;6;2076;1500;7.8;1600;234;1000	AUC;AUC;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1906-F28240	a3385a59-9fd2-4e64-b6c4-6d6169bf5042	1	1038	1038	Not Available	Not Available	Not Available	Not Available	Not Available	10	YES	NO	Not Available	236	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	10	G3									Not Available	Not Available	1906	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	11-20 mm	Ovary	YES	Dead	2009	2006
TCGA-25-2390	80	FEMALE		Serous Cystadenocarcinoma	Ovary			Not Available	0				Not Available		80	Not Available	TCGA-25-2390	01abf2cf-541c-4610-8ce8-318016db6e59	5	-29257	Not Applicable	0	Not Available																								Not Available	Not Available																												FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Not Available	Not Available	Not Available	Not Available	1	Not Available									Not Available	Not Available	2390	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	Not Available	Ovary	Not Available	Not Available	2010	2003
TCGA-10-0936	69	FEMALE	1123	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1123			WITH TUMOR		69	Bilateral	TCGA-10-0936	7016714b-6af8-45dd-8341-1493927e5515	6	-25454	1123	0	1089	TCGA-10-0936-D24473;TCGA-10-0936-D24467;TCGA-10-0936-D24471;TCGA-10-0936-D24468;TCGA-10-0936-D24470;TCGA-10-0936-D24469;TCGA-10-0936-D24474;TCGA-10-0936-D24472	335550af-0cce-4f0b-bb51-d2a7c0427588;9bd9d92a-4775-495d-9209-1475005505f4;edcae4f7-3cd7-420f-b9d8-a8a91be49e85;3886dc45-0ac8-4881-8901-ed14880ac3c6;ee4d18da-f9a9-41f5-b867-87deff293046;84fd790c-fc01-4d6d-bd3b-c4860f0e78b4;38fab685-29ce-4fff-9179-8691a08107d1;f6bca061-1141-4801-8241-cd2004e60d5d	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18;18;18;18	1007;62;800;194;678;194;615;936	939;20;678;89;621;89;237;810	Gemcitabine;Taxol;Doxil;Taxol;Carboplatin;Carboplatin;Letrozole;Taxotere	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3	03;Not Available;03;Not Available;03;Not Available;Not Available;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/day;mg/m2	PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11200;1615;225;1800;1035;2280;2.5;750	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/day;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	0	NOT HISPANIC OR LATINO	TCGA-10-0936-F24466	8a1857ba-c686-4630-b137-6c45ba21274c	6	1123	1089	0	Not Available	Not Available	Not Available	Not Available	3									Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	0936	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	>20 mm	Ovary	Not Available	Dead	2009	2005
TCGA-31-1955	43	FEMALE	1293	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	918.0		Recurrence	WITH TUMOR		43	Bilateral	TCGA-31-1955	cce34351-1700-405b-818f-a598f63a33e8	19	-15926	Not Applicable	0	1293	TCGA-31-1955-D27706;TCGA-31-1955-D27708;TCGA-31-1955-D27707;TCGA-31-1955-D27705	8a4bfe3d-6d89-4c2c-81c6-56515d7caf3d;0b6c3e47-9f51-45cd-8472-8b584f993367;757d2b76-c7e5-4149-b65c-a27c6ad1cd5d;a8c5e460-08d8-4949-8b43-c0ef7c599020	Not Available;Not Available;Not Available;Not Available	19;19;19;19	147;Not Available;Not Available;147	42;1189;1189;42	Paciltaxel;Paciltaxle;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available	10;10;10;10	06;Not Available;Not Available;06	Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;mg	ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;YES;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1560;Not Available;Not Available;3600	mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-31-1955-F27704	7651c94b-9420-44da-afbc-a38c01e82d6d	19	Not Applicable	1293	Not Available	Not Available	Not Available	Not Available	Not Available	10	YES	YES	Not Available	918	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	YES	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	10	G3									Not Available	Not Available	1955	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-31-1955-R27709	fab3cfc3-7617-4789-a761-dc8d585db8b2	Not Available	19	1149	1138	Not Available	10	10	0300	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	31	No Macroscopic disease	Ovary	YES	Alive	2009	2005
TCGA-20-1685	45	FEMALE	508	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	508			TUMOR FREE		45	Bilateral	TCGA-20-1685	cbc5b936-ead5-4858-ab90-e639402789b0	2	-16745	Not Applicable	0	508	TCGA-20-1685-D25556;TCGA-20-1685-D25555;TCGA-20-1685-D25557	61e2a648-eede-4da8-98d8-b59dd2b3d85a;480d3ba4-151c-424e-ac1c-bbfeb855e517;431a1b7d-0bb3-4262-bf04-9b427b1764d9	Not Available;Not Available;Not Available	27;27;27	144;144;144	39;39;39	Carboplatin;Bevacizumab;Taxol	Not Available;Not Available;Not Available	7;7;7	06;06;06	Not Available;Not Available;Not Available	Not Available;mg/kg;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	6;15;175	Not Available;mg/kg;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	0	NOT HISPANIC OR LATINO	TCGA-20-1685-F25554	f74f942b-3336-4eab-b6f5-96ea2715a52e	2	Not Applicable	508	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1685	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	1-10 mm	Ovary	NO	Alive	2009	2008
TCGA-24-0979	53	FEMALE	1264	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	428.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-24-0979	9a30dee8-962a-49db-a85a-c39515c91b68	11	-19595	1264	0	1264	TCGA-24-0979-D25893;TCGA-24-0979-D25892	8942e664-0aaa-4893-ab7d-027ca7215144;95fa449a-d622-4c36-a4d4-fe256899666f	Not Available;Not Available	11;11	187;187	15;15	Taxol;Carboplatin	Not Available;Not Available	5;5	8;8	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-24-0979-F25891	ebe9f336-2883-4474-a721-cb68273f0c20	11	1264	1264	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	YES	Not Available	428	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	0979	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-24-0979-R25894	faed94c3-b6af-485d-be70-907d82f81d1e	Not Available	11	357	338	Not Available	5	14	3500	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2009	2003
TCGA-23-2645	54	FEMALE	137	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	137			Not Available		54	Right	TCGA-23-2645	66a0df9b-096b-4e8e-9b9c-54bf8637720b	9	-19758	Not Applicable	0	137																								Not Available	NOT HISPANIC OR LATINO	TCGA-23-2645-F25818	71f12d16-2ab6-4744-b46d-f2021677b3e4	9	Not Applicable	137	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	2645	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	No Macroscopic disease	Ovary	Not Available	Alive	2009	2009
TCGA-24-1564	67	FEMALE	787	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	221.0		Recurrence	WITH TUMOR		67	Bilateral	TCGA-24-1564	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	13	-24668	787	0	787	TCGA-24-1564-D26261;TCGA-24-1564-D26268;TCGA-24-1564-D26262;TCGA-24-1564-D26265;TCGA-24-1564-D26269;TCGA-24-1564-D26267;TCGA-24-1564-D26270;TCGA-24-1564-D26263;TCGA-24-1564-D26264;TCGA-24-1564-D26271;TCGA-24-1564-D26266	f3a01cf8-d968-4223-82cc-bd63aa6e9e04;2179241a-2d85-45a8-ba4f-489c7af8a09b;4274b50b-6f29-4a5b-8db4-d3a6bf59e040;57fa40c2-e908-4f10-b4a6-d694ac8a1cbd;885692fc-e283-4f72-9e5a-3fe4b23f90df;5ee39715-291f-406e-84f2-8e4b5ba1beab;a5908269-249e-4154-b6c3-3255d80efacf;51e43b92-611a-4890-9826-27aff4d67584;69a543c6-6550-4db1-a0a8-b9826d22017c;505397d8-457f-4ff7-8a80-079b34298244;550d7621-efda-4cae-917c-292e022877ba	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;13;13;13;13	116;568;116;295;624;463;624;295;295;Not Available;406	8;499;8;248;589;435;589;248;248;736;333	Cisplatin;Taxol;Taxol;Amitostine;VP16;Doxil;Gezmar;Taxol;Carboplatin;Tamoxifen;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;5	06;11;06;04;02;02;02;04;04;Not Available;04	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	ADJUVANT;PROGRESSION;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;PO;IV;IV;IV;IV;PO;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	779;1496;1396;5080;1500;136;2462;1200;5080;20;32.5	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1564-F26260	69d2cd4f-e4ac-476b-a837-030181905bb8	13	787	787	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	YES	Not Available	221	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1564	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-24-1564-R26272	931c1c42-9fbe-4f2d-91a9-89e79ec27ff5	Not Available	13	Not Available	Not Available	Not Available	5	Not Available	Not Available	Not Available	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1997
TCGA-13-0804	73	FEMALE	1073	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	329.0		Recurrence	WITH TUMOR		73	Bilateral	TCGA-13-0804	7e34d3c1-1fab-4326-9a69-4260d2bac558	25	-27021	1073	0	1073	TCGA-13-0804-D24634;TCGA-13-0804-D24636;TCGA-13-0804-D24635	9120000f-695e-4598-948b-393f49a35d72;53652d84-be01-4719-b091-1e0c5a336931;9ba0bb7a-0471-4d62-a672-769e560548fd	Not Available;Not Available;Not Available	15;15;15	161;270;161	26;270;26	Carboplatin;90Y-HU3S193;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	6;Not Available;6	Not Available;Not Available;Not Available	Not Available;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;IV	NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0804-F24633	3a4fad46-797d-4276-b625-8cc78d3545f1	25	1073	1073	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	329	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0804	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-04-1356	62	FEMALE	1499	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIC	G3	1	156.0		Recurrence	WITH TUMOR		62	Bilateral	TCGA-04-1356	8652ddee-98f4-4584-b450-e6f2f5c9d7ec	26	-22855	1499	0	Not Available	TCGA-04-1356-D24006;TCGA-04-1356-D24007	dcc12929-7c55-426b-83cd-0f693a953cfb;6d03f8af-3a97-4801-bded-4dd5c67c3e8d	Not Available;Not Available	10;10	312;312	161;161	Taxol;Carboplatin	Not Available;Not Available	11;11	06;06	Not Available;Not Available	mg;mg	RECURRENCE;RECURRENCE	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1824.5;4531.3	mg;mg	Not Available;Not Available	2009;2009	Not Available	HISPANIC OR LATINO	TCGA-04-1356-F24005	5860debc-e1f5-4cbf-a327-55eaada5452e	26	1499	Not Available	Not Available	Not Available	Not Available	80	Not Available	3	YES	NO	Not Available	156	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Preoperative	WITH TUMOR	NO	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	YES	3	G3									Not Available	Not Available	1356	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	YES	Dead	2009	2004
TCGA-61-1725	40	FEMALE	956	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	844.0		Recurrence	WITH TUMOR		40	Bilateral	TCGA-61-1725	a6eb0cd0-fe57-41b0-8593-776208684293	2	-14782	Not Applicable	0	956	TCGA-61-1725-D28144;TCGA-61-1725-D28145;TCGA-61-1725-D28146;TCGA-61-1725-D28148;TCGA-61-1725-D28149;TCGA-61-1725-D28150;TCGA-61-1725-D28147	ff470391-4fb2-4ee9-b99a-db1ca43e94df;de6d03ff-d938-406d-934b-3b682ca22abc;f8dca13c-4cb2-443d-852d-5f8c0ef3f597;ae6635ba-24c7-4ef6-9109-fcb345f40100;e3c3aa0d-b3cf-4832-a3b3-7edb59254a73;0b003971-e65d-4cad-886b-054a4cb03a53;be9ce53c-8440-43ce-9790-f43f463a4749	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4	158;158;158;Not Available;Not Available;Not Available;577	45;45;45;908;908;908;235	Taxol;Cisplatin;Taxol;Avastin;Carboplatin;Gamzar;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12	06;06;06;06;06;06;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV;IV;IV;IV;IV	NO;NO;NO;YES;YES;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1548;585;456;8550;4368;2400;3204	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1725-F28143	4795b469-2ea1-4e65-bb8f-5b401b6632d5	2	Not Applicable	956	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	844	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1725	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	11-20 mm	Ovary	YES	Alive	2009	2007
TCGA-09-1674	79	FEMALE	260	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	260			WITH TUMOR		79	Bilateral	TCGA-09-1674	1ede8063-e0e9-466d-891c-ac8916f1b5fa	2	-28878	Not Applicable	0	260	TCGA-09-1674-D24324;TCGA-09-1674-D24323	a0689762-9c26-4b5d-abd0-e97287570a20;c829fcf0-0841-4229-adf3-10798090ed07	Not Available;Not Available	6;6	145;145	41;41	Carboplatin;Taxol	Not Available;Not Available	8;8	6;6	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	6;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1674-F24322	ab2e6ae3-6c0c-435d-b0a5-93e3643cd442	2	Not Applicable	260	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1674	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	1-10 mm	Ovary	NO	Alive	2009	2008
TCGA-24-2267	58	FEMALE	1446	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIB	G3	1	512.0		Recurrence	WITH TUMOR		58	Bilateral	TCGA-24-2267	99a61986-7b23-46b5-99a4-efba6bad3766	16	-21293	1446	0	1446	TCGA-24-2267-D26548;TCGA-24-2267-D26553;TCGA-24-2267-D26554;TCGA-24-2267-D26547;TCGA-24-2267-D26550;TCGA-24-2267-D26551;TCGA-24-2267-D26546;TCGA-24-2267-D26552;TCGA-24-2267-D26549;TCGA-24-2267-D26545;TCGA-24-2267-D26555	be3d0294-80f9-4963-a9e2-1cb9cd844483;e6f21e39-f7e8-4d1b-bd85-610ce88ab7e9;6bb395af-f4f7-4d4d-9e89-b91f4208e217;04311818-c59d-4fb2-8a48-9c6e708a25de;299c0ea3-e684-4499-8259-f831fced1a2f;ac6e2596-885c-4402-bd72-a60cd1a76c62;e1443b92-f117-4894-90a5-9dce2d137e05;5ac265d1-a02c-4322-b595-e41e47f869dc;ee87030e-ab29-41cc-ab1f-578c59409e73;2f85a28c-7869-4a5d-b332-7968861c41ca;a457bccc-0352-40de-8b76-62e657783707	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16;16;16;16;16;16;16	793;1332;1332;793;997;1011;219;1332;946;219;1381	580;1172;1172;580;983;1011;6;1172;827;6;1347	Carboplatin;Carboplatin #1;Cisplatin #2-7;Taxol;Navelbine;Topotecan;Cytoxan;Taxol;Hexalen;carboplatin;Gemzar	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3;3;3	08;07;07;08;03;01;08;07;Not Available;08;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;Not Available;mg;mg	RECURRENCE;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;PO;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	836;375;375;2524;145;2.4;7740;2302;Not Available;5570;4560	mg;mg;mg;mg;mg;mg;mg;mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2267-F26544	a78cf572-e891-4896-a60b-698428cc5672	16	1446	1446	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;955	512;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	2267	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	No Macroscopic disease	Ovary	Not Available	Dead	2010	1993
TCGA-25-1315	50	FEMALE	1583	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	153.0		Progression of Disease	WITH TUMOR		50	Bilateral	TCGA-25-1315	635f5335-b008-428e-b005-615776a6643f	27	-18263	1583	0	1553	TCGA-25-1315-D26641;TCGA-25-1315-D26640;TCGA-25-1315-D26642;TCGA-25-1315-D26643;TCGA-25-1315-D26644	c395c2f1-e27d-4a82-81f6-4762e3f4988d;38092d51-5b3f-48c2-a4e2-05502242355f;d4f35481-a6a4-428f-a818-6234b6ced3c3;b8fab70f-4e15-47c4-8b5e-ab9d6db13556;c50db350-ba19-4e40-b7b1-7487af0619b7	Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27	334;153;334;334;153	153;30;153;143;30	Taxol;Cisplatin;Carbo;Taxol;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	Not Available;6;6;2;6	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1315-F26639	5f76897a-afa8-4e00-a593-08ad2e7a93d7	27	1583	1553	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;153	153;Not Available	Progression of Disease;Locoregional Disease	Not Available;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1315	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-09-0364	80	FEMALE	887	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIC	G3	1	395.0		Recurrence	WITH TUMOR		80	Right	TCGA-09-0364	6746533a-8d0b-4ebc-87ec-49c8738121a8	4	-29262	887	0	Not Available	TCGA-09-0364-D24199;TCGA-09-0364-D24200	57b55461-64a0-45a0-baef-0650a107f9bf;780b9212-5bfd-40ff-acef-8d60cb64bdb2	Not Available;Not Available	27;27	188;188	31;31	Carboplatinum;taxol	Not Available;Not Available	3;3	6;6	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;125	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-0364-F24198	c1122b65-e8b1-4c58-99b9-d78c3678332c	4	887	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	YES	Not Available	395	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G3									Not Available	Not Available	0364	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence	TCGA-09-0364-R24201	5f377a9a-dcdb-4c6c-ba0e-4629d6a0254c	Not Available	4	538	502	Not Available	3	Not Available	4400	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	11-20 mm	Ovary	NO	Dead	2009	1998
TCGA-13-0724	72	FEMALE	83	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	83.0		Progression of Disease	WITH TUMOR		72	Right	TCGA-13-0724	a9abe7a7-4126-414b-87d2-a6d25abcf1fa	24	-26342	83	0	83	TCGA-13-0724-D24508	821d3091-cd9c-4958-a260-e9ea9cc10b72	Not Available	16	75	75	Carboplatin	Not Available	4	1	Not Available	Not Available	ADJUVANT	Not Applicable	Not Available	IV	Not Available	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2009	Not Available	HISPANIC OR LATINO	TCGA-13-0724-F24507	f97cc3a0-d1f0-4e85-bcb8-52e1d2d9cd79	24	83	83	Not Available	Not Available	Not Available	80	Not Available	2	YES	NO	Not Available	83	Progression of Disease	Not Available	Not Available	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Excisional Biopsy	Not Available	80	Not Available	2	G3									Not Available	Not Available	0724	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-25-1316	55	FEMALE	1279	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	276.0		Progression of Disease	WITH TUMOR		55	Right	TCGA-25-1316	58427bce-6b81-4083-aeda-25f59e292bbc	27	-20331	1279	0	1126	TCGA-25-1316-D26647;TCGA-25-1316-D26649;TCGA-25-1316-D26648	937633f3-8ac6-4073-b96b-b491f465f7f6;8c815216-6c85-454c-b0ae-2f590d0c8aef;367c6a85-9774-4f94-a158-d267423a02ae	Not Available;Not Available;Not Available	27;27;27	214;214;406	61;61;276	Carbo;Taxol;Topotecan	Not Available;Not Available;Not Available	3;3;3	Not Available;Not Available;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1316-F26646	66d2e9b2-0219-4b9a-aa62-d52e65461829	27	1279	1126	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	276	Progression of Disease	Not Available	Not Available	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1316	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-30-1861	74	FEMALE	1058	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1058			Not Available		74	Bilateral	TCGA-30-1861	0724f800-e873-45d0-bc56-809d0ec4f6e9	2	-27103	1058	0	1058																								Not Available	NOT HISPANIC OR LATINO																												FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1861	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-13-0755	75	FEMALE	76	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	34.0		Progression of Disease	WITH TUMOR		75	Bilateral	TCGA-13-0755	2956e414-f167-438f-8747-a46fe0723622	24	-27438	76	0	76	TCGA-13-0755-D24532	b1fd19c5-0fce-4869-ae4b-9b46b4361b96	Not Available	17	41	19	Carboplatin	Not Available	4	2	Not Available	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	Not Available	Chemotherapy	Not Available	230	mg/m2	Not Available	2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0755-F24531	b113f83e-be11-460a-9ade-2f5c506930f9	24	76	76	Not Available	Not Available	Not Available	40	Not Available	2	YES	NO	Not Available	34	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	40	Not Available	2	G3									Not Available	Not Available	0755	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-09-2043	69	FEMALE	188	Serous Cystadenocarcinoma	Ovary	Alive	Stage IC	G3	0	188			TUMOR FREE		69	Left	TCGA-09-2043	2e05cd3a-a55f-43b8-b2a9-72fb742b89c9	2	-25480	Not Applicable	0	188																								Not Available	NOT HISPANIC OR LATINO	TCGA-09-2043-F24332	4c13cde4-7fc0-4c9a-bcf9-cc338506c17c	2	Not Applicable	188	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	11	G3									Not Available	Not Available	2043	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2009
TCGA-04-1347	81	FEMALE	1919	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	1919			TUMOR FREE		81	Bilateral	TCGA-04-1347	f0c353fd-947c-41e2-b643-3ecc0d69796c	26	-29695	Not Applicable	0	1919	TCGA-04-1347-D23962;TCGA-04-1347-D23964;TCGA-04-1347-D23963;TCGA-04-1347-D23965	064dd296-90e7-493a-a26b-0e9d1aa58b13;a176cad9-0e04-4138-802e-18d4935f981f;8ee7bc23-3af3-437e-a1c3-82da7ded82ba;2f680d7c-a16e-4c02-97dc-b8735edfd538	Not Available;Not Available;Not Available;Not Available	9;9;9;9	173;173;173;173	19;19;19;19	Taxol;Carboplatin;Carboplatin;Taxotere	Not Available;Not Available;Not Available;Not Available	11;11;11;11	6;2;6;2	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1764;750;2400;200	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	0	NOT HISPANIC OR LATINO	TCGA-04-1347-F23961	930a5b42-2e0e-4912-901d-b712de302d38	26	Not Applicable	1919	0	Not Available	Not Available	100	Not Available	3									Not Available	Preoperative	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	100	NO	3	G3									Not Available	Not Available	1347	Preoperative	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	No Macroscopic disease	Ovary	NO	Alive	2009	2004
TCGA-29-2431	59	FEMALE	1285	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	1	960.0		Recurrence	WITH TUMOR		59	Bilateral	TCGA-29-2431	996313ef-11e7-459d-ba5f-ac1a4d0de513	4	-21833	Not Applicable	0	1285	TCGA-29-2431-D27486;TCGA-29-2431-D27490;TCGA-29-2431-D27487;TCGA-29-2431-D27488;TCGA-29-2431-D27489	e8857415-3e93-4361-930e-4ccb6671e0c1;4697eff4-cb13-4836-8a81-0e4382d5b5fe;02256292-b3b7-427a-9157-5147ef0ba72c;c63c5158-3a3d-4f97-92f7-c6cba8fdb995;90ddaf81-71b9-42e3-b499-498c241002c3	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4	138;390;138;1145;1145	33;33;33;977;977	Docetaxel;Bevacizumab;Oxaliplatin;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	06;Not Available;6;8;08	140;1120;160;335;530	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	0	Not Available	TCGA-29-2431-F27485	660c77d7-5cc1-458b-940f-993ed928fa78	4	Not Applicable	1285	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	960	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	2431	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Alive	2010	2006
TCGA-10-0925	58	FEMALE	1652	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G1	1	558.0		Recurrence	WITH TUMOR		58	Bilateral	TCGA-10-0925	869c9aae-85eb-4faa-8893-b3f487e8981c	5	-21498	1652	0	1652	TCGA-10-0925-D24408;TCGA-10-0925-D24406;TCGA-10-0925-D24404;TCGA-10-0925-D24409;TCGA-10-0925-D24407;TCGA-10-0925-D24410;TCGA-10-0925-D24405;TCGA-10-0925-D24411	f759a3d3-377f-4eab-ab14-84a4d30dba5b;10140623-084f-46ad-b207-672f4b228676;4411d09e-4315-4204-aef6-ee87de442231;73fa5659-2aae-4310-9744-237bc5d74ea4;5d6b4186-c9d2-419c-93d3-3555fc8058f7;399884f4-0245-4df5-bad4-9c599adac869;353e255d-4a5f-422b-b3ae-7f92abc7edf0;2673b75d-e190-43f5-96f3-440828653be4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5	1447;293;125;1496;1028;1630;125;593	1308;156;20;1454;593;1517;20;321	Carboplatin;Carboplatin;Carboplatin;Taxol;Carboplatin;Doxil;Taxol;Tamoxifen	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2;2	05;06;06;03;15;05;06;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;PO	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2118;3000;3380;925;7500;326;1400;9600	mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-10-0925-F24403	c1c5689d-52ce-407d-a8da-6e7c103202d9	5	1652	1652	Not Available	Not Available	Not Available	80	Not Available	2	YES	NO	Not Available	558	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G1									Not Available	Not Available	0925	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	1-10 mm	Ovary	Not Available	Dead	2010	2000
TCGA-13-0916	49	FEMALE	1785	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	1785			TUMOR FREE		49	Bilateral	TCGA-13-0916	5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4	25	-18189	Not Applicable	0	644	TCGA-13-0916-D24768;TCGA-13-0916-D24766;TCGA-13-0916-D24767;TCGA-13-0916-D24769	d5f8a386-7074-40a4-9d62-699ba2571deb;e035fe81-878f-4509-ad6e-98266495e5bd;d53e97a9-93d9-46ad-9bd1-1851d1cff4a4;a5460512-89a7-41f5-9ea2-63e47680924a	Not Available;Not Available;Not Available;Not Available	16;16;16;16	161;161;161;182	35;35;35;70	Paclitaxel;Cisplatin;Paclitaxel;Bevacizumab	Not Available;Not Available;Not Available;Not Available	4;4;4;4	6;6;6;Not Available	Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IP;IV;Not Available	Not Available;Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	60;75;135;15	mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0916-F24765;TCGA-13-0916-F72631	e104764b-efb0-4872-8f3f-d164a3d89d09;956B3950-5354-4481-AAE4-18887FCE8A40	25;30	Not Applicable;Not Applicable	644;1785	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;Not Available	2;7									Not Available;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0916	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2006
TCGA-24-1463	70	FEMALE	2218	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	971.0		Recurrence	WITH TUMOR		70	Bilateral	TCGA-24-1463	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	16	-25734	2218	0	2218	TCGA-24-1463-D26012;TCGA-24-1463-D26015;TCGA-24-1463-D26018;TCGA-24-1463-D26020;TCGA-24-1463-D26019;TCGA-24-1463-D26011;TCGA-24-1463-D26010;TCGA-24-1463-D26013;TCGA-24-1463-D26016;TCGA-24-1463-D26014;TCGA-24-1463-D26017	c98d3bb2-e60e-4279-b057-73e950818533;3b745d08-afcc-48eb-8a61-35314bdb9ee8;1d34f8bd-3209-421a-a381-503783bec76d;ed822373-fdf3-4ff0-b016-89d6d3a79706;f8497cc1-74f7-4707-81d7-cd60360edb9b;e6da954d-4e2e-4695-8f5e-e641e746c8e5;cfa3c675-5453-420f-81dd-b11485a4d8de;9a2292f5-c1c1-4c34-baa7-75659a6b31a0;094334ef-5942-45f8-ab0a-d1b1ef328303;a858e299-ace2-4e04-928c-9a5938100d07;6510eb77-3a5d-419f-980b-ca3687eb0f83	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16;16;16;16;16;16;16	1084;1383;1558;1791;1733;123;123;1084;1383;1084;1558	976;1270;1465;1742;1600;18;18;976;1270;976;1465	Taxol;Topotecan;Doxil;Cisplatin;Taxol;Taxol;Carboplatin;Carboplatin;Navelbine;Cisplatin;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4;4;4;4;4	6;6;5;2;17;6;6;6;6;2;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1660;49.4;277;168;2275;1712;3310;1895;508;172;20684	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-24-1463-F26009	9b5f38dd-e6ee-4d19-af8b-c1a46f8b00c0	16	2218	2218	Not Available	Not Available	Not Available	Not Available	Not Available	4	YES	NO	Not Available	971	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	1463	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2009	2000
TCGA-10-0926	63	FEMALE	788	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	287.0		Recurrence	WITH TUMOR		63	Bilateral	TCGA-10-0926	e641aed9-1dd8-4c30-b231-f12b20a76df0	6	-23307	788	0	788	TCGA-10-0926-D24416;TCGA-10-0926-D24414;TCGA-10-0926-D24415;TCGA-10-0926-D24417	2ed5c38f-994f-4aae-ad6f-2be5d242946e;7d7d38a9-711f-480d-a3f2-1c866145b0aa;8651d712-bb73-4b45-bbcf-1f5054c30742;a6419a7d-cf48-41ab-ae3c-4e1e5746e9ad	Not Available;Not Available;Not Available;Not Available	18;18;18;18	729;143;143;Not Available	290;8;8;232	Doxil;Taxol;Carboplatin;Interleukin-12	Not Available;Not Available;Not Available;Not Available	3;3;3;3	13;06;06;Not Available	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	RECURRENCE;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Not Applicable;Adjuvant and Progression;Ajuvant and Progression;Adjuvant and Progression	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available	975;860;4500;22,920	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	Not Available	TCGA-10-0926-F24413	7f3cdaf9-ed64-4b9a-8f24-2e9037eb0f86	6	788	788	Not Available	Not Available	Not Available	80	Not Available	3	YES	NO	Not Available	287	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Complete Remission/Response	YES	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	NO	3	G3									Not Available	Not Available	0926	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Not Available	TCGA-10-0926-R24418	7cbe85ce-dc87-48dc-a107-3917c90294b3	Not Available	18	Not Available	273	Not Available	3	Not Available	Not Available	NO	Not Available	Not Applicable	Not Available	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	11-20 mm	Ovary	NO	Dead	2009	2000
TCGA-25-1633	64	FEMALE	1891	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	616.0		Recurrence	WITH TUMOR		64	Bilateral	TCGA-25-1633	20336269-5a5b-4ba7-8fe8-665a1f9af738	2	-23407	1891	0	1843	TCGA-25-1633-D26743;TCGA-25-1633-D26747;TCGA-25-1633-D26746;TCGA-25-1633-D26745;TCGA-25-1633-D26744	926932a0-85d9-4736-b465-0f4c56b8a5af;427c83f1-26f0-4fe8-9a55-0084402a72e5;6fbbf988-5e98-4f81-bf14-b1ab4ee1fe6a;2974ff47-ecb9-4eb0-9fb1-64a7abe5887b;5d315761-84c9-49cf-8c15-eaa878daade1	Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17	184;740;740;184;184	26;617;617;26;26	Taxol;Carboplatin;Taxol;Gemzar;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	08;08;08;08;08	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1633-F26742	bdb1af60-d13a-43c7-a60d-2e6e2406beba	2	1891	1843	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	616	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1633	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-25-2398	71	FEMALE	1369	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	577.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-25-2398	fd4740db-76a8-4362-be71-7b609479bb67	5	-26267	1369	0	1369	TCGA-25-2398-D26815;TCGA-25-2398-D26813;TCGA-25-2398-D26816;TCGA-25-2398-D26814	3e6a6ff7-6b15-4b7b-b636-374a1ff5b5c4;36111e26-366f-4d5d-a6d5-42950816aaaf;f6a05e71-bcad-4194-9d40-47255dd4cb92;41fdf2d1-c9cc-49c5-83c4-a444f3bb2ce0	Not Available;Not Available;Not Available;Not Available	5;5;5;5	638;151;638;151	608;31;603;31	Taxol;Taxol;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available	1;1;1;1	06;06;06;06	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-25-2398-F26812	0fa5671b-b95a-432f-a2ef-0baed081c586	5	1369	1369	Not Available	Not Available	Not Available	Not Available	Not Available	1	YES	NO	Not Available	577	Recurrence	Not Available	First Seen At Further Surgery	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2398	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2010	2004
TCGA-61-2113	53	FEMALE	676	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIC	G3	1	291.0		Recurrence	Not Available		53	Right	TCGA-61-2113	71faa2c1-0d5b-4dcc-bdf9-f2405f29907c	7	-19722	676	0	676	TCGA-61-2113-D28480;TCGA-61-2113-D28482;TCGA-61-2113-D28481	d22d635b-1e7e-4114-9e2d-0d2b6db38ded;235aa36e-7dcb-4f30-bc39-310e5bca1a66;d4d534c2-01be-4eff-bfb2-369ee917dcf2	Not Available;Not Available;Not Available	7;7;7	143;392;143	49;336;49	Taxol;Doxil;Carboplatin	Not Available;Not Available;Not Available	12;12;12	06;02;06	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1480;418;4026	mg/m2;mg/m2;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2113-F28479	58e8e9bc-2bf0-47e6-a806-3a51341022fb	7	676	676	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES	NO	Not Available	291	Recurrence	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	2113	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	YES	Dead	2009	1999
TCGA-57-1584	47	FEMALE	643	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	530.0		Recurrence	WITH TUMOR		47	Bilateral	TCGA-57-1584	ed21615c-0de3-421c-9e8d-8996026c4431	2	-17263	Not Applicable	0	643	TCGA-57-1584-D28073;TCGA-57-1584-D28074	0c8bcfba-47b8-4021-9897-453225bb8218;ebf8762c-60c4-480c-b622-f381bd0c690b	Not Available;Not Available	28;28	Not Available;Not Available	573;573	Taxol;Carboplatin	Not Available;Not Available	7;7	Not Available;Not Available	Not Available;Not Available	mg/m2;Not Available	RECURRENCE;RECURRENCE	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	175;6	mg/m2;Not Available	Not Available;Not Available	2009;2009	0	NOT HISPANIC OR LATINO	TCGA-57-1584-F28072	aca7dfdd-2755-43e1-a775-1687dee80c72	2	Not Applicable	643	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;532	530;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	NO	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1584	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	57	1-10 mm	Ovary	YES	Alive	2009	2007
TCGA-31-1950	76	FEMALE	571	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	1	349.0		Recurrence	WITH TUMOR		76	Bilateral	TCGA-31-1950	4ca9c0e8-75a7-4665-9d88-6dd2bb44b1e1	19	-28100	Not Applicable	0	571	TCGA-31-1950-D27690;TCGA-31-1950-D27689	4979d025-1341-4190-b965-c7dc0349b252;15db6c90-507f-4efe-82aa-9cb243720c1e	Not Available;Not Available	19;19	571;144	431;33	Paciltaxel;Carboplatin	Not Available;Not Available	10;10	18;06	Not Available;Not Available	mg;mg	RECURRENCE;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1440;3300	mg;mg	Not Available;Not Available	2009;2009	1	NOT HISPANIC OR LATINO	TCGA-31-1950-F27688	28f0e73c-c8c7-4bb4-9d20-f86f2d874e27	19	Not Applicable	571	1	Not Available	Not Available	Not Available	Not Available	10	YES	NO	Not Available	349	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	10	G2									Not Available	Not Available	1950	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	31	1-10 mm	Ovary	NO	Alive	2009	2007
TCGA-13-1411	81	FEMALE	531	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	238.0			WITH TUMOR		81	Not Available	TCGA-13-1411	a9d3a7b0-faf8-4e56-8600-d9e6882a4f23	20	-29874	Not Applicable	0	128	TCGA-13-1411-D24829;TCGA-13-1411-D24830	97303643-4e4a-41e8-b679-e3bfef06de2e;b3cf475f-ff22-4efe-a7a9-8909dff55877	Not Available;Not Available	30;30	128;128	8;8	Carboplatin;Paclitaxel	Not Available;Not Available	6;6	6;6	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1411-F24828;TCGA-13-1411-F72662	aea78ebe-c26b-47e2-a50f-000c9e792fa0;5E4A0AA1-D236-462C-BE4B-3F52CB5A7C4F	20;31	Not Applicable;531	128;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;238	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Partial Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1411	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-10-0934	50	FEMALE	204	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	111.0		Recurrence	WITH TUMOR		50	Bilateral	TCGA-10-0934	65ddccd2-70a7-48b3-88e1-9d6fd1dcd11b	6	-18602	204	0	119	TCGA-10-0934-D24459;TCGA-10-0934-D24460	369dd738-d6cc-4e91-a5bb-a317fe8f262b;8905b636-eb21-4da2-9c21-10097b036851	Not Available;Not Available	18;18	56;56	40;40	Taxol;Carboplatin	Not Available;Not Available	3;3	3;3	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	525;Not Available	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-10-0934-F24458	0d547712-8f13-4099-8c98-dbbd9132acee	6	204	119	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;75	111;Not Available	Recurrence;Metastatic	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G3									Not Available	Not Available	0934	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-25-2391	57	FEMALE	1492	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1492			TUMOR FREE		57	Bilateral	TCGA-25-2391	f5033d52-ec36-4e67-88d8-b6d898b81b2f	5	-20939	1492	0	1492	TCGA-25-2391-D26798;TCGA-25-2391-D26797;TCGA-25-2391-D26799	80def7b0-0486-484f-b014-381d703f1ff1;416777aa-730e-4ecb-9f3e-193f5095066c;c57fb4b0-6cdc-4067-95a8-0f82c14e07ac	Not Available;Not Available;Not Available	5;5;5	153;153;153	31;31;31	Taxol;Carboplatin;Taxotere	Not Available;Not Available;Not Available	1;1;1	05;06;01	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	Not Available;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-25-2391-F26796	6ec2f13a-7241-400e-ba92-e194af3034c7	5	1492	1492	Not Available	Not Available	Not Available	Not Available	Not Available	1									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2391	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	>20 mm	Ovary	Not Available	Dead	2010	2003
TCGA-59-2349	71	FEMALE	2437	Serous Cystadenocarcinoma	Ovary	Dead	Stage IA	G3	0	2437			Not Available		71	Left	TCGA-59-2349	2222b629-02ab-4ead-997f-09d91c6f7cf4	29	Not Available	2437	0	Not Available																								Not Available	Not Available	TCGA-59-2349-F28100	a70c772a-bc64-4db5-82aa-f4a429a8ee3f	29	2437	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1									Not Available	Not Available	Not Available	Not Available	Complete Remission/Response	Not Available	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2349	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	59	No Macroscopic disease	Ovary	Not Available	Dead	2010	1994
TCGA-13-0799	44	FEMALE	2535	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1262.0			TUMOR FREE		44	Bilateral	TCGA-13-0799	b9418c6d-94f7-4db4-a1e4-f384b09d54cb	25	-16171	Not Applicable	0	237	TCGA-13-0799-D24613;TCGA-13-0799-D24612;TCGA-13-0799-D24611	8484fd14-0e7e-45a2-86ce-bcd6b8dfdc48;a3617379-b708-456a-9810-14b2afa80f6d;9d2e034d-d90b-4a71-9671-3b061af0102a	Not Available;Not Available;Not Available	16;16;16	146;146;146	36;36;36	Paclitaxel;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available	4;4;4	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	60;135;75	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0799-F24610;TCGA-13-0799-F72611	20105ff9-cc71-41ab-942d-44454c233406;D33DF974-173A-47AB-BE8E-C9A201712C32	25;30	Not Applicable;Not Applicable	237;2535	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	80;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;1262	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0799	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-25-1623	71	FEMALE	565	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	342.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-25-1623	808eb134-9c7d-43bb-b86c-2f3259193954	2	-26060	565	0	565	TCGA-25-1623-D26709;TCGA-25-1623-D26710;TCGA-25-1623-D26708	8a30a7a1-bdd1-481a-bde2-e96b6f7d9ab0;f38d9a87-50ec-4e63-9295-238f9c127577;d9439bd7-877e-492d-85c7-8c04fff9154d	Not Available;Not Available;Not Available	17;17;17	138;138;Not Available	16;16;Not Available	Taxol;Carboplatin;A202171 Protocol	Not Available;Not Available;Not Available	6;6;6	6;6;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1623-F26707	3089d69d-a5cf-47d4-ae07-46478224b106	2	565	565	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	342	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1623	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	No Macroscopic disease	Ovary	Not Available	Dead	2009	2006
TCGA-13-1819	59	FEMALE	2025	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIC	G3	1	429.0		Recurrence	WITH TUMOR		59	Right	TCGA-13-1819	82e96c6c-a88c-4e52-be56-7f24f6c7b835	2	-21635	Not Applicable	0	1946	TCGA-13-1819-D24983;TCGA-13-1819-D24984;TCGA-13-1819-D24986;TCGA-13-1819-D24985;TCGA-13-1819-D24987	6c86d95a-46b8-4081-b2ed-bd6dd58012e6;6c54ce7d-b124-476e-8341-548977e62fd6;9a7fac23-e0cf-4cfa-8f3a-9acb4fb940d9;3100c47f-1118-4567-ab6c-dae3e00e0af2;d0e3c1c6-6f7f-4d26-80dc-677236827dcb	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;8;8;8	149;149;646;518;646	37;37;539;518;539	Carboplatin;Paclitaxel;Carboplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	6;6;6;1;6	Not Available;175;Not Available;135;175	AUC;mg/m2;AUC;mg/m2;mg/m2	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	5;Not Available;5;Not Available;Not Available	AUC;mg/m2;AUC;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-13-1819-F24982;TCGA-13-1819-F72642	2ec4e86e-6a9d-414f-97c6-d306d094109e;A77F7D3C-9B79-47BF-86E0-253FD3EE3589	2;31	Not Applicable;2025	1946;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	6;7	YES;YES;Not Available	YES;YES;Not Available	Not Available;483;Not Available	429;Not Available;429	Recurrence;Locoregional Disease;Unknown	Not Available;YES;Not Available	Imaging Study;Imaging Study;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1819	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2004
TCGA-29-1710	54	FEMALE	951	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	315.0		Recurrence	WITH TUMOR		54	Bilateral	TCGA-29-1710	4261267c-7042-4c6e-83ed-12fb401003fc	2	-19969	951	0	889	TCGA-29-1710-D27296;TCGA-29-1710-D27295;TCGA-29-1710-D27298;TCGA-29-1710-D27297;TCGA-29-1710-D27304;TCGA-29-1710-D27302;TCGA-29-1710-D27303;TCGA-29-1710-D27305;TCGA-29-1710-D27301;TCGA-29-1710-D27299;TCGA-29-1710-D27300	cb4c7e37-e52e-4fb8-8fa2-b06c4fbe488f;8d6988ea-2c98-4eee-8af3-1f1b8f6e91dd;1870b77f-b3fb-4d51-96e7-40c68e3af351;2f49fa88-c076-48ba-94c2-fa4d9a572e80;84cb2e2e-ce41-4f1d-a1cd-a6d742fb2eab;a00ec514-4300-45f1-801d-4a792374bdf9;d6f9fb02-9165-45de-bb0e-4af029666a8c;e024dbec-28ae-40c1-9e8f-79c02f82ff18;5b6525f0-9d61-446a-83e7-b1a19eff710c;6303ae09-5316-4b1f-9a64-00d5aad22cb6;c217baa5-64ae-4d44-9f6c-3f18651504b7	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;15;15;15;15;15;15	150;150;52;52;52;766;853;653;580;437;542	88;88;31;31;31;682;780;619;556;322;468	Paclitaxel;Carboplatin;Docetaxel;Oxaliplatin;Bevacizumab;Paclitaxel;Topotecan;CEP 11981;Carboplatin;Doxorubincin HCL;Gemcitabine HCL	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;3;3;3;3;3;3	4;4;02;02;Not Available;05;03;Not Available;02;05;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;Not Available;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;Not Available;IV;IV;Not Available;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1200;2790;260;300;1870;310;7;Not Available;700;70;1410	mg;mg;mg;mg;mg;mg;mg;Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-29-1710-F27294	6a1d6bdf-cecf-4c60-a745-f3cf0ebcb1bb	2	951	889	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;878	315;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1710	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Dead	2009	2006
TCGA-30-1887	67	FEMALE	738	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	0	738			WITH TUMOR		67	Bilateral	TCGA-30-1887	f7e01929-733b-420a-ab2b-051dd4a992e5	2	-24495	738	0	738	TCGA-30-1887-D27634;TCGA-30-1887-D27635;TCGA-30-1887-D27638;TCGA-30-1887-D27637;TCGA-30-1887-D27636	e96002ef-d950-4ede-b623-c6ca3cdff2f2;18d7a1d8-66b8-4c1c-ad1c-13862bf6263b;f0f317a4-a2de-4a8f-8fff-54f488ba5642;867b6ed3-96ff-40dc-a6e7-722a047a5b95;d1a4e7ac-6745-47f8-8a98-0b3be8413eca	Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21	433;134;671;482;134	328;27;503;454;27	Gemcitabine;Taxol;Taxol;Topotecan;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	Not Available;06;Not Available;03;06	Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2;AUC	PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	800;175;64;3;5	mg/m2;mg/m2;mg/m2;mg/m2;AUC	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1887-F27633	74d29a4a-9838-4af5-9038-55466876772b	2	738	738	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G2									Not Available	Not Available	1887	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	YES	Dead	2009	2005
TCGA-24-1426	43	FEMALE	163	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	163			TUMOR FREE		43	Bilateral	TCGA-24-1426	c8acee1b-6854-409b-86ab-bf69dbe22ab6	16	-15949	Not Applicable	0	163	TCGA-24-1426-D25953;TCGA-24-1426-D25952;TCGA-24-1426-D25954	ccad2740-e09b-4453-8196-ca0bba953c68;15275f97-b04f-43e1-822e-15c46ca9b9b8;b9d51cf6-9d92-4497-97a8-30a39aea0f11	Not Available;Not Available;Not Available	16;16;16	142;142;142	-8;-8;-8	Cisplatin;Taxoterecin;Taxol	Not Available;Not Available;Not Available	4;4;4	06;06;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	900;780;720	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1426-F25951	dcc9dd22-4227-46a6-b054-4b094b5f6718	16	Not Applicable	163	Not Available	Not Available	Not Available	Not Available	Not Available	4									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	4	G3									Not Available	Not Available	1426	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-13-1487	74	FEMALE	681	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	GX	1	412.0		Recurrence	WITH TUMOR		74	Not Available	TCGA-13-1487	c9e28934-8379-4511-817c-d787f2c4ca3a	31	-27176	681	0	681	TCGA-13-1487-D24866;TCGA-13-1487-D24868;TCGA-13-1487-D24869;TCGA-13-1487-D24867	d30e9978-634d-4cb5-8263-c7e78d3a0bb7;9e538e9a-48e2-4dfc-8da2-35cc24c05393;178b0653-c6f6-4a46-ac22-de69d34385c9;9247a4c9-3d8f-4842-9356-c21ae0c3bfd0	Not Available;Not Available;Not Available;Not Available	30;30;30;30	129;208;412;129	17;208;257;17	Carboplatin;Cisplatin;Paciltaxel;Docetaxel	Not Available;Not Available;Not Available;Not Available	6;6;6;6	6;1;6;6	Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IP;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	300;75;135;75	mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1487-F24865	07b2d67b-3f42-45db-8fc3-334fad4ceaee	31	681	681	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	412	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	GX									Not Available	Not Available	1487	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Dead	2009	2002
TCGA-36-2533	55	FEMALE		Serous Cystadenocarcinoma	Ovary		Stage IIIC	G3	0				Not Available		55	Right	TCGA-36-2533	f7dece2a-d12c-4363-b8c3-2683c32d8271	14	-20187	Not Applicable	0	0																								Not Available	Not Available																												FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	9	G3									Not Available	Not Available	2533	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	Not Available	Ovary	Not Available	Not Available	2010	2007
TCGA-20-1684	51	FEMALE	581	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	581			TUMOR FREE		51	Bilateral	TCGA-20-1684	94030805-8beb-441a-af73-11a80768edb5	2	-18755	Not Applicable	0	581	TCGA-20-1684-D25552;TCGA-20-1684-D25551;TCGA-20-1684-D25550	67c20b40-f5e3-4937-a3fc-41ae888dc1a7;a6105f0f-4f35-45eb-9a4c-25692167301e;fd8ac1c7-65cb-4bca-bfa6-fab399cf7e57	Not Available;Not Available;Not Available	27;27;27	120;120;120	42;42;42	Bevacizumab;Taxol;Carboplatin	Not Available;Not Available;Not Available	7;7;7	04;04;04	Not Available;Not Available;Not Available	mg/kg;mg/m2;AUC	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IP;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	15;60;6	mg/kg;mg/m2;AUC	Not Available;Not Available;Not Available	2009;2009;2009	0	NOT HISPANIC OR LATINO	TCGA-20-1684-F25549	c1f2eb5c-51d5-469f-9319-30cfcaec69e4	2	Not Applicable	581	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1684	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	1-10 mm	Ovary	NO	Alive	2009	2007
TCGA-36-1580	82	FEMALE	737	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	440.0		Recurrence	WITH TUMOR		82	Not Available	TCGA-36-1580	533f5ff9-466c-4cdb-9c46-b841c2626775	2	-29992	737	0	737	TCGA-36-1580-D27891;TCGA-36-1580-D27890	e781ca54-c93a-4270-99d5-4d97f278b1f6;9fd38eaf-a33b-4dc5-9d51-7f07a8c2f098	Not Available;Not Available	15;15	348;553	18;454	Carboplatin;Liposomal Doxorubicin	Not Available;Not Available	1;1	11;04	Not Available;Not Available	mg;mg	ADJUVANT;PROGRESSION	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	4796;222	mg;mg	Not Available;Not Available	2010;2010	1	Not Available	TCGA-36-1580-F27889	0a7f42d0-c9d3-4d5c-8122-53760a34e6e1	2	737	737	1	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	440	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1580	Preoperative	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	Not Available	Dead	2009	2007
TCGA-25-1324	74	FEMALE	1035	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1035			Not Available		74	Bilateral	TCGA-25-1324	c73244fd-d486-439f-a94f-fb0bd4e9ac8f	27	-27090	1035	0	1035	TCGA-25-1324-D26686;TCGA-25-1324-D26687	1f668234-3cb1-44c3-b63d-ddd8accfe042;db95bdbb-40b6-444b-b6c7-f8cfd3d260d7	Not Available;Not Available	27;27	Not Available;Not Available	Not Available;Not Available	Taxol;Carbo	Not Available;Not Available	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1324-F26685	275c717d-977d-4a05-a58a-4b111387938a	27	1035	1035	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1324	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-30-1859	56	FEMALE	1463	Serous Cystadenocarcinoma	Ovary	Dead		G3	1			Locoregional Disease	WITH TUMOR		56	Bilateral	TCGA-30-1859	dac8d825-dd47-47ed-a426-0ee75feb76f3	2	-20498	1463	0	1463	TCGA-30-1859-D27575;TCGA-30-1859-D27572;TCGA-30-1859-D27574;TCGA-30-1859-D27569;TCGA-30-1859-D27576;TCGA-30-1859-D27568;TCGA-30-1859-D27571;TCGA-30-1859-D27567;TCGA-30-1859-D27570;TCGA-30-1859-D27573;TCGA-30-1859-D27577;TCGA-30-1859-D27578	93b2bc44-d1e0-47f3-9e5b-acbef8b3a702;adb0eafc-52e6-4a08-9a54-550b06ff59ef;2fe73c42-528a-49b7-8ace-300e3463ab5b;d9e87488-f292-4809-82e9-b9d72576d084;bb4f183e-5f3e-46f4-9694-2a4f046344e2;39b99982-93f4-4457-a0fe-8336aafbe6dd;afacbc4a-1d91-481a-9356-4e49172e7a00;2994f82f-4e05-4b8d-b9ca-755057a83d52;1c7d824c-50bd-44c9-8d9b-885a9264aaf6;c6e94b43-b6ed-43ef-b8bb-65ed70ca8fb9;d9868c5b-53d0-4d6b-8ac2-95b76c3a77b4;4f6ba9dd-c995-4de2-8e41-6f52823d25d7	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21;21;21;21;21;21;21;27	1376;593;1197;199;1379;199;199;199;199;1103;1166;1131	1214;369;1162;31;1334;31;31;31;31;982;1135;1104	Taxol;Trabectedin;Doxil;Carboplatin;Cytoxan;Gemcitabine;Topotecan;Taxol;Adriamycin;Carboplatin;Armidex;Sargramostin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12;12;1	Not Available;08;02;09;Not Available;09;09;09;09;05;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;AUC;Not Available;mg/m2;mg/m2;mg/m2;mg/m2;AUC;Not Available;Not Available	PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;PO;IV;IV;IV;IV;IV;Not Available;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	80;500;40;5;Not Available;1000;1.25;175;25;5;Not Available;Not Available	mg/m2;mg/m2;mg/m2;AUC;Not Available;mg/m2;mg/m2;mg/m2;mg/m2;AUC;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2010	0	NOT HISPANIC OR LATINO	TCGA-30-1859-F27566	653cdd67-0520-483f-9dcd-db752961bc6e	2	1463	1463	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	210	Not Available	Locoregional Disease	YES	Not Available	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1859	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-13-1504	68	FEMALE	1059	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	548.0			TUMOR FREE		68	Bilateral	TCGA-13-1504	cd49126a-ec15-43fa-9e43-3f7460d43f2b	31	-25008	Not Applicable	0	504	TCGA-13-1504-D24937;TCGA-13-1504-D24936	3bc4b2ec-79d0-491f-81ea-9d7c5eb58a96;92d2f0c8-9875-41f1-8429-6a929ec4166f	Not Available;Not Available	29;29	283;283	Not Available;Not Available	Paclitaxel;Carboplatin	Not Available;Not Available	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1504-F24935;TCGA-13-1504-F72652	7c17b972-4f30-4f6f-8771-949a26381448;34F26CCF-A381-4A8E-803A-E548A51521CC	31;31	Not Applicable;1059	504;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;548	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	60	Not Available	3	G3									Not Available	Not Available	1504	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2007
TCGA-20-1687	46	FEMALE	81	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	81			TUMOR FREE		46	Bilateral	TCGA-20-1687	9bf16a89-2fc7-4c08-93bc-3105eec5c3cc	2	-16961	Not Applicable	0	81	TCGA-20-1687-D25564;TCGA-20-1687-D25565	c94c5c61-aaa1-4029-bcb9-34b31ebc25d2;345ae7fa-8baa-4247-bcbb-f86a0ab0aa37	Not Available;Not Available	26;26	172;172	42;42	Taxol;Carboplatin	Not Available;Not Available	10;10	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-20-1687-F25563	f16936bd-4107-4e50-bcd0-da8f76ba03eb	2	Not Applicable	81	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1687	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-13-1405	49	FEMALE	868	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	228.0			TUMOR FREE		49	Bilateral	TCGA-13-1405	29dccd25-4c4a-463b-a353-38a193337f38	20	-18218	Not Applicable	0	224	TCGA-13-1405-D24804;TCGA-13-1405-D24805	e2a55a7f-4bfd-43db-bd46-3d41ad1008e8;036b3384-1b94-4426-af17-f314a1c6fe38	Not Available;Not Available	30;30	147;147	23;23	Carboplatin;Paclitaxel	Not Available;Not Available	6;6	7;7	Not Available;Not Available	mg;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	599;175	mg;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1405-F24803;TCGA-13-1405-F72656	94feaf68-9597-4648-bc84-fe7e67afc7c7;ADA5AB3C-26E6-46CE-9F56-F7C4F3B47AC2	20;31	Not Applicable;868	224;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;228	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	3	G3									Not Available	Not Available	1405	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-29-2427	60	FEMALE	1900	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1582.0		Recurrence	WITH TUMOR		60	Left	TCGA-29-2427	6f25001a-f890-4fd0-a994-e62a9ea5c6f3	8	-21940	Not Applicable	0	1900	TCGA-29-2427-D27472;TCGA-29-2427-D27473;TCGA-29-2427-D27471;TCGA-29-2427-D27474;TCGA-29-2427-D27476;TCGA-29-2427-D27475	47d4b680-8d55-4cf4-868b-ae44e3ae1436;ee7023c9-49e0-48c5-8781-e28ef2609827;5f00d7f8-73b2-4db4-ba11-5a41234d2ca1;3d7a84c3-cc88-4b27-84a0-697e76c7cbc7;8b87346f-baaf-46c2-9c7d-07ad0af96ad2;ee835a1c-74f7-4113-a155-edb8c347a4b2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;20;20	49;1690;49;1900;157;157	7;1584;7;1816;73;73	Paclitaxel;Carboplatin;Carboplatin;Abraxane;Cyclophosphamide;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;10;10	2;06;03;5;6;6	Not Available;Not Available;Not Available;Not Available;940;110	Not Available;AUC;AUC;mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IV;IV;IP;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	0;6;5;510;5640;660	Not Available;AUC;AUC;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2011;2011	0	Not Available	TCGA-29-2427-F27470	43e966c8-610e-48a8-9e83-b2635e874aa0	8	Not Applicable	1900	0	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	1582	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	2427	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Alive	2010	2004
TCGA-57-1586	66	FEMALE	679	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	259.0		Recurrence	WITH TUMOR		66	Bilateral	TCGA-57-1586	48e66676-dbed-48a4-9a7f-a6d247b15c17	2	-24304	Not Applicable	0	679	TCGA-57-1586-D28081;TCGA-57-1586-D28083;TCGA-57-1586-D28086;TCGA-57-1586-D28088;TCGA-57-1586-D28085;TCGA-57-1586-D28084;TCGA-57-1586-D28087;TCGA-57-1586-D28082	bbf33820-9f76-4cfb-afe0-79a5c0eb3edb;d67969e3-a53c-49a7-9e9d-e199f334de35;f5064788-37a0-4453-8e48-7afd74568b5a;c50fed41-30b0-467a-9fce-96067cfa97d2;154aa145-3583-4eae-b349-106673305fb4;5948359f-b509-4b5a-ba6a-be19c611bbce;ded42d21-aa2e-4520-a82a-0e2c905d3c55;39d706ee-04ea-4d4b-b740-faa6cc534736	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15;15;15	163;Not Available;542;Not Available;406;Not Available;Not Available;163	49;259;433;553;323;259;553;49	Taxol;Gemzar;Topotecan;Taxol;Doxil;Cisplatin;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9;9	08;04;Not Available;01;03;04;01;08	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-57-1586-F28080	63a6f203-f1b7-48b2-bb80-5d6fd277e34c	2	Not Applicable	679	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	259	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1586	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	57	11-20 mm	Ovary	YES	Alive	2009	2007
TCGA-25-1318	54	FEMALE	1064	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	185.0		Recurrence	WITH TUMOR		54	Bilateral	TCGA-25-1318	13319c20-02f6-4b5f-b24f-3d8f4084094c	27	-19755	1064	0	1064	TCGA-25-1318-D26656;TCGA-25-1318-D26657;TCGA-25-1318-D26658	9f44ee55-e19b-4469-a2ca-6ca3de3dea19;34a3d4ed-3134-4055-807f-d263f12fbe00;e9dbb616-a754-4560-91d3-70c2166bff27	Not Available;Not Available;Not Available	27;27;27	122;122;273	30;30;212	Taxol;Carbo;Topetecan	Not Available;Not Available;Not Available	3;3;3	6;6;4	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1318-F26655	f632b553-5ecb-48ef-84bc-d5372657f82a	27	1064	1064	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;181	185;Not Available	Recurrence;Metastatic	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1318	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-57-1992	62	FEMALE	882	Serous Cystadenocarcinoma	Ovary	Alive	Stage IC	G3	0	882			TUMOR FREE		62	Left	TCGA-57-1992	419a486f-7fa5-4fbd-9e98-2f8f4c6d5081	4	Not Available	Not Applicable	0	882																								Not Available	NOT HISPANIC OR LATINO	TCGA-57-1992-F28090	f99aac95-b604-411a-9a3b-1fbf4662054f	4	Not Applicable	882	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	1992	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	57	No Macroscopic disease	Ovary	YES	Alive	2009	2006
TCGA-61-2088	51	FEMALE	145	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	145			TUMOR FREE		51	Bilateral	TCGA-61-2088	242943fe-1fa0-4a12-8f7e-9c6c4af1194d	7	-18770	Not Applicable	0	145	TCGA-61-2088-D28379;TCGA-61-2088-D28378	3b8a8370-edc0-494d-8215-80aaae8e9888;f85675b8-465d-493f-b708-2e8f9ca175a4	Not Available;Not Available	7;7	145;145	34;34	Taxotere;Carboplatin	Not Available;Not Available	12;12	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	900;3900	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2088-F28377	90f9f7a2-99d8-496e-9276-a94390ef4587	7	Not Applicable	145	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	TUMOR FREE	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	12	G3									Not Available	Not Available	2088	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	NO	Alive	2009	2009
TCGA-29-1761	80	FEMALE	528	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	528			WITH TUMOR		80	Bilateral	TCGA-29-1761	374ea8df-ecc4-44b0-b519-33efa5078018	2	-29337	528	0	517	TCGA-29-1761-D27313;TCGA-29-1761-D27314	fe321eac-53ee-44e1-a7b6-8047473fcbf2;c8045157-0494-4ff3-81f0-5ad85149afb6	Not Available;Not Available	18;30	202;202	49;Not Available	Carboplatin;Paclitaxel	Not Available;Not Available	11;11	03;03	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-29-1761-F27312	d8897df7-fd26-4fd4-b696-00efd70cb5fc	2	528	517	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1761	Not Available	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Dead	2009	1998
TCGA-04-1651	53	FEMALE	1102	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	990.0		Recurrence	Not Available		53	Bilateral	TCGA-04-1651	55153632-1673-487a-85c0-f156377db1fc	2	-19628	1102	0	Not Available	TCGA-04-1651-D24175;TCGA-04-1651-D24176;TCGA-04-1651-D24174;TCGA-04-1651-D24173;TCGA-04-1651-D24177	50b984e7-efd8-4d76-9551-883eeda43257;49f8c5a0-530d-41d5-93aa-dd3accbc566d;a960436a-2466-4c72-8ef7-89b73f8a0114;2d418f76-5289-4b42-bccd-367cc6177bdd;302abefb-98a4-4ae9-b633-f083742d1dcc	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	150;Not Available;150;150;Not Available	24;638;24;24;994	Taxol;Cisplatin;Carboplatin;Gemcitibine;Gemcitibine	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	06;Not Available;06;06;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;mg;mg;Not Available	ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	1869;Not Available;3228;4416;Not Available	mg;Not Available;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	1	NOT HISPANIC OR LATINO	TCGA-04-1651-F24172	f182f145-563e-4e9e-9d35-77b5e6e2dcae	2	1102	Not Available	1	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	990	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1651	Pre-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	2004
TCGA-36-2530	38	FEMALE	1004	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	630.0		Recurrence	WITH TUMOR		38	Bilateral	TCGA-36-2530	92a1a8f3-54f2-4983-bb14-dcb73658d897	17	-13885	Not Applicable	0	1004	TCGA-36-2530-D27907;TCGA-36-2530-D27908;TCGA-36-2530-D27910;TCGA-36-2530-D27909;TCGA-36-2530-D27911	1de2a511-cd83-4b35-8503-f3f0dc13bb5b;4e54a205-21a1-4976-8efb-8bf32ebc5abf;215057f5-f69e-4580-ae14-b0022e318d6a;4444d108-727d-4d9d-a952-8bbcb1dbb4f9;25e8b24b-f738-482a-9dfc-14cda1f2e880	Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17	135;135;763;763;982	21;21;639;639;639	Carboplatin;Paclitaxel;Paclitaxel;Carboplatin;Cediranib Placebo	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	06;06;06;06;Not Available	660;78;179;560;15	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IP;IP;IV;IV;PO	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available	3960;1836;1196;3808;Not Available	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-36-2530-F27906	eb2af194-4072-4aae-8504-3c74a9900431	17	Not Applicable	1004	Not Available	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	630	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	NO	8	G3									Not Available	Not Available	2530	Not Available	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	11-20 mm	Ovary	Not Available	Alive	2010	2007
TCGA-42-2588	61	FEMALE	880	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	112.0		Progression of Disease	WITH TUMOR		61	Bilateral	TCGA-42-2588	654d02ab-05b4-4863-99d9-04d087ff91b4	3	-22377	Not Applicable	0	287	TCGA-42-2588-D28043;TCGA-42-2588-D28042;TCGA-42-2588-D28041;TCGA-42-2588-D28040;TCGA-42-2588-D28833;TCGA-42-2588-D28825;TCGA-42-2588-D28827;TCGA-42-2588-D28822;TCGA-42-2588-D28826;TCGA-42-2588-D28824;TCGA-42-2588-D28937;TCGA-42-2588-D28834;TCGA-42-2588-D28831	2c83e6ca-240b-4be5-b796-006d114d3975;b4616f91-0148-4e23-8b9d-ab3fd76760d7;ad0e141f-2887-4cee-9a89-8172ebda8ce7;06643023-c853-4442-ba1b-5cd6259c1b6b;d04a7679-dc92-4c44-8f30-ad96ecf65f2c;800d12e7-9f55-4e4a-80b4-0d6d58cca353;575215c3-b906-40ca-a891-4f6663e92d32;1d0588af-256c-45d7-b974-d57254093ea4;c56b5635-c884-4eba-be7b-af5898e3ce77;30c139f2-e12d-4ed8-a1b3-31fc9eb5bb59;74BDD96A-B5A2-41A7-926D-5F07411E36B7;dedd22e6-28a2-4020-8f6d-c266b1f48fe7;b29f6f17-e86e-411b-a740-fec10c2f256b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;26;26;26;26;26;26;26;26;26	258;258;90;104;819;427;602;399;595;399;784;819;784	161;161;22;48;735;427;427;315;455;343;687;744;687	Carboplatin;Taxol;Carboplatin;Taxol;Gemcitabine;Cisplatin;Gemcitabine;Doxil;Carboplatin;Avastin;Megestrol Acetate;Carboplatin;Femara	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;1;1;1;1;1;1;1;1;1	4;04;4;3;04;01;08;04;07;03;1;04;Not Available	590;97;558;137;675;72;621;60;266;747;400;300;2.5	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;06;04;04;03;04;03;05;06;05	IP;IV;IV;IV;IV;IV;IV;IV;IV;IV;PO;IV;PO	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Hormone Therapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2360;1146;2169;948;4881;72;10302;248;1862;2323;39200;1203;245	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2012;2012;2012;2012;2012;2012;2012;2012;2012	2	NOT HISPANIC OR LATINO	TCGA-42-2588-F28039;TCGA-42-2588-F28821	3e3af7ca-94f5-4761-9790-5c81d0ada2a6;32c5dbaa-fb36-4b5b-9cd2-387c31275f16	3;26	Not Applicable;880	287;Not Available	2;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	6;1	YES;YES;YES	NO;NO;NO	Not Available;141;Not Available	112;Not Available;267	Progression of Disease;Metastatic;Progression of Disease	Not Available;YES;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available	Preoperative;Not Available	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	NO;NO	Alive;Dead	2010;2012	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	YES	6	G3									Not Available	Not Available	2588	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R2	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	42	>20 mm	Ovary	Not Available	Alive	2010	2009
TCGA-24-1920	74	FEMALE	298	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	298			TUMOR FREE		74	Right	TCGA-24-1920	97efb80d-4f46-4aef-b95e-20d260de01b2	3	-27042	Not Applicable	0	298	TCGA-24-1920-D26375;TCGA-24-1920-D26377;TCGA-24-1920-D26374;TCGA-24-1920-D26376	dbe3b69a-5471-42c9-b8e2-7f0a3447efca;7df933df-bf58-41f3-81b9-772e4f0b5960;d93c627d-3367-4275-af6c-0f3fb99702c6;60e3adc8-609a-4ba5-823a-c75a423ac0b5	Not Available;Not Available;Not Available;Not Available	3;3;3;3	144;144;144;144	24;24;24;24	Cisplatin;Carboplatin;Taxotere;Taxol	Not Available;Not Available;Not Available;Not Available	2;2;2;2	06;06;06;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IV;IP	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	354;593;540;224	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	0	Not Available	TCGA-24-1920-F26373	d6fe4337-d7f6-4b68-bd9f-e3473853b265	3	Not Applicable	298	0	Not Available	Not Available	Not Available	Not Available	2									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	1920	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2010	2009
TCGA-61-2092	57	FEMALE	1573	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	1573			TUMOR FREE		57	Bilateral	TCGA-61-2092	c183d3fb-2eee-44f8-890e-b9bf907141e6	8	-21072	Not Applicable	0	1573	TCGA-61-2092-D28383;TCGA-61-2092-D28382	310d2d4f-8dad-40ae-b4e9-74aad0299ebd;1690eed1-9060-4323-bdef-31b6bfdd2e65	Not Available;Not Available	8;8	160;160	41;41	Carboplatin;Taxol	Not Available;Not Available	12;12	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-61-2092-F28381	fbfa4e68-8edf-44d8-84cb-ced0ddad76bd	8	Not Applicable	1573	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	12	G3									Not Available	Not Available	2092	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	NO	Alive	2009	2004
TCGA-24-2035	65	FEMALE	857	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	287.0		Recurrence	WITH TUMOR		65	Left	TCGA-24-2035	062982f8-9f49-425a-99e9-008af5ed9040	29	-23855	857	0	857	TCGA-24-2035-D26499;TCGA-24-2035-D26503;TCGA-24-2035-D26500;TCGA-24-2035-D26497;TCGA-24-2035-D26498;TCGA-24-2035-D26501;TCGA-24-2035-D26502	8b07cdb1-fd20-4693-a570-d3d9a65a391d;9b196005-4792-4e49-a9b9-fd9018c4606a;ed9654da-c2f1-4280-ac44-e22812dd52ef;7ec23e69-94f3-444b-b7c0-69dec024718f;baefbf0e-5174-4efb-90d2-283e5f1c4c4c;1d759db4-e008-4860-82be-d4e68759c228;66b642e8-83f9-47bc-871f-e6156f363161	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	29;29;29;29;29;29;29	Not Available;Not Available;Not Available;Not Available;Not Available;679;Not Available	Discrepancy;688;Discrepancy;Not Available;Not Available;343;688	Taxol;Ifostamide;PSC833;Cisplatin;Taxol;Topotecan;VP16	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3	02;Not Available;02;06;06;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	RECURRENCE;PROGRESSION;RECURRENCE;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;PO;IV;IV;IV;Not Available;PO	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-24-2035-F26496	629fe779-5b72-4d3e-92ff-c21f8cd387d0	29	857	857	0	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	287	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2035	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	1996
TCGA-04-1348	44	FEMALE	1483	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G3	1	575.0		Recurrence	WITH TUMOR		44	Bilateral	TCGA-04-1348	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4	26	-16236	1483	0	Not Available	TCGA-04-1348-D23971;TCGA-04-1348-D23968;TCGA-04-1348-D23972;TCGA-04-1348-D23970;TCGA-04-1348-D23975;TCGA-04-1348-D23974;TCGA-04-1348-D23969;TCGA-04-1348-D23973	d3abae36-f4b5-4d43-b4f8-af47f4ad136e;98897791-90ee-47b0-a526-1c8571b319a8;396df1c7-00b5-467a-965a-fbd8b603be40;bb7bed55-0fc3-4776-9cfe-59bd4adbbe7a;7e036a8c-1559-4399-885d-8a1e4d32ed53;9ae97b2d-2789-4e9c-97a4-28a084433803;06f08769-e9a9-463f-9dc2-feddab17d6a0;90f7c316-6484-466c-8ed0-6b2808bbdf32	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17;17;17;17	976;184;1157;853;1432;1249;184;1157	884;2;1006;672;1279;1218;2;1006	Topotecan;Taxol;Cisplatin/Gemzar;Doxil;Doxil;Taxotere;Carboplatin;Gemzar	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11	Not Available;8;9;7;Not Available;3;8;9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	HISPANIC OR LATINO	TCGA-04-1348-F23967	4bd91396-4007-4ff3-9673-58e37b089fe6	26	1483	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;1463	575;Not Available	Recurrence;Metastatic	Not Available;YES	Molecular Markers;Molecular Markers	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	1348	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	2004
TCGA-13-0911	55	FEMALE	1355	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	279.0		Progression of Disease	WITH TUMOR		55	Bilateral	TCGA-13-0911	8cad4217-5699-4735-9be3-fc0015a8d262	25	-20276	Not Applicable	0	843	TCGA-13-0911-D24750;TCGA-13-0911-D24751	8823c209-2882-4f55-ab70-ec250593c4dc;e179932c-db69-4bfd-bb18-71681cf970e4	Not Available;Not Available	15;15	189;189	49;49	Carboplatin;paclitaxel	Not Available;Not Available	4;4	7;7	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0911-F24749;TCGA-13-0911-F72628	18191146-bbb5-4110-af84-0c6698d2afc0;61905284-E333-4CE3-8CA9-280B7FA060F8	25;30	Not Applicable;1355	843;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	279;279	Progression of Disease;Unknown	Not Available;Not Available	Molecular Markers;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Partial Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	2	G3									Not Available	Not Available	0911	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2005
TCGA-42-2589	54	FEMALE	1278	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	364.0		Recurrence	TUMOR FREE		54	Bilateral	TCGA-42-2589	dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb	3	-19852	Not Applicable	0	230	TCGA-42-2589-D28046;TCGA-42-2589-D28048;TCGA-42-2589-D28047;TCGA-42-2589-D28802;TCGA-42-2589-D28805	811bc53a-f05b-4779-a676-128d0da2822a;6a1466ac-1f06-4617-a34e-604e6945dac0;1a6c0376-6bc1-4d52-ad00-2a5d128b8232;F4DC11FC-B77B-4047-A7F3-0C9AC3E36A26;180D0212-9DF5-42F7-928C-EB0455BB8FAE	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;11;9	132;126;41;504;644	21;63;21;377;377	Taxol;Cisplatin;Carboplatin;Carboplatin;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;5;6	06;4;2;06;11	308;140;696;475;1038-1400	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;02;02	IP;IV;IP;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	2046;545;1392;2375;21398	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2011;2011	Not Available	NOT HISPANIC OR LATINO	TCGA-42-2589-F28045;TCGA-42-2589-F28800;TCGA-42-2589-F39385;TCGA-42-2589-F41366	99416484-a8e7-4141-8120-c9be36ef04db;76D3B479-1411-4678-AE45-EB690D33A1A5;45F7924C-D860-471C-8589-A438DDF08BD9;0BD8D506-45AC-46FD-B54C-7FEC74EE4880	3;10;15;15	Not Applicable;Not Applicable;Not Applicable;Not Applicable	230;587;1278;1278	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Additional New Tumor Event;Additional New Tumor Event	Not Available;Not Available;Progressive Disease;Progressive Disease	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;NO;NO	6;5;3;3	None;YES;YES;YES;YES;YES	None;NO;NO;NO;NO;YES	None;Not Available;Not Available;Not Available;Not Available;Not Available	None;364;1028;364;1028;1274	None;Recurrence;Progression of Disease;Recurrence;Unknown;Unknown	None;Not Available;Not Available;Not Available;Not Available;Not Available	None;Imaging Study;Imaging Study;Imaging Study;Imaging Study;Not Available	None;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;YES;YES	Not Available;Not Available;Not Available;Not Available	TUMOR FREE;WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES;YES	Complete Remission/Response;Not Available;Complete Remission/Response;Complete Remission/Response	NO;NO;NO;NO	Alive;Alive;Alive;Alive	2010;2011;2013;2013	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	Not Available	YES	6	G3									Not Available	Not Available	2589	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	42	1-10 mm	Ovary	Not Available	Alive	2010	2009
TCGA-09-2048	63	FEMALE	138	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	138			WITH TUMOR		63	Bilateral	TCGA-09-2048	184aac07-44c1-47f1-8adf-50acbcc1762c	3	-23043	138	0	Not Available	TCGA-09-2048-D24352	36759fad-df49-4c76-9c80-ccbd66d8d40a	Not Available	3	Not Available	60	Not Available	Not Available	11	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	Not Available	Not Available	NO	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-2048-F24351	7d525bd5-fc5d-4c60-aff2-5dbece847b51	3	138	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	11	G3									Not Available	Not Available	2048	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	1-10 mm	Ovary	YES	Dead	2009	1999
TCGA-13-1499	56	FEMALE	3500	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	583.0		Recurrence	WITH TUMOR		56	Not Available	TCGA-13-1499	b25570ed-baca-4e3f-87c6-2ef18119ba49	31	-20668	Not Applicable	0	1168	TCGA-13-1499-D24921;TCGA-13-1499-D24922;TCGA-13-1499-D24920;TCGA-13-1499-D24923;TCGA-13-1499-D24924	b836dca7-cd27-4236-9bb7-f652bd595c60;54dea9e5-ade7-4b1f-abfc-f3b1d49dde54;9b87ff6d-772b-4abc-ad28-e0def040c38f;8c6e1a45-35e8-4195-b1e6-3ffe359242d3;765962d6-30d0-4181-a602-50b728f75df8	Not Available;Not Available;Not Available;Not Available;Not Available	29;29;29;29;29	97;187;97;187;187	76;118;76;118;118	Paclitaxel;Cisplatin;Carboplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	2;4;2;4;4	Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;Not Available;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IV;IV;IP;IP	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	135;75;6;135;60	mg/m2;mg/m2;Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1499-F24919;TCGA-13-1499-F72649	23f13a5e-8099-432a-a6a2-a3e2d887b8ba;A4129888-255B-4F68-8329-CA4D6FFFB2D6	31;31	Not Applicable;Not Applicable	1168;3500	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	80;Not Available	Not Available;Not Available	3;7	YES;YES;Not Available	NO;NO;Not Available	Not Available;595;Not Available	583;Not Available;583	Recurrence;Locoregional Disease;Unknown	Not Available;YES;Not Available	Imaging Study;Imaging Study;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	ASHKENAZI	80	Not Available	3	G3									Not Available	Not Available	1499	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2005
TCGA-23-2077	45	FEMALE	3525	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1232.0		Recurrence	TUMOR FREE		45	Left	TCGA-23-2077	ef57bc45-858f-4d4e-8407-b7eadfa43be5	20	-16552	Not Applicable	0	3525	TCGA-23-2077-D25765;TCGA-23-2077-D25764;TCGA-23-2077-D25768;TCGA-23-2077-D25766;TCGA-23-2077-D25769;TCGA-23-2077-D25767	55580b30-aed7-4821-a5e6-3c6723d59d3b;5880f08c-91d2-4a3a-b546-c5f38ad84b21;9c985cb2-5676-4ad4-ae8f-cfd416c28bbb;5521e637-59d8-4ddf-87cb-146a5266b295;1fa345ea-b957-4961-9564-ba4fc0bbc1fc;0963b087-b1d1-46a8-ac6f-a9fca75b64a8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	20;20;20;20;20;20	155;155;1758;1622;1758;1622	22;22;1653;1622;1653;1622	Taxol;Carboplatin;Carboplatin;Carboplatin;Taxotere;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	06;06;05;01;05;01	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	751;3300;2206;460;600;275	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-2077-F25763	f560f5c0-882a-44ba-b631-892ccda55b7e	20	Not Applicable	3525	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES;YES	NO;NO	Not Available;1345	1232;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	11	G3									Not Available	Not Available	2077	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	No Macroscopic disease	Ovary	YES	Alive	2009	1999
TCGA-29-1693	72	FEMALE	3096	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	694.0		Recurrence	WITH TUMOR		72	Left	TCGA-29-1693	6fb71a0c-bc50-48c8-acfa-db94be1e151a	2	-26300	Not Applicable	0	3096	TCGA-29-1693-D27176;TCGA-29-1693-D27175;TCGA-29-1693-D27179;TCGA-29-1693-D27182;TCGA-29-1693-D27185;TCGA-29-1693-D27187;TCGA-29-1693-D27183;TCGA-29-1693-D27178;TCGA-29-1693-D27189;TCGA-29-1693-D27186;TCGA-29-1693-D27188;TCGA-29-1693-D27181;TCGA-29-1693-D27177;TCGA-29-1693-D27184;TCGA-29-1693-D27180	fb8da9b0-00a9-430c-a45e-3800eb539f96;0757d278-2318-4b45-9678-47eb8fcd786e;42a47a83-7947-4c60-bd0b-68bc8f373b71;0db74b13-ee6a-4798-8578-305ae89eded5;7c9b327c-69b8-4fed-86a2-711957766a83;c12cf4bd-c639-48b1-805a-bb3f7fd66ebc;e4783d5b-4f80-410d-8ebf-7cbc99d4bb3e;4489659a-4376-4edb-b06d-0f34644d7822;edd1f6b0-04b0-4e5e-9c38-9e06e27bd456;2b068aab-26e8-4d5a-a660-39db26909fe9;7b31538c-cb7a-49f2-b298-883d0d7265ad;48ad0517-e616-4bc4-a5c8-66eb467f5e18;911cfe1e-c684-4c8b-a1de-9819fbfb1f3a;914a0b3d-a2b8-4daf-878e-bb64c869e520;09f2c506-a8de-433b-8463-52ecb7d8023b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;24;24;24;24;24;24;24;24;24;24;24;24;24	191;191;1157;1892;2669;Not Available;2058;814;1724;3018;Not Available;1724;814;2239;Not Available	19;19;1069;1780;2627;3124;2027;717;1668;2788;3124;1668;717;2232;1300	Paclitaxel;Carboplatin;Xyotax;Doxil;Paclitaxel;Cytoxan;Carboplatin;Paclitaxel;Bevacizumab;Paclitaxel;Bevacizumab;Gemzar;Carboplatin;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;3;3;3;3;3;3;3;3;3;3;3;3;3	08;08;05;05;Not Available;Not Available;02;06;Not Available;Not Available;Not Available;03;06;02;08	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;Not Available;mg;Not Available;mg/m2;mg;Not Available;mg;mg;AUC;Not Available;mg	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;PO;IV;IV;Not Available;IV;Not Available;IV;IV;IV;IV	NO;NO;NO;NO;NO;YES;NO;NO;NO;NO;YES;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2240;3430;300;70;Not Available;50;Not Available;135;740;Not Available;600;1375;5;Not Available;345	mg;mg;mg;mg;Not Available;mg;Not Available;mg/m2;mg;Not Available;mg;mg;AUC;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-29-1693-F27174	12658bed-f067-4263-b749-1e9839821a25	2	Not Applicable	3096	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	YES;YES	Not Available;2050	694;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1693	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-29-1693-R27190	89ba49fe-0519-4ca3-ae20-23dc5d6a5ff2	Not Available	3	2331	2270	Not Available	6	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	OTHER, SPECIFY IN NOTES	Progression/pallative	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	YES	Alive	2009	2001
TCGA-24-1604	66	FEMALE	2688	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	2688			WITH TUMOR		66	Bilateral	TCGA-24-1604	65435f50-a35d-49e3-a36e-b95d9e274ca0	13	-24471	2688	0	2688	TCGA-24-1604-D26301;TCGA-24-1604-D26302;TCGA-24-1604-D26300;TCGA-24-1604-D26303	bed4ffb4-9a55-4d58-b397-da646f96aa74;85fca390-b524-4247-a5db-7f6c3f76196e;6f7f507e-ed71-4327-97f9-50366d7aae44;b92fd08e-07a3-48f6-8490-99db36a1e4ff	Not Available;Not Available;Not Available;Not Available	13;13;13;13	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Taxol;Not Available;Carboplatin;Doxil	Not Available;Not Available;Not Available;Not Available	5;5;5;5	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV	NO;Not Available;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1604-F26299	36c37a67-9b4f-42cc-93e8-4aea5cb551a4	13	2688	2688	Not Available	Not Available	Not Available	Not Available	Not Available	5									Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1604	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-24-1604-R26304	f525e3cc-c70a-4e0d-b2eb-cb6999c51466	Not Available	13	Not Available	Not Available	Not Available	5	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	Not Available	Ovary	Not Available	Dead	2009	1996
TCGA-13-0891	73	FEMALE	3128	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	762.0		Recurrence	WITH TUMOR		73	Bilateral	TCGA-13-0891	0740321b-f8a5-4e1d-b390-ca6187598fac	25	-26886	Not Applicable	0	2099	TCGA-13-0891-D24687;TCGA-13-0891-D24688	c72e692b-29dd-4292-add3-4b3889f27442;6b1c33ed-7ea9-49aa-b1ad-eaadf84463b8	Not Available;Not Available	15;15	183;183	71;71	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	6;6	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;1050	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0891-F24686;TCGA-13-0891-F72621	86624f11-e43c-4e2a-8e31-1b53b70c599e;E86B53B7-F015-4846-821B-32F166B12C69	25;30	Not Applicable;3128	2099;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	762;762	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	ASHKENAZI	80	Not Available	2	G3									Not Available	Not Available	0891	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2003
TCGA-25-2404	38	FEMALE	883	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	426.0		Recurrence	WITH TUMOR		38	Bilateral	TCGA-25-2404	22178c3c-6b04-46d8-8041-dc83fa195029	5	-14184	883	0	883	TCGA-25-2404-D26832;TCGA-25-2404-D26835;TCGA-25-2404-D26834;TCGA-25-2404-D26833	ee45824f-b834-4398-9099-e4d8084dda45;0e941bf3-b016-4c1b-950e-b8376803e7df;4123b5ea-9752-4c53-b3c4-a2caeb17b133;1b5f7082-be2b-44dd-a5b6-9dc5903110fc	Not Available;Not Available;Not Available;Not Available	5;5;5;5	122;306;306;122	0;184;184;0	Taxol;Carboplatin;Taxol;Carboplatin	Not Available;Not Available;Not Available;Not Available	1;1;1;1	06;04;04;06	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-25-2404-F26831	8b0b1002-3ed9-4317-ba15-982dc5522748	5	883	883	Not Available	Not Available	Not Available	Not Available	Not Available	1	YES	NO	Not Available	426	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2404	Not Available	WITH TUMOR	Not Available	Not Available	AMERICAN INDIAN OR ALASKA NATIVE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	No Macroscopic disease	Ovary	Not Available	Dead	2010	2005
TCGA-24-1558	73	FEMALE	594	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	273.0		Recurrence	WITH TUMOR		73	Bilateral	TCGA-24-1558	ba68f2cf-9271-41fd-9655-1fac7681f588	2	-27004	594	0	594	TCGA-24-1558-D26214;TCGA-24-1558-D26217;TCGA-24-1558-D26218;TCGA-24-1558-D26216;TCGA-24-1558-D26213;TCGA-24-1558-D26215;TCGA-24-1558-D26219	e59ea4e0-2e2c-4f4a-942b-7efb1c0870fe;4c049036-fc07-4cb7-aefb-4b246a630259;63155ebc-160a-4045-a54a-e81db14d275a;265b7191-2211-4f94-b21e-ae81322cb380;e3d7f2e6-d2ae-4801-b607-03c8f2c13303;ec054464-9e15-41b0-94b1-a7143163f896;7e540806-6473-46d6-a1ed-008e4c59cd9e	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28;28	247;382;588;382;247;247;487	37;316;515;316;37;37;403	Carboplatin;Taxotere;Gemcitabine;Gemcitabine;Topotecan;Taxol;Doxil	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7	10;04;04;04;10;10;04	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;OTHER, SPECIFY IN NOTES;PROGRESSION;OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Persistent disease treament;Not Applicable;Persistent disease treatment;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	43.75;524;11810;3600;14.4;1800;277	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1558-F26212	e5c8a6ca-1b37-4965-bf50-3c988437af33	2	594	594	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	273	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1558	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-09-2045	50	FEMALE	1069	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	1	631.0		Recurrence	WITH TUMOR		50	Bilateral	TCGA-09-2045	3768d34f-1527-40db-b116-cd80cee5ec3a	3	-18285	1069	0	Not Available	TCGA-09-2045-D24343;TCGA-09-2045-D24340;TCGA-09-2045-D24345;TCGA-09-2045-D24341;TCGA-09-2045-D24342;TCGA-09-2045-D24346;TCGA-09-2045-D24339;TCGA-09-2045-D24344;TCGA-09-2045-D24349;TCGA-09-2045-D24347;TCGA-09-2045-D24348	bb92bbda-df68-4f6d-a51e-95da220fb45c;868ce7a4-1bfe-46fb-a1ef-f297525b252a;b04e60fd-6a47-4141-b49a-075c34588c7b;455a8a8b-4170-4478-a4a4-32a2082271d7;7d3b6c00-c2bf-482b-bdf9-a3362a8457a0;fc471499-6c71-4641-a6a2-46d6521a837d;6c79b320-a371-4afe-a40c-af0f28090dc7;0298c721-f7a3-4b0b-836d-a7499fcfd188;77d77b01-fb4c-4cf8-8f03-8ecd740b662a;ae26f30d-0995-4c38-837c-9dcc29376e15;2b57866b-5b39-4bd7-b317-a69e3f2c3143	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;11;11;11	239;11;808;94;94;895;11;239;939;808;939	121;11;678;64;64;875;11;121;933;678;933	Cisplatinum;Taxol;Taxotere;Cisplatinum;Taxol;Etoposide;Carboplatin;Taxol;Gemcitibine;Toptecan;Carboplatinum	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;12;12;12	5;1;6;2;2;2;1;5;2;6;2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;Not Available;mg;mg/m2;mg;mg/m2;mg	ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;OTHER, SPECIFY IN NOTES;PROGRESSION	Not Applicable;Not Applicable;Recurrent and progression;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Recurrent and progression;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;PO;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	50;135;70;50;100;Not Available;810;135;1600;.665;560	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;Not Available;mg;mg/m2;mg;mg/m2;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-2045-F24338	0174cdfc-8808-4567-97bc-03c86ce40b50	3	1069	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES	NO	Not Available	631	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	11	G2									Not Available	Not Available	2045	Not Available	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	1-10 mm	Ovary	YES	Dead	2009	1996
TCGA-61-1737	42	FEMALE	1364	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	1364			TUMOR FREE		42	Bilateral	TCGA-61-1737	0aa020cb-69d2-4235-a609-c279a133d8bb	2	-15515	Not Applicable	0	1364	TCGA-61-1737-D28183;TCGA-61-1737-D28185;TCGA-61-1737-D28188;TCGA-61-1737-D28187;TCGA-61-1737-D28184;TCGA-61-1737-D28186	36e353f0-bed3-40a3-affc-66fbe869646f;9a678242-a8a6-4502-b315-c6433876552a;83835e07-7625-4324-9530-b58a5533f592;567b59df-038a-4301-84af-f74ac4ccfccd;bde9b500-2bbc-4635-9b62-37438f743031;593c4bb6-7022-48d5-a8df-50583f549c87	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4	106;176;Not Available;176;106;176	43;127;582;127;43;127	Taxotere;Taxotere;Tamoxifen;Paclitaxel;Carboplatin;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12	04;03;Not Available;03;04;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg/day;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IV;Not Available;IV;IV;IP;IV	NO;NO;YES;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	480;270;19000;198;2600;372	mg;mg;mg/day;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1737-F28182	36c9e79e-9559-4eb1-bc79-7274be460b42	2	Not Applicable	1364	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1737	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Alive	2009	2005
TCGA-29-1696	43	FEMALE	1032	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	342.0		Recurrence	WITH TUMOR		43	Right	TCGA-29-1696	8a98a6e6-b763-4824-858b-fd2738e6c9a3	2	-15818	1032	0	1025	TCGA-29-1696-D27207;TCGA-29-1696-D27208;TCGA-29-1696-D27211;TCGA-29-1696-D27213;TCGA-29-1696-D27210;TCGA-29-1696-D27214;TCGA-29-1696-D27212;TCGA-29-1696-D27209	5a0a45c1-c2b7-49f9-a424-cd55b46658ac;935ba94e-17b1-42bb-bfcb-777d7af0b574;74cef5fc-3be7-47ae-9823-b91fc4246b28;a99ed1d2-8b6d-4027-869a-87359a36904f;46c5e2a6-3891-4521-9859-437c416d0ad3;2391893d-dd51-43c2-b966-532867973538;02efd7a1-75d6-4e57-b6e6-9146747f5cc3;9b52668c-3ac3-46d0-824a-5e670e09207e	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;7;7;7;7;7;7	171;171;791;997;573;997;934;479	17;17;598;948;507;633;864;357	Paclitaxel;Carboplatin;Carboplatin;Cyclophosphamide;Gemcitabine;Bevacizumab;Paclitaxel;Doxorubicin HCL	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;4;4;4;4;4;4	08;08;10;02;03;Not Available;09;04	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;AUC;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;Not Available;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2550;5472;6;1305;8321;660;140;70	mg;mg;AUC;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-29-1696-F27206	82bd749e-d9aa-4da7-bd7d-57255e9c7e2e	2	1032	1025	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;454	342;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G2									Not Available	Not Available	1696	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-09-1669	54	FEMALE	928	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIA	G3	0	928			WITH TUMOR		54	Right	TCGA-09-1669	b1c90c69-6149-4105-8182-ab9212f196be	2	-20052	Not Applicable	0	928	TCGA-09-1669-D24306;TCGA-09-1669-D24307	50dcc375-fa24-4050-ad1e-92cd42c75e97;30c1255f-a36c-4d86-8f8e-a064143d8315	Not Available;Not Available	6;6	132;132	27;27	Taxol;Carboplatin	Not Available;Not Available	8;8	6;6	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;6	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1669-F24305	be4d9604-3e6b-4bf2-bd2a-0be49751832a	2	Not Applicable	928	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1669	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2004
TCGA-24-1422	82	FEMALE	23	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	23			Not Available		82	Bilateral	TCGA-24-1422	05ba5839-e00a-4a9e-8ba3-ecb490781e62	16	-30234	23	0	23																								Not Available	Not Available	TCGA-24-1422-F25934	53ee42c9-00e7-4df7-9070-362b248e998a	16	23	23	Not Available	Not Available	Not Available	Not Available	Not Available	4									Not Available	Not Available	Not Available	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	1422	Not Available	Not Available	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2008
TCGA-13-0900	59	FEMALE	4077	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	4077			TUMOR FREE		59	Bilateral	TCGA-13-0900	9e48a4b1-6917-4625-9d78-e4832eb816a5	20	-21698	Not Applicable	0	1736	TCGA-13-0900-D24709;TCGA-13-0900-D24710	3dd1d8e2-9bf1-47fb-8fb4-41360012da50;e939513a-a319-4a7f-b724-3d9a24dbb312	Not Available;Not Available	30;30	162;162	38;38	Carboplatin;Paciltaxal	Not Available;Not Available	6;6	6;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0900-F24708;TCGA-13-0900-F72637	62a46c9c-b36f-4c67-9dcd-7c820b5e8a3c;8F0CF5FC-FF55-47B3-B6FB-D7305EE36462	20;30	Not Applicable;Not Applicable	1736;4077	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	60;Not Available	Not Available;Not Available	3;7									Not Available;NO	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	60	Not Available	3	G3									Not Available	Not Available	0900	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2004
TCGA-04-1343	72	FEMALE	361	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	361			WITH TUMOR		72	Bilateral	TCGA-04-1343	b7715ff6-57a6-4513-9447-aa8bc93f16d4	26	-26428	361	0	Not Available	TCGA-04-1343-D23957;TCGA-04-1343-D23950;TCGA-04-1343-D23952;TCGA-04-1343-D23954;TCGA-04-1343-D23955;TCGA-04-1343-D23953;TCGA-04-1343-D23951;TCGA-04-1343-D23956	981f0805-35b4-4c8d-9cf6-08473727598d;4ef4a550-feb8-4a47-b61a-30e9bbcd4b3f;3e3aefa8-7cdc-4c16-ae47-9cce76c8de3f;613cb525-ddfb-4892-ab3c-647aec37b7b9;9334cb5b-be90-441f-b19d-9281c212dea9;790fc301-5777-4c02-801c-688ce341e629;295a9456-0793-4458-acb2-2766e579c1dd;b259ff22-9552-43f2-a065-fab193830b68	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	24;24;24;24;24;24;24;24	354;170;170;262;323;262;170;323	323;50;50;170;262;170;50;262	Topotecan;Paclitaxel;Gemcitabine;Carboplatin;Topotecan;Taxotere;Carboplatin;Navelbine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11	Not Available;05;05;2;4;2;05;4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2;Not Available;Not Available;Not Available;AUC;Not Available	PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;IV;IV;Not Available;Not Available;Not Available;IV;Not Available	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;175;800;Not Available;Not Available;Not Available;5;Not Available	Not Available;mg/m2;mg/m2;Not Available;Not Available;Not Available;AUC;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	3	NOT HISPANIC OR LATINO	TCGA-04-1343-F23949	4e21e399-0648-4940-99e9-5e7eb3bd9c68	26	361	Not Available	3	Not Available	Not Available	Not Available	Not Available	3									Not Available	Preoperative	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1343	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	>20 mm	Ovary	Not Available	Dead	2009	2002
TCGA-13-1511	52	FEMALE	1650	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	459.0			WITH TUMOR		52	Bilateral	TCGA-13-1511	756f6768-e69a-4fe9-aa41-7c58aabe4577	31	-19258	Not Applicable	0	119	TCGA-13-1511-D24966;TCGA-13-1511-D24968;TCGA-13-1511-D24967	4247d127-1642-4e0e-b9e0-63c1f16c4436;8c238471-c7de-4922-875e-68b8c9ee6f25;311d0b25-b216-4f8d-a58a-b484fff48914	Not Available;Not Available;Not Available	29;1;1	46;186;186	21;67;67	Carboplatin;Gemcitabine;Carboplatin	Not Available;Not Available;Not Available	6;2;2	2;6;6	Not Available;800;600	Not Available;mg/m2;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5;Not Available;Not Available	Not Available;mg/m2;mg	Not Available;Not Available;Not Available	2009;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1511-F24965;TCGA-13-1511-F72680	4b9ab047-2f5e-4454-8f69-f40a45d563cf;90AE922B-8B77-4051-AD1D-62E91F80323A	31;31	Not Applicable;1650	119;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;459	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Partial Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	60	Not Available	3	G3									Not Available	Not Available	1511	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-36-2537	39	FEMALE	788	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	431.0		Progression of Disease	WITH TUMOR		39	Bilateral	TCGA-36-2537	5075cdc1-1b7c-4e25-98ea-fb568bd35f2d	18	-14595	Not Applicable	0	788	TCGA-36-2537-D27925;TCGA-36-2537-D27924;TCGA-36-2537-D27926;TCGA-36-2537-D27927;TCGA-36-2537-D27928	c3174758-216c-4fc8-8a98-36a43e572c20;95758800-a6d0-45e1-8d9a-5752cd7fc5a6;13bac041-aab1-4e77-b1bf-d66aab5c449c;f86a3fa0-169d-4c38-b7ae-1895cedf7055;ef10bbf8-5e83-430a-ab10-ddebd51a9219	Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18	125;125;614;614;763	20;20;474;474;721	Paclitaxel;Carboplatin;Carboplatin;Liposomal Doxorubicin;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	06;06;06;06;06	301;893;850;55;1512	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	1806;5358;5100;330;9072	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	2	Not Available	TCGA-36-2537-F27923	16ec4be7-a32c-4b9e-bae5-30c468066390	18	Not Applicable	788	2	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	431	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2537	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	Not Available	Alive	2010	2008
TCGA-29-1774	82	FEMALE	527	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	234.0		Recurrence	WITH TUMOR		82	Bilateral	TCGA-29-1774	d3dd5e69-9752-4b50-9b1f-814afbc2c3dd	2	-29991	Not Applicable	0	527	TCGA-29-1774-D27393;TCGA-29-1774-D27395;TCGA-29-1774-D27392;TCGA-29-1774-D27394;TCGA-29-1774-D27396	8f0d525a-84cc-4376-80b4-468b67a8058f;a3f71688-b40d-4551-91df-ad954d163bcc;c9297a2b-c8a3-47df-a05f-0986a27f2382;a01ca2d5-3332-453a-b76e-75339728fa1f;8c33e373-811e-4dbf-8c56-ea8a94342b13	Not Available;Not Available;Not Available;Not Available;Not Available	26;26;26;26;9	14;86;380;37;133	14;86;247;37;65	Carboplatin;Gemcitabine;Gemcitabine;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;2	01;01;05;01;03	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	340;1075;1425;410;340	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2010	2	NOT HISPANIC OR LATINO	TCGA-29-1774-F27391	19fa8c30-7468-4755-a242-b26569e255da	2	Not Applicable	527	2	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	234	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1774	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-13-1510	62	FEMALE	1359	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	1189.0			TUMOR FREE		62	Left	TCGA-13-1510	dac96910-0cb2-44ea-b108-2d6d51b07112	31	-22708	Not Applicable	0	78	TCGA-13-1510-D24963;TCGA-13-1510-D24962	762831bf-cafb-4024-af33-72efdf3f5222;20863438-765d-4a56-a8a5-dcf76e119ac3	Not Available;Not Available	8;8	174;174	62;62	Paclitaxel;Carboplatin	Not Available;Not Available	2;2	6;6	325;300	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	mg;mg	Not Available;Not Available	2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1510-F24961;TCGA-13-1510-F72679	d8c042c4-cd72-4511-b639-9c2e3d05248c;B03E30AF-E66C-45A1-9436-FE4B7855E8CD	31;31	Not Applicable;1359	78;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;1189	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	TUMOR FREE;WITH TUMOR	Not Available;Not Available	Not Available;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1510	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-13-0894	53	FEMALE	1509	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	565.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-13-0894	e8372916-7ac7-4535-ae97-0248208224f5	20	-19466	1509	0	1509	TCGA-13-0894-D24696;TCGA-13-0894-D24697;TCGA-13-0894-D24698	cadb50a3-648a-458a-a426-dcc49348f377;517b624b-f0c2-425b-a217-8e665840df42;ec90a0ce-59ed-478e-9502-8bce222e6276	Not Available;Not Available;Not Available	30;30;30	216;216;330	47;47;307	Carboplatin;Paciltaxel;Cisplatin	Not Available;Not Available;Not Available	6;6;6	8;8;2	Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5;175;600	Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0894-F24695	5f3daf92-4a48-465c-a5a1-c4ea0a54d15e	20	1509	1509	Not Available	Not Available	Not Available	80	Not Available	3	YES	NO	Not Available	565	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	3	G3									Not Available	Not Available	0894	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-24-1416	34	FEMALE	194	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	194			TUMOR FREE		34	Bilateral	TCGA-24-1416	f9793a4b-c0e7-4475-bf80-69543b7ee2f6	1	-12772	Not Applicable	0	194	TCGA-24-1416-D25916;TCGA-24-1416-D25918;TCGA-24-1416-D25917;TCGA-24-1416-D25915	97a17aa1-374b-4024-b74c-8329f9811fc9;9b15719a-2356-4fa2-9a7f-42274bbac4a7;d5c511d8-151f-4705-9bc4-f38116984562;c1f341c3-2bb0-4ba5-be48-5a13a54fc492	Not Available;Not Available;Not Available;Not Available	1;1;1;1	170;170;170;170	16;16;16;16	Cisplatin;Carboplatin;Taxol;Taxotere	Not Available;Not Available;Not Available;Not Available	4;4;4;4	08;08;08;08	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV;IP;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	946;422;647;934	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1416-F25914	cf7ad1d4-c805-41b7-8c74-2e09210bfd7e	1	Not Applicable	194	Not Available	Not Available	Not Available	Not Available	Not Available	4									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	1416	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-04-1652	76	FEMALE	969	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	880.0		Recurrence	WITH TUMOR		76	Right	TCGA-04-1652	d86adfac-56be-4a69-9315-5a90b4113e65	2	-28101	969	0	Not Available	TCGA-04-1652-D24180;TCGA-04-1652-D24181;TCGA-04-1652-D24183;TCGA-04-1652-D24182	6f994167-d0ff-4613-a3f7-193b4dc243f6;7c7d1c47-ed7b-411b-b974-274f7e527369;e710f8e4-0ad9-47d6-9682-6bb5c7ec4ca1;bc27edb0-7d82-454f-9fcf-dfaefff83fad	Not Available;Not Available;Not Available;Not Available	17;17;17;17	199;199;955;199	60;60;894;60	Carboplatin;Paciltaxel;Docetaxel;Gemicitabine	Not Available;Not Available;Not Available;Not Available	11;11;11;11	08;08;04;08	Not Available;Not Available;Not Available;Not Available	AUC;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	5;175;30;800	AUC;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	Not Available	TCGA-04-1652-F24179	cbce6aad-81f9-4b94-9970-869f1d53218e	2	969	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	880	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G2									Not Available	Not Available	1652	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	NO	Dead	2009	2004
TCGA-13-0920	65	FEMALE	1484	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	297.0		Recurrence	WITH TUMOR		65	Bilateral	TCGA-13-0920	85a85a11-7200-4e96-97af-6ba26d680d59	25	-24064	Not Applicable	0	420	TCGA-13-0920-D24776	7886c638-9120-43dc-a93d-657bae62d49d	Not Available	16	151	Not Available	Carboplatin	Not Available	4	Not Available	Not Available	Not Available	ADJUVANT	Not Applicable	Not Available	IV	Not Available	Chemotherapy	Not Available	Not Available	Not Available	Not Available	2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0920-F24775;TCGA-13-0920-F72633	7520c61e-b168-410f-9eeb-cda2deaed2a7;CBC19D48-E58F-4218-90A5-AFCA7A957A8C	25;30	Not Applicable;1484	420;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	297;297	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0920	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2007
TCGA-61-1907	63	FEMALE	952	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	743.0		Recurrence	WITH TUMOR		63	Bilateral	TCGA-61-1907	7ab3765f-910a-41c9-86cc-08534d2a4e4b	1	-23204	Not Applicable	0	952	TCGA-61-1907-D28251;TCGA-61-1907-D28254;TCGA-61-1907-D28252;TCGA-61-1907-D28253	ad0cedb8-9cfe-4c7d-a378-44814f214092;46b1d80a-bd2f-47c1-b54e-9840ed2f9d2f;81f78f66-be55-4b92-8c94-7e94311bbce0;b7771071-32ea-49c0-95ce-797ccca2d8b5	Not Available;Not Available;Not Available;Not Available	4;4;4;4	163;927;163;357	37;774;37;37	Oxaliplatin;Carboplatin;Docetaxel;Avastin	Not Available;Not Available;Not Available;Not Available	12;12;12;12	06;06;06;17	Not Available;Not Available;Not Available;Not Available	mg;Not Available;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	768;Not Available;678;14280	mg;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1907-F28250	62747011-66cb-4750-a1b1-5614de54b2e5	1	Not Applicable	952	Not Available	Not Available	Not Available	Not Available	Not Available	10	YES	NO	Not Available	743	Recurrence	Not Available	Not Available	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	10	G3									Not Available	Not Available	1907	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	11-20 mm	Ovary	YES	Alive	2009	2006
TCGA-24-1844	64	FEMALE	113	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	113			Not Available		64	Bilateral	TCGA-24-1844	a36a4440-15ef-4837-904b-380a964d16f1	2	-23542	Not Applicable	0	113	TCGA-24-1844-D26337;TCGA-24-1844-D26338;TCGA-24-1844-D26336	0a33fed2-263a-493b-9cdd-9f88ce31ef9b;0839f9cf-d618-4e02-b47c-6400449516f1;a38574db-890c-452c-abb7-3c28b26d82af	Not Available;Not Available;Not Available	24;24;24	134;134;134	24;24;24	Paclitaxel;Carboplatin;Docetaxel	Not Available;Not Available;Not Available	8;8;8	05;05;05	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1285;2660;405	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1844-F26335	cdb065d3-625b-4540-9004-d6477da35365	2	Not Applicable	113	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1844	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-24-1614	57	FEMALE	1470	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	644.0		Recurrence	WITH TUMOR		57	Right	TCGA-24-1614	d3164236-c14a-4230-b527-ecd1a3992f02	13	-20993	1470	0	1470	TCGA-24-1614-D26311;TCGA-24-1614-D26308;TCGA-24-1614-D26310;TCGA-24-1614-D26312;TCGA-24-1614-D26313;TCGA-24-1614-D26307;TCGA-24-1614-D26309	3d68a968-d13b-4ac5-bf8d-30f04aec9604;182d6037-89ec-4b51-9376-02ae5255ef66;d4a208fe-06b7-4a31-929e-0f583e7fb3d7;fa6b707e-13d5-41cc-baf3-af81fce80495;9e5ef115-0bd9-4e75-b594-70ec7010fc98;cfb807b3-6f3b-4d81-ba3b-b873bc99e8de;c1b63ae7-ab4d-4099-9c0e-258e497592cb	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13	1133;188;888;1133;1443;188;888	1010;22;644;1010;1284;22;644	Carboplatin;Taxol;Navelbine;Taxol;Doxil;Carboplatin;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5	06;08;11;06;04;08;11	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;Not Available;IV;IV;IV;Not Available	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1614-F26306	2e7f89f0-bf3f-4bb8-b6ac-2bb6fb323440	13	1470	1470	Not Available	Not Available	Not Available	100	Not Available	5	YES	NO	Not Available	644	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	100	Not Available	5	G3									Not Available	Not Available	1614	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-31-1959	49	FEMALE	67	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G2	0	67			WITH TUMOR		49	Bilateral	TCGA-31-1959	186d40cd-624c-4016-a497-b30c892d393c	20	-18247	Not Applicable	0	67	TCGA-31-1959-D27716;TCGA-31-1959-D27717	5b3d6d1e-fcaa-435b-b73d-24586385e15c;47c2d5b6-061b-4fb7-be57-74717e442a52	Not Available;Not Available	20;20	Not Available;Not Available	26;26	Carboplatin;Paciltaxel	Not Available;Not Available	10;10	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	YES;YES	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-31-1959-F27715	2550cdb2-11f6-4349-91e8-39780c044dbd	20	Not Applicable	67	Not Available	Not Available	Not Available	Not Available	Not Available	10									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Excisional Biopsy	Not Available	Not Available	YES	10	G2									Not Available	Not Available	1959	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	31	Not Available	Ovary	YES	Alive	2009	2009
TCGA-04-1371	58	FEMALE	2506	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	2506			TUMOR FREE		58	Bilateral	TCGA-04-1371	bff84539-7862-45b2-b5fc-e77291fcca8b	26	-21243	Not Applicable	0	2506	TCGA-04-1371-D24069;TCGA-04-1371-D24068;TCGA-04-1371-D24067	3ab89f04-e991-431d-a5de-de29b6dc3b31;d7136f6a-05fe-45b2-99b6-45ee4fdc1b75;dc9acb16-b331-4c9a-8486-ceeac1cb85e1	Not Available;Not Available;Not Available	9;9;9	199;199;199	7;7;7	Taxol;Gemcitibine;Carboplatin	Not Available;Not Available;Not Available	11;11;11	08;08;08	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1160;13200;5120	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	0	Not Available	TCGA-04-1371-F24066	5ec41cd6-f520-4e24-99eb-0885ce8ff21b	26	Not Applicable	2506	0	Not Available	Not Available	Not Available	Not Available	3									Not Available	Pre-Adjuvant Therapy	TUMOR FREE	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1371	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Alive	2009	2001
TCGA-04-1525	47	FEMALE	1167	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	213.0		Recurrence	WITH TUMOR		47	Bilateral	TCGA-04-1525	2bb96e1e-6992-434d-83e5-2f03713b3911	3	-17469	1167	0	Not Available	TCGA-04-1525-D24102;TCGA-04-1525-D24101;TCGA-04-1525-D24100	45a99f98-e53d-40d6-891d-5787134ff44e;17234cea-5e59-4520-bb0c-3ab4230d7138;5ff6409a-b31a-4c1d-9be5-cb0e87dcd044	Not Available;Not Available;Not Available	10;10;10	464;184;184	436;16;16	Irolfluvin;Carboplatin;Taxotere	Not Available;Not Available;Not Available	11;11;11	Not Available;08;08	Not Available;Not Available;Not Available	mg;AUC;mg	PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;IP;IV;IP;IV	NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	31;5;888	mg;AUC;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-04-1525-F24099	375c3a71-0dc9-475a-bf5d-bea64f332b78	3	1167	1167	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	213	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1525	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	NO	Dead	2009	2005
TCGA-09-0365	70	FEMALE	288	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	251.0		Recurrence	WITH TUMOR		70	Left	TCGA-09-0365	7621ed77-98bc-4b4e-8011-e18fcd014071	4	-25703	288	0	Not Available	TCGA-09-0365-D24204;TCGA-09-0365-D24205	c742fa3b-01b4-42d8-94a9-f5909f22b5d9;8c488ff2-8e08-47d4-ab18-b271a8d00717	Not Available;Not Available	27;27	70;70	46;15	carboplatin;taxol	Not Available;Not Available	3;3	3;3	Not Available;Not Available	mg;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	273;175	mg;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-0365-F24203	d6b85df6-097b-473c-b7bf-794e3fda6850	4	288	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	251	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	NO	3	G3									Not Available	Not Available	0365	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Dead	2009	1999
TCGA-36-1575	83	FEMALE	260	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	0	260			TUMOR FREE		83	Not Available	TCGA-36-1575	6ea9877f-eb8d-4ee9-af4c-32a78474d9a6	2	-30592	Not Applicable	0	260																								Not Available	Not Available	TCGA-36-1575-F27872	a467ed8b-fffc-416c-baec-1a137a98d03b	2	Not Applicable	260	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1575	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	No Macroscopic disease	Ovary	NO	Alive	2009	2006
TCGA-23-1028	43	FEMALE	1503	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	133.0		Recurrence	WITH TUMOR		43	Left	TCGA-23-1028	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	23	-16018	Not Applicable	0	1503	TCGA-23-1028-D25627;TCGA-23-1028-D25629;TCGA-23-1028-D25628;TCGA-23-1028-D25631;TCGA-23-1028-D25637;TCGA-23-1028-D25634;TCGA-23-1028-D25626;TCGA-23-1028-D25636;TCGA-23-1028-D25635;TCGA-23-1028-D25630;TCGA-23-1028-D25632;TCGA-23-1028-D25625;TCGA-23-1028-D25633	850beb81-2d13-437e-ae2a-8d4377df3ef9;b09d45b1-238e-42ff-be29-a0aa4024010a;04a1186c-fbac-46cc-9511-f3410889dfca;987f46e8-6c27-4d5a-b765-c5125640486e;7f691d4d-5047-4632-9a47-8b0354586a4e;02d68082-acf3-4467-b42a-da9e8cd5c130;7891f1ae-b0a9-448d-b9c0-c4f15de2e582;be0eed66-9759-46f5-861d-85d2b3c7dcd4;f26754f2-8f61-4593-9928-59d785330f4e;266bdf06-86e9-4dde-a5f7-5f96cc3c6eca;b5320a45-929d-4b52-b0d4-d3a67e2a6e60;dc8137b1-aa0c-46f3-b4bb-fb1b22ed2913;9d1e5abe-9d8b-4399-930e-7a32f508b7ff	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27;27;27;27;27;27;27;27	229;859;859;1335;1489;1461;110;1489;1461;1006;1153;110;1461	173;749;749;1112;1468;1461;26;1468;1461;908;1140;26;1363	Doxorubicin;Docetaxel;Carboplatin;Doxorubicin;Cisplatin;Gemcitabine;Carboplatin;Gemcitabine;Carboplatin;Topotecan;Topotecan;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3;3;3;3;3	3;6;6;8;2;1;4;2;1;11;3;4;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	201;846;2802;417.5;100;1552;2900;3100;525;40.89;10.3;1600;2667	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	HISPANIC OR LATINO	TCGA-23-1028-F25624	775ea41c-8d7e-4dd1-af91-41ee25e480d1	23	Not Applicable	1503	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	NO;NO	Not Available;133	133;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1028	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	YES	Alive	2009	2004
TCGA-09-1672	78	FEMALE	178	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G1	0	178			TUMOR FREE		78	Right	TCGA-09-1672	66dc6379-a98b-498f-8109-e3a811d043ea	2	-28556	Not Applicable	0	178	TCGA-09-1672-D24315;TCGA-09-1672-D24316	0374f5fb-511c-41e7-a7b1-0438a5f9110a;39aa2254-337c-461d-97c1-1733b934db3d	Not Available;Not Available	6;6	Not Available;Not Available	30;30	Taxol;Carboplatin	Not Available;Not Available	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1672-F24314	a4b07c67-1c4e-4d96-97dc-9cc364302992	2	Not Applicable	178	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G1									Not Available	Not Available	1672	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	Not Available	Ovary	YES	Alive	2009	2008
TCGA-61-2097	71	FEMALE	1844	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G2	0	1844			TUMOR FREE		71	Bilateral	TCGA-61-2097	47681e4b-01e8-4779-b966-ce57aff4b712	7	-25961	Not Applicable	0	1844	TCGA-61-2097-D28414;TCGA-61-2097-D28416;TCGA-61-2097-D28415	070e6cd1-5dac-4a4d-b01c-582c4b2e1bc9;ae9a2672-4912-4212-8eba-36c96d2e1d6f;12fc9951-d8e0-437b-8f44-647e2e6662d1	Not Available;Not Available;Not Available	7;7;7	167;Not Available;167	48;48;48	Carboplatin;Interferon gamma;Taxol	Not Available;Not Available;Not Available	12;12;12	06;Not Available;06	Not Available;Not Available;Not Available	mg;Not Available;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;IV	NO;Not Available;NO	Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available	3060;Not Available;1814	mg;Not Available;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-61-2097-F28413	351a21ef-4b26-45db-93f0-92941df09685	7	Not Applicable	1844	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G2									Not Available	Not Available	2097	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Alive	2009	2003
TCGA-04-1337	78	FEMALE	61	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	0	61			WITH TUMOR		78	Bilateral	TCGA-04-1337	d1e974e7-dd68-40cc-ad06-2b57d964e5a1	26	-28626	61	0	Not Available																								1	NOT HISPANIC OR LATINO	TCGA-04-1337-F23931	08769910-7006-46f3-a58f-3c6a4c34bf1f	26	61	Not Available	1	Not Available	Not Available	Not Available	Not Available	3									Not Available	Preoperative	WITH TUMOR	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G2									Not Available	Not Available	1337	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	No Macroscopic disease	Ovary	Not Available	Dead	2009	2005
TCGA-04-1514	45	FEMALE	1720	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIA	G2	1	1221.0		Recurrence	TUMOR FREE		45	Bilateral	TCGA-04-1514	e9483296-cb91-497a-b955-39a3c3289dac	2	-16725	1720	0	Not Available	TCGA-04-1514-D24073;TCGA-04-1514-D24076;TCGA-04-1514-D24082;TCGA-04-1514-D24075;TCGA-04-1514-D24078;TCGA-04-1514-D24080;TCGA-04-1514-D24083;TCGA-04-1514-D24081;TCGA-04-1514-D24084;TCGA-04-1514-D24074;TCGA-04-1514-D24085;TCGA-04-1514-D24079;TCGA-04-1514-D24072;TCGA-04-1514-D24077	c3d7e061-f05f-4211-85db-5b591fbe106b;4cb85ca0-8248-46f3-8435-d03a54f46c7f;86d58252-790f-4acb-9709-e59dc68d05de;debdaa66-085a-4ee2-a1fb-322bc4779f60;2cb5bd71-e88f-4c88-8bfa-7fcecdd82169;be57a53e-ba99-469a-87a4-dd76ba5de4f8;73b76fec-4906-4c95-8a9b-c65b2072f5c3;fcab5840-933e-49df-8fef-a82d594a24f2;73a0fc31-688d-4661-a134-2088b85cbe37;d74e569d-d9e0-41af-807e-10728d5b9b7c;825eb0a8-3865-4461-a42b-9822af8fabe2;94351318-f494-4b2a-9dd7-b81d8e95c476;0734b108-d85e-4880-b4f3-5df1a9e97f32;25acdb52-aea6-43a1-8a86-00831b905e8d	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	24;24;24;24;24;24;24;24;24;24;24;24;24;24	126;185;1587;185;1342;1495;1587;1587;1676;126;1676;1434;185;1342	34;126;1525;126;1221;1434;1464;1525;1615;34;1615;1372;34;1221	Cisplatin;Taxotere;Navelbine;Carboplatin;Taxotere;Doxil;Avastin;Topotecan;Cisplatin;Paclitaxel;Gemcitabine;Patupilone;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11;11;11;11;11;11	05;03;04;03;06;03;3;04;03;05;03;03;05;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;AUC;mg;mg;mg;mg;mg;mg;mg;mg;mg;AUC	ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IP;IP;IV;Not Available;IP;IV;Not Available;Not Available;Not Available;Not Available;Not Available;IP;Not Available;Not Available;IV;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	617;333;336;5;665;201;1750;33.6;292;494;7792;51;1112;5	mg;mg;mg;AUC;mg;mg;mg;mg;mg;mg;mg;mg;mg;AUC	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	1	NOT HISPANIC OR LATINO	TCGA-04-1514-F24071	5d6ed657-10c2-447e-bd5e-9a72631507ab	2	1720	Not Available	1	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;1284	1221;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Preoperative	TUMOR FREE	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G2									Not Available	Not Available	1514	Preoperative	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	No Macroscopic disease	Ovary	Not Available	Dead	2009	2004
TCGA-09-1659	51	FEMALE	304	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	304			WITH TUMOR		51	Bilateral	TCGA-09-1659	644a88a7-dc56-468a-af5c-60278aab7642	2	-18733	304	0	Not Available	TCGA-09-1659-D24229;TCGA-09-1659-D24227;TCGA-09-1659-D24230;TCGA-09-1659-D24228;TCGA-09-1659-D24231	e95461e2-9e4c-4e78-823c-562005b13fd2;1bf3b092-4fd1-4d22-828b-a0912d5a57cb;e135fb8b-9cfc-4dd4-b2c5-dea588329278;89fc6845-3c63-4c2f-ac1a-f3f53d98090f;c8db72a7-72b7-4d98-a402-2e064104a929	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	137;137;137;137;176	16;16;37;16;176	Taxol;Cisplatin;Taxol;Cisplatin;Hexamethylmelamine	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	6;6;6;6;1	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;PO	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;75;110;75;50	Not Available;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1659-F24226	43fa1bf4-aebc-4742-975b-f4fac71b3092	2	304	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1659	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	>20 mm	Ovary	NO	Dead	2009	1997
TCGA-04-1362	59	FEMALE	1348	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIC	G3	1	223.0		Recurrence	WITH TUMOR		59	Bilateral	TCGA-04-1362	1d192835-524e-429d-bf74-3c4727acb446	26	-21745	1348	0	Not Available	TCGA-04-1362-D24021;TCGA-04-1362-D24024;TCGA-04-1362-D24022;TCGA-04-1362-D24025;TCGA-04-1362-D24026;TCGA-04-1362-D24023	5a583495-0c6e-4fcf-a5cb-c8bf245de3f9;815d5029-02f6-4c96-9417-c5b01dcde4f5;3337ba21-cbbd-4aa9-a0eb-fbf135127996;af62b4e7-990c-4aad-a592-6ece7da45fd8;0eead925-93f1-4a66-a5cb-434ff454c034;3c1ece80-31b8-4d36-b4f4-d0ab005acc4b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10	172;Not Available;172;Not Available;Not Available;172	7;658;7;658;658;7	Carboplatin;Carboplatin;Taxol;Doxil;Topotecan;Gemcitibine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	06;Not Available;06;Not Available;Not Available;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;mg;Not Available;Not Available;mg	ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2593;Not Available;1689;Not Available;Not Available;13856	mg;Not Available;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	1	Not Available	TCGA-04-1362-F24020	f6d3414e-afc6-44a6-a4e2-0e59c5b2a796	26	1348	Not Available	1	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	223	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1362	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-25-1313	62	FEMALE	820	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	394.0		Recurrence	WITH TUMOR		62	Bilateral	TCGA-25-1313	d73a0a33-e4e8-44bd-9580-2038ab06583a	27	-22982	820	0	820	TCGA-25-1313-D26629;TCGA-25-1313-D26630;TCGA-25-1313-D26631	9a05fe1c-906f-4d7a-9f6e-1d0ff03b187b;4f66c38b-6088-4295-adf1-a6dfc5e09598;64b80a98-0e23-47cf-bcb1-77881ca35bf0	Not Available;Not Available;Not Available	27;27;27	151;151;547	29;29;394	Taxol;Carbo;Topotecan	Not Available;Not Available;Not Available	3;3;3	6;6;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1313-F26628	61ada3f9-4015-4673-ac92-e08e99fa05b8	27	820	820	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	394	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	Not Available	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1313	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-36-1570	49	FEMALE	655	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	375.0		Recurrence	WITH TUMOR		49	Bilateral	TCGA-36-1570	0f530b3e-5b6d-4892-9ebd-9138d76fdca7	2	-17956	Not Applicable	0	655	TCGA-36-1570-D27858;TCGA-36-1570-D27860;TCGA-36-1570-D27859	1ab5a040-88b7-41b1-a6ee-4bbb809a9b42;90a5225e-1532-4db6-aef6-b5596c72151e;630cd072-7436-4d96-9eeb-af8fcd0dcd9b	Not Available;Not Available;Not Available	15;15;15	133;432;133	23;432;23	Carboplatin;Gemcitabine;Paclitaxel	Not Available;Not Available;Not Available	1;1;1	05;01;05	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	2808;1200;1330	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	0	Not Available	TCGA-36-1570-F27857	15fa99c0-2fe6-4a73-9c6b-612cf8d56d53	2	Not Applicable	655	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	375	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1570	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	YES	Alive	2009	2007
TCGA-13-0884	39	FEMALE	3260	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	1251.0		Recurrence	WITH TUMOR		39	Bilateral	TCGA-13-0884	63a75e0b-9241-4f0e-9236-01a2e2c05b7e	20	-14538	3260	0	3260	TCGA-13-0884-D24653;TCGA-13-0884-D24654;TCGA-13-0884-D24656;TCGA-13-0884-D24652;TCGA-13-0884-D24655	7cffdd63-0cfb-4c4c-98e9-ac1d35615574;3eeaa9ad-d6c1-4843-8a53-d76c3243380c;f696b7ed-1114-49b6-a2a4-8d394fdcfa43;fc570206-ca8e-42f3-a1f2-a46aea37a65e;29c3e4e5-9940-499e-94ec-de4979d77ff0	Not Available;Not Available;Not Available;Not Available;Not Available	30;30;30;30;30	191;191;307;191;307	55;55;240;55;240	Paciltaxel;Gemicitabine;Cisplatin;Carboplatin;Paciltaxel	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6	6;6;4;6;4	Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IP;IV;IV;IP;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	60;800;74;5;133	mg/m2;mg/m2;mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0884-F24651	e819d979-7efe-4737-b8b4-0a64e5588d4b	20	3260	3260	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	1251	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0884	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-61-2102	74	FEMALE	197	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	197			WITH TUMOR		74	Right	TCGA-61-2102	7a08efd0-f984-430e-a8eb-1881047214b6	7	-27256	197	0	197	TCGA-61-2102-D28439;TCGA-61-2102-D28440	43d7605a-1774-4181-a4da-677d897ac471;9c357105-fe4d-4ec2-93e3-529f563fd5d8	Not Available;Not Available	7;7	Not Available;Not Available	14;14	Taxol;Carboplatin	Not Available;Not Available	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-61-2102-F28438	0b2aa437-7686-4d29-ac07-bc166237edbf	7	197	197	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	12	G3									Not Available	Not Available	2102	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	Not Available	Dead	2009	1999
TCGA-25-2408	37	FEMALE	943	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	1	334.0		Recurrence	WITH TUMOR		37	Bilateral	TCGA-25-2408	fdd4adb8-9295-480a-9352-305b5eb51187	5	-13606	943	0	943	TCGA-25-2408-D26838;TCGA-25-2408-D26839	d85bbcd3-e90c-46cb-ac16-f0e6fb8ce699;39386c00-8aa3-4ae3-9a10-8f09e244de14	Not Available;Not Available	5;5	Not Available;Not Available	61;61	Taxol;Carboplatin	Not Available;Not Available	1;1	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-25-2408-F26837	f82208f0-6255-4dd7-8523-c0c9da6e0800	5	943	943	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available;Not Available	NO;NO	Not Available;334	334;Not Available	Recurrence;Metastatic	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G2									Not Available	Not Available	2408	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2010	2005
TCGA-24-2019	46	FEMALE	148	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	148			Not Available		46	Bilateral	TCGA-24-2019	bbad2efe-e9c7-4f8f-924b-ebbbe4c181d4	16	-17009	Not Applicable	0	148																								1	Not Available	TCGA-24-2019-F26429	478f18ec-c7d2-485e-b83d-1b416c86ac20	16	Not Applicable	148	1	Not Available	Not Available	Not Available	Not Available	3									Not Available	Other	Not Available	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2019	Other	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2010	2009
TCGA-29-2429	79	FEMALE	421	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	421			WITH TUMOR		79	Right	TCGA-29-2429	4309ca23-1cf9-40a2-a01c-ccee90f958b2	4	-29156	421	0	Not Available	TCGA-29-2429-D27483;TCGA-29-2429-D27482	e4df2fd2-1dc4-424a-b456-c3e415c37ace;c75fad2f-73f0-4fa6-8870-e9a28e7ae23a	Not Available;Not Available	4;4	Not Available;Not Available	Not Available;Not Available	Paclitaxel;Carboplatin	Not Available;Not Available	6;6	1;1	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-29-2429-F44633	AB2FB3AE-FB9F-4F4D-89CB-FF9DDA843F99	20	421	Not Available	Not Available	Not Available	Not Applicable	Not Available	YES	8									NO	Not Available	Not Available	Not Available	Unknown	Unknown	Dead	2013	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	2429	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Dead	2010	2005
TCGA-25-1314	42	FEMALE	1004	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	274.0		Progression of Disease	WITH TUMOR		42	Bilateral	TCGA-25-1314	0b2ea4b7-98bb-4190-b682-2c75b447c90a	27	-15462	1004	0	974	TCGA-25-1314-D26634;TCGA-25-1314-D26636;TCGA-25-1314-D26635;TCGA-25-1314-D26637	2bc86970-b813-419d-8821-e2a618a9af3d;579ce73b-269e-4c24-894b-9066edf721fb;547d8656-df9f-4efe-b7be-f94cd726c8b9;56d387be-95f9-4b53-ae0c-c4b479c8a965	Not Available;Not Available;Not Available;Not Available	27;27;27;27	Not Available;425;Not Available;Not Available	31;274;31;31	Carbo;Topotecan;Cisplatinum;Taxol	Not Available;Not Available;Not Available;Not Available	3;3;3;3	6;7;2;8	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1314-F26633	fe94fad3-1f4c-4204-ad9b-d8a1ab9b75cc	27	1004	974	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;274	274;Not Available	Progression of Disease;Locoregional Disease	Not Available;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1314	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-29-1695	62	FEMALE	1229	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	0	1229			Not Available		62	Left	TCGA-29-1695	33d36b64-4688-40a7-9a4f-7cd3d4cc683d	2	-22895	1229	0	Not Available																								Not Available	Not Available	TCGA-29-1695-F27204	1a796fc4-467e-422f-b7bf-d9857180bafa	2	1229	24	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	Not Available	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1695	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Dead	2009	2003
TCGA-24-1843	66	FEMALE	106	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	106			Not Available		66	Right	TCGA-24-1843	9ec86cbd-8c74-4697-90da-529ab91ab835	2	-24469	Not Applicable	0	106	TCGA-24-1843-D26331;TCGA-24-1843-D26332;TCGA-24-1843-D26333	e6b12e88-599d-4d24-8628-c3d561b959f1;eb2bc7df-1c3d-4cb5-8759-e3e1f218165b;56bb4b8e-25cd-4200-8444-4be7bf4dbc66	Not Available;Not Available;Not Available	24;24;24	134;134;134	20;20;20	Taxol;Taxotere;Carboplatin	Not Available;Not Available;Not Available	8;8;8	05;05;05	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	373;582;2957	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1843-F26330	9871548e-8f1f-4d83-87f7-e813b54143bc	2	Not Applicable	106	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1843	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-25-2400	76	FEMALE	1278	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	577.0		Recurrence	WITH TUMOR		76	Bilateral	TCGA-25-2400	5c127332-5ca0-45f1-a5ac-4876ad94e491	5	-27789	1278	0	1278	TCGA-25-2400-D26825;TCGA-25-2400-D26827;TCGA-25-2400-D26824;TCGA-25-2400-D26826	ca0c6a83-308f-49c2-8e37-8b1f9a7132ec;bbae9713-7efb-4282-ae16-6d2982fdbce5;6e054b23-144e-4321-9b35-9402bf36de69;b2c304b8-84cc-401b-96cf-efb9ef1818ac	Not Available;Not Available;Not Available;Not Available	5;5;5;5	182;669;182;669	61;577;61;577	Carboplatin;Carboplatin;Taxol;Taxol	Not Available;Not Available;Not Available;Not Available	1;1;1;1	06;05;06;05	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-25-2400-F26823	97a1075f-1009-4e51-ad56-1d86ab3f66fa	5	1278	1278	Not Available	Not Available	Not Available	Not Available	Not Available	1	YES	NO	Not Available	577	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2400	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	No Macroscopic disease	Ovary	Not Available	Dead	2010	2004
TCGA-29-1781	69	FEMALE	255	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	255			TUMOR FREE		69	Bilateral	TCGA-29-1781	f6ebf3a7-31c6-4f4c-9a0b-74cf35bfedf6	2	-25404	Not Applicable	0	255	TCGA-29-1781-D27428;TCGA-29-1781-D27429	cf2a312b-1bea-47bb-8927-fec695033234;ca447e99-c2a8-46bb-a4db-19480aae1034	Not Available;Not Available	10;10	255;255	52;52	Carboplatin;Paclitaxel	Not Available;Not Available	12;12	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	2970;2322	mg;mg	Not Available;Not Available	2009;2009	1	Not Available	TCGA-29-1781-F27427	1b223132-ee30-413c-b80b-15986f45f9a3	2	Not Applicable	255	1	Not Available	Not Available	Not Available	Not Available	6									Not Available	Pre-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1781	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	No Macroscopic disease	Ovary	Not Available	Alive	2009	2009
TCGA-23-2649	60	FEMALE	116	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	116			Not Available		60	Left	TCGA-23-2649	ae5fa7cb-1984-423f-aa88-571314860943	9	-22210	Not Applicable	0	116																								Not Available	NOT HISPANIC OR LATINO	TCGA-23-2649-F25822	62d9fa88-d505-4cf2-b3f5-6512e940dba6	9	Not Applicable	116	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	2649	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	YES	Alive	2009	2009
TCGA-24-1842	49	FEMALE	253	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	253			TUMOR FREE		49	Bilateral	TCGA-24-1842	09c77947-a333-4392-b18d-a6c1f08764a1	2	-18227	Not Applicable	0	253	TCGA-24-1842-D26328;TCGA-24-1842-D26326;TCGA-24-1842-D26327	df6ea24c-564d-43a8-adf8-78174c16894c;7171dab9-2b07-41ce-92ac-dda733de4616;740a180c-a931-483e-be25-7580f2c5f4e9	Not Available;Not Available;Not Available	24;24;24	253;253;253	43;24;24	Bevacizumiab/ versus Placebo;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available	8;8;8	Not Available;06;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;IV;IV	NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	14331;4355;2043	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	0	Not Available	TCGA-24-1842-F26325	ea813aa8-df86-407b-aea1-092fb2c8608e	2	Not Applicable	253	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Other	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1842	Other	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-29-1764	49	FEMALE	1914	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	1	792.0		Recurrence	WITH TUMOR		49	Bilateral	TCGA-29-1764	c70228cc-79c0-4c00-8926-6671c1474701	2	-18012	Not Applicable	0	1914	TCGA-29-1764-D27341;TCGA-29-1764-D27340;TCGA-29-1764-D27339;TCGA-29-1764-D27347;TCGA-29-1764-D27345;TCGA-29-1764-D27348;TCGA-29-1764-D27343;TCGA-29-1764-D27346;TCGA-29-1764-D27344;TCGA-29-1764-D27342	83c24fb9-19f6-410f-aaaf-62de9ce57d42;669fa902-94cd-4761-a34a-ea52ea36e477;85cefe8c-1946-4726-86f9-76af29868908;4c572c40-ea4e-48bd-9a55-2181e2a7a827;990413d8-d086-4927-80af-1ad44a3a2002;3b9a01d6-eba5-46dd-9f01-cca971cfa936;2ed46035-c347-455e-9929-04ea06ea6a27;6ec309e5-10b4-426d-b870-50ae85cfacdf;0f5f3466-2df4-4ffd-ace9-bbcf4c0edd98;43f88f80-cf14-4b7a-aeaf-28fc5909aab4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;21;21;21;21;21;21;21	167;87;167;1973;1515;1973;968;1785;1343;818	15;15;111;1816;1366;1816;822;1785;1301;797	Carboplatin;Gemcitabine;Paclitaxel;Topotecan HCL;Doxil;Bevacizumab;Carboplatin;Doxil;Carboplatin;Docetaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;4;4;4;4;4;4;4	07;06;03;06;06;Not Available;08;01;03;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;Not Available;mg	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;PROGRESSION;RECURRENCE;PROGRESSION;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;Not Available;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4581;12000;1050;6;80;1100;590;80;Not Available;60	mg;mg;mg;mg;mg;mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-29-1764-F27338	8de913c5-72f9-4108-b6ec-8add802932b2	2	Not Applicable	1914	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	792	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1764	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Alive	2009	2004
TCGA-24-2290	56	FEMALE	1102	Serous Cystadenocarcinoma	Omentum	Dead	Stage IIIC	G3	1	324.0		Recurrence	WITH TUMOR		56	Not Available	TCGA-24-2290	2b14123b-8fcd-402c-9399-4e7c47f20252	19	-20530	1102	0	1102	TCGA-24-2290-D26585;TCGA-24-2290-D26596;TCGA-24-2290-D26589;TCGA-24-2290-D26592;TCGA-24-2290-D26584;TCGA-24-2290-D26587;TCGA-24-2290-D26591;TCGA-24-2290-D26595;TCGA-24-2290-D26590;TCGA-24-2290-D26593;TCGA-24-2290-D26594;TCGA-24-2290-D26586;TCGA-24-2290-D26588	76e08919-c8aa-463f-94ef-39dd7a978a2f;347a3fb1-1fa2-4ba3-963c-15dc7ba75973;457c381a-169a-40b2-8c7d-830abe8195e0;9820826f-3bc0-4f1d-a77a-c94f988b7243;53051e26-96ea-4381-935b-d86d4e464e6e;d5c6eadd-a0ce-4465-b7c7-7e3097a30df4;7019634d-a409-44df-8bad-84a1aca17ae3;8176d176-b9b6-4830-a395-f70cdbb3a561;6e13ad8f-bd41-4fa0-85b0-746ed6cc06d4;9886b603-9d94-4810-9353-3667147b2718;ee1d8054-d6cb-4ac4-a322-4504c3bdf623;7d77c5da-5552-44b1-8c6c-576ffdeebe86;1a112873-89ab-4529-bc98-8ed1d92e82f2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	19;19;19;19;19;19;19;19;19;19;19;19;19	119;1055;599;705;119;412;705;Not Available;614;823;939;412;550	7;1005;578;663;7;349;663;Not Available;607;727;855;349;439	Taxol;Tamoxifen;Taxol;Cisplatin;Carboplatin;Carboplatin;Taxol;Not Available;Gemzar;Topotecan;Vamydex;Taxol;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2;2;2;2;2;2;2	6;Not Available;04;03;06;04;03;Not Available;02;05;05;04;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;mg;mg;mg;mg;mg;Not Available;mg;mg;mg;mg;mg	ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV;IV;IV;IV;Not Available;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;Not Available;NO;NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1800;Not Available;600;279;4620;3000;780;Not Available;7060;60;2250;1270;707	mg;Not Available;mg;mg;mg;mg;mg;Not Available;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-24-2290-F26583	f90e554e-790a-4892-875c-01886dd88b5f	19	1102	1102	0	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	324	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8441/3	C48.1	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	2290	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Omentum	Not Available	Dead	2010	1997
TCGA-04-1517	79	FEMALE	608	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	349.0		Recurrence	WITH TUMOR		79	Bilateral	TCGA-04-1517	35916942-e7aa-45db-ad27-03cba67d4d5b	3	-29045	608	0	Not Available	TCGA-04-1517-D24093;TCGA-04-1517-D24094;TCGA-04-1517-D24095;TCGA-04-1517-D24096	c2db098e-b4d0-4a08-b35a-3821b685becf;c7c8f6df-41a9-4999-8081-49601b1917e2;4e373c73-a0c8-4c20-adfc-68c098db3867;06f97b5a-43e9-4fe2-b385-20b3fff0cd82	Not Available;Not Available;Not Available;Not Available	17;17;17;17	144;144;421;421	35;35;352;352	Taxotere;Carboplatin;Gemzar;Doxil	Not Available;Not Available;Not Available;Not Available	11;11;11;11	06;06;03;03	Not Available;Not Available;Not Available;Not Available	mg/m2;AUC;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	70;6;Not Available;Not Available	mg/m2;AUC;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	Not Available	TCGA-04-1517-F24092	b75fd0b7-9f36-44b6-81e4-69d7cddd5ec3	3	608	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	349	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1517	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	>20 mm	Ovary	NO	Dead	2009	2006
TCGA-13-0803	81	FEMALE	1334	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	337.0		Recurrence	WITH TUMOR		81	Bilateral	TCGA-13-0803	54cf3bfe-51c0-4cca-9054-bf76b05a9371	25	-29685	1334	0	1334	TCGA-13-0803-D24631;TCGA-13-0803-D24630	4b3bed15-25df-47c4-8876-bd93ec815e04;9df60126-cad0-4536-be8b-92e6d5bc5864	Not Available;Not Available	15;15	147;147	Not Available;Not Available	Paclitaxel;Carboplatin	Not Available;Not Available	4;4	6;6	Not Available;Not Available	mg/m2;AUC	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;6	mg/m2;AUC	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0803-F24629	f2f628f8-dfed-4f61-9678-1be00a4dea71	25	1334	1334	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	337	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0803	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Dead	2009	2001
TCGA-61-2610	61	FEMALE	1579	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	524.0		Recurrence	WITH TUMOR		61	Left	TCGA-61-2610	1098441d-fb10-4590-a302-0a7cc2332798	7	-22481	1579	0	1579	TCGA-61-2610-D28485;TCGA-61-2610-D28486;TCGA-61-2610-D28487;TCGA-61-2610-D28488	d0b1651f-f3cd-4ccb-b9f5-cd3b5e34a0b5;741fb562-5cf2-415d-a54f-11bcb861ea9a;4974f4a7-8f86-480b-a922-48a07a10417c;efec5670-4d2b-42da-9e6f-aff946b9e90c	Not Available;Not Available;Not Available;Not Available	7;7;7;7	530;357;357;1130	439;29;29;591	Toptecan;Carboplatin;Taxol;Doxil	Not Available;Not Available;Not Available;Not Available	9;9;9;9	4;12;12;12	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	Not Available	TCGA-61-2610-F28484	f2bc30dc-be52-4d63-8e28-76c312eb84c6	7	1579	1579	Not Available	Not Available	Not Available	Not Available	Not Available	9	YES;YES	YES;YES	Not Available;554	524;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	9	G3									Not Available	Not Available	2610	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence	TCGA-61-2610-R28489	1a8a6db2-18c8-4ab6-a4c5-46d737fea6d7	Not Available	7	1187	1151	Not Available	9	30	4000	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	cGy	2010	R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	11-20 mm	Ovary	Not Available	Dead	2010	1998
TCGA-23-1118	45	FEMALE	2616	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	2616			TUMOR FREE		45	Left	TCGA-23-1118	700e91bb-d675-41b2-bbbd-935767c7b447	20	-16471	Not Applicable	0	2616	TCGA-23-1118-D25709	553ae8b5-bba0-4760-bc39-007b45663eba	Not Available	27	196	56	Carboplatin	Not Available	3	6	Not Available	mg	ADJUVANT	Not Applicable	Not Available	IP	NO	Chemotherapy	Not Available	300	mg	Not Available	2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1118-F25708	2c2e8996-31a2-4d40-ae52-a14131eb9684	20	Not Applicable	2616	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1118	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	>20 mm	Ovary	YES	Alive	2009	2001
TCGA-57-1993	56	FEMALE	763	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	763			TUMOR FREE		56	Bilateral	TCGA-57-1993	15fc17cd-d073-4f81-a4a2-2db3cb9d7069	7	-20498	Not Applicable	0	763	TCGA-57-1993-D28093;TCGA-57-1993-D28094	b07a8455-73a1-4571-bd1b-3e468ec2f2f8;6953096a-c7ed-4c25-b134-8dca8f12f670	Not Available;Not Available	9;9	Not Available;Not Available	62;62	Carboplatin;Taxol	Not Available;Not Available	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-57-1993-F28092	c5c65b87-f672-4576-8cc3-10552aea8459	7	Not Applicable	763	Not Available	Not Available	Not Available	Not Available	Not Available	1									Not Available	Not Available	TUMOR FREE	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	1	G3									Not Available	Not Available	1993	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	57	No Macroscopic disease	Ovary	YES	Alive	2010	2007
TCGA-29-2414	75	FEMALE	2621	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	552.0		Recurrence	WITH TUMOR		75	Left	TCGA-29-2414	a2319490-b85d-4219-a1b0-fa1ec432d5c8	9	-27417	2621	0	2621	TCGA-29-2414-D27456;TCGA-29-2414-D27455;TCGA-29-2414-D27452;TCGA-29-2414-D27453;TCGA-29-2414-D27454;TCGA-29-2414-D27458;TCGA-29-2414-D27457;TCGA-29-2414-D27459	f1b37728-c715-49d5-8f09-f3ccd3f67332;625a1bad-817a-495e-bbe8-b1b729a59ddc;132a139a-586a-4d1a-af97-fa14a99ca34a;1bb30d93-19c1-43d9-aff6-31304c0e1cab;d3474bc8-4f86-4d81-95e2-3bc02d4caeaf;317f4820-8ca1-4a04-914d-ed26beb2ab02;b3519929-e195-4d53-a529-432c75296acc;d4828223-bc26-41cd-87bd-0dc1451bb931	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;10;10;12	131;131;2151;2287;2424;1171;1171;1171	3;3;2042;2256;2315;996;996;996	Cisplatin;Paclitaxel;Carboplatin;Doxil;Topotecan;Carboplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;3;3;3	06;06;06;02;03;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;AUC;mg/m2;mg/m2;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	75;20;5;40;3;Not Available;Not Available;Not Available	mg/m2;mg/m2;AUC;mg/m2;mg/m2;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-29-2414-F27451	955879e7-53f1-48e3-85c2-47d63a4b8113	9	2621	2621	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	YES;YES	Not Available;2222	552;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Other Method;Other Method	Fine needle apsiration (cytology);Fine needle apsiration (cytology)	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G2									Not Available	Not Available	2414	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-29-2414-R27460	4f455d1b-8492-4c47-bc16-01de2ac1898a	Not Available	9	Not Available	1705	Not Available	2	Not Available	6600	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2010	R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	11-20 mm	Ovary	NO	Dead	2010	1998
TCGA-04-1341	85	FEMALE	33	Serous Cystadenocarcinoma	Ovary	Alive		G3	0	33			Not Available		85	Not Available	TCGA-04-1341	92badeb5-a50e-4a62-a67e-6a8a59c948ab	26	-31215	Not Applicable	0	33																								Not Available	NOT HISPANIC OR LATINO	TCGA-04-1341-F23940	081a449e-6733-4d5e-9dd0-b22add890b42	26	Not Applicable	Not Available	Not Available	Scheduled Follow-up Submission	Not Available	Not Available	Not Available	3									Not Available	Not Available	WITH TUMOR	Not Available	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Not Available	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1341	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	04	Not Available	Ovary	Not Available	Alive	2009	2006
TCGA-61-2095	54	FEMALE	1875	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	445.0		Recurrence	WITH TUMOR		54	Bilateral	TCGA-61-2095	778ce436-a825-4689-81c1-b7c965404163	7	-19797	1875	0	Not Available	TCGA-61-2095-D28392;TCGA-61-2095-D28394;TCGA-61-2095-D28395;TCGA-61-2095-D28396;TCGA-61-2095-D28390;TCGA-61-2095-D28391;TCGA-61-2095-D28393	78845da3-7582-496a-a208-b129f7fb4348;e9c95270-88d0-44f3-972d-75a8bfd8447e;40f7e2ed-0250-4c2b-9f7c-bcfa87bce830;e6c07ec3-5875-407b-a937-5379bdc53ed6;6a0849e1-a42b-4ac6-a5f9-7a36be83542d;954df6b0-eb97-48ef-8420-fc927a9cd581;579b6224-4d67-44a5-b5fa-72d19bcd0692	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7	1188;1389;Not Available;447;602;602;1264	783;1360;1474;210;59;59;1193	Doxil;Oxaliplatin;Gemzar;Ovarex MA6 B43.13;Taxol;Carboplatin;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12	12;Not Available;Not Available;Not Available;06;06;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg;Not Available;mg;Not Available;Not Available;Not Available	RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;IV;Not Available;IV;IV;IV;Not Available	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;468;Not Available;12;Not Available;Not Available;Not Available	Not Available;mg;Not Available;mg;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2095-F28389	b64c63f4-4421-42fe-b4f4-fe30be2673cb	7	1875	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES;YES	NO;NO	Not Available;452	445;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	12	G2									Not Available	Not Available	2095	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	YES	Dead	2009	2003
TCGA-04-1649	74	FEMALE	1966	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1672.0		Recurrence	Not Available		74	Bilateral	TCGA-04-1649	314e446d-3a57-4c91-ac2e-4fc211456ee6	2	-27165	Not Applicable	0	1966	TCGA-04-1649-D24169;TCGA-04-1649-D24170	976c28f1-f941-4649-a5eb-1f8377e55c18;bef99616-fb63-4a21-bb71-09f9e6a33c99	Not Available;Not Available	9;9	Not Available;Not Available	1704;1704	Taxotere;Carboplatin	Not Available;Not Available	11;11	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	RECURRENCE;RECURRENCE	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	1	Not Available	TCGA-04-1649-F24168	f9735bfe-c3b8-450d-9d52-4b36a3a90e03	2	Not Applicable	1966	1	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	1672	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	Not Available	NO	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1649	Preoperative	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Alive	2009	2003
TCGA-13-1410	57	FEMALE	2464	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	GX	1	319.0			TUMOR FREE		57	Bilateral	TCGA-13-1410	c3f9ee36-d34f-472b-ac7f-801a0d400aa4	20	-20950	Not Applicable	0	143	TCGA-13-1410-D24826;TCGA-13-1410-D24823;TCGA-13-1410-D24824;TCGA-13-1410-D24825	5ce755e2-cf11-4bd2-a179-6f9305bb2378;93edac67-ef10-41aa-afd0-fb99734e5700;d0ba7a4c-cd7a-491e-b632-d4ddef4a09e8;14439b25-7a92-4ff8-a783-68936013e4bc	Not Available;Not Available;Not Available;Not Available	30;30;30;30	125;83;83;125	103;39;39;103	Paclitaxel;Carboplatin;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available;Not Available	6;6;6;6	2;3;3;2	Not Available;Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IV;IV;IP;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	135;5;175;75	mg/m2;Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1410-F24822;TCGA-13-1410-F72661	498f0f25-c651-48d1-a28a-371ba22a446d;169C6F83-97C5-4E8F-85FE-6F8FE26DC5FE	20;31	Not Applicable;Not Applicable	143;2464	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;319	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	60	Not Available	3	GX									Not Available	Not Available	1410	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2008
TCGA-57-1582	50	FEMALE	731	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	731			WITH TUMOR		50	Left	TCGA-57-1582	4ea50685-3b63-440a-b037-597ef2529e7d	2	Not Available	731	0	731	TCGA-57-1582-D28064;TCGA-57-1582-D28065;TCGA-57-1582-D28066;TCGA-57-1582-D28061;TCGA-57-1582-D28060;TCGA-57-1582-D28063;TCGA-57-1582-D28062	9041086b-05e4-47fa-a97e-8a2434ee502f;52fe6e4b-e0f3-45ac-a637-1646983fa465;64899839-fe30-4966-ad41-a6039e479566;6e3807f9-6043-4aec-aa04-b7e7feab6f77;4476f55a-92b6-41f6-86a8-d943b07880fc;cf142304-ee75-49b0-9661-d6a7f35b0e5f;465a4575-5435-43fd-83d8-e1e1e3f854a2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28;28	597;718;718;170;170;505;Not Available	505;597;597;17;17;444;260	Topotecan;Carboplatin;Gemzar;Taxotere;Carboplatin;Doxil;Patupilone	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7	Not Available;Not Available;Not Available;06;06;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;IV;IV;IV;Not Available	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-57-1582-F28059	d6ebac21-c97c-456d-b42e-726017a129d6	2	731	731	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1582	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	57	1-10 mm	Ovary	YES	Dead	2009	2006
TCGA-24-1436	57	FEMALE	260	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	260			WITH TUMOR		57	Right	TCGA-24-1436	6e84e89d-4f35-43b8-b47d-b1343b8c1ab9	12	-20881	260	0	260	TCGA-24-1436-D26006;TCGA-24-1436-D26005;TCGA-24-1436-D26007	af7ffeda-3c58-4d51-a79b-eb8aac840cf2;075db38d-494a-43d6-87ac-701eef1c15bb;82fcfea2-5e77-496f-9bc7-3f26570982f2	Not Available;Not Available;Not Available	12;12;12	135;135;223	24;24;157	Taxol;Carboplatin;Topotecan	Not Available;Not Available;Not Available	5;5;5	05;05;03	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1282;2730;28.25	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1436-F26004	cc0a65c7-68c1-48e5-8e0a-7fc5a09d1317	12	260	260	Not Available	Not Available	Not Available	Not Available	Not Available	5									Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	5	G3									Not Available	Not Available	1436	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-24-2261	76	FEMALE	24	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	24			WITH TUMOR		76	Left	TCGA-24-2261	eec69ea9-ceb8-456a-aff4-41fb8a261e36	15	-27897	24	0	24																								Not Available	Not Available	TCGA-24-2261-F26540	d38e75d8-914a-44fe-8f84-904c95b9a680	15	24	24	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	2261	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	11-20 mm	Ovary	Not Available	Dead	2010	1992
TCGA-24-1927	59	FEMALE	500	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	290.0		Recurrence	WITH TUMOR		59	Bilateral	TCGA-24-1927	8c47ae58-91c7-4247-b420-50f31f5eb00d	1	-21719	500	0	500	TCGA-24-1927-D26399;TCGA-24-1927-D26397;TCGA-24-1927-D26400;TCGA-24-1927-D26398;TCGA-24-1927-D26401	a191ec4f-2b7b-4766-8c5b-1bad03dbc5d3;86eca33e-cb34-4166-9875-5c1d0a83466b;2ecf64b7-e849-4d43-bf62-b9e2074a9a34;d7b1885b-3bef-4eb1-996e-229cbcd78c8d;ad8c1787-5794-4bc3-95ed-0ed4f4b84efa	Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1	328;132;435;132;132	293;15;372;15;15	Gaminocamptothecin;Taxol;Aminopterin;Carboplatin;SCH 58500	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	02;06;02;06;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg	RECURRENCE;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;Not Available	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available	3750;1587;8100;3947;4200	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-1927-F26396	961f5963-db18-487d-b99d-18ca0a9c78f9	1	500	500	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	290	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1927	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	1999
TCGA-5X-AA5U	61	FEMALE	361	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	GX	0	361			TUMOR FREE		61	Right	TCGA-5X-AA5U	BC84C5C5-1785-4EDD-B732-8987F862063E	1	-22438	Not Applicable	0	277	TCGA-5X-AA5U-D68523;TCGA-5X-AA5U-D69109;TCGA-5X-AA5U-D69110	BCE4C9F7-2318-4C8B-8545-9F0283051595;22AB155E-AD49-40BF-BE96-92E5512C3A5C;75E7835F-DABB-414B-939A-450620B2352C	Not Available;Not Available;Not Available	24;29;29	178;178;178	66;63;63	Taxotere;Cisplatin;Carboplatin	Complete Response;Complete Response;Complete Response	11;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	2014;2014;2014	0	Not Evaluated	TCGA-5X-AA5U-F69358	9DD9459C-FB46-4499-8C14-14E222B1DDFD	7	Not Applicable	361	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	1									NO	Not Available	Not Available	YES	Complete Remission/Response	NO	Alive	2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Not Applicable	Tumor resection	Not Evaluated	100	NO	10	GX									NO	Yes, History of Synchronous/Bilateral Malignancy	AA5U	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			R0	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	YES	NO	5X	Not Available	Ovary	NO	Alive	2014	2013
TCGA-25-1319	73	FEMALE	1977	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	730.0		Recurrence	Not Available		73	Bilateral	TCGA-25-1319	914d8613-3c25-4a10-be50-28b42f4d3a5d	27	-26786	1977	0	1977	TCGA-25-1319-D26662;TCGA-25-1319-D26661	994fc650-88ad-49bc-83d0-b2f707ef5859;c61612c2-a456-4253-97b0-a3354dfbd96a	Not Available;Not Available	27;27	Not Available;Not Available	61;61	Taxol;Carbo	Not Available;Not Available	3;3	6;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1319-F26660	760f24c1-7601-415f-8c8f-79778d72eea4	27	1977	1977	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	730	Recurrence	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1319	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	11-20 mm	Ovary	Not Available	Dead	2009	2000
TCGA-24-2023	54	FEMALE	1364	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIA	G3	1	1069.0		Recurrence	WITH TUMOR		54	Bilateral	TCGA-24-2023	5201ee13-2aed-4641-9169-4d5ee07a23da	16	-19901	1364	0	1364	TCGA-24-2023-D26444;TCGA-24-2023-D26446;TCGA-24-2023-D26447;TCGA-24-2023-D26445;TCGA-24-2023-D26443;TCGA-24-2023-D26448	723fff60-9a4d-4926-9ddc-5c109565804f;16528892-89f9-4770-a7b5-a9fa9bde5046;b78b10cb-7049-4c3c-b560-95defbc79e0a;e8d6fbd5-5369-4e58-8efe-8b2f82ce54d6;e6e1767b-c704-4c4c-a6fa-108c9024c4a7;6037de33-2474-48a3-bb85-c4f84c3f0f75	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16;16	214;502;1245;502;214;1245	6;273;1126;273;6;1126	Taxol;Cytoxan;Taxol;Cisplatin;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	08;08;06;08;08;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2151;3000;2100;450;5775;2740	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2023-F26442	478e3654-2c9e-4ee7-b80d-d63e0a5c5ebe	16	1364	1364	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	1069	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2023	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	1994
TCGA-61-2104	53	FEMALE	2338	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G2	1	1680.0		Recurrence	Not Available		53	Bilateral	TCGA-61-2104	05263959-c4f5-4540-b6d2-d8c8a128861f	7	-19432	Not Applicable	0	2338	TCGA-61-2104-D28447;TCGA-61-2104-D28446;TCGA-61-2104-D28445;TCGA-61-2104-D28444;TCGA-61-2104-D28448;TCGA-61-2104-D28443	172b7324-19f1-4c6a-9b48-f25584cfe417;32cf4d72-b8d4-4a25-99aa-7918878ab0d8;bc697473-6eba-4dfb-8a1c-4a4b60daa0d1;6d9216c8-daf8-4211-927c-874a245d8a96;a1b6da11-0c8e-4f50-bdd0-5590dcf6b817;16e277f4-06cf-4d80-8c70-a07667591497	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7	1681;Not Available;Not Available;Not Available;2338;Not Available	1680;1197;1197;6;1838;6	Cisplatin;Taxol;Carboplatin;Taxol;Taxane;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12	01;Not Available;Not Available;06;Not Available;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available;Not Available;Not Available	RECURRENCE;ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IP;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	200;Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-61-2104-F28442	02ac5e72-78e8-458e-9966-f78a3fb86f69	7	Not Applicable	2338	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES;YES	NO;NO	Not Available;1680	1680;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	Not Available	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	12	G2									Not Available	Not Available	2104	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	NO	Alive	2009	2003
TCGA-29-2432	61	FEMALE	653	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	174.0		Recurrence	WITH TUMOR		61	Bilateral	TCGA-29-2432	0e6c9433-289c-4744-a0c1-47ec67774047	4	-22605	653	0	360	TCGA-29-2432-D27494;TCGA-29-2432-D27493;TCGA-29-2432-D27495	ec863682-01e3-4e42-b640-495a71b085bc;d5720bb9-fbde-4f8d-a0b5-7bb82df87ce2;cebea2c3-9245-4c77-b299-33df263ad6d7	Not Available;Not Available;Not Available	4;4;4	157;157;157	14;14;38	Paclitaxel;Carboplatin;Bevacizumab	Not Available;Not Available;Not Available	6;6;6	06;06;Not Available	303;540;1010	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;PO	NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	1809;3150;Not Available	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	TCGA-29-2432-F27492	5b747676-eca5-410c-8d08-36ff1266ba07	4	653	360	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	174	Recurrence	Not Available	Not Available	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	2432	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	11-20 mm	Ovary	Not Available	Dead	2010	2008
TCGA-13-0912	58	FEMALE	1145	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	469.0		Recurrence	WITH TUMOR		58	Bilateral	TCGA-13-0912	58d34254-4f5b-40a4-9e9f-7160062fb2a4	25	-21427	Not Applicable	0	1036	TCGA-13-0912-D24756;TCGA-13-0912-D24755;TCGA-13-0912-D24754	f039ec8f-f07a-4b69-9b57-674eb3fe8816;60f29631-b790-49a0-92f3-2834f89bfbc7;12cfb557-540b-425c-a068-9897165c526a	Not Available;Not Available;Not Available	15;15;15	147;147;147	35;35;35	Paclitaxel;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available	4;4;4	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IV	Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	60;135;75	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0912-F24753;TCGA-13-0912-F72629	8236ba4d-8089-40c1-93ae-156ca8543db8;816DBA8B-D1AD-4222-A4F9-E2D1DA18938B	25;30	Not Applicable;1145	1036;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	469;469	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	80	Not Available	2	G3									Not Available	Not Available	0912	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2006
TCGA-20-1682	56	FEMALE	837	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	GX	0	837			TUMOR FREE		56	Bilateral	TCGA-20-1682	94bd4c68-4bfc-4db3-9365-97c867747133	2	-20583	Not Applicable	0	837	TCGA-20-1682-D25541;TCGA-20-1682-D25542	f9a9b49a-eefa-4274-b8b0-542674f06e3e;6817b450-bd86-4a72-a6f2-d2ebbc268095	Not Available;Not Available	27;27	145;145	40;40	Taxol;Carboplatin	Not Available;Not Available	7;7	06;06	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;6	mg/m2;Not Available	Not Available;Not Available	2009;2009	0	NOT HISPANIC OR LATINO	TCGA-20-1682-F25540	c82c3d5f-bdba-4a46-bfd1-92e930c8674b	2	Not Applicable	837	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	GX									Not Available	Not Available	1682	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	11-20 mm	Ovary	YES	Alive	2009	2007
TCGA-13-2061	58	FEMALE	2339	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	2339			TUMOR FREE		58	Bilateral	TCGA-13-2061	a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3	1	-21543	Not Applicable	0	328	TCGA-13-2061-D25007;TCGA-13-2061-D25009;TCGA-13-2061-D25010;TCGA-13-2061-D25005;TCGA-13-2061-D25004;TCGA-13-2061-D25008;TCGA-13-2061-D25011;TCGA-13-2061-D25006	ee41741e-220a-4998-a17d-e0b871f7eb88;24744559-e344-4016-8695-c4b55f3cd1cb;929e7c01-97cc-47d1-bcf0-6b3f02535241;df08b0fe-5176-4c16-80b1-2f2f54bbfe8e;99777074-d6b2-4ece-ae49-81c07c9a25aa;12097149-87dd-4fa1-8f0d-5088a4c8062a;ba1d69c2-a882-4e82-b282-25f168fbcdf9;728138db-9e40-4995-af75-4b90bfd5d6a7	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1;1;1;1;1;1;1;1	133;133;168;112;112;133;168;112	126;126;147;63;63;126;147;63	Carboplatin;Paclitaxel;Carboplatin;Paclitaxel;Cisplatin;Paclitaxel;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2;2	1;1;2;3;3;1;2;3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	AUC;mg/m2;Not Available;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IP;IP;IV;IV;IP;IV;IV;IP	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	AUC;mg/m2;Not Available;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-2061-F25003;TCGA-13-2061-F72686	ee9b0f94-0f32-4777-ba2e-56f6abd2c7bb;F556FD4C-0279-488E-A662-D6F0E94E2DAA	1;31	Not Applicable;Not Applicable	328;2339	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	80;Not Available	Not Available;Not Available	2;7									Not Available;NO	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2010;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	2	G3									Not Available	Not Available	2061	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2010	2009
TCGA-36-1576	76	FEMALE	915	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	817.0		Recurrence	WITH TUMOR		76	Not Available	TCGA-36-1576	3445c524-5a37-40b6-8614-956d76eed939	2	-27778	Not Applicable	0	915	TCGA-36-1576-D27876;TCGA-36-1576-D27875	0dad68a9-7536-434e-9a5c-be93632dbd1b;80ba7cc4-fcbf-4b2d-9604-42e785b2d9ec	Not Available;Not Available	15;15	222;222	12;12	Paclitaxel;Carboplatin	Not Available;Not Available	1;1	08;08	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	2528;3648	mg;mg	Not Available;Not Available	2010;2010	2	Not Available	TCGA-36-1576-F27874	606c8ee1-145a-4a52-85af-906e692faaba	2	Not Applicable	915	2	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	817	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1576	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	YES	Alive	2009	2006
TCGA-61-1727	74	FEMALE	564	Serous Cystadenocarcinoma	Ovary	Alive	Stage IC	G3	0	564			TUMOR FREE		74	Right	TCGA-61-1727	99407c1d-40b5-4ded-ba29-1e40dfd65be4	2	-27203	Not Applicable	0	564	TCGA-61-1727-D28153;TCGA-61-1727-D28154	5b0e1651-62e8-40b8-8bd2-0b31b786ad3d;131ac56b-194e-470a-b9b1-98791766dc47	Not Available;Not Available	4;4	153;153	62;62	Taxotere;Carboplatin	Not Available;Not Available	12;12	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	600;2250	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1727-F28152	4604d1b5-1dbc-456f-9c29-2deabd74636e	2	Not Applicable	564	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1727	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	NO	Alive	2009	2007
TCGA-13-0793	40	FEMALE	3263	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	1	351.0		Recurrence	WITH TUMOR		40	Left	TCGA-13-0793	5e90e1ed-cbfd-44ba-a6ff-63ff576b3c73	24	-14708	Not Applicable	0	873	TCGA-13-0793-D24596;TCGA-13-0793-D24595;TCGA-13-0793-D24594	3a56ec6c-8b7f-482d-b6b0-4d64e56a91e4;12f8b3a0-deed-409d-8434-0c0a13501dc7;75b465bb-15eb-4d7f-8398-3c39d9ada2c0	Not Available;Not Available;Not Available	15;15;15	362;159;159	200;47;47	Abagovomab or Placebo;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available	4;4;4	Not Available;6;6	Not Available;Not Available;Not Available	mg;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;IV;IV	Not Available;NO;Not Available	Immunotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	2;175;Not Available	mg;mg/m2;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0793-F24593;TCGA-13-0793-F72606	a19d6f1b-9782-4721-89d1-65d0aaf06ea7;6871EB4A-AD29-4467-88E6-14031C7FFCA6	24;30	Not Applicable;Not Applicable	873;3263	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	351;351	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0793	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2006
TCGA-25-1323	72	FEMALE	395	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	365.0		Progression of Disease	WITH TUMOR		72	Bilateral	TCGA-25-1323	2ee36d9d-128b-4761-aa1a-a637da106f3d	27	-26602	395	0	365	TCGA-25-1323-D26681;TCGA-25-1323-D26683;TCGA-25-1323-D26682	5457762b-8086-46df-b0f1-b18019f572b8;8f1e9ed6-2060-4f4b-a9db-76db4190ce6a;bfd7343e-9a15-493c-9b9d-0895f18fde09	Not Available;Not Available;Not Available	27;27;27	365;122;122	365;30;30	Doxil;Carbo;Taxol	Not Available;Not Available;Not Available	3;3;3	2;5;5	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	Not Available;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1323-F26680	7dca5a46-41d3-4c92-bfbc-ff6a771731a1	27	395	365	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	365	Progression of Disease	Not Available	Physical Examination	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1323	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-13-0795	66	FEMALE	619	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	325.0		Recurrence	WITH TUMOR		66	Bilateral	TCGA-13-0795	b1e11e94-646b-4c44-9d33-1ca67d8356fb	25	-24403	Not Applicable	0	596	TCGA-13-0795-D24603;TCGA-13-0795-D24604	a99e93f3-ba26-4014-bbbc-3504115a7f8c;422f22dc-5eed-420f-a1bb-c308c2a9f817	Not Available;Not Available	16;16	205;205	101;101	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	6;6	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	6;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0795-F24602;TCGA-13-0795-F72608	ca8e4422-c168-479c-a85b-b3b7807d6443;F569C20E-01C7-4884-8A74-19018019DF5B	25;30	Not Applicable;619	596;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	325;325	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	80	Not Available	2	G3									Not Available	Not Available	0795	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Alive	2009	2007
TCGA-13-0924	45	FEMALE	2614	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	1	962.0			TUMOR FREE		45	Bilateral	TCGA-13-0924	fbb45305-de8d-4baf-8bd0-047b29c2e9d9	25	-16670	Not Applicable	0	185	TCGA-13-0924-D24790;TCGA-13-0924-D24789;TCGA-13-0924-D24788;TCGA-13-0924-D24791	1d2653d7-cad8-4cba-805f-3b87337a64ed;93dd4066-d984-4869-acfe-682e0aa79846;2b11dd9d-5b35-4573-8f46-fb5d477ef580;b2c02e5d-3faf-4541-9a7b-a92e1694a52e	Not Available;Not Available;Not Available;Not Available	16;16;16;16	143;143;143;213	60;38;38;164	Bevacizumab or Placebo;Paclitaxel;Carboplatin;Bevacizumab or placebo	Not Available;Not Available;Not Available;Not Available	4;4;4;4	Not Available;6;6;Not Available	Not Available;Not Available;Not Available;Not Available	mg;mg/m2;Not Available;mg/kg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;IV;IV;Not Available	Not Available;Not Available;Not Available;Not Available	Targeted Molecular therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	920;175;Not Available;15	mg;mg/m2;Not Available;mg/kg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0924-F24787;TCGA-13-0924-F72636	fae23792-aeda-4037-82cf-b8d048036938;4D3711CA-5188-4A7C-81E5-101087686659	25;30	Not Applicable;Not Applicable	185;2614	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	Not Available;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;962	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	ASHKENAZI	Not Available	Not Available	2	G3									Not Available	Not Available	0924	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-09-1664	37	FEMALE	2279	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G1	0	2279			Not Available		37	Bilateral	TCGA-09-1664	3438c018-9856-4628-ae59-7d365713647f	2	-13739	2279	0	Not Available	TCGA-09-1664-D24269;TCGA-09-1664-D24270	c82effc8-6fc1-410b-8c82-5aeaf9c1a564;5c586019-e92b-4f51-ad6c-5eb9366488d5	Not Available;Not Available	4;4	139;139	15;15	Taxotere;Carboplatin	Not Available;Not Available	9;9	6;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	70;6	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1664-F24268	c96ac4bb-27ed-4e18-8939-9b1cfc8ead4d	2	2279	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G1									Not Available	Not Available	1664	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	1-10 mm	Ovary	NO	Dead	2009	2002
TCGA-13-1497	47	FEMALE	3871	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	813.0		Recurrence	WITH TUMOR		47	Not Available	TCGA-13-1497	bc4bc342-20bf-40c3-af26-2c6f942da93d	31	-17528	Not Applicable	0	1652	TCGA-13-1497-D24911;TCGA-13-1497-D24910;TCGA-13-1497-D24909;TCGA-13-1497-D24912	2bd40f8d-6333-4afe-a21c-f54e28cd9a14;61d36d63-ca80-4df2-8f45-5b89934ca979;05f16e3d-5c91-4368-8769-2b40f285d9ff;96fed8b4-c5f5-4ca0-95c4-183c1c2de11b	Not Available;Not Available;Not Available;Not Available	29;29;29;29	185;127;127;71	185;22;22;22	Cisplatin;Paclitaxel;Carboplatin;Cetuximab	Not Available;Not Available;Not Available;Not Available	6;6;6;6	1;6;6;Not Available	Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IV;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available	75;175;6;250	mg/m2;mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1497-F24908;TCGA-13-1497-F72646	d8a1710d-bba3-4b22-9c76-124568b7b543;69B1CFE7-AD47-4110-B2AC-26D7EB98133D	31;31	Not Applicable;Not Applicable	1652;3871	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	80;Not Available	Not Available;Not Available	3;7	YES;YES;Not Available	NO;NO;Not Available	Not Available;861;Not Available	813;Not Available;813	Recurrence;Metastatic;Unknown	Not Available;YES;Not Available	Imaging Study;Imaging Study;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	3	G3									Not Available	Not Available	1497	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2004
TCGA-36-1574	48	FEMALE	686	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	648.0		Recurrence	WITH TUMOR		48	Bilateral	TCGA-36-1574	eeb9d147-608d-4692-8adf-2f601d23a8ff	2	-17847	Not Applicable	0	686	TCGA-36-1574-D27869;TCGA-36-1574-D27870	6eb02c37-b4e7-4e56-9f69-931e6671a4bb;b60340a0-dad8-46b3-93d0-e6f6518416c5	Not Available;Not Available	15;15	204;204	15;15	Carboplatin;Paclitaxel	Not Available;Not Available	1;1	08;08	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	0	Not Available	TCGA-36-1574-F27868	a362d009-06b1-4ec1-a13b-762036f060a8	2	Not Applicable	686	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	648	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1574	Preoperative	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	Not Available	Alive	2009	2007
TCGA-13-0899	60	FEMALE	2012	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	547.0		Recurrence	WITH TUMOR		60	Bilateral	TCGA-13-0899	5c6f3cd4-19c5-418d-b1be-d3fbf63e99db	25	-22031	Not Applicable	0	1708	TCGA-13-0899-D24706;TCGA-13-0899-D24705	f1500cb6-1acc-4eba-a03d-bdf3b9327360;24164473-0e73-4062-bf9b-dc624f95510a	Not Available;Not Available	15;15	126;126	16;16	Paclitaxel;Carboplatin	Not Available;Not Available	4;4	6;6	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1050;Not Available	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0899-F24704;TCGA-13-0899-F72623	fd6b2332-5712-4df7-bf7b-366934559985;9493D064-5F49-4972-9EA8-DE6E0586C7B3	25;30	Not Applicable;2012	1708;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	547;547	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0899	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2004
TCGA-13-1404	48	FEMALE	2469	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1581.0			TUMOR FREE		48	Bilateral	TCGA-13-1404	8e107f4b-1912-4d3e-814a-b863e2d65ed7	20	-17784	Not Applicable	0	201	TCGA-13-1404-D24800;TCGA-13-1404-D24799;TCGA-13-1404-D24801	62d968f7-b34f-48cd-a123-77d8acab6661;8596919f-9468-4131-9aa4-a6f21e70cebf;2e7b6ee1-77d0-40f3-b598-8959537575bb	Not Available;Not Available;Not Available	30;30;30	274;156;156	232;50;50	Cisplatin;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available	6;6;6	3;6;6	Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;6;175	mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1404-F24798;TCGA-13-1404-F72655	b605a929-f33e-4bfa-98c1-3bd3d2ce980a;1C83E71D-3642-48B3-86EF-26A2BBAFC624	20;31	Not Applicable;Not Applicable	201;2469	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;1581	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	60	Not Available	3	G3									Not Available	Not Available	1404	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-61-1903	55	FEMALE	396	Serous Cystadenocarcinoma	Ovary	Alive	Stage IB	G3	0	396			TUMOR FREE		55	Bilateral	TCGA-61-1903	b3df9c0a-420c-4cc2-a3e0-56df1ed7e997	1	-20381	Not Applicable	0	396	TCGA-61-1903-D28234;TCGA-61-1903-D28232;TCGA-61-1903-D28233	438d748a-9cd1-4c10-8e86-c856d91b1b2b;a528c65e-1612-4b37-ae33-ae6ecab7b7e1;d44ae97c-2ba5-4224-bb8e-a2b0df6b511a	Not Available;Not Available;Not Available	4;4;4	147;147;147	32;32;32	Taxol;Cisplatin;Taxol	Not Available;Not Available;Not Available	12;12;12	06;06;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	412;560;120	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-61-1903-F28231	28eb5a27-818e-40de-8c31-7bc1d2bdb26a	1	Not Applicable	396	Not Available	Not Available	Not Available	Not Available	Not Available	10									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	10	G3									Not Available	Not Available	1903	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	NO	Alive	2009	2007
TCGA-30-1853	58	FEMALE	1103	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	634.0		Recurrence	WITH TUMOR		58	Bilateral	TCGA-30-1853	5d603bba-62e6-48fb-b8fc-401109abcaee	2	-21404	1103	0	1103	TCGA-30-1853-D27543;TCGA-30-1853-D27544;TCGA-30-1853-D27546;TCGA-30-1853-D27548;TCGA-30-1853-D27545;TCGA-30-1853-D27547	8a8fea1c-af3d-4d12-abe1-1732158991df;02e54e5c-6ffc-4742-92ba-1de798919bf9;d1cdcf9f-1d4f-495b-9ca3-3f1820988c17;87eb4360-2370-42e4-9920-32b4be6791ba;23159ed1-9189-4f06-bf1f-100d10cfbf8b;aee7c046-3c2e-4a58-80b4-4b642c08a7e9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28	778;126;778;1011;126;932	669;42;669;950;42;886	Carboplatin;Carboplatin;Taxol;Doxil;Taxol;Trabectedin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12	06;06;06;Not Available;06;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	AUC;AUC;mg/m2;mg/m2;mg/m2;mg/m2	RECURRENCE;ADJUVANT;RECURRENCE;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;175;40;175;580	AUC;AUC;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1853-F27542	333dfd72-26d5-496a-bcc6-c256a5360b5c	2	1103	1103	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;654	634;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1853	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-24-1469	71	FEMALE	277	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	277			TUMOR FREE		71	Right	TCGA-24-1469	cd6e5d3d-1c86-40dd-9cb3-b2e2075dec56	13	-25937	Not Applicable	0	277	TCGA-24-1469-D26062;TCGA-24-1469-D26061	8b7e3c93-43ce-4a4c-88e0-eebfe8e5373a;0669881e-ea31-48f5-a8fb-5f91b62e6e9c	Not Available;Not Available	13;13	135;135	Not Available;Not Available	Taxol;Carboplatin	Not Available;Not Available	5;5	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-24-1469-F26060	a5d9372b-c1cc-4361-84ee-e8d6dd21dcfb	13	Not Applicable	277	Not Available	Not Available	Not Available	Not Available	Not Available	5									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1469	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-04-1646	60	FEMALE	848	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	508.0		Recurrence	WITH TUMOR		60	Bilateral	TCGA-04-1646	d38ca631-ed5c-4182-a647-625060726fa7	2	-22207	848	0	Not Available	TCGA-04-1646-D24153;TCGA-04-1646-D24157;TCGA-04-1646-D24155;TCGA-04-1646-D24156;TCGA-04-1646-D24154	d6ee5514-3071-4e54-a301-10301dbdb0dd;6d910b78-da27-4662-a1be-49ce6a177002;9e09e80f-02fb-4097-be1a-c9bfadf68c36;609ef3ee-d20e-4681-be55-2fdaa9070a04;74086d54-72be-400c-b01d-a365f36d5674	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9	239;Not Available;239;Not Available;239	18;522;18;522;18	Gemcitibine;Topotecan;Taxol;Doxil;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	08;Not Available;08;Not Available;08	Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;mg;Not Available;mg	ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT	Not Applicable;Unknown;Not Applicable;Unknown;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;Not Available;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	8188;Not Available;1504;Not Available;4709	mg;Not Available;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	0	Not Available	TCGA-04-1646-F24152	6e0aedca-a9c4-4ced-be43-52fde9e4c113	2	848	Not Available	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	508	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1646	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-61-1900	51	FEMALE	176	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	0	176			TUMOR FREE		51	Bilateral	TCGA-61-1900	ef653772-e5d2-46ec-8610-f81d75d7353c	1	-18963	Not Applicable	0	176	TCGA-61-1900-D28224;TCGA-61-1900-D28223;TCGA-61-1900-D28222	ee2b9e79-59a9-465a-bef5-7c013a3693c7;ab4e8e00-7f0c-4de9-96bb-e60b0987d787;abc2cd6c-fb56-402d-b274-676c502e0ea5	Not Available;Not Available;Not Available	4;4;4	76;76;76	35;35;35	Taxol;Cisplatin;Taxol	Not Available;Not Available;Not Available	12;12;12	02;02;02	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;135;250	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1900-F28221	8b7bebba-673b-4d44-b33d-6a5d7409982f	1	Not Applicable	176	Not Available	Not Available	Not Available	Not Available	Not Available	10									Not Available	Not Available	TUMOR FREE	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	NO	10	G3									Not Available	Not Available	1900	Not Available	TUMOR FREE	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	NO	Alive	2009	2008
TCGA-29-1701	56	FEMALE	515	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	298.0		Recurrence	WITH TUMOR		56	Bilateral	TCGA-29-1701	86b513ba-df09-485d-92d4-fb9e888f7350	2	-20737	515	0	514	TCGA-29-1701-D27245;TCGA-29-1701-D27244;TCGA-29-1701-D27246;TCGA-29-1701-D27247	8a9dbe36-b51f-41ec-a7f0-2cd48435ff0e;3afc4585-7d77-43be-9d92-ae8b9b0b2bbf;80f36875-2327-4911-af6e-4d9c45dbafc4;2cc1b601-8961-400e-906f-a8d1ec418ba8	Not Available;Not Available;Not Available;Not Available	10;10;21;21	160;160;381;472	31;31;318;409	Carboplatin;Paclitaxel;Doxil;Carboplatin	Not Available;Not Available;Not Available;Not Available	12;12;4;4	05;05;03;03	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;AUC	ADJUVANT;ADJUVANT;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	4505;1280;75;6	mg;mg;mg;AUC	Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010	1	Not Available	TCGA-29-1701-F27243	54915dda-c60b-4540-8ba8-7325a9fe50c7	2	515	514	1	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	298	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	NO	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1701	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	Not Available	Ovary	YES	Dead	2009	2004
TCGA-24-1567	54	FEMALE	524	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G3	1	319.0		Recurrence	WITH TUMOR		54	Bilateral	TCGA-24-1567	2cb50c2d-e749-4172-b101-d975507435c5	2	-19843	524	0	524	TCGA-24-1567-D26281;TCGA-24-1567-D26282;TCGA-24-1567-D26280	f43d1ffa-d988-4cc3-acfd-7e4947d8ced1;31ebe1d0-b99f-4a7e-8abb-aa91ab2aec48;37c78ac7-dfc0-49fd-903a-05a2a8300aef	Not Available;Not Available;Not Available	24;24;24	153;Not Available;153	41;Discrepancy;41	Carboplatin;Topecan;Taxol	Not Available;Not Available;Not Available	7;7;7	6;Not Available;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1567-F26279	282f1e10-3acf-4ade-bf0f-83cf6b487059	2	524	524	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	319	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1567	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-09-1662	58	FEMALE	2717	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	1046.0		Recurrence	WITH TUMOR		58	Left	TCGA-09-1662	867f9563-16c9-45a8-b519-6df61ba1b6b7	2	-21246	2717	0	Not Available	TCGA-09-1662-D24257;TCGA-09-1662-D24255;TCGA-09-1662-D24248;TCGA-09-1662-D24253;TCGA-09-1662-D24258;TCGA-09-1662-D24249;TCGA-09-1662-D24252;TCGA-09-1662-D24251;TCGA-09-1662-D24260;TCGA-09-1662-D24261;TCGA-09-1662-D24245;TCGA-09-1662-D24250;TCGA-09-1662-D24247;TCGA-09-1662-D24259;TCGA-09-1662-D24263;TCGA-09-1662-D24266;TCGA-09-1662-D24264;TCGA-09-1662-D24265;TCGA-09-1662-D24256;TCGA-09-1662-D24246;TCGA-09-1662-D24262;TCGA-09-1662-D24254;TCGA-09-1662-D24244	93e131ee-3380-4200-9ca5-10131c10abd1;7bf5f35f-f997-4287-83d2-d5da4cbd556a;cc5ab7ed-36cd-4a9f-ba48-c87a1b240f45;a397d96b-fb24-4610-8181-c118d12f2166;f4b7d2bb-c87b-49eb-a81a-6cbe1bd786a3;588fd714-20ca-4600-90be-76b54f2c0ef8;c0a0b2df-b4d4-41ae-9463-423066932bf7;1f1c006f-2912-44a7-ba4e-034e98c93d89;7631cb67-7111-4c19-8711-ccc70c4fc2c4;d6211b06-5b18-4f9e-851d-53c7a86bc37d;e1273eb6-bb20-46c9-9bb2-cc41b942d77c;31879e3c-bfe5-4c2f-955d-f4e7af0fbdfb;dc5a3d32-2094-4917-8a07-9bbfa17045f5;692318d5-4cc3-48f4-8464-e4debb508e72;1b5d2909-0c97-4346-a6ad-8b64797214eb;4c9e6e33-7a19-48a4-85ca-dcccef13eba1;c53df0bc-2ac3-472e-9241-c6c1790d02cb;de3b0446-d6ae-4fee-ad51-8c322e73ee15;1161bec0-3bbb-49c2-88af-0a7123eb3c6a;678644d3-1d86-43d5-828b-5ff5529a97d5;203a528e-89f3-4e4f-bf39-ef1ad477079b;fb873564-df62-4403-9335-80c56c7b00f9;f41683e3-2b52-4a8f-a371-5830f1687c3a	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5	2461;2399;1233;1968;2602;1233;1968;1732;2650;2537;15;1732;141;2623;2697;2650;Not Available;2517;2650;15;2697;2052;141	2457;2073;1128;1947;2482;1128;1947;1590;2623;2530;15;1590;32;2608;2684;2566;1926;2503;2426;15;2684;1989;32	Topotecan;Doxil;Carboplatin;Taxotere;Toptecan;Taxotere;Carboplatin;Taxotere;Topotecan;Gemzar;Carboplatin;Carboplatin;Gemzar;Toptecan;Gemzar;Avastin;Armidex;Avastin;Topotecan;Taxol;Cisplatin;Taxotere;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8;8	9;12;6;2;9;6;2;9;9;2;1;9;6;9;3;Not Available;Not Available;Not Available;9;1;3;6;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;Not Available;mg/m2;mg/m2;mg/m2;mg;mg/m2;mg/m2;Not Available;Not Available;Not Available;mg/m2;mg/m2;mg;mg/kg;mg;mg/kg;mg/m2;mg/m2;mg;mg;mg/m2	PROGRESSION;RECURRENCE;RECURRENCE;RECURRENCE;PROGRESSION;RECURRENCE;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;Not Available;Not Available;Not Available;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Hormone Therapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;40;5;98;4;60;390;60;4;Not Available;6;5;600;2;954;10;1;10;2;175;47;100;75	mg/m2;mg/m2;Not Available;mg/m2;mg/m2;mg/m2;mg;mg/m2;mg/m2;Not Available;Not Available;Not Available;mg/m2;mg/m2;mg;mg/kg;mg;mg/kg;mg/m2;mg/m2;mg;mg;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1662-F24243	0b2f4ddb-fa9e-45ec-97ab-a8fc3d0f4be8	2	2717	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;1081	1046;Not Available	Recurrence;Both Locoregional and Distant Metastasis	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1662	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	1-10 mm	Ovary	YES	Dead	2009	2001
TCGA-24-1562	67	FEMALE	1384	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	229.0		Recurrence	WITH TUMOR		67	Bilateral	TCGA-24-1562	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	13	-24747	1384	0	1384	TCGA-24-1562-D26242;TCGA-24-1562-D26246;TCGA-24-1562-D26241;TCGA-24-1562-D26244;TCGA-24-1562-D26243;TCGA-24-1562-D26245;TCGA-24-1562-D26239;TCGA-24-1562-D26238;TCGA-24-1562-D26240	ee1fa917-d739-42c0-a6a9-ed708dfb432d;9953bd31-98a7-4304-9edc-fd8d0a59cea7;983f19e8-c170-4e8c-a957-2fd3136788b3;bdfeb5b7-63f2-4a09-ac87-33fa567a3c19;4b34bcc3-f52f-492f-9ba7-1937763104e1;b7064ebb-533d-4713-9120-c9eb84ab6ce2;0334ce07-bbcf-45f3-bfca-861ce3612e89;a426f399-4902-40c8-b6d3-f24a234dac4e;108a7baa-7cfc-4e5f-b5a3-fd69f3093a19	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;13;13	Not Available;1157;Not Available;Not Available;642;Not Available;152;152;405	848;Not Available;848;677;531;677;21;21;257	Taxol;Taxol;Carboplatin;Carboplatin;Doxil;Taxol;Taxol;Cisplatin;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5	01;10;01;Not Available;05;Not Available;06;06;08	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;mg;Not Available;Not Available;Not Available;Not Available	RECURRENCE;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;Not Available	NO;NO;Not Available;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;375;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;mg;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-24-1562-F26237	28786767-c3fa-429e-a296-8677b91c77fe	13	1384	1384	0	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	229	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1562	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-23-1023	65	FEMALE	1233	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	490.0		Recurrence	WITH TUMOR		65	Right	TCGA-23-1023	9e18238f-ae85-4b75-ae87-d92da9731a40	23	-23826	Not Applicable	0	1233	TCGA-23-1023-D25589;TCGA-23-1023-D25591;TCGA-23-1023-D25588;TCGA-23-1023-D25590;TCGA-23-1023-D25592;TCGA-23-1023-D25596;TCGA-23-1023-D25594;TCGA-23-1023-D25599;TCGA-23-1023-D25601;TCGA-23-1023-D25602;TCGA-23-1023-D25593;TCGA-23-1023-D25598;TCGA-23-1023-D25595;TCGA-23-1023-D25597;TCGA-23-1023-D25600	de887de7-b839-47a9-8ed7-e5edd06adf99;4c3c5329-14f8-452b-a67e-9fee4792426e;719d9c8c-f6ea-48b1-8f10-6c8c8931e44d;adcca623-3353-4ce2-9458-70cf557d250f;2ff9ec4a-25a5-4e13-855b-28beb08405c6;1245e6b4-623f-4373-837a-30b186dd53e6;401feab7-c57d-45b1-97e3-c8c0809643b4;1038377c-956a-4017-bf37-e559748251c8;b43cacae-9796-4b39-aa27-28671ff77f47;011de666-fcd8-42fc-9990-b3f6da3c087f;5f56f9d2-2a3c-4f5e-a512-7e633a7f29e7;5caf6ccc-58cf-4133-8594-9687bcbe0cac;324ff779-6c57-4e1f-adf7-34b7d3bd72e8;5005f67e-ca1d-4c05-baf1-36cff1fd4a1d;45e660fe-4782-4a00-b0f5-2ff47a27a7b2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;26;26;26;26;26;26;26;26;26;26;26	1603;1407;1455;1364;120;609;1455;560;468;1665;120;509;609;509;560	1582;1386;1427;1272;29;557;1427;539;155;1616;29;509;557;509;539	Cisplatin;Carboplatin;Cisplatin;Doxil;Carboplatin;Cisplatin;Cisplatin;Gemcitabine;Ovarex/Placebo;Topotecan;Paclitaxel;Cisplatin;Gemcitabine;Gemcitabine;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;4;4;4;4;4;4;4;4;4;4;4	02;02;02;04;05;05;02;03;06;04;05;01;05;01;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;RECURRENCE;ADJUVANT;RECURRENCE;OTHER, SPECIFY IN NOTES;RECURRENCE;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Persistent;Persistent;Not Applicable;Not Applicable;Not Applicable;Persistant;Not Applicable;Not Applicable;Persistant;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IP;IV;IV;IP;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	198;1100;120;300;2021;369;120;4860;12;23.6;1492;195;7800;1560;640	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1023-F25587	a457d6c8-d9cb-4d35-8e5c-54d0ef69de98	23	Not Applicable	1233	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	NO;NO	Not Available;1209	490;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Other Method;Other Method	Colonoscopy;Colonoscopy	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1023	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	YES	Alive	2009	2005
TCGA-09-0366	55	FEMALE	1757	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	190.0		Recurrence	WITH TUMOR		55	Bilateral	TCGA-09-0366	23771dab-2aab-4d2b-95e2-9af7092cee6b	4	-20440	1757	0	Not Available	TCGA-09-0366-D24209;TCGA-09-0366-D24208;TCGA-09-0366-D24210	ac21dd09-cdc4-45dd-bf7e-3ae965e1d90b;6c5228bf-8c8a-4919-8775-626e30a7370e;b0230f3d-a6f8-4e55-a04e-d6d0d37c99e4	Not Available;Not Available;Not Available	27;27;27	113;113;288	5;5;225	taxol;Carbo;topotecan	Not Available;Not Available;Not Available	3;3;3	6;6;4	Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	135;Not Available;1.5	mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-09-0366-F24207	06ba5b59-0675-4fde-a4aa-237171de4442	4	1757	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES;YES	NO;NO	Not Available;190	190;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8441/3	C48.1	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G3									Not Available	Not Available	0366	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	1-10 mm	Ovary	NO	Dead	2009	1999
TCGA-29-2433	61	FEMALE	620	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	620			TUMOR FREE		61	Bilateral	TCGA-29-2433	fd806e1d-b5ea-4556-9b12-5254fd9f00a2	4	-22315	Not Applicable	0	620	TCGA-29-2433-D27502;TCGA-29-2433-D27499;TCGA-29-2433-D27500;TCGA-29-2433-D27501;TCGA-29-2433-D27498;TCGA-29-2433-D27503	e13efaba-05ce-4654-aeba-b4a2ec4de5f9;fd6d33a9-4c41-4913-8419-21223bb1d0fd;6c774a12-0b32-4828-af0e-0361420497ac;02db8301-db04-448c-8746-b7444a422db3;2e115b5c-8485-45e4-8df9-75e36bafe736;d4f86338-7a09-4c77-a277-30cd5198568f	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;11	137;14;67;67;14;137	94;14;42;42;14;94	Docetaxel;Paclitaxel;Carboplatin;Paclitaxel;Cisplatinum;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;6;6	03;1;2;2;1;3	100;Not Available;540;175;Not Available;450	mg;Not Available;mg;mg;Not Available;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IP;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	300;Not Available;1040;280;Not Available;1350	mg;Not Available;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-29-2433-F27497	32b8eb59-b260-4b31-bd88-743cd3f87230	4	Not Applicable	620	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	2433	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	No Macroscopic disease	Ovary	Not Available	Alive	2010	2008
TCGA-36-1571	53	FEMALE	695	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G3	1	375.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-36-1571	12581634-eebb-4841-8498-71dc9d78c546	2	-19608	695	0	695	TCGA-36-1571-D27864;TCGA-36-1571-D27865;TCGA-36-1571-D27863;TCGA-36-1571-D27866	1478fbc5-996d-422f-b992-85c1bdc1d14d;6c4703e2-a040-46b1-8900-b41aa4c1e515;5e7ee568-9720-4fc7-aa9a-93f967ae30bc;6ad7f24d-3255-4eb0-abb2-2de5df56d30e	Not Available;Not Available;Not Available;Not Available	15;15;15;15	173;531;173;531	32;384;32;384	Paclitaxel;Carboplatin;Carboplatin;Gemcitabine	Not Available;Not Available;Not Available;Not Available	1;1;1;1	06;08;06;08	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	2100;4920;5130;26752	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	Not Available	TCGA-36-1571-F27862	00574d51-b04f-42c8-ba1a-f4d8af2e4ebd	2	695	695	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	375	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1571	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	No Macroscopic disease	Ovary	NO	Dead	2009	2007
TCGA-42-2587	75	FEMALE	722	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	722			TUMOR FREE		75	Bilateral	TCGA-42-2587	eef62876-7d17-496a-8971-2c7008d77014	3	-27510	Not Applicable	0	276	TCGA-42-2587-D28036;TCGA-42-2587-D28037;TCGA-42-2587-D28035;TCGA-42-2587-D28034;TCGA-42-2587-D28799;TCGA-42-2587-D28798;TCGA-42-2587-D28796	ffec8b1d-1d6c-4050-b6c3-f453bbffc47e;32127c37-e882-42f0-ab66-04c4714e1a54;b35f1439-dc93-4cce-84ce-54954bd7c017;1e1bb656-c424-468b-bd66-cb465f9f5eae;6b469b25-b567-4107-b82e-efe85e137b95;f8ec148f-6eed-4601-8312-6fe0888b92b3;61a1c2b5-2d22-4594-b3a4-46f029c4a77c	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;22;22;22	Not Available;Not Available;94;94;605;276;290	150;150;17;17;326;276;283	Taxol;Carboplatin;Carboplatin;Taxol;Clinical Trial;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;8;8;8	5;5;3;3;10;5;01	119;515;395;160;267;Not Available;117	mg;mg;mg;mg;mg;Not Available;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Maintenance;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;03;02;02	IV;IP;IV;IV;IV;IP;IV	YES;YES;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1507;2575;1183;1018;2694;Not Available;234	mg;mg;mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2011;2011;2011	Not Available	NOT HISPANIC OR LATINO	TCGA-42-2587-F28033;TCGA-42-2587-F28795	1d73b669-822d-4b7a-9614-01cc92a2e983;897a2b59-77f9-472a-b8a4-d2c9db024b60	3;19	Not Applicable;Not Applicable	276;722	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	6;8									Not Available;Not Available	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;YES	Complete Remission/Response;Complete Remission/Response	NO;NO	Alive;Alive	2010;2011	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	2587	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	42	>20 mm	Ovary	YES	Alive	2010	2009
TCGA-25-1878	60	FEMALE	2587	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	971.0		Recurrence	WITH TUMOR		60	Bilateral	TCGA-25-1878	9bdbaccf-b43b-4ec3-8b9b-dff65215eb00	2	-22035	2587	0	2587	TCGA-25-1878-D26781;TCGA-25-1878-D26782;TCGA-25-1878-D26783;TCGA-25-1878-D26780	0a18dede-dff1-44eb-a51c-a1d4c4e62aee;48b9c418-a412-48f8-a53d-e838216fdb8d;48a35437-9288-49cd-ae24-3a823d6bcb0f;0ead63ed-b358-4809-b61d-f26d2ce59642	Not Available;Not Available;Not Available;Not Available	20;20;20;20	Not Available;Not Available;Not Available;Not Available	61;61;976;976	Cytoxan;Cisplatin;Cisplatin;Taxol	Not Available;Not Available;Not Available;Not Available	11;11;11;11	06;06;05;05	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1878-F26779	a827269a-ecd1-4a70-b55c-3a36cff2de7c	2	2587	2587	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	971	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1878	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	1994
TCGA-24-1552	77	FEMALE	1259	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	403.0		Recurrence	WITH TUMOR		77	Left	TCGA-24-1552	62379be5-13f0-474b-94d3-6f944ec4ee96	13	-28129	1259	0	1259	TCGA-24-1552-D26150;TCGA-24-1552-D26155;TCGA-24-1552-D26152;TCGA-24-1552-D26154;TCGA-24-1552-D26151;TCGA-24-1552-D26153;TCGA-24-1552-D26149	ecf05a0e-1a8f-4c2b-9370-808c3f91f4ba;8712ebf0-ac5c-4247-9ef9-0182dfcbe756;2c4df149-3420-49af-ac83-0c6141b6cb6e;f3e0bfc1-9550-4386-a99e-ea615344961c;c1aee209-7e03-4455-8b8d-d94c99b25758;b0251e28-66c8-4d66-8438-ae12f29c7ff0;98b74f89-c75a-4ca7-93bf-6870cf515821	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13	265;1170;851;1030;587;1030;265	53;1044;728;876;479;876;53	Taxol;Carboplatin;Doxil;Amitostine;Topotecan;Taxol;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5	06;05;05;04;Not Available;04;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg;mg;mg;Not Available;mg;Not Available	ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;1925;350;4325;Not Available;822;Not Available	Not Available;mg;mg;mg;Not Available;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-24-1552-F26148	9ea4de18-69c5-4737-b8ec-956d3c28d2c2	13	1259	1259	0	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	403	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	5	G3									Not Available	Not Available	1552	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1997
TCGA-04-1350	46	FEMALE	1946	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	111.0		Recurrence	WITH TUMOR		46	Bilateral	TCGA-04-1350	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	26	-16942	1946	0	Not Available	TCGA-04-1350-D23996;TCGA-04-1350-D23992;TCGA-04-1350-D23991;TCGA-04-1350-D23998;TCGA-04-1350-D23994;TCGA-04-1350-D23997;TCGA-04-1350-D23989;TCGA-04-1350-D23990;TCGA-04-1350-D23999;TCGA-04-1350-D23993;TCGA-04-1350-D23995	c6ca377d-35fb-4558-a98e-6a2722f37fa1;b7cd073a-7ba3-48ec-8172-0a230b6c0f7a;196d7307-35f0-4476-80ac-ee00c4b5a305;3f2319b5-98cf-40ee-ada2-7bd9e041c3e3;25b6f90e-7d0b-493c-8353-1e83e32684ab;a5e9b1ee-6713-4f06-abd5-4450057f0ca5;d3bc267a-90d8-490c-ac82-32383c4ca950;823bb81f-7708-4a0f-b91f-02f8f375c263;cae5bb23-53c0-40bc-8bfc-d3541ebd7b2d;ce73824b-a2d9-4f29-9172-453c72baefa6;566e0b34-13c1-442d-853d-ec2a4a8b70cd	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10;10;10;10;10;10	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1580;720;363;1726;1389;1622;216;216;1726;1389;1389	Tamoxifen;Gemcitibine;Cisplatin;Fuluestrant;Gemcitibine;Aromasin;Taxol;Carboplatin;Faslodex;Cisplatin;Avastin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11;11;11	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;IV;IV;Not Available;IV;Not Available;IV;IV;Not Available;IV;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-04-1350-F23988	7b044c52-3464-4207-bbec-d65b1cc081f0	26	1946	Not Available	0	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	111	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	NO	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1350	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	>20 mm	Ovary	Not Available	Dead	2009	2003
TCGA-09-0367	67	FEMALE	547	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	547			WITH TUMOR		67	Bilateral	TCGA-09-0367	9bbc01b4-056c-4ddc-aca4-ff20718646d0	4	-24473	547	0	Not Available	TCGA-09-0367-D24214;TCGA-09-0367-D24213;TCGA-09-0367-D24215	4e41a6a2-7536-4235-b3e2-307541a2f55e;5947ae4d-2a9e-4e90-87e6-dca175e44cc6;c830352b-ac14-400e-a5e8-24d933b324ce	Not Available;Not Available;Not Available	27;27;27	92;92;Not Available	9;9;153	taxol;Carbo;gemcitabine	Not Available;Not Available;Not Available	3;3;3	5;5;4	Not Available;Not Available;Not Available	mg/m2;Not Available;mg	ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Not Available	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	175;Not Available;1145	mg/m2;Not Available;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-0367-F24212	76060e1e-8ff9-4936-8b9a-5dd98ffb89b3	4	547	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	0367	Not Available	WITH TUMOR	Not Available	Not Available	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	1-10 mm	Ovary	YES	Dead	2009	2001
TCGA-59-A5PD	55	FEMALE	624	Serous Cystadenocarcinoma	Ovary	Dead	Stage IC	G3	1	145.0		Recurrence	WITH TUMOR		55	Right	TCGA-59-A5PD	7EBC776E-BDE1-4563-ADB1-8BD441872733	25	-20263	624	0	Not Available																								0	NOT HISPANIC OR LATINO																												FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Unknown	100	YES	6	G3	YES;YES	NO;NO	Not Available;Not Available	145;145	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Imaging Study	Not Applicable;Not Applicable	YES	Yes, History of Synchronous/Bilateral Malignancy	A5PD	Preoperative	WITH TUMOR	NO	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	59	Not Available	Ovary	YES	Dead	2013	2011
TCGA-29-1776	63	FEMALE	360	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	360			WITH TUMOR		63	Bilateral	TCGA-29-1776	7472b3ba-9b15-4d97-8708-a2dd82ca0f45	2	-23016	Not Applicable	0	360	TCGA-29-1776-D27410;TCGA-29-1776-D27413;TCGA-29-1776-D27412;TCGA-29-1776-D27411	dc28acfe-77b0-4f61-b4d1-2cefb76d2598;ab1add4a-31c8-482e-a205-0e9c8a61be8b;a9e8a531-b7c7-4ded-a8d8-72c12e8cf1b2;383ee8a0-b591-49b5-91f3-fe0b14dbf094	Not Available;Not Available;Not Available;Not Available	7;7;7;7	154;592;592;154	32;522;522;32	Carboplatin;Bevacizumab;Docetaxel;Paclitaxel	Not Available;Not Available;Not Available;Not Available	4;4;4;4	06;Not Available;03;06	Not Available;Not Available;Not Available;Not Available	AUC;mg;mg;mg/m2	ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV	NO;YES;YES;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	6;2184;88;175	AUC;mg;mg;mg/m2	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	0	Not Available	TCGA-29-1776-F27409	fd4ab0eb-64c8-4130-b885-6ce0dabfa184	2	Not Applicable	360	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1776	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-13-0910	58	FEMALE	3548	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1212.0			TUMOR FREE		58	Bilateral	TCGA-13-0910	b783f33b-734a-4801-bf39-b559a2035c6f	25	-21473	Not Applicable	0	1128	TCGA-13-0910-D24747;TCGA-13-0910-D24745;TCGA-13-0910-D24746	b87c89fa-619d-4ba5-899d-e78c89e963c1;4c9aed17-53a5-4788-8dbe-f3b825e6785e;f8475db6-26ee-485e-ad19-8ec781617a10	Not Available;Not Available;Not Available	15;15;15	289;175;175	238;70;70	Cisplatin;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	3;6;6	Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IV	Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	60;Not Available;175	mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0910-F24744;TCGA-13-0910-F72627	895d2750-b01e-4251-8e26-7d30e2eb6983;D67A53E0-29BE-4B7E-B70F-2B4054D5233F	25;30	Not Applicable;Not Applicable	1128;3548	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	60;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;1212	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	60	Not Available	2	G3									Not Available	Not Available	0910	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2005
TCGA-24-1556	50	FEMALE	2148	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIB	G3	1	539.0		Recurrence	WITH TUMOR		50	Left	TCGA-24-1556	7592a659-7175-486f-a16e-24a4b4365a36	2	-18517	2148	0	2148	TCGA-24-1556-D26186;TCGA-24-1556-D26189;TCGA-24-1556-D26185;TCGA-24-1556-D26190;TCGA-24-1556-D26187;TCGA-24-1556-D26191;TCGA-24-1556-D26188	5525035e-275d-4663-86b4-e8498b97943e;9c0ce3f1-7ff4-48b3-81d4-8462c10b43b4;7e3fdad5-f18b-4551-8eac-a51ba6bf4320;d5ae144a-c41e-497b-9f77-a10744c020b8;ce8d232a-8763-494e-a177-a4bc0bd01733;3384e1f5-7a6b-474c-bcbb-ea510df68def;b8d6bbad-95c7-45ab-a561-b962d3d39d4f	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28;28	Not Available;Not Available;Not Available;1832;Not Available;1832;628	Not Available;Not Available;Not Available;1724;Not Available;1724;539	Cytoxan;Cisplatin;Carboplatin;Carboplatin;Taxol;Taxotere;Toptecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7	4;06;06;05;2;05;07	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	Not Available;Not Available;Not Available;NO;Not Available;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1556-F26184	ae13e174-65c7-41d1-a531-10166f114bfe	2	2148	2148	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	YES;YES	Not Available;762	539;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1556	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence	TCGA-24-1556-R26192	2f80b629-8ce2-406f-9495-6bf0d707b63c	Not Available	28	Not Available	1298	Not Available	7	Not Available	Not Available	NO	Not Available	Not Applicable	PROGRESSION	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-24-1930	53	FEMALE	2467	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	544.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-24-1930	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	5	-19387	2467	0	2467	TCGA-24-1930-D26415;TCGA-24-1930-D26414;TCGA-24-1930-D26421;TCGA-24-1930-D26417;TCGA-24-1930-D26419;TCGA-24-1930-D26412;TCGA-24-1930-D26413;TCGA-24-1930-D26418;TCGA-24-1930-D26426;TCGA-24-1930-D26420;TCGA-24-1930-D26423;TCGA-24-1930-D26416;TCGA-24-1930-D26425;TCGA-24-1930-D26411;TCGA-24-1930-D26424;TCGA-24-1930-D26422	a9a826f0-b068-4db5-8615-3b2a585578f0;e547bd75-7dc8-4f1b-842e-a0194ce97a1a;dc04c370-83b2-43a7-9056-046e157157ab;a301ab51-acb4-43f8-aa33-f545f90b0e05;1c7de380-a8bf-42e1-bcc3-74884e150e50;ca6822ec-a578-4121-b321-ab2c95e1258f;42a297e9-ec61-4400-8745-73b1640c5461;9086fde0-9ee3-4bd6-b4a4-5d839da5a442;49444753-00db-4017-92ca-a382d843fd92;02605ba7-d542-46e5-bcfe-98776bd33895;95d84403-e2dd-44a7-8788-27ee16d4f0a1;204bad86-3701-46aa-87bf-b90605370054;6363893c-0be6-4cef-8d0f-77cddb3d53fc;cb1b0037-5317-42e9-aa49-71ed0d133007;463db060-351c-40c4-879a-df2335f578fb;72bb79de-05db-4399-a015-de42d19cbb55	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5	631;274;1475;1112;1275;274;274;1112;2325;1389;2144;1083;2325;274;2144;1684	547;14;1422;1112;1135;14;14;1112;2164;1331;2052;726;2164;14;2052;1492	Ovarex/placebo;Amitostin;Gemcitabine;Carboplatin;Carboplatin;Carboplatin;Cisplatin;Taxol;Cisplatin;Doxil;Topotecan;Topotecan;Gemzar;Taxol;Navelbine;Hexamethymelamine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4	05;13;03;01;07;13;13;01;08;03;05;12;08;13;05;07	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available	RECURRENCE;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;PO	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;1960;11435;450;3170;4020;518;305;896;218;44.8;95.4;23008;2286;448;49	Not Available;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-24-1930-F26410	4e109663-798b-40df-a011-0527bb6151ff	5	2467	2467	0	Not Available	Not Available	100	Not Available	4	YES;YES;YES	YES;YES;YES	Not Available;1923;670	544;Not Available;Not Available	Recurrence;Locoregional Disease;Metastatic	Not Available;YES;YES	Imaging Study;Imaging Study;Imaging Study	Not Applicable;Not Applicable;Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	100	Not Available	4	G3									Not Available	Not Available	1930	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-24-1930-R26427	109437d5-619c-4fe7-912e-982af9627594	Not Available	5	707	684	Not Available	4	Not Available	3750	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2010	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	1998
TCGA-23-2647	49	FEMALE	135	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	135			Not Available		49	Bilateral	TCGA-23-2647	246404ae-3bc4-4db7-aee3-0346ca3f7322	9	-18205	Not Applicable	0	135																								Not Available	NOT HISPANIC OR LATINO	TCGA-23-2647-F25820	b5927514-b7c2-406a-8d24-0911d1f849ff	9	Not Applicable	135	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G3									Not Available	Not Available	2647	Not Available	Not Available	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	YES	Alive	2009	2009
TCGA-09-1670	57	FEMALE	547	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIA	G3	1	547.0		Recurrence	WITH TUMOR		57	Bilateral	TCGA-09-1670	60014a6e-6a13-4f92-bbfd-eeeee9632f98	2	-21147	Not Applicable	0	547	TCGA-09-1670-D24310;TCGA-09-1670-D24312;TCGA-09-1670-D24311	0425c8ba-5351-4002-8ce5-99d9f36dac5d;a9036291-7a11-408c-bf4d-69e72c45fe65;e72190f5-2626-4416-8a8c-e8435831131c	Not Available;Not Available;Not Available	6;6;6	Not Available;179;179	Not Available;74;74	Taxol;Taxol;Carboplatin	Not Available;Not Available;Not Available	8;8;8	Not Available;6;6	Not Available;Not Available;Not Available	Not Available;mg/m2;Not Available	OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT	Not Available;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;175;6	Not Available;mg/m2;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-09-1670-F24309	80b17801-1c09-408a-bb5b-a95402c021c0	2	Not Applicable	547	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	547	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1670	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2005
TCGA-36-2534	72	FEMALE	907	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	383.0		Progression of Disease	WITH TUMOR		72	Right	TCGA-36-2534	e08a619d-8a55-435d-8c41-a77a112ed889	18	-26621	Not Applicable	0	907	TCGA-36-2534-D27919;TCGA-36-2534-D27920;TCGA-36-2534-D27921	13620b52-e2ce-4432-a515-5fa70c731e9f;6a4a8078-bc7d-4d80-a77b-932a4360fe9a;25f3327a-f99f-435e-b0c9-374a05c7adac	Not Available;Not Available;Not Available	18;18;18	154;154;685	27;27;544	Carboplatin;Docetaxel;Carboplatin	Not Available;Not Available;Not Available	8;8;8	07;07;06	470;135;600	mg;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	3735;949;3720	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	1	Not Available	TCGA-36-2534-F27918	ffa8c288-a2f2-4a74-8e66-b437588e8ba5	18	Not Applicable	907	1	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	383	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2534	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	Not Available	Alive	2010	2007
TCGA-13-0725	44	FEMALE	377	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	190.0		Recurrence	WITH TUMOR		44	Bilateral	TCGA-13-0725	446ce2a3-d328-443c-a419-3344baad0e16	24	-16086	377	0	377	TCGA-13-0725-D24513;TCGA-13-0725-D24512;TCGA-13-0725-D24511	98617757-5925-4a7b-b333-b843536db376;24e5e7f8-08b6-4217-8e45-c7a6ce7ceb03;c01c8aa8-2ad3-4add-9c4a-56fa32923507	Not Available;Not Available;Not Available	16;16;16	215;131;131	190;15;15	Cisplatin;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available	4;4;4	2;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IV	Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;175;Not Available	mg/m2;mg/m2;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	HISPANIC OR LATINO	TCGA-13-0725-F24510	24a9120f-4794-4b42-8edf-6794e062f04d	24	377	377	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	190	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0725	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-13-0908	58	FEMALE	1843	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	552.0		Recurrence	WITH TUMOR		58	Bilateral	TCGA-13-0908	0ba7b6cc-e5f5-47d7-859a-24e31aa336ab	20	-21422	Not Applicable	0	1364	TCGA-13-0908-D24741;TCGA-13-0908-D24740;TCGA-13-0908-D24742	e0ae3a10-31dd-43b6-b2f1-bebf0fc5128b;411e47eb-8e4a-4db8-90e6-dab616f52f95;a715aa27-039d-4fc8-b247-fc6db02155cf	Not Available;Not Available;Not Available	30;30;30	135;135;244	24;24;198	Paciltaxel;Carboplatin;Cisplatin	Not Available;Not Available;Not Available	6;6;6	6;6;3	Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	175;6;70	mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0908-F24739;TCGA-13-0908-F72639	93339bf4-f92d-41ed-bba7-29236a13ccd3;577767E5-13E5-4E9B-B035-DCE895BDD1C3	20;30	Not Applicable;1843	1364;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	3;7	YES;Not Available	NO;Not Available	Not Available;Not Available	552;552	Recurrence;Unknown	Not Available;Not Available	Molecular Markers;Not Available	Not Applicable;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0908	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2005
TCGA-61-2612	63	FEMALE	193	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	179.0		Recurrence	WITH TUMOR		63	Bilateral	TCGA-61-2612	c040df8a-9d6d-43bd-911a-17a7b4e1ec74	7	-23074	193	0	193	TCGA-61-2612-D28498;TCGA-61-2612-D28497	ac6ec127-0170-49d5-9779-1f00c29d2825;e6638335-cf6e-49bd-bf75-5b476c5ad5d5	Not Available;Not Available	7;7	151;151	20;20	Carboplatin;Taxol	Not Available;Not Available	9;9	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-61-2612-F28496	9d18705d-71b9-44c3-9737-de3fe27e89e1	7	193	193	Not Available	Not Available	Not Available	Not Available	Not Available	9	YES;YES	NO;NO	Not Available;189	179;Not Available	Recurrence;Locoregional Disease	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	9	G3									Not Available	Not Available	2612	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Dead	2010	2002
TCGA-29-1707	41	FEMALE	1277	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G3	1	1201.0		Recurrence	Not Available		41	Left	TCGA-29-1707	7fd6ab8a-201e-431d-a886-6ab553b6ca36	2	-15017	Not Applicable	0	1277	TCGA-29-1707-D27289;TCGA-29-1707-D27290;TCGA-29-1707-D27292;TCGA-29-1707-D27291	e28df67d-25f3-4d16-9603-b74cb561c0df;fc8868bb-2ed5-4725-a212-cd48bbf7c30f;708f4379-a553-4e68-bf82-a4c4c10480b1;07440f16-26f4-408f-bed7-79da5f4f959b	Not Available;Not Available;Not Available;Not Available	10;10;15;15	143;143;1375;1326	24;24;1277;1277	Carboplatin;Paclitaxel;Carboplatin;Doxorubicin	Not Available;Not Available;Not Available;Not Available	12;12;3;3	06;06;03;02	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3840;1789;570;50	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010	0	Not Available	TCGA-29-1707-F27288	eefdc8c2-4c4c-4b1d-94b8-2e7210df54c3	2	Not Applicable	1277	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;1248	1201;Not Available	Recurrence;Metastatic	Not Available;YES	Other Method;Other Method	CT;CT	Not Available	Post-Adjuvant Therapy	Not Available	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1707	Post-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	No Macroscopic disease	Ovary	Not Available	Alive	2009	2006
TCGA-61-1910	56	FEMALE	1127	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G3	0	1127			TUMOR FREE		56	Bilateral	TCGA-61-1910	75f2d97a-b96c-403f-8055-5c5c8083e856	1	-20779	Not Applicable	0	1127	TCGA-61-1910-D28257;TCGA-61-1910-D28258	1156e454-75aa-4807-9098-9c0c7f48c158;4a16e1dc-aba9-48c9-b387-2f5461cbc49b	Not Available;Not Available	4;4	161;161	56;56	Carboplatin;Taxol	Not Available;Not Available	12;12	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	4550;756	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1910-F28256	ef3544b8-339a-4e76-a50b-3d8c27dfb9de	1	Not Applicable	1127	Not Available	Not Available	Not Available	Not Available	Not Available	10									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	10	G3									Not Available	Not Available	1910	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Alive	2009	2006
TCGA-13-0766	42	FEMALE	1725	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	628.0		Recurrence	WITH TUMOR		42	Bilateral	TCGA-13-0766	8fe44099-b313-4bfd-a94a-27e72f2a818c	24	-15571	Not Applicable	0	651	TCGA-13-0766-D24568;TCGA-13-0766-D24569;TCGA-13-0766-D24570	3b508635-6136-468c-965e-6c9f011017c6;b3b92756-81fc-4d20-8fbe-2be751f193c3;e98199f4-62f6-444e-804c-fea51774aa05	Not Available;Not Available;Not Available	15;15;15	Not Available;182;182	Not Available;Not Available;Not Available	Carboplatin;Cisplatin;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	2;4;4	Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;100	Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0766-F24567;TCGA-13-0766-F72601	6f218d11-5224-464e-a2ee-d18e3eaf0dc5;9B0A75C2-C1C0-4480-AB8A-A414B7DEC03F	24;30	Not Applicable;1725	651;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	Not Available;Not Available	Not Available;Not Available	2;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	628;628	Recurrence;Unknown	Not Available;Not Available	Physical Examination;Not Available	Not Applicable;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;Unknown	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0766	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2006
TCGA-24-1413	51	FEMALE	192	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	192			TUMOR FREE		51	Bilateral	TCGA-24-1413	3fc8f799-5bd3-4f48-baf0-c458ce86ab7e	9	-18846	Not Applicable	0	192	TCGA-24-1413-D25911;TCGA-24-1413-D25912	2c6dac55-044c-46d6-a296-897bda1add73;86d3680c-7af1-4bcf-9466-ac5d0d032144	Not Available;Not Available	9;27	145;145	34;34	Paclitaxel;Carboplatin	Not Available;Not Available	3;3	6;6	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	1340;3864	mg;mg	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-24-1413-F25910	00e61bdc-fccd-47a7-bd23-8ce0506d6b7b	9	Not Applicable	192	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	1413	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-09-2049	64	FEMALE	3419	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	953.0		Recurrence	WITH TUMOR		64	Left	TCGA-09-2049	05eb8bd5-d31b-4595-921a-366e53ea5a8b	3	-23410	Not Applicable	0	3419	TCGA-09-2049-D24360;TCGA-09-2049-D24355;TCGA-09-2049-D24358;TCGA-09-2049-D24357;TCGA-09-2049-D24362;TCGA-09-2049-D24365;TCGA-09-2049-D24359;TCGA-09-2049-D24363;TCGA-09-2049-D24356;TCGA-09-2049-D24361;TCGA-09-2049-D24364	97c98396-8ea6-4581-95af-2fff74d5e182;d83a8dfc-81b1-45fe-bc71-8e50301f9067;e5d8d89d-7b09-4fa9-9f96-e01af2ad30e6;8c700aae-89fb-479f-a035-ba766d117f7d;bdb2cde3-1c7d-4820-a9c0-a667e68e6daf;be355cf1-4bc6-4561-83f9-c530a6ea6e7a;edad049f-fccf-495c-ad9b-e04a09872cf0;8d9c2b58-92c9-49bc-a943-f506dac97ef4;806b0a19-adfb-4091-99e5-f53f85ab70c3;8b6d5d68-4a96-4b7f-9198-f3decc4e3817;41c6a131-9a0b-4745-ab82-cf90e8d54de4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3;3;3	995;172;981;981;1431;1964;995;1431;172;1110;1768	995;42;962;962;1410;1779;995;1410;42;1017;1712	Taxol;Carboplatin;Taxol;Carboplatin;Cisplatin;Taxotere;Carboplatin;Gemcitibane;Taxol;Topotecan;Gemcitibine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11;11;11	1;6;3;3;2;20;1;2;6;4;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;AUC;mg;mg;Not Available;mg;mg;Not Available;mg/m2;mg;mg	RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;PROGRESSION;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	322;6;92;218;Not Available;46;649;Not Available;175;2;1600	mg;AUC;mg;mg;Not Available;mg;mg;Not Available;mg/m2;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-2049-F24354	5b946b52-500f-4b9c-b99f-10c53af9b68f	3	Not Applicable	3419	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES	NO	Not Available	953	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	11	G3									Not Available	Not Available	2049	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	>20 mm	Ovary	NO	Alive	2009	1999
TCGA-24-2262	57	FEMALE	11	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	11			WITH TUMOR		57	Right	TCGA-24-2262	1d0225b5-f515-4197-bba7-3dc17e502b88	15	-20861	11	0	11																								Not Available	Not Available	TCGA-24-2262-F26542	30c94fb2-d573-4b84-a3c1-26710ad63770	15	11	11	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2262	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	1992
TCGA-24-1553	53	FEMALE	1767	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G3	1	553.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-24-1553	08c64000-d320-4e4d-974b-da503d48890c	13	-19393	1767	0	1767	TCGA-24-1553-D26169;TCGA-24-1553-D26159;TCGA-24-1553-D26161;TCGA-24-1553-D26166;TCGA-24-1553-D26164;TCGA-24-1553-D26167;TCGA-24-1553-D26160;TCGA-24-1553-D26163;TCGA-24-1553-D26162;TCGA-24-1553-D26165;TCGA-24-1553-D26158;TCGA-24-1553-D26168	4ab24572-b866-4291-91b9-130da20b76d5;f6cf4869-e5f8-4d25-80ea-1d2edb7be439;802977b2-5136-4d4c-b3fe-39420081c9ba;97353178-8b14-4304-83e8-5d36dbcc9d0d;3aadf80a-15eb-4f7c-a794-8d20c2571504;0786542b-f7dd-4a39-96a6-561bf1c5f560;2c52a49d-a429-4fc4-b3a6-b0a71736b176;5c874880-be44-4e11-b790-426708bd6e46;e9f1ebec-2d11-4a31-9f6b-8611497ee60d;bad48395-48e1-49eb-ae95-8f224ae67640;2022d5b4-4eb4-4828-a336-9b0339315ee4;ab504577-5032-4dd4-a101-1013de5f8513	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;13;13;13;13;13	1293;154;735;1623;1224;1691;735;1224;1283;1623;154;1735	1243;17;566;1309;944;1659;566;944;864;1309;17;1735	Tamoxifen;Taxol;Taxol;Carboplatin;Gemzar;Xeloda;Carboplatin;Doxil;Topotecan;Taxol;Carboplatin;Doxil	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;5;5	Not Available;06;06;12;09;02;06;09;03;12;06;1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	PROGRESSION;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;RECURRENCE;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PO;IV;IV;IV;IV;PO;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	20;1732;1740;3800;29746;6000;3360;448;70.2;3360;2715;63	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1553-F26157	7622d214-fe68-459f-80a3-c4740b69af22	13	1767	1767	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	553	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1553	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1997
TCGA-36-2529	71	FEMALE	1066	Serous Cystadenocarcinoma	Peritoneum ovary	Alive	Stage IIIC	G3	1	567.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-36-2529	20ac688c-04c1-45a6-823a-6b523002ce92	17	-26092	Not Applicable	0	1066	TCGA-36-2529-D27898;TCGA-36-2529-D27904;TCGA-36-2529-D27899;TCGA-36-2529-D27903;TCGA-36-2529-D27902;TCGA-36-2529-D27901;TCGA-36-2529-D27900	5b9c44a0-5967-43a8-a397-f66f878463e7;83421639-814a-411d-92dd-307c3db6c2a0;f97ac4b2-d650-4e0b-82ef-023ec4a9925c;eff0b655-1129-4e38-9a79-2aa737b79883;bca15819-c1b5-4032-b2f1-f535ccbcddb3;7982e596-7543-4260-943d-63f1887475e5;96151d8e-dc0a-4199-ae71-fdf09fd5aaa6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17;17;17	136;Not Available;136;990;925;738;738	17;1026;17;962;830;591;591	Carboplatin;Paclitaxel;Paclitaxel;Liposomal Doxorubicin;Carboplatin;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8	06;3;06;02;04;06;06	484;238;276;64;465;296;454	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;YES;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2904;714;1656;128;1860;1776;2724	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-36-2529-F27897	8c9865eb-7ad9-47f8-bc03-649131604c68	17	Not Applicable	1066	0	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	567	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C48.2	8441/3	C48.2	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2529	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Peritoneum ovary	Not Available	Alive	2010	2007
TCGA-24-1551	53	FEMALE	1579	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	764.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-24-1551	499a9b57-ee1a-4012-bbab-c6ad955b5e0a	13	-19661	1579	0	1579	TCGA-24-1551-D26142;TCGA-24-1551-D26143;TCGA-24-1551-D26146;TCGA-24-1551-D26140;TCGA-24-1551-D26144;TCGA-24-1551-D26141;TCGA-24-1551-D26145	ec427308-ea67-43e0-9b4e-a4c9e2db1d3e;9df28b30-f8dc-426a-865e-15ce20302858;a38abeb3-1386-434d-b0b9-71f5beff97c4;b10b8c3a-9710-41f3-bd63-884d87cc52a3;cb2ba36d-6d1b-4a6a-b054-158386921e0c;76c2ecc7-ea48-46b9-8b1f-e4f6186921fc;7960a8b0-06e3-44a3-886f-bfae511a0a3d	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13	790;975;1549;135;1254;135;1437	790;842;1549;10;1227;10;1289	Topotecan;Carboplatin;Doxil;Carboplatin;Doxil;Taxol;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5	01;06;01;07;02;07;19	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	RECURRENCE;RECURRENCE;PROGRESSION;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12.5;3600;80;4140;160;2080;3020	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	1	Not Available	TCGA-24-1551-F26139	bbe90a89-5f83-4b5d-9ef9-9a9e8a5159fd	13	1579	1579	1	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	764	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1551	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1997
TCGA-13-0761	51	FEMALE	1156	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	424.0		Recurrence	WITH TUMOR		51	Bilateral	TCGA-13-0761	00630714-7ab3-44e1-afff-186300edae44	24	-18697	Not Applicable	0	1036	TCGA-13-0761-D24547;TCGA-13-0761-D24546	bcdda631-62b9-4f30-a4ed-6edd08a6dcd2;f9983963-5c1a-496b-8282-939554cd4f52	Not Available;Not Available	17;17	221;221	53;53	Docetaxel;Carboplatin	Not Available;Not Available	4;4	8;8	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	75;5	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0761-F24545;TCGA-13-0761-F72596	0304c298-144b-43f2-997d-be1fb1d59cab;4EF3D622-B98D-4A9E-B234-3587998C4330	24;30	Not Applicable;1156	1036;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	424;424	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0761	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2006
TCGA-61-1740	71	FEMALE	74	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	74			WITH TUMOR		71	Right	TCGA-61-1740	005a6517-2e5a-4ea3-ab36-531522723607	2	-26169	74	0	74	TCGA-61-1740-D28199	bc6d55fe-44ed-4ff5-92ae-80281edfcb66	Not Available	4	74	23	Tamoxifen	Not Available	12	Not Available	Not Available	mg	ADJUVANT	Not Applicable	Not Available	Not Available	NO	Hormone Therapy	Not Available	1020	mg	Not Available	2009	3	NOT HISPANIC OR LATINO	TCGA-61-1740-F28198	0e3413d9-8c58-4ac6-a310-028165e36dcd	2	74	74	3	Not Available	Not Available	Not Available	Not Available	6									Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1740	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	>20 mm	Ovary	YES	Dead	2009	2005
TCGA-36-2540	26	FEMALE	724	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G1	1	665.0		Recurrence	WITH TUMOR		26	Bilateral	TCGA-36-2540	30c7efdd-5a86-4418-a33c-a5d27fe56e42	18	-9760	Not Applicable	0	724	TCGA-36-2540-D27937;TCGA-36-2540-D27940;TCGA-36-2540-D27938;TCGA-36-2540-D27939	ae88c1fa-9bf0-4d92-8b5b-786a2cdb17ca;e4be68cd-4638-4590-b0f3-6f83e64f48b0;eb3e8ac7-0199-40aa-b642-d77d932a1478;d8bff8c2-883d-4027-bb84-1ed49eb546f2	Not Available;Not Available;Not Available;Not Available	18;18;18;18	185;Not Available;185;Not Available	46;726;46;726	Carboplatin;Paclitaxel;Paclitaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available	8;8;8;8	06;Not Available;06;Not Available	1280;300;370;940	mg;mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;YES;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	7680;Not Available;2220;Not Available	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	0	NOT HISPANIC OR LATINO	TCGA-36-2540-F27936	e4383d0b-9cc4-4fb5-a4a1-312928dd2e34	18	Not Applicable	724	0	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	665	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	8	G1									Not Available	Not Available	2540	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	YES	Alive	2010	2008
TCGA-24-1544	71	FEMALE	820	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	643.0		Progression of Disease	WITH TUMOR		71	Bilateral	TCGA-24-1544	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	2	-26141	820	0	820	TCGA-24-1544-D26086;TCGA-24-1544-D26083;TCGA-24-1544-D26082;TCGA-24-1544-D26084;TCGA-24-1544-D26081;TCGA-24-1544-D26085	0270a543-8f1d-42a0-a604-ddd1749bb8cd;accbdf55-0909-4132-b4d5-18989608b05f;10643fbe-cd7a-449d-97de-e788fcb322c4;20b56992-e730-4408-b8ea-3e27d43407b5;6cf2832e-8a89-462e-8fea-dd6919a4d1a1;b0f731bc-150c-4aa5-a5e0-66f092fb26cd	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28	799;203;203;470;203;638	777;18;18;243;18;533	Carboplatin;Taxol;Topotecan;Doxil;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7	02;08;08;09;08;04	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	PROGRESSION;ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Persistent stabel disease;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	595;1356;12.6;2100;3080;2500	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1544-F26080	56ec21c8-c3b5-41b3-abdc-964351237f88	2	820	820	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	643	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1544	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-13-0913	53	FEMALE	3325	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	871.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-13-0913	3e8a51bf-7e1f-4eab-af83-3c60d04db1bf	25	-19573	Not Applicable	0	912	TCGA-13-0913-D24760;TCGA-13-0913-D24761;TCGA-13-0913-D24759;TCGA-13-0913-D24762;TCGA-13-0913-D24763	fd329f71-cbc1-4149-9e26-3483110f7c08;e6c2ede1-ccee-463d-b028-c4eb8a176960;0d3b6f19-f63f-41e7-9130-380e82642bb3;895b449e-1a4b-4abe-b8d2-5f86b7aba4f0;31cc917f-186a-4e24-bd6a-6344b86f756a	Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;8;8	161;161;161;1071;1071	35;35;35;962;962	Paclitaxel;Paclitaxel;Cisplatin;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;3;3	6;6;6;6;6	Not Available;Not Available;Not Available;Not Available;175	mg/m2;mg/m2;mg/m2;AUC;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IP;IV;IV	Not Available;NO;Not Available;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	135;60;75;5;Not Available	mg/m2;mg/m2;mg/m2;AUC;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0913-F24758;TCGA-13-0913-F72630	2196fa5e-c624-4376-a480-5aacc1c81f86;0ABAA3DB-68EA-4D04-A907-CD39DAE8AC40	25;30	Not Applicable;Not Applicable	912;3325	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	80;Not Available	Not Available;Not Available	2;7	YES;YES;Not Available	NO;NO;Not Available	Not Available;912;Not Available	871;Not Available;871	Recurrence;Metastatic;Unknown	Not Available;YES;Not Available	Imaging Study;Imaging Study;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0913	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2006
TCGA-61-1911	55	FEMALE	1293	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIA	G3	1	844.0		Recurrence	WITH TUMOR		55	Left	TCGA-61-1911	93095c36-2263-438f-a619-a4a4d6ae13c7	1	-20144	Not Applicable	0	1293	TCGA-61-1911-D28261;TCGA-61-1911-D28264;TCGA-61-1911-D28267;TCGA-61-1911-D28265;TCGA-61-1911-D28263;TCGA-61-1911-D28266;TCGA-61-1911-D28262	07995a31-b89c-4dcf-a2ac-8df6206991d6;57b42526-f8f9-4174-9f48-ef76fc389e56;35c6a1ab-a350-42c4-adc4-1f8a13363ab3;d1f8adbb-656c-4ba2-897a-f44078508729;0cdd8ba8-eb65-46bb-aed4-903e1f8e4311;d66c5aa9-31ea-436a-b0f6-83a2a727862c;50d13255-fa36-4270-9b48-bf97f80061db	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4	144;998;1432;1432;998;1432;144	34;893;1306;1306;893;1306;34	Carboplatin;Carboplatin;Carboplatin;Gemzar;Gemzar;Avastin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12	06;06;07;07;06;07;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4650;3000;5700;9800;8400;500;1710	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1911-F28260	722712b4-0368-42bd-9d7c-39f03d146e63	1	Not Applicable	1293	Not Available	Not Available	Not Available	Not Available	Not Available	10	YES;YES	NO;NO	Not Available;855	844;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	10	G3									Not Available	Not Available	1911	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	YES	Alive	2009	2005
TCGA-25-1631	73	FEMALE	9	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	9			TUMOR FREE		73	Bilateral	TCGA-25-1631	6a1be87b-c4e0-4fd4-b050-50a245b22038	2	-26687	9	0	9																								Not Available	NOT HISPANIC OR LATINO	TCGA-25-1631-F26733	e5c704b8-3c25-452d-9629-1b554ad6dc1e	2	9	9	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1631	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-13-0751	44	FEMALE	1678	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	GX	1	653.0		Recurrence	WITH TUMOR		44	Bilateral	TCGA-13-0751	15c84da3-16e5-4909-aea9-cb5894b0f8af	24	-16304	1678	0	1678	TCGA-13-0751-D24526;TCGA-13-0751-D24528;TCGA-13-0751-D24529;TCGA-13-0751-D24527	06eeae3a-bfc4-461d-8499-af38bf92d8ed;025efed8-6699-48d2-8596-788a6337a354;1e6a17fb-ccae-4774-885a-87fff00779a2;ff901552-345c-4d2f-882f-4f90f4b6cb65	Not Available;Not Available;Not Available;Not Available	16;16;16;16	126;266;266;126	7;195;195;7	Carboplatin;Cisplatin;Gemcitabine;Paclitaxel	Not Available;Not Available;Not Available;Not Available	4;4;4;4	6;4;2;6	Not Available;Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IP;IP;IV	Not Available;Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;75;500;175	Not Available;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0751-F24525	830bb982-a48a-4d97-8836-251f0cd6440d	24	1678	1678	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	653	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	GX									Not Available	Not Available	0751	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-29-1778	77	FEMALE	454	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	454			TUMOR FREE		77	Right	TCGA-29-1778	44e840c9-ea54-4dba-9b2a-264ef1f2c304	2	-28147	Not Applicable	0	454	TCGA-29-1778-D27423;TCGA-29-1778-D27421;TCGA-29-1778-D27424;TCGA-29-1778-D27425;TCGA-29-1778-D27422	af76c927-da93-45aa-a1f7-96a6182eaa7a;76ba3141-d32e-463c-a900-bae906b194f2;1622a274-30ac-42b7-b84f-9a475d6681f6;fef2287b-ade4-4f49-808f-23aac02719c6;7b208018-f74b-4c65-ae60-865ca874ba40	Not Available;Not Available;Not Available;Not Available;Not Available	26;26;26;26;26	80;125;80;80;125	17;101;17;17;101	Paclitaxel;Docetaxel;Paclitaxel;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10	04;02;04;04;02	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	325;110;325;500;410	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-29-1778-F27420	04e3ce5f-feff-436c-82c2-ccf22cdc34ff	2	Not Applicable	454	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1778	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-20-1686	75	FEMALE	89	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	89			TUMOR FREE		75	Bilateral	TCGA-20-1686	f007fa7a-7da9-4cb0-8aea-623af1a122c5	2	-27588	Not Applicable	0	89	TCGA-20-1686-D25560;TCGA-20-1686-D25561	a175f848-af9d-492d-8e22-cb3522f495a7;d4a19506-867a-4ff5-914f-9656355a77dc	Not Available;Not Available	27;27	131;131	26;26	Taxol;Carboplatin	Not Available;Not Available	7;7	06;06	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;5	mg/m2;Not Available	Not Available;Not Available	2009;2009	0	NOT HISPANIC OR LATINO	TCGA-20-1686-F25559	e8bfa672-1402-4260-a0e1-041491db061c	2	Not Applicable	89	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1686	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-61-1913	48	FEMALE	1488	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	0	1488			TUMOR FREE		48	Right	TCGA-61-1913	8516d4f2-0b98-4847-99c6-4d7269fa4af2	1	-17575	Not Applicable	0	1488	TCGA-61-1913-D28270;TCGA-61-1913-D28271	a567da40-6f3c-49d1-b3f8-ce39c43506a2;490e164d-620b-44b0-bb79-d767b6bd4d4c	Not Available;Not Available	4;4	127;127	21;21	Docetaxel;Carboplatin	Not Available;Not Available	12;12	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	720;3930	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1913-F28269	13bbd5c0-51bc-4d78-800b-adad5eaa8d38	1	Not Applicable	1488	Not Available	Not Available	Not Available	Not Available	Not Available	10									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	10	G3									Not Available	Not Available	1913	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Alive	2009	2005
TCGA-24-1924	65	FEMALE	919	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	320.0		Recurrence	WITH TUMOR		65	Bilateral	TCGA-24-1924	26558703-a659-43f2-86cb-0695989bc14e	26	-23801	919	0	919	TCGA-24-1924-D26390;TCGA-24-1924-D26393;TCGA-24-1924-D26387;TCGA-24-1924-D26392;TCGA-24-1924-D26388;TCGA-24-1924-D26394;TCGA-24-1924-D26389;TCGA-24-1924-D26391	6afe2675-ab28-4150-b5ab-93fa07fdbd99;e36c9e00-fc2f-4c5e-b431-98eba3c2118a;c723aeb5-e5fe-484c-99f6-21e20b245735;ad26b9f3-a159-4558-87f5-8659e0f24ca6;56f40dff-03e0-4832-bcad-78ced0f5ca2a;b0797198-ab1c-487a-8587-9d4b65e76dd1;e22e432e-4877-404e-b67c-452eaeef5a91;5f75fd73-f687-48f7-9cc1-f4a8ec07679b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	26;26;26;26;26;26;26;26	583;681;161;681;161;743;525;583	553;597;21;597;21;706;329;553	Topotecan;Gemzar;Carboplatin;Cisplatin;Taxol;Hexalen;Doxil;Navelbine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2;2	02;05;06;05;06;02;08;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg	PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;PO;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18.4;7914;2595;441;1621;12600;576;184	mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-1924-F26386	21cccc06-a7a4-4bdc-a840-cd5f49ce523a	26	919	919	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	320	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1924	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	2001
TCGA-29-2435	78	FEMALE	34	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	34			Not Available		78	Left	TCGA-29-2435	8fa35df3-f544-4c47-bdd1-e4d6fc6662be	7	-28779	Not Applicable	0	34	TCGA-29-2435-D27511;TCGA-29-2435-D27512	4b060dcb-322a-4357-b030-8cbe7307bc71;9d87155a-3587-4120-8dd9-6703aa7a39c4	Not Available;Not Available	7;7	Not Available;Not Available	30;30	Carboplatin;Paclitaxel	Not Available;Not Available	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-29-2435-F27510	7e45664f-cd17-468b-a8c8-fdb76b752062	7	Not Applicable	34	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Not Available	Not Available	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	2435	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	11-20 mm	Ovary	Not Available	Alive	2010	2009
TCGA-24-0968	59	FEMALE	598	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	598			WITH TUMOR		59	Left	TCGA-24-0968	619b14f3-b8cc-4c0a-8304-6719853d592a	10	-21664	Not Available	0	598	TCGA-24-0968-D25886;TCGA-24-0968-D25881;TCGA-24-0968-D25884;TCGA-24-0968-D25885;TCGA-24-0968-D25888;TCGA-24-0968-D25882;TCGA-24-0968-D25887;TCGA-24-0968-D25883;TCGA-24-0968-D25889	98a1282c-fc9a-4ae4-a806-3cd66d04a656;33f57318-3e28-48d4-b198-23a2ab37b5ea;e3ed5ab9-5714-4914-8344-71cafcd55745;4bd719b9-d64e-4581-85e3-5806c52eecc0;44789b67-0fe7-4ee7-9461-8adc8b68a710;80e7d102-6aab-4e2b-a2f5-5e98667313d4;3b897a94-6154-4608-9a7b-720eb376d971;46c69a64-5995-4736-b17c-f77e8e340301;c04896d2-d54b-40dc-a0dd-6dae1fccadd8	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10;10;10;25	Not Available;119;Not Available;Not Available;Not Available;119;Not Available;Not Available;Not Available	Not Available;35;Not Available;Not Available;Not Available;35;Not Available;Not Available;Not Available	Topotecan;Carboplatin;Cisplatin;Gemzar;Cytoxan;Paclitaxel;Navelbine;Doxil;Gemzar	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;2	4;5;1;1;Not Available;5;4;1;1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg;Not Available;Not Available;mg/day;mg;Not Available;Not Available;Not Available	PROGRESSION;ADJUVANT;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;PROGRESSION;ADJUVANT;PROGRESSION;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Persitant disease; Given with Gemzar;Persitant Disease; Given 1x with Doxil;Not Applicable;Not Applicable;Not Applicable;Persitant Disease; Given with Gemzar;Persistant disease; Given 1x with Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;PO;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;2790;Not Available;Not Available;50;1378;Not Available;Not Available;Not Available	Not Available;mg;Not Available;Not Available;mg/day;mg;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2010	Not Available	Not Available	TCGA-24-0968-F25880	f0d9fae8-b67d-4afc-b337-8433ef184f86	10	Not Available	598	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	YES	3	G3									Not Available	Not Available	0968	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2005
TCGA-24-1464	70	FEMALE	379	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	323.0		Recurrence	WITH TUMOR		70	Left	TCGA-24-1464	4160e048-f0b0-40f5-805b-e277a5893a3b	23	-25874	379	0	379	TCGA-24-1464-D26023;TCGA-24-1464-D26024;TCGA-24-1464-D26025	00cf7ce9-c07f-4dad-9bb6-c753b989cc0a;b1703138-84c6-4bae-8a50-718ca2ebde6f;5610bcd5-4bfb-40ee-bdd7-15c71555094a	Not Available;Not Available;Not Available	24;12;12	163;163;343	28;28;342	Taxol;Carboplatin;Toptecan	Not Available;Not Available;Not Available	4;5;5	07;07;01	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1937;5555;8.44	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	1	Not Available	TCGA-24-1464-F26022	77ea97ca-736c-4ab4-9670-0941b73c1bb3	23	379	379	1	Not Available	Not Available	Not Available	Not Available	3	YES	YES	Not Available	323	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	1464	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-24-1464-R26026	98f6f36f-33c4-45c5-9ae5-6a9cff35285a	Not Available	12	Not Available	353	Not Available	5	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2009	1998
TCGA-36-2548	57	FEMALE	431	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	395.0		Recurrence	WITH TUMOR		57	Right	TCGA-36-2548	3250e604-d12a-4922-aaca-6f0cae095842	18	-20897	Not Applicable	0	431	TCGA-36-2548-D27964;TCGA-36-2548-D27963	c61c0ee3-7792-4556-a74e-0f4ce2ceb27b;7905da51-efd8-42a9-9ef7-e165f09bb674	Not Available;Not Available	18;18	267;267	58;58	Paclitaxel;Carboplatin	Not Available;Not Available	8;8	09;9	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-36-2548-F27962	e62733f2-7722-4da0-9627-f34bce5e5c29	18	Not Applicable	431	Not Available	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	395	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Colonoscopy and biopsy	Other method, specify:	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2548	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	Not Available	Alive	2010	2008
TCGA-13-1488	59	FEMALE	2154	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	351.0		Recurrence	WITH TUMOR		59	Bilateral	TCGA-13-1488	a85f6f9c-1e1d-44fc-85eb-3b2d96cfbc61	31	-21726	2154	0	2154	TCGA-13-1488-D24873;TCGA-13-1488-D24872	8b1f61bc-dd0d-42e7-818b-d437b5b7c0a6;72712026-5c3c-4b6c-9520-11796bee3a34	Not Available;Not Available	30;30	165;165	8;8	Paciltaxel;Carboplatin	Not Available;Not Available	6;6	8;8	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;5	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1488-F24871	f8cc6ee8-0004-4c4c-9d2e-38888cd6c5c4	31	2154	2154	Not Available	Not Available	Not Available	80	Not Available	3	YES	NO	Not Available	351	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	3	G3									Not Available	Not Available	1488	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	11-20 mm	Ovary	Not Available	Dead	2009	2002
TCGA-24-2027	51	FEMALE	3337	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	617.0		Recurrence	WITH TUMOR		51	Bilateral	TCGA-24-2027	219f54ef-4235-482d-b799-f2fa9930105c	15	-18835	3337	0	3337	TCGA-24-2027-D26463;TCGA-24-2027-D26469;TCGA-24-2027-D26466;TCGA-24-2027-D26467;TCGA-24-2027-D26461;TCGA-24-2027-D26464;TCGA-24-2027-D26470;TCGA-24-2027-D26474;TCGA-24-2027-D26472;TCGA-24-2027-D26465;TCGA-24-2027-D26462;TCGA-24-2027-D26471;TCGA-24-2027-D26468;TCGA-24-2027-D26473	e1480191-f1f7-4995-a17e-fda2f9dee553;4e98ff92-93cd-4216-842d-416ba1559929;f2bd2c6e-2dcd-4f31-a184-ca1b3b57f630;2d2b4a81-4f1d-47a5-a5b0-372469ed0d16;2d43a2fe-8c73-4fc0-b6df-5bdf7e245f96;67b0bdd5-4fb4-45ad-9910-b53124852ebb;4629f733-986c-4921-836a-29f1968e7f2c;f0bcae84-ea4c-4013-ae03-5fcbde163417;7a0c196f-7579-4417-8df7-250b3790b44e;54208a6d-19e0-4665-a518-330bd875c85b;a3364f64-b01d-4bd7-bc80-7f57e825af8f;10a2545f-f218-4b9f-9b3d-a0efb8844d26;39b52851-9ea8-4dcb-b413-aa58da9233b1;abff2c37-622f-462a-9cfd-3f9b51bf3440	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	15;15;15;15;15;15;15;15;15;15;15;15;15;15	784;2591;1985;2216;258;784;2591;3273;2951;784;258;2745;2540;3154	624;2577;1614;2048;6;624;2577;3168;2759;624;6;2602;2400;2982	Carboplatin;Gemzar;Topotecan;Taxol;Taxol;Taxol;Cisplatin;Taxol;Taxol;Cisplatin;Carboplatin;Navelbine;Doxil;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3;3;3;3;3;3	07;01;17;20;12;07;01;06;18;07;12;07;06;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;PROGRESSION;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;ADJUVANT;PROGRESSION;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3411;1992;151;1747;3724;1860;83;1052;1108;88;9838;311;400;67.05	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-24-2027-F26460	734e79c4-b7b3-4238-aa0b-d3f1fe501a3b	15	3337	3337	0	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	617	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2027	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1995
TCGA-13-0883	61	FEMALE	2097	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	819.0		Recurrence	WITH TUMOR		61	Bilateral	TCGA-13-0883	5c159ab5-8475-4d93-89b8-b6befed4a5b3	25	-22395	2097	0	2097	TCGA-13-0883-D24647;TCGA-13-0883-D24649;TCGA-13-0883-D24648	d214b9d5-80dd-4328-91a0-0c5f62e7c3c2;10e5d0de-68b8-4480-bc66-6fb0d0544380;0f78c3d5-a61e-42c2-9a2a-3d649afbcfc4	Not Available;Not Available;Not Available	15;15;15	143;350;143	31;227;31	Carbobplatin;Cisplatin;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	6;6;6	Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	6;75;175	Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0883-F24646	0ad0a258-a395-4214-915d-499fb9671a1e	25	2097	2097	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	819	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	ASHKENAZI	Not Available	Not Available	2	G3									Not Available	Not Available	0883	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-25-2409	71	FEMALE	821	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	304.0		Recurrence	WITH TUMOR		71	Bilateral	TCGA-25-2409	dce71741-ccbe-40b7-a0b8-2048d07187a4	5	-26267	821	0	821	TCGA-25-2409-D26842;TCGA-25-2409-D26844;TCGA-25-2409-D26843	6e085dc2-54ad-4fd4-b583-556c47e0fceb;e4044ad0-3ce1-44b3-9b0a-9b22bab4fe96;f9e622c7-2103-4813-979c-461082e72b52	Not Available;Not Available;Not Available	5;5;5	182;Not Available;182	31;Not Available;31	Carboplatin;Tamoxifen;Taxotere	Not Available;Not Available;Not Available	1;1;1	6;Not Available;6	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;Not Available;IV	NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-25-2409-F26841	c42fe3b3-07fd-4f77-9037-972142140153	5	821	821	Not Available	Not Available	Not Available	Not Available	Not Available	1	YES	NO	Not Available	304	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2409	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2010	2005
TCGA-13-2060	51	FEMALE	2369	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	1	1475.0			TUMOR FREE		51	Bilateral	TCGA-13-2060	196f4600-b6c9-4652-9f77-65c92883f8c1	16	-18635	Not Applicable	0	262	TCGA-13-2060-D24999;TCGA-13-2060-D25000;TCGA-13-2060-D25001	1f942379-637b-4d34-9ebe-08a3e2d9152a;f813388d-644d-46c4-b29c-f935cfaf6bc4;f6f38882-1d0e-426f-af54-275027957055	Not Available;Not Available;Not Available	16;16;16	143;143;143	31;31;31	Cisplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available	12;12;12	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;135;600	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-13-2060-F24998;TCGA-13-2060-F72683	970fa6e8-453c-4cff-b1e0-f5cadfc60973;83381640-F886-4788-A867-7D9435E6FC0E	16;31	Not Applicable;Not Applicable	262;2369	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	80;Not Available	Not Available;Not Available	12;7	None;Not Available	None;Not Available	None;Not Available	None;1475	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	12	G3									Not Available	Not Available	2060	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-24-1550	49	FEMALE	1249	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	892.0		Recurrence	WITH TUMOR		49	Left	TCGA-24-1550	1858b58f-fdf4-413c-9c29-96ae85b88a74	13	-18049	1249	0	1249	TCGA-24-1550-D26133;TCGA-24-1550-D26134;TCGA-24-1550-D26131;TCGA-24-1550-D26136;TCGA-24-1550-D26132;TCGA-24-1550-D26135;TCGA-24-1550-D26137	816567f8-959f-4ac6-881e-af02c374aea7;57b1a47e-8ee1-430f-947c-2aa9308fe0a5;216cba1d-50e3-40b2-83a8-1c94cf9b2c59;4a1b352e-113a-4b57-8c5d-a68cd3a08e2e;4ab59025-4c19-46a1-8a2f-10774327df1b;06c0b8ce-5bc9-4141-b182-d5e9235ad517;c32b99a6-9f34-4281-9364-de59a8a6f66c	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13	965;1107;174;1211;174;1211;1233	902;986;8;1164;8;1164;1233	Topotecan;Carboplatin;Taxol;Carboplatin;Cisplatin;Taxol;Doxil	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5	04;06;07;03;07;03;01	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	RECURRENCE;PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	405;4200;2070;1950;165;837;64	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	1	Not Available	TCGA-24-1550-F26130	5bda2645-5465-4ed5-a000-c378ffe3ba62	13	1249	1249	1	Not Available	Not Available	Not Available	Not Available	5	YES;YES	NO;NO	Not Available;1121	892;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1550	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1997
TCGA-24-2297	56	FEMALE	1699	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1699			Not Available		56	Bilateral	TCGA-24-2297	2ab32e11-80d6-4ed0-a42e-da612219bbdd	26	-20487	1699	0	1699	TCGA-24-2297-D26614;TCGA-24-2297-D26613	bade886c-5107-470b-a559-711bc8169b7c;e6ac7e27-9cfb-4e5a-9db9-eeac915c3e23	Not Available;Not Available	26;26	153;153	19;19	Cytoxan;Carboplatin	Not Available;Not Available	2;2	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5530;3981	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-24-2297-F26612	02c7c92c-2df2-46d9-a3db-88f6135c8fd6	26	1699	1699	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	Not Available	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	2297	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1993
TCGA-30-1869	50	FEMALE	1563	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	767.0		Recurrence	WITH TUMOR		50	Bilateral	TCGA-30-1869	84f5876d-82b0-45ff-8f3d-a10653683454	2	-18398	1563	0	1563	TCGA-30-1869-D27616;TCGA-30-1869-D27609;TCGA-30-1869-D27610;TCGA-30-1869-D27612;TCGA-30-1869-D27614;TCGA-30-1869-D27613;TCGA-30-1869-D27615;TCGA-30-1869-D27608;TCGA-30-1869-D27617;TCGA-30-1869-D27611;TCGA-30-1869-D27618	baf2c401-c86f-49bf-a41e-7796a1bdab3e;d9cac678-a898-49d5-b2a4-66e0b4a3f093;3e6d063a-3c03-4260-a94a-c80bf3c5d04a;99f53275-3d20-47d8-b7a2-9abc8e23d5ec;f1585f4b-3343-44d0-a65c-ea6a32f8f8f9;b19d902f-e78b-4c03-8c6d-10e286a434f3;2a21156d-6a16-4035-bcbe-3876506d6d74;65d2783e-d0d4-43f0-b528-fa7114edf7cd;140f7ef0-28fe-4f59-83ca-87f440debd96;2e966536-4070-4988-b610-3209fb63fbd4;9c9e5af4-0f8a-426b-8a5a-445a5fcbc1d1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21;21;21;21;21;21;27	1489;179;179;943;1331;1211;1489;179;1534;943;1175	1398;22;22;767;1279;1184;1398;22;1510;767;1132	Taxol;Gemcitabine;Carboplatin;Carboplatin;SNS 595;Doxil;Carbplatin;Taxol;Topotecan;Alimta;Avastin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12;1	06;09;09;08;02;Not Available;06;09;03;08;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;AUC;mg/m2;mg/m2;mg/m2;AUC;mg/m2;mg/m2;mg/m2;mg	PROGRESSION;ADJUVANT;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	175;1000;5;400;48;40;5;175;3;500;30	mg/m2;mg/m2;AUC;mg/m2;mg/m2;mg/m2;AUC;mg/m2;mg/m2;mg/m2;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1869-F27607	abee4203-c623-4b6e-8808-cd75ae936da3	2	1563	1563	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	767	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1869	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	Not Available	Dead	2009	2004
TCGA-31-1944	47	FEMALE	1386	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	678.0		Recurrence	WITH TUMOR		47	Bilateral	TCGA-31-1944	6fee41dc-b8a9-4347-8085-b7e05f813ad0	19	-17207	Not Applicable	0	1386	TCGA-31-1944-D27675;TCGA-31-1944-D27669;TCGA-31-1944-D27671;TCGA-31-1944-D27676;TCGA-31-1944-D27674;TCGA-31-1944-D27670;TCGA-31-1944-D27673;TCGA-31-1944-D27677;TCGA-31-1944-D27672	39eb5ea5-4df1-41c4-b4e9-3369be3f31fd;fd7a3513-ddff-4504-a30a-3788779f9e79;1d97e4b9-be4e-4cee-a355-0b45ddc151f3;23580769-8adf-40ec-b355-47fff6d32793;1808b6be-23eb-4458-a360-341875a10491;9abcadac-29d0-4872-bf15-828eb4d2e730;d9a922f5-a0b8-49a9-b586-fd2fcc484996;e2d31a97-b9d2-412e-b26f-0484d481e4c5;fc93f3e4-6ccb-4337-9034-702229893171	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	19;19;19;19;19;19;19;19;19	1099;126;223;Not Available;841;126;841;944;223	944;7;153;1032;721;7;721;479;153	Megace;Carboplatin;Cisplatin;AZD 2281;Paciltaxel;Paciltaxel;Carboplatin;Tamoxifen;Paciltaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10;10;10;10	Not Available;06;03;Not Available;06;06;06;Not Available;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;mg;mg;Not Available;mg;mg;mg;mg;mg	OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;RECURRENCE;ADJUVANT	Switched from Tamozifen;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PO;IV;IP;PO;IV;IV;IV;Not Available;IP	NO;NO;NO;YES;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;4200;345;Not Available;1650;1650;3300;9140;835	Not Available;mg;mg;Not Available;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-31-1944-F27668	d1397f20-f35b-48a1-8d55-fdf484d16766	19	Not Applicable	1386	Not Available	Not Available	Not Available	Not Available	Not Available	10	YES;YES	NO;NO	Not Available;701	678;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	10	G3									Not Available	Not Available	1944	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	31	No Macroscopic disease	Ovary	YES	Alive	2009	2005
TCGA-04-1360	65	FEMALE		Serous Cystadenocarcinoma	Ovary		Stage IA	G3	0				Not Available		65	Not Available	TCGA-04-1360	e0502c47-3234-4609-a8d5-730a9e6eb5b8	26	-23993	Not Applicable	0	Not Available																								Not Available	Not Available	TCGA-04-1360-F24011	5f8f3a39-d1e6-4a2c-9f74-9c4eb792fa5f	26	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Not Available	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1360	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	Not Available	Alive	2009	2005
TCGA-13-A5FT	67	FEMALE	2143	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	2143			TUMOR FREE		67	Bilateral	TCGA-13-A5FT	F3618472-32DC-4C90-A407-90050F68BE85	26	-24743	Not Applicable	0	1296	TCGA-13-A5FT-D43570;TCGA-13-A5FT-D43571	36283F3D-1E06-4D7C-A64E-DF9B07460DD9;F6311109-F942-40EE-BBC7-BC3334388892	Not Available;Not Available	26;26	111;117	49;48	Cisplatin;Paclitaxel	Complete Response;Complete Response	5;5	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	Not Evaluated	TCGA-13-A5FT-F58072;TCGA-13-A5FT-F72595	47557746-8652-4B47-8CA5-06831E01FA32;EB441837-961C-4E2E-BBF4-B2CB721E586E	1;30	Not Applicable;Not Applicable	1666;2143	Not Available;Not Available	Scheduled Follow-up Submission;Not Available	Complete Remission/Response;Complete Remission/Response	Not Available;Not Available	NO;Not Available	4;7									NO;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Alive;Alive	2014;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	70	Unknown	5	G3									NO	No	A5FT	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			RX	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	13	No Macroscopic disease	Ovary	Unknown	Alive	2013	2009
TCGA-29-1783	58	FEMALE	220	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	220			TUMOR FREE		58	Right	TCGA-29-1783	460616ec-f66f-483b-88c1-757edd86261d	2	-21284	Not Applicable	0	220	TCGA-29-1783-D27432;TCGA-29-1783-D27434;TCGA-29-1783-D27433	c784772b-4edc-4349-9d95-598ee3dd7271;282d262f-4bb3-40a5-81c7-dc51c8aa8886;896921c8-ee1c-44b6-93d4-67af63d3a66a	Not Available;Not Available;Not Available	10;10;10	156;430;156	30;52;30	Carboplatin;Bevacizumab;Paclitaxel	Not Available;Not Available;Not Available	12;12;12	06;Not Available;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;Not Available;IP;IV	NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available	4536;9750;1623	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	1	Not Available	TCGA-29-1783-F27431	86e62f5a-909d-4d9b-971e-eccc8073dad3	2	Not Applicable	220	1	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1783	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-61-1741	76	FEMALE	1024	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G3	1	488.0		Recurrence	WITH TUMOR		76	Bilateral	TCGA-61-1741	16ced1b8-64d5-4498-82df-4d37bfe5b310	2	-27762	1024	0	1024	TCGA-61-1741-D28203;TCGA-61-1741-D28206;TCGA-61-1741-D28205;TCGA-61-1741-D28202;TCGA-61-1741-D28204	de49cd91-151a-46e9-a204-106b50968a1f;286c1a59-9223-4a69-b1f8-b72959043137;5aea964c-d67f-417c-94a3-3c4307475905;ce5d7a64-d023-4d01-946f-515257c9017a;846166d2-712d-44eb-9155-a202bd1f1136	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4	180;Not Available;605;180;605	12;Not Available;522;12;522	Taxol;Tamoxifen;Carboplatin;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	08;Not Available;03;08;03	Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;mg;mg;mg	ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;PO;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	2240;Not Available;1750;3799;838	mg;Not Available;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1741-F28201	6c399b77-3d5e-4eb6-ae9a-f4857b8b5dab	2	1024	1024	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	488	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1741	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence	TCGA-61-1741-R28207	3b9ed17e-e786-430b-b4fb-e07eeaf4becb	Not Available	3	717	711	Not Available	6	05	0020	NO	EXTERNAL BEAM	Not Applicable	PALLIATIVE	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	>20 mm	Ovary	NO	Dead	2009	2004
TCGA-23-2079	46	FEMALE	2788	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	283.0		Recurrence	TUMOR FREE		46	Bilateral	TCGA-23-2079	e3ea5137-76b8-4afc-9b80-ed74714e7172	20	-17122	Not Applicable	0	2788	TCGA-23-2079-D25778;TCGA-23-2079-D25776;TCGA-23-2079-D25779;TCGA-23-2079-D25777	366f4c76-78f8-4c6e-afa5-375494d96d7e;8b9712e1-d798-4f32-b9a7-1087b0a93e16;fb19a65d-7489-4347-8ea4-b6d265cdcaf6;04a0cf5a-70ec-4199-bbaa-75569a40bec1	Not Available;Not Available;Not Available;Not Available	20;20;20;20	489;125;2147;125	296;4;2102;4	Doxil;Paclitaxel;Carboplatin;Carboplatin	Not Available;Not Available;Not Available;Not Available	11;11;11;11	09;06;03;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	663;1800;1651;3420	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-2079-F25775	0b186b74-05f4-4e60-86de-30afe98b56e3	20	Not Applicable	2788	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES;YES	NO;NO	Not Available;2488	283;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	YES	11	G3									Not Available	Not Available	2079	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	No Macroscopic disease	Ovary	YES	Alive	2009	2001
TCGA-04-1519	48	FEMALE	24	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	24			Not Available		48	Not Available	TCGA-04-1519	e9b5336e-d724-4e7d-8c81-1147abd0a80d	3	-17671	Not Applicable	0	Not Available																								Not Available	Not Available	TCGA-04-1519-F58470	8553B172-7AE7-4A72-8769-5EC3B9F4B20D	10	Not Applicable	24	Not Available	Scheduled Follow-up Submission	Unknown	Not Available	YES	4									Unknown	Not Available	Unknown	Not Available	Unknown	Unknown	Alive	2014	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Not Available	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1519	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	Not Available	Not Available	2009	2007
TCGA-61-2094	63	FEMALE	2182	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	2182			TUMOR FREE		63	Bilateral	TCGA-61-2094	b31d85cc-d2e2-4bd1-9986-d6bbe30e657f	8	-23273	Not Applicable	0	2182	TCGA-61-2094-D28387;TCGA-61-2094-D28386	8ca7bbee-0d63-40d2-b769-73f7e9411a50;384a2e6a-6501-479e-b41c-10713af19c13	Not Available;Not Available	8;8	166;166	24;24	Carboplatin;Taxol	Not Available;Not Available	12;12	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2094-F28385	d6ca83f9-d13e-48c8-9739-0ddfe7467b49	8	Not Applicable	2182	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	12	G3									Not Available	Not Available	2094	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	Not Available	Alive	2009	2003
TCGA-13-0765	50	FEMALE	1389	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	668.0		Recurrence	WITH TUMOR		50	Bilateral	TCGA-13-0765	774ce281-96b2-467a-9170-079797ee10f7	24	-18574	Not Applicable	0	869	TCGA-13-0765-D24561;TCGA-13-0765-D24563;TCGA-13-0765-D24565;TCGA-13-0765-D24564;TCGA-13-0765-D24562;TCGA-13-0765-D24560	ddc1fe71-a09c-4c22-8676-91f17fb10e63;58a14e2a-e159-49b3-8dcf-21e5a3d30352;6d3b20f2-3254-4eda-82dc-bace5d8bf3fd;77457f7e-2ffc-46d6-839d-6e6edfefaebc;e10f7682-e704-4461-99a6-bfb0f4230525;071ec052-a24e-4f07-98bc-11b7f907e959	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17;17	163;654;519;155;163;163	50;589;176;71;50;50	Paclitaxel;Tamoxifen;Bevacizumab;Bevacizumab;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4	6;Not Available;Not Available;Not Available;6;6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg;mg/kg;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;Not Available;Not Available;IP;IP	NO;NO;NO;NO;NO;NO	Chemotherapy;Hormone Therapy;Targeted Molecular therapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	135;20;15;15;60;75	mg/m2;mg;mg/kg;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0765-F24559;TCGA-13-0765-F72600	2a56cd1f-6cf2-4e9d-842a-b2a72e8dc65f;F17CDCE7-F69C-45BD-92E9-46ED49708622	24;30	Not Applicable;1389	869;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	668;668	Recurrence;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0765	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2006
TCGA-13-0723	63	FEMALE	1204	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	210.0		Progression of Disease	WITH TUMOR		63	Bilateral	TCGA-13-0723	ff530f28-0ec0-4494-bb54-44bb055bae1c	24	-23094	1204	0	1204	TCGA-13-0723-D24504;TCGA-13-0723-D24505	bb7c2bfe-7d7b-485e-a5f7-145a5a680ef7;2da9827e-d8d0-4341-9c31-da97c92e0d3f	Not Available;Not Available	16;16	200;200	28;28	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	8;8	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0723-F24503	6575a21c-5073-473d-8606-98a740946cb5	24	1204	1204	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	YES	Not Available	210	Progression of Disease	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0723	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Dead	2009	2002
TCGA-24-2280	74	FEMALE	2143	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	535.0		Recurrence	WITH TUMOR		74	Bilateral	TCGA-24-2280	97ad0360-3be4-401a-a94c-7f2800a1b519	5	-27356	Not Applicable	0	2143	TCGA-24-2280-D26562;TCGA-24-2280-D26565;TCGA-24-2280-D26568;TCGA-24-2280-D26567;TCGA-24-2280-D26563;TCGA-24-2280-D26564;TCGA-24-2280-D26566	9c3be379-ed37-4783-be42-e672ea742981;4f041d9d-20ed-4b8c-b24e-f02931809265;d053512b-b2e1-474b-8f28-2aca5360d223;d4c1aa33-8106-4504-b217-27a2fb6accfc;2b16b758-e19d-49e6-9459-6aff9e5f60c5;56d3c465-44f3-4e81-8160-e949e0ad7d63;ea7b837d-bd0d-492e-a86c-465e4bf2be80	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5	178;766;1025;1025;178;178;1025	17;538;906;906;17;17;906	Taxol;Doxil;Avastin;Carboplatin;Carboplatin;Doxil;Taxotere	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4	08;08;Not Available;06;08;08;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;Not Available;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2248;478;57.5;2882;4240;192;599	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-24-2280-F26561	c813bb0e-af6a-403d-a7b5-f3561ccc6326	5	Not Applicable	2143	0	Not Available	Not Available	Not Available	Not Available	4	YES	NO	Not Available	535	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	2280	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2010	2004
TCGA-09-1675	50	FEMALE	2967	Serous Cystadenocarcinoma	Ovary	Alive	Stage IC	G2	0	2967			TUMOR FREE		50	Left	TCGA-09-1675	0fc8777c-8f12-472f-a0ea-085139b35d1f	2	-18596	Not Applicable	0	2967	TCGA-09-1675-D24327;TCGA-09-1675-D24330;TCGA-09-1675-D24328;TCGA-09-1675-D24329	b14864f9-e7b2-4987-ac25-a5804bc74634;6af7d774-e00a-4411-bb4b-30be83bfa4ad;855b5a4b-8752-46eb-ad51-3917f471d8e9;c83250a3-fa1a-4fba-9d68-7656b0ae9ff0	Not Available;Not Available;Not Available;Not Available	6;6;6;6	187;187;68;68	75;75;54;54	Carboplatin;Taxol;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available	8;8;8;8	15;15;3;3	Not Available;Not Available;Not Available;Not Available	mg;mg/m2;mg;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	190;80;190;60	mg;mg/m2;mg;mg/m2	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1675-F24326	b6bc98b0-daf9-4803-aed3-b2fa0751638a	2	Not Applicable	2967	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G2									Not Available	Not Available	1675	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2001
TCGA-30-1867	46	FEMALE	37	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	GX	0	37			WITH TUMOR		46	Not Available	TCGA-30-1867	f9824a6e-7a97-445c-8846-df8d8cddedaa	2	-17159	37	0	37																								Not Available	Not Available	TCGA-30-1867-F27605	b412d4a8-d468-4489-ad11-87d530725059	2	37	37	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	GX									Not Available	Not Available	1867	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	Not Available	Ovary	Not Available	Dead	2009	2004
TCGA-09-1673	50	FEMALE	92	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	92			WITH TUMOR		50	Bilateral	TCGA-09-1673	4e6f88de-7624-4719-8234-4c9e5b2e2988	2	-18599	Not Applicable	0	92	TCGA-09-1673-D24320;TCGA-09-1673-D24319	61389628-3aff-4fa0-bc4b-566c03bd0019;930899a5-34a2-46c3-9584-8203d90c4173	Not Available;Not Available	6;6	Not Available;Not Available	25;25	Carboplatin;Taxol or Taxotere	Not Available;Not Available	8;8	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1673-F24318	7596faa8-43be-4930-a899-cefee1f4f8c7	2	Not Applicable	92	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1673	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	>20 mm	Ovary	YES	Alive	2009	2008
TCGA-36-2532	61	FEMALE	897	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	897			WITH TUMOR		61	Bilateral	TCGA-36-2532	04abcf51-c52a-4e74-a5f4-4bc4fb444902	17	-22333	Not Applicable	0	897	TCGA-36-2532-D27914;TCGA-36-2532-D27915	cbd4dd5a-2acc-4498-bc13-dd61c64eaa82;11a22433-ac29-46a9-ad76-efd5fe41bfce	Not Available;Not Available	17;17	140;140	27;27	Carboplatin;Paclitaxel	Not Available;Not Available	8;8	06;06	564;93	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IP;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;2201.2	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-36-2532-F27913	a4cbfcc9-9288-4209-8e36-b74c3b6692cc	17	Not Applicable	897	Not Available	Not Available	Not Available	Not Available	Not Available	8									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Excisional Biopsy	Not Available	Not Available	YES	8	G3									Not Available	Not Available	2532	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	No Macroscopic disease	Ovary	YES	Alive	2010	2007
TCGA-25-2397	59	FEMALE	365	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	365			Not Available		59	Bilateral	TCGA-25-2397	4c099644-047c-42a3-8187-bfcbfe6662e4	5	-21581	365	0	365																								Not Available	NOT HISPANIC OR LATINO	TCGA-25-2397-F26810	3eeab957-b68a-427b-8555-1c33a30d4c18	5	365	365	Not Available	Not Available	Not Available	Not Available	Not Available	1									Not Available	Not Available	Not Available	Not Available	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2397	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	No Macroscopic disease	Ovary	Not Available	Dead	2010	2004
TCGA-13-0801	46	FEMALE	1399	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	345.0			TUMOR FREE		46	Bilateral	TCGA-13-0801	b8c3d99c-429b-42a3-b486-6fbcb90cc2e0	25	-16812	Not Applicable	0	252	TCGA-13-0801-D24622;TCGA-13-0801-D24623;TCGA-13-0801-D24621	48845041-4684-4ce0-afb3-b87310cdec68;bb31a332-a1a0-4581-9d52-56985e1e12bc;15a73dea-bc43-4bd4-94be-918dc9428c2e	Not Available;Not Available;Not Available	15;15;15	144;144;144	32;32;32	Paclitaxel;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available	4;4;4	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0801-F24620;TCGA-13-0801-F72613	7198f423-8333-4349-8ee6-65e5a4322771;1AA9E1EA-9306-4C42-9690-64AFD2D3977C	25;30	Not Applicable;1399	252;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;345	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	2	G3									Not Available	Not Available	0801	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-04-1365	87	FEMALE	947	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	1	947.0		Recurrence	WITH TUMOR		87	Left	TCGA-04-1365	0484a929-7a7f-4926-8d25-470ddab082ec	26	-31925	Not Applicable	0	947	TCGA-04-1365-D24046;TCGA-04-1365-D24050;TCGA-04-1365-D24048;TCGA-04-1365-D24047;TCGA-04-1365-D24045;TCGA-04-1365-D24049	e830225c-50d9-49db-9d48-4186bbc20fd6;94df838e-3175-48e9-9671-4922ad649d5f;dd8b96a9-d738-4494-aec8-a4892eb9ba68;1d817f79-6e5a-4729-857d-41100fd09200;90c97127-c03c-4650-9dce-516d12af44d2;c7f23742-9c3b-4bef-ad13-5888915ae592	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	24;24;24;24;24;24	189;947;947;947;189;947	21;947;947;947;21;947	Carboplatin;Carboplatin;Carboplatin;Carboplatin;Gemcitabine;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	8;1;4;6;8;2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	AUC;Not Available;AUC;AUC;mg;AUC	ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;Not Available;5;5;11760;4	AUC;Not Available;AUC;AUC;mg;AUC	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	1	NOT HISPANIC OR LATINO	TCGA-04-1365-F24044	5342e1bf-6201-45cf-8499-dc41206e4420	26	Not Applicable	947	1	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	947	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	3	G3									Not Available	Not Available	1365	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	Not Available	Alive	2009	2003
TCGA-30-1855	61	FEMALE	75	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	75			WITH TUMOR		61	Not Available	TCGA-30-1855	7d1e9451-7a6a-4086-af7f-3ed57505daf0	2	-22394	75	0	75																								Not Available	NOT HISPANIC OR LATINO	TCGA-30-1855-F27550	87943368-20bb-43f9-8d5a-b63c57b9e63d	2	75	75	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1855	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	NO	Dead	2009	2001
TCGA-25-2393	81	FEMALE	1157	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	305.0		Recurrence	WITH TUMOR		81	Left	TCGA-25-2393	b4b49027-7815-4813-9769-a3fe3a26a37a	5	-29585	1157	0	1157	TCGA-25-2393-D26804;TCGA-25-2393-D26805;TCGA-25-2393-D26806	f9f70865-c436-451d-b7cb-66c175893433;74515577-69c9-4221-9daf-8dd8bca545c2;9208f692-32d6-4340-b523-c6d8ae520f26	Not Available;Not Available;Not Available	5;5;5	123;123;517	31;31;305	Taxol;Carboplatin;Doxil	Not Available;Not Available;Not Available	1;1;1	06;06;08	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-25-2393-F26803	ca8b79a1-aba9-4f39-a940-ad6da40efd5b	5	1157	1157	Not Available	Not Available	Not Available	Not Available	Not Available	1	YES	NO	Not Available	305	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2393	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	11-20 mm	Ovary	Not Available	Dead	2010	2003
TCGA-23-2084	45	FEMALE	1516	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	619.0		Recurrence	WITH TUMOR		45	Right	TCGA-23-2084	2cb82948-7cbe-4b6c-8414-c02f662de2d0	18	-16493	1516	0	Not Available	TCGA-23-2084-D25807;TCGA-23-2084-D25802;TCGA-23-2084-D25808;TCGA-23-2084-D25799;TCGA-23-2084-D25805;TCGA-23-2084-D25798;TCGA-23-2084-D25801;TCGA-23-2084-D25796;TCGA-23-2084-D25803;TCGA-23-2084-D25806;TCGA-23-2084-D25797;TCGA-23-2084-D25800;TCGA-23-2084-D25804	087ed361-e202-4f43-ad80-7548e4afddcc;11a3ce02-a4a6-4448-bc5b-d75b5e18eea8;63edb1bd-5389-42c8-9cb6-56f0558c4a86;6e3564f4-d965-41f4-8f26-06c247e46d23;0cb1799a-62c8-4961-a97c-6a3042a78457;18d6f8ad-a8f1-49e1-bb97-9234ae71d25e;cf73ecb9-0c9c-4f5a-a6ef-a0c18c63995e;3e7107e7-5d80-4ac1-9a79-d3bcc79ef6dc;938c58a6-fd84-45a0-b087-8f3fb48c7b86;7bd3a692-65be-4684-9346-157cc286a6aa;eb6393b4-8b07-467d-9140-7edec56177f7;a695bdf7-521c-40a8-bfdb-7b26c2f2b383;78eeb3f1-4910-4452-adf8-b5bb45819a16	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18;18;18;18;18;18;18;18;18	1425;1302;1485;701;1401;701;1240;155;1359;1425;155;1169;1401	1425;1261;1457;631;1381;631;1183;6;1324;1425;6;1127;1381	Cisplatin;Taxotere;Etoposide (VP16);Gemzar;Carboplatin;Cisplatin;Doxil;Carboplatin;Topotecan;Ifosfamide;Paclitaxel;Rhumab/Ind;Ifosfamide	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11;11;11;11;11;11	01;03;02;06;02;06;03;08;04;01;08;03;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;RECURRENCE;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;PO;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	100;360;100;12600;920;700;195;4240;14;730;2200;1680;1615	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-2084-F25795	64e0a5f8-5338-401d-9c5b-85d0b1c484d4	18	1516	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES;YES	NO;NO	Not Available;627	619;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	YES	11	G3									Not Available	Not Available	2084	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	No Macroscopic disease	Ovary	YES	Dead	2009	2000
TCGA-29-1694	45	FEMALE	1187	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	GX	1			Locoregional Disease	WITH TUMOR		45	Bilateral	TCGA-29-1694	1db60f09-7f5a-4f21-8003-06a6abc781db	2	-16523	1187	0	Discrepancy	TCGA-29-1694-D27198;TCGA-29-1694-D27193;TCGA-29-1694-D27197;TCGA-29-1694-D27199;TCGA-29-1694-D27196;TCGA-29-1694-D27194;TCGA-29-1694-D27201;TCGA-29-1694-D27195;TCGA-29-1694-D27200	07cd68f0-122d-49b4-b143-3c7b65ac8a72;537110ed-8116-4d74-99e4-41d8b322fe29;3a3e5828-1122-4499-bc15-0ce8f44feeb3;81ddb67a-43e6-4641-8513-cf5f881a7693;e0acd0c1-67c5-4fec-9a4e-5fa66cabb881;cc3697a1-5e61-408e-bd54-3f001f19f4c8;3808c300-3209-4949-9587-1d31449fa233;ade1f387-8cb7-4e4d-8868-333460058f40;b5f367a1-a738-4e22-a8a7-2955c3f77f89	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5	1071;161;928;1071;719;161;658;485;1108	969;43;750;1057;658;43;339;241;1101	Gemcitabine;Carboplatin;Doxorubicin HCL Liposomal;Cisplatin;CT2103 Taxane Analog;Paclitaxel;Tamoxifen;Cisplatin;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4;4;4	Not Available;Not Available;06;02;04;Not Available;Not Available;06;01	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;AUC;mg;mg;mg;mg/m2;Not Available;mg/m2;mg	PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;Not Available;IP;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1020;4;56;40;243;150;Not Available;50;4	mg;AUC;mg;mg;mg;mg/m2;Not Available;mg/m2;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010	1	Not Available	TCGA-29-1694-F27192	a17e36f4-a75c-4d56-a8a4-f79d48e9513b	2	1187	Discrepancy	1	Not Available	Not Available	Not Available	Not Available	6	YES	YES	206	Not Available	Locoregional Disease	YES	First Seen At Further Surgery	Not Applicable	Not Available	Other	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	GX									Not Available	Not Available	1694	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Not Available	TCGA-29-1694-R27202	9d0c7d69-92d2-43d4-a009-1e652022bf2f	Not Available	3	Not Available	202	Not Available	6	Not Available	Not Available	NO	RADIOISOTOPE	Not Applicable	PROGRESSION	one time intraperitoneal	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	11-20 mm	Ovary	Not Available	Dead	2009	2002
TCGA-61-2012	81	FEMALE	932	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G2	0	932			Not Available		81	Left	TCGA-61-2012	20c6be4d-7baf-4ea0-93e2-a5212f2e9b9c	8	-29830	Not Applicable	0	932	TCGA-61-2012-D28353;TCGA-61-2012-D28354	d10ed0e0-e577-49c9-8ed4-ad2fb0a269bd;03ea578a-6288-48d0-aac8-a043b050c091	Not Available;Not Available	8;8	Not Available;Not Available	29;29	Carboplatin;Taxol	Not Available;Not Available	12;12	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2012-F28352	c66877b2-6de0-46a6-8a98-f8808fc13af9	8	Not Applicable	932	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	Not Available	YES	Not Available	YES	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G2									Not Available	Not Available	2012	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available	Not Available	TCGA-61-2012-R28355	8ff12e8c-3408-423b-abb2-27198cd04420	Not Available	29	Not Available	Not Available	Not Available	3	Not Available	Not Available	Not Available	Not Available	Not Applicable	ADJUVANT	Not Available	Not Available	2010	Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	YES	Alive	2009	2006
TCGA-25-1870	59	FEMALE	455	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	243.0		Recurrence	WITH TUMOR		59	Bilateral	TCGA-25-1870	15f1a992-0724-4d76-a71a-702ac7753a41	2	-21550	455	0	455	TCGA-25-1870-D26764;TCGA-25-1870-D26767;TCGA-25-1870-D26766;TCGA-25-1870-D26765	0b248d06-5a2e-4a14-9ab0-886deac002cc;b2a59205-5185-49f2-86a8-2afc4d4ccf2b;f889655c-9daa-433c-a1a9-86d2e757677e;4bc62a25-6c3d-4d78-954d-188ffcb588d9	Not Available;Not Available;Not Available;Not Available	20;20;20;20	Not Available;Not Available;Not Available;Not Available	31;151;151;31	Carboplatin;Carboplatin;Cytoxan;Cytoxan	Not Available;Not Available;Not Available;Not Available	11;11;11;11	04;02;02;04	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1870-F26763	d8dd85e5-4709-40cf-8e60-34f345303195	2	455	455	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;243	243;Not Available	Recurrence;Metastatic	Not Available;YES	First Seen At Further Surgery;First Seen At Further Surgery	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1870	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	11-20 mm	Ovary	Not Available	Dead	2009	1994
TCGA-29-1771	76	FEMALE	686	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	1	595.0		Recurrence	WITH TUMOR		76	Bilateral	TCGA-29-1771	7b042fb2-8f53-4fb1-8a44-40cd2128b279	2	-28093	Not Applicable	0	686	TCGA-29-1771-D27386;TCGA-29-1771-D27389;TCGA-29-1771-D27385;TCGA-29-1771-D27384;TCGA-29-1771-D27388;TCGA-29-1771-D27387	03cb09e7-1cf9-421c-a6b1-1647d5106a8b;d1e90be4-8811-4a8f-a1c5-b914364b9454;2c7306f8-d949-46b9-93fc-b192664a6e89;359e1584-0379-4f8d-a2a5-25b007e48c08;16adb117-4d4b-4234-b6bb-d2c6435b6e4d;80543e63-933d-4f44-b5c2-c3062cc2448e	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18;18	140;728;728;728;595;140	27;602;602;602;189;27	Carboplatin;Bevacizumab;Pacilatxel;Carboplatin;Abagovomag vs Placebo;Paciltaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	06;Not Available;07;07;Not Available;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;IV;Not Available;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	345;695;245;319;2;200	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-29-1771-F27383	61b33725-0889-4c2f-b027-45264eb718c5	2	Not Applicable	686	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	595	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1771	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Alive	2009	2007
TCGA-24-2030	87	FEMALE	972	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	646.0		Recurrence	WITH TUMOR		87	Left	TCGA-24-2030	d2ccefea-c1d6-465f-97b1-e51e29c5f1f8	3	-31900	972	0	972	TCGA-24-2030-D26483;TCGA-24-2030-D26481;TCGA-24-2030-D26484;TCGA-24-2030-D26486;TCGA-24-2030-D26485;TCGA-24-2030-D26482;TCGA-24-2030-D26488;TCGA-24-2030-D26487	70169bdf-9305-4494-a6f9-4d83f54bdc26;86e9993c-2161-4fd6-8e3b-d782e8d7b07c;d7b6b9ee-28f5-434d-9f33-4f7733e9670b;f3d03ec6-706d-44d0-a89b-d662bc0bb9ea;5e971953-a98a-4612-bf01-e5f656e45ff8;29f56a89-c0a3-487d-8cde-7998973ac418;b3ffba76-89e3-409b-8ffa-d79a8440d978;983be44f-bafd-4148-897e-f00814c3f649	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16;16;16;16	790;127;790;972;972;127;972;972	657;13;657;972;864;13;972;972	Taxol;Taxol;Carboplatin;Doxil;Topotecan;Carboplatin;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3	06;06;06;01;06;06;05;11	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1380;1064;1778;50;48;2334;1420;1100	mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2030-F26480	074d1e6b-3a3f-4b8c-9638-617b4d07067a	3	972	972	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	646	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	2030	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1995
TCGA-13-1509	64	FEMALE	2438	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	1	578.0			TUMOR FREE		64	Bilateral	TCGA-13-1509	fe402983-70da-44db-b7b1-c32702ddde26	31	-23481	Not Applicable	0	127	TCGA-13-1509-D24959;TCGA-13-1509-D24958	f341bfee-7f12-4172-be59-3f8386e19360;64ec67ad-a633-4554-afc3-8584cf9cf42c	Not Available;Not Available	29;29	127;127	21;21	Paclitaxel;Carboplatin	Not Available;Not Available	6;6	6;6	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	175;5	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1509-F24957;TCGA-13-1509-F72678	770c3446-50ed-4950-b822-5710cfea1b64;183B98D7-5234-4394-8BDF-4601AAB38464	31;31	Not Applicable;Not Applicable	127;2438	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	40;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;578	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	ASHKENAZI	40	Not Available	3	G3									Not Available	Not Available	1509	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-59-2350	44	FEMALE	679	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	211.0		Progression of Disease	WITH TUMOR		44	Bilateral	TCGA-59-2350	e978a457-92ff-4eab-b759-ec6e74d973e8	29	Not Available	679	0	Not Available																								Not Available	Not Available	TCGA-59-2350-F28102	3623594b-c07c-40e0-9eba-0a95a662d146	29	679	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	1	Not Available;Not Available	Not Available;Not Available	Not Available;211	211;Not Available	Progression of Disease;Locoregional Disease	Not Available;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	Not Available	Partial Remission/Response	Not Available	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2350	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	59	1-10 mm	Ovary	Not Available	Dead	2010	1995
TCGA-13-1506	45	FEMALE	1039	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	666.0			TUMOR FREE		45	Bilateral	TCGA-13-1506	1cc02c64-a34e-46ae-9bc7-5d50f2fefb31	31	-16734	Not Applicable	0	134	TCGA-13-1506-D24948;TCGA-13-1506-D24947;TCGA-13-1506-D24946;TCGA-13-1506-D24945;TCGA-13-1506-D24950;TCGA-13-1506-D24949	3f0348d6-1607-4e20-9dad-1c18f02ca8e6;d8424615-0858-44a6-a544-4f86f99b6742;db2514fa-f3d7-4744-aeb2-3ea6191e9513;eed33a2f-1991-431e-aed9-a80e2fff5f9a;334b7af7-5669-4098-b07a-2e3d85e88871;58d4d7d7-f9d6-4800-a354-11dc5d9a086e	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	29;29;29;29;1;1	80;80;51;51;197;197	79;79;50;50;99;99	Gemcitabine;Cisplatin;Docetaxel;Cisplatin;Gemcitabine;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;6;6;6;2;2	1;1;1;1;5;5	Not Available;Not Available;Not Available;Not Available;800;Not Available	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;AUC	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV;IP;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	800;75;65;75;Not Available;4	mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;AUC	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1506-F24944;TCGA-13-1506-F72675	c38894f1-b486-48fd-acc2-f53027cb3ffa;418B4CC1-852C-4998-AB55-8C04A0526522	31;31	Not Applicable;1039	134;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;666	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	3	G3									Not Available	Not Available	1506	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2008
TCGA-04-1369	53	FEMALE	642	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	315.0		Progression of Disease	WITH TUMOR		53	Bilateral	TCGA-04-1369	6c43727d-631a-40fb-b1a1-242a12889eaa	12	-19571	642	0	Not Available	TCGA-04-1369-D24059;TCGA-04-1369-D24060;TCGA-04-1369-D24057;TCGA-04-1369-D24058	288c7d8e-3290-493e-aff8-83a7df40547a;933f5331-cf37-4d58-a9c7-5eaa2a3d234a;57014ef4-02a2-4f6f-a4ec-f63d59a47947;102518d8-179f-447a-96fe-c67cccb6bdf7	Not Available;Not Available;Not Available;Not Available	12;12;12;12	238;445;154;238	175;392;56;56	Paclitaxel;BA4 43 9006;Gemcitabine;Carboplatin	Not Available;Not Available;Not Available;Not Available	8;8;8;8	04;02;04;08	275;400;3140;464	mg;mg;mg;mg	ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;PO;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1100;30000;12560;4539	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	0	NOT HISPANIC OR LATINO	TCGA-04-1369-F24056	590a9f8c-922d-4d99-92b9-f7ed95f172b5	12	642	Not Available	0	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	315	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	8	G2									Not Available	Not Available	1369	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2010	2004
TCGA-25-1312	69	FEMALE	31	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	31			Not Available		69	Left	TCGA-25-1312	66face4a-f35c-4364-90e5-8f28e6372606	27	-25537	31	0	31																								Not Available	NOT HISPANIC OR LATINO	TCGA-25-1312-F26626	988ebd14-2804-4352-b66e-133006ea6a1e	27	31	31	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	Not Available	Not Available	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1312	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-30-1857	64	FEMALE	8	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	0	8			WITH TUMOR		64	Right	TCGA-30-1857	45baebac-32ae-4093-9eba-488b95c1a58d	2	-23689	8	0	8																								Not Available	NOT HISPANIC OR LATINO	TCGA-30-1857-F27564	1e076431-07c6-4bfb-a0e1-fbe4498b5035	2	8	8	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1857	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	Not Available	Ovary	Not Available	Dead	2009	2001
TCGA-61-1904	60	FEMALE	276	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	276			TUMOR FREE		60	Bilateral	TCGA-61-1904	2cdd5154-ee5c-4d67-b2eb-947dfaa56be2	1	-22009	Not Applicable	0	276	TCGA-61-1904-D28237;TCGA-61-1904-D28238	849f17c4-a3e6-4980-83f5-dd6cfc965087;9631e833-0db2-4797-ad8d-eebda0dea026	Not Available;Not Available	4;4	161;161	42;42	Taxotere;Cisplatin	Not Available;Not Available	12;12	05;05	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IV;IP;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	720;2600	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1904-F28236	babf7376-e2bc-4165-acda-25c8f38e15ca	1	Not Applicable	276	Not Available	Not Available	Not Available	Not Available	Not Available	10									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	10	G3									Not Available	Not Available	1904	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	NO	Alive	2009	2007
TCGA-13-0901	41	FEMALE	589	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	390.0		Recurrence	WITH TUMOR		41	Bilateral	TCGA-13-0901	27920e1e-b9ab-4587-970a-0cba7025becb	20	-15333	Not Applicable	0	589	TCGA-13-0901-D24715;TCGA-13-0901-D24714;TCGA-13-0901-D24713	87333d18-17bb-4cd5-b969-f6fdcf69dd36;6d3211ce-35d2-455e-975e-81723a31ec32;efb4d63b-68d6-452f-9457-fb4fe0c251df	Not Available;Not Available;Not Available	30;30;30	88;165;165	44;44;44	Cetuximab;Paciltaxel;Cisplatin	Not Available;Not Available;Not Available	6;6;6	Not Available;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;IV;IV	NO;NO;NO	Targeted Molecular therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	250;175;6	mg/m2;mg/m2;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0901-F24712	98ec4905-62a5-4fb5-9da0-a73e7e2b4368	20	Not Applicable	589	Not Available	Not Available	Not Available	80	Not Available	3	YES	NO	Not Available	390	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	3	G3									Not Available	Not Available	0901	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Alive	2009	2004
TCGA-42-2591	51	FEMALE	1240	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	GX	0	1240			TUMOR FREE		51	Bilateral	TCGA-42-2591	0750ebcc-348a-4ea9-9dd2-6274d5e6eeaa	3	-18654	Not Applicable	0	232	TCGA-42-2591-D28055;TCGA-42-2591-D28056;TCGA-42-2591-D28794	72d60219-e3a7-4bcb-9264-f882a37c8488;72191190-2d62-46d3-ae53-fc701676bbb8;5782a341-5e6f-45a5-bd62-6a5e998694fc	Not Available;Not Available;Not Available	3;3;22	204;204;561	23;23;253	Taxol;Carboplatin;Taxol	Not Available;Not Available;Not Available	6;6;8	8;8;12	120;715;270	mg;mg;mg	ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Maintenance	Not Available;Not Available;02	IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	2747;5720;3240	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2011	Not Available	NOT HISPANIC OR LATINO	TCGA-42-2591-F28054;TCGA-42-2591-F28793;TCGA-42-2591-F41420	a92c90e0-1d55-4feb-8fc8-c2bd25153893;1eb2b34d-438c-47f9-b92f-1c9f3f888fc9;01F5C3AF-B966-47CB-80A1-CC1B65E03CB8	3;22;18	Not Applicable;Not Applicable;Not Applicable	232;681;1240	Not Available;Not Available;Not Available	Not Available;Not Available;Scheduled Follow-up Submission	Not Available;Not Available;Complete Remission/Response	Not Available;Not Available;Not Available	Not Available;Not Available;NO	6;8;3									Not Available;Not Available;NO	Not Available;Not Available;Not Available	TUMOR FREE;TUMOR FREE;TUMOR FREE	YES;YES;YES	Complete Remission/Response;Complete Remission/Response;Complete Remission/Response	NO;NO;NO	Alive;Alive;Alive	2010;2011;2013	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	GX									Not Available	Not Available	2591	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	42	No Macroscopic disease	Ovary	Not Available	Alive	2010	2009
TCGA-61-1722	89	FEMALE	19	Serous Cystadenocarcinoma	Ovary	Alive	Stage IB	G3	0	19			WITH TUMOR		89	Bilateral	TCGA-61-1722	47feba88-1ec9-4904-b0e2-3718f294badb	2	-32853	Not Applicable	0	19	TCGA-61-1722-D28130;TCGA-61-1722-D28132;TCGA-61-1722-D28131;TCGA-61-1722-D28133	08dcb240-abe5-4cd2-8b81-b865b8e57bf9;1ebe6dcf-919d-439f-ad65-eca304b64bc0;905dc122-807e-446f-80c3-408de2511c9f;594842d6-0c7e-4151-b277-bf6fbd04c4ab	Not Available;Not Available;Not Available;Not Available	4;4;4;12	19;19;19;19	19;19;19;19	Cytoxan;Vincristine;Mitoxantrone;Decodron	Not Available;Not Available;Not Available;Not Available	12;12;12;3	03;03;03;Not Available	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	3000;6;29;30	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2010	Not Available	Not Available	TCGA-61-1722-F28129	2633c1c8-3dd9-4dfa-93cd-be433aa18856	2	Not Applicable	19	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	NO	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1722	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	NO	Alive	2009	2008
TCGA-24-1417	54	FEMALE	238	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	0	238			TUMOR FREE		54	Left	TCGA-24-1417	48f831b0-5d91-44ae-bc4e-db57ca84fe46	1	-19775	Not Applicable	0	238	TCGA-24-1417-D25921;TCGA-24-1417-D25922	df82d543-c4f6-4f73-8dfa-b8a5c33a8cce;f6dfbc3c-363e-4bc3-8873-82cbcf734bfa	Not Available;Not Available	1;1	156;156	25;25	Taxol;Carboplatin	Not Available;Not Available	4;4	08;08	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	2538;5500	mg;mg	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-24-1417-F25920	6f2f5940-f189-4422-93fc-7571c6f994ba	1	Not Applicable	238	Not Available	Not Available	Not Available	Not Available	Not Available	4									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	1417	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-13-0897	54	FEMALE	2182	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	554.0		Recurrence	WITH TUMOR		54	Right	TCGA-13-0897	79e6e31c-22a1-481c-903b-ab5499cbd450	25	-19894	Not Applicable	0	1748	TCGA-13-0897-D24702;TCGA-13-0897-D24701	ca45bc16-c21b-49db-bf56-ee1313f059ee;cc1f5f91-e9e0-43f6-9e1f-688daa23a656	Not Available;Not Available	15;15	140;140	35;35	Paclitaxel;Carboplatin	Not Available;Not Available	4;4	6;6	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1050;Not Available	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0897-F24700;TCGA-13-0897-F72622	575c5f5c-ba76-49e9-8a0b-fe1f1223bd4d;B0944371-41D3-4CBD-9B7D-0E8DD51FF8E1	25;30	Not Applicable;2182	1748;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;YES;Not Available	NO;NO;Not Available	Not Available;568;Not Available	554;Not Available;554	Recurrence;Locoregional Disease;Unknown	Not Available;YES;Not Available	Imaging Study;Imaging Study;Not Available	Not Applicable;Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	ASHKENAZI	80	Not Available	2	G3									Not Available	Not Available	0897	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2004
TCGA-25-1326	61	FEMALE	1249	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	396.0		Recurrence	WITH TUMOR		61	Bilateral	TCGA-25-1326	07a859fc-6f78-4905-9035-90e2403dbe8d	27	-22339	1249	0	945	TCGA-25-1326-D26694;TCGA-25-1326-D26695;TCGA-25-1326-D26693;TCGA-25-1326-D26696;TCGA-25-1326-D26692	58e93434-8106-4fde-8237-8f06debfac04;c162c533-1b7a-47a4-9eef-32d33fbd1c44;793c8970-8384-4df9-a64a-7f0044bb4524;e9376983-d8c4-4462-94bd-b2bdfe55ab02;135291be-0cf9-4eff-a32f-e251268a5f6b	Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27	153;153;153;518;153	31;31;31;396;31	Taxol;Taxol;Carbo;Doxil;Topetecan	Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3	8;8;8;Not Available;8	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	Not Available;Not Available;Not Available;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1326-F26691	7a9ac328-f776-41a3-9f99-0fa250c41f24	27	1249	945	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	396	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1326	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-24-1418	68	FEMALE	243	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	243			TUMOR FREE		68	Bilateral	TCGA-24-1418	195ecf43-06bd-4ffe-8d8b-a766f3f7179b	16	-24842	Not Applicable	0	243	TCGA-24-1418-D25926;TCGA-24-1418-D25925;TCGA-24-1418-D25927	9911f81a-48c0-47f9-aa6e-343694b85003;cbfa21bd-902b-45ff-9d92-67b836fa99b9;2e35c3fb-6a4e-42c0-bb5d-928456c65618	Not Available;Not Available;Not Available	16;16;16	161;161;231	23;23;43	Carboplatin;Taxol;Bevacizamab/Placebo	Not Available;Not Available;Not Available	4;4;4	06;06;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	2554;1510;8459	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	0	Not Available	TCGA-24-1418-F25924	f9fbcec6-98e7-4e71-8bbd-99bbec66ca0f	16	Not Applicable	243	0	Not Available	Not Available	Not Available	Not Available	4									Not Available	Other	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	1418	Other	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-13-1491	55	FEMALE	1595	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	508.0		Recurrence	WITH TUMOR		55	Bilateral	TCGA-13-1491	c8febeef-8e7e-459e-88cb-8086692dc559	31	-20262	1595	0	1595	TCGA-13-1491-D24886;TCGA-13-1491-D24885;TCGA-13-1491-D24887	375f90a7-f4e6-4437-95a7-823503ea757c;c98fcc34-f54b-4813-97a9-80b88b3a26a1;3068ce31-34ef-41d5-98e5-2a49dde8ea1d	Not Available;Not Available;Not Available	30;30;30	154;154;401	42;42;245	Paciltaxel;Carboplatin;Paciltaxel	Not Available;Not Available;Not Available	6;6;6	6;6;6	Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	175;4;135	mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1491-F24884	89c0fc41-0c77-4699-b8f9-44ca68ef7c2a	31	1595	1595	Not Available	Not Available	Not Available	60	Not Available	3	YES;YES	NO;NO	Not Available;1298	508;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	60	Not Available	3	G3									Not Available	Not Available	1491	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Dead	2009	2002
TCGA-13-0797	49	FEMALE	2121	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	525.0			TUMOR FREE		49	Bilateral	TCGA-13-0797	0de910b1-edaf-47e4-a265-727ee12ac1c3	25	-18051	Not Applicable	0	265	TCGA-13-0797-D24607;TCGA-13-0797-D24608	88409662-1902-43f0-bc49-17443a879455;d8ca87b3-32a4-4fad-9419-710ff00e2cb0	Not Available;Not Available	16;16	146;146	42;42	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	6;6	Not Available;Not Available	mg;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	599;135	mg;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0797-F24606;TCGA-13-0797-F72609	7a9f7b35-642f-4607-89fb-d55ba2600b53;6B845366-8766-4993-88E1-6BF15470F330	25;30	Not Applicable;Not Applicable	265;2121	Not Available;Not Available	Not Available;Not Available	Not Available;Stable Disease	80;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;525	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	0797	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-23-1022	67	FEMALE	1511	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	450.0		Recurrence	WITH TUMOR		67	Left	TCGA-23-1022	d0673efd-3315-4dd5-8ab6-912bfa07dceb	20	-24798	1511	0	Not Available	TCGA-23-1022-D25578;TCGA-23-1022-D25580;TCGA-23-1022-D25585;TCGA-23-1022-D25583;TCGA-23-1022-D25581;TCGA-23-1022-D25584;TCGA-23-1022-D25577;TCGA-23-1022-D25579;TCGA-23-1022-D25582	331fc9fd-da0f-4cac-99d7-e00038d4bd7c;f1fa07d1-a044-41de-8df7-59d7e43dd7d0;d09f3ba6-475f-44a0-a551-0ce2cf7fc770;02f03126-9559-4f48-b898-b7f5637a68b3;abf39c56-803d-4f80-a5df-e3b2694ada67;b1b96f3b-7fe8-4b7b-838b-327f628319fb;74e65174-6f54-47f9-bf5b-d0f1391cb0dc;fb478bd8-7b3a-4ac6-8819-9d01950ecfe0;0a90f6a3-ec5d-4d6a-9b2f-7faa331d8147	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27;27;27;27	162;741;1378;1252;818;1357;162;741;937	29;614;1378;1056;762;1274;29;614;853	Paclitaxel;Cisplatin;Gemcitabine;Carboplatin;Topotecan;Cyclophosphamide;Carboplatin;Gemcitabine;Docetaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3	7;12;1;7;5;5;7;12;10	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg	ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2170;820;1560;2500;27.5;8120;2730;17200;640	mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1022-F25576	b55a527b-1275-4988-9dd9-7451a0b6a70c	20	1511	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	450	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1022	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	YES	Dead	2009	2003
TCGA-25-1634	75	FEMALE	1091	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	380.0		Recurrence	WITH TUMOR		75	Bilateral	TCGA-25-1634	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	2	-27749	1091	0	1081	TCGA-25-1634-D26752;TCGA-25-1634-D26751;TCGA-25-1634-D26750;TCGA-25-1634-D26753	677bee05-2917-4607-845e-3e4a39387f0f;9a6ce675-728d-4759-b42a-6c3646dcff73;77f0fa9e-4f0e-4ad7-9b9c-164793954696;8e382f61-b38a-43a3-9947-df69a2c74a5b	Not Available;Not Available;Not Available;Not Available	17;17;17;17	206;206;206;843	29;29;29;380	Taxol;Carboplatin;Toptecan;Tamoxifen	Not Available;Not Available;Not Available;Not Available	6;6;6;6	08;08;08;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1634-F26749	116c7279-c17b-4dbb-8ff7-3939c33d41fb	2	1091	1081	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	YES	Not Available	380	Recurrence	Not Available	Other Method	FNA lymph node	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1634	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Primary Tumor Field	TCGA-25-1634-R26754	34c70aad-f121-4fa2-917e-fc7c099eff6f	Not Available	3	573	539	Not Available	6	5000	5000	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	No Macroscopic disease	Ovary	Not Available	Dead	2009	2002
TCGA-61-2109	40	FEMALE	629	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	465.0		Recurrence	WITH TUMOR		40	Bilateral	TCGA-61-2109	dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5	7	-14900	629	0	629	TCGA-61-2109-D28451;TCGA-61-2109-D28452;TCGA-61-2109-D28454;TCGA-61-2109-D28453	c0bde517-fee3-47fb-8d5f-e06a0012720c;8e1688ad-53a1-4989-98a4-ba00ccbb8717;fd722d54-c930-4c8a-b35d-106c76576754;2ea9b28a-6af9-4fcd-aa66-d49a600f60ac	Not Available;Not Available;Not Available;Not Available	7;7;7;7	253;253;601;601	14;14;486;486	Taxol;Carboplatin;Cisplatin;Gemzar	Not Available;Not Available;Not Available;Not Available	12;12;12;12	10;10;05;05	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3125;8910;325;9060	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2109-F28450	716014bf-2f9f-4dc8-81fe-c2baa9c4303c	7	629	629	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES	NO	Not Available	465	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	NO	12	G3									Not Available	Not Available	2109	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	>20 mm	Ovary	NO	Dead	2009	1999
TCGA-36-2538	37	FEMALE	763	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	1	523.0		Recurrence	WITH TUMOR		37	Right	TCGA-36-2538	3ea880f4-7a78-4cb7-bfe4-54b3c30a812e	18	-13681	Not Applicable	0	763	TCGA-36-2538-D27932;TCGA-36-2538-D27933;TCGA-36-2538-D27934;TCGA-36-2538-D27931	21626185-0374-4efb-867e-ac1a9976bdd6;705a490a-ccbc-41a1-809c-d3f33a0265f2;5c21d21c-6cbb-45e6-89d4-afdc7839cae1;387a8a6f-3cad-4e2f-b5ac-9faf5418cfe4	Not Available;Not Available;Not Available;Not Available	18;18;18;18	212;682;682;212	72;542;542;72	Pacitaxel;Carboplatin;Liposomal Doxorubicin;Carboplatin	Not Available;Not Available;Not Available;Not Available	8;8;8;8	06;06;06;06	270;680;38;690	mg;mg;mg;mg	ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1620;4080;238;4140	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	Not Available	TCGA-36-2538-F27930	89084cd7-3421-4d79-be7e-f24a2bdf54c6	18	Not Applicable	763	Not Available	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	523	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	NO	8	G3									Not Available	Not Available	2538	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	11-20 mm	Ovary	NO	Alive	2010	2008
TCGA-13-0905	51	FEMALE	3746	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1535.0			TUMOR FREE		51	Left	TCGA-13-0905	2038fd65-d8f1-4b16-af90-b1c8f9a379a7	20	-18757	Not Applicable	0	1455	TCGA-13-0905-D24732;TCGA-13-0905-D24731;TCGA-13-0905-D24730	00d12b24-ecbd-4ee0-b3c9-86d1f2051ea3;d16052dd-7975-441f-919e-4fcf9463a163;feedb04f-785c-4c0c-a091-d00618dea595	Not Available;Not Available;Not Available	30;30;30	223;125;125	153;20;20	Cisplatin;Paciltaxel;Carboplatin	Not Available;Not Available;Not Available	6;6;6	4;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	500;175;6	mg/m2;mg/m2;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0905-F24729;TCGA-13-0905-F72638	bbd54f4d-22ab-4f0a-9678-3e2a9d683ac7;F102AD41-8128-483F-A3C8-F80C8C87D616	20;30	Not Applicable;Not Applicable	1455;3746	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;1535	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	3	G3									Not Available	Not Available	0905	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2005
TCGA-13-1498	73	FEMALE	2012	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	534.0		Progression of Disease	WITH TUMOR		73	Not Available	TCGA-13-1498	56a30462-2819-4c18-95be-8e73880a4921	31	-26820	Not Applicable	0	1144	TCGA-13-1498-D24916;TCGA-13-1498-D24915;TCGA-13-1498-D24917	e3d7554b-1876-4b8c-b4e8-d94f161120b4;c1a4c33c-8d2f-461f-ae07-8b782306e443;5ec3392e-4e4f-462e-9925-77d964be0ddf	Not Available;Not Available;Not Available	29;29;29	216;216;632	7;7;250	Paclitaxel;Carboplatin;Femara	Not Available;Not Available;Not Available	6;6;6	10;10;Not Available	Not Available;Not Available;Not Available	mg/m2;Not Available;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	175;5;2.5	mg/m2;Not Available;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1498-F24914;TCGA-13-1498-F72647	9bef7216-b734-4d71-b19d-86c2b34ba46e;6632B420-E8BD-422F-BA4B-56B734B2B055	31;31	Not Applicable;2012	1144;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	3;7	YES;Not Available	NO;Not Available	Not Available;Not Available	534;534	Progression of Disease;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Partial Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	60	Not Available	3	G3									Not Available	Not Available	1498	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Alive	2009	2006
TCGA-04-1342	80	FEMALE	563	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	0	563			WITH TUMOR		80	Bilateral	TCGA-04-1342	8727855e-120a-4216-a803-8cc6cd1159be	26	-29501	563	0	Not Available	TCGA-04-1342-D23946;TCGA-04-1342-D23947;TCGA-04-1342-D23944;TCGA-04-1342-D23945;TCGA-04-1342-D23943	a8f2443d-7a47-40b8-978c-2221d8a39987;5e0e55b4-42eb-4772-8dcc-a984731aacc9;bbc04766-0c66-4944-983f-535608ffe36d;3d1f08e6-6295-4b2f-85b8-c9e4c70d9073;d4959712-ca57-45a4-996c-550163f99420	Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9	478;478;478;478;142	170;170;170;170;32	Doxorubicin;Topotecan;Taxol;Taxotere;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	Not Available;Not Available;Not Available;Not Available;6	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	2	Not Available	TCGA-04-1342-F23942	6e216144-e4b9-40a2-a542-ca6a7d037eae	26	563	Not Available	2	Not Available	Not Available	Not Available	Not Available	3									Not Available	Preoperative	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G2									Not Available	Not Available	1342	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	>20 mm	Ovary	Not Available	Dead	2009	2006
TCGA-13-0794	60	FEMALE	1919	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	845.0		Recurrence	WITH TUMOR		60	Bilateral	TCGA-13-0794	b63cad1b-b4c7-4e50-8acb-5cee4e9ce4a9	24	-21945	Not Applicable	0	923	TCGA-13-0794-D24600;TCGA-13-0794-D24599	3ae6ca7f-d54e-40bb-9545-a9cbe96a034e;281b15dd-f21d-45da-8ba4-98a7232df8d8	Not Available;Not Available	17;17	132;132	26;26	Docetaxel;Carboplatin	Not Available;Not Available	4;4	6;6	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IV;IP	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	60;Not Available	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0794-F24598;TCGA-13-0794-F72607	9805702d-3f0c-44bf-a09e-b342a981b370;1457CC0F-AF2C-48D8-B685-D15A10C32009	24;30	Not Applicable;1919	923;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	845;845	Recurrence;Unknown	Not Available;Not Available	Physical Examination;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	60	Not Available	2	G3									Not Available	Not Available	0794	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2006
TCGA-13-0889	75	FEMALE	2894	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	GX	0	2894			TUMOR FREE		75	Right	TCGA-13-0889	e3712e5a-4575-440f-89d1-8db9498baa88	25	-27674	Not Applicable	0	1881	TCGA-13-0889-D24680;TCGA-13-0889-D24679	bdee55fd-304d-4731-a737-d755e3b0bb00;464ba663-795e-42ab-b946-a067761a2965	Not Available;Not Available	15;15	159;159	54;54	Paclitaxel;Carboplatin	Not Available;Not Available	4;4	6;6	Not Available;Not Available	mg/m2;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	mg/m2;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0889-F24678;TCGA-13-0889-F72619	f2a35721-d4a7-426d-baa6-7c0f749ad28c;09C5FA9D-5D9D-4D04-97E6-259BF6424A8F	25;30	Not Applicable;2894	1881;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Unknown	60;Not Available	Not Available;Not Available	2;7									Not Available;Unknown	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;Unknown	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	60	Not Available	2	GX									Not Available	Not Available	0889	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2003
TCGA-25-1871	70	FEMALE	760	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	230.0		Recurrence	WITH TUMOR		70	Bilateral	TCGA-25-1871	ff844242-7559-4b07-b09e-69ea40e5ac6b	2	-25627	760	0	760	TCGA-25-1871-D26771;TCGA-25-1871-D26772;TCGA-25-1871-D26770	924836ed-90a7-4364-a68e-5ab77f2c0e5f;c52ffe62-beb4-4e65-8800-9ad2f5d6ddc3;d92a92dd-9124-458e-bc3c-4809ba6811c5	Not Available;Not Available;Not Available	20;20;20	Not Available;Not Available;Not Available	47;47;233	Cisplatin;Carboplatin;Taxol	Not Available;Not Available;Not Available	11;11;11	06;06;06	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1871-F26769	797eae07-f777-48e4-a573-c5cbad320184	2	760	760	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;334	230;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Physical Examination;Physical Examination	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1871	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	11-20 mm	Ovary	Not Available	Dead	2009	1993
TCGA-36-2544	58	FEMALE	638	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	325.0		Progression of Disease	WITH TUMOR		58	Bilateral	TCGA-36-2544	da56dfbe-35ae-4bd7-9a11-d9bbb02b1833	18	-21384	Not Applicable	0	638	TCGA-36-2544-D27950;TCGA-36-2544-D27949;TCGA-36-2544-D27951;TCGA-36-2544-D27952	f7dd65b4-7325-4b8e-a966-a1d861d1b258;d7582250-4e83-4f98-9c7e-db0b477604b2;1aab2bea-e290-440c-af43-f14733a32813;cf3913cd-287d-4a0c-a040-c13ae4ef276f	Not Available;Not Available;Not Available;Not Available	18;18;18;18	128;128;343;343	23;23;343;343	Paclitaxel;Carboplatin;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available;Not Available	8;8;8;8	06;06;01;01	247;546;605;260	mg;mg;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1542;3276;605;260	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	Not Available	TCGA-36-2544-F27948	6cf6fd0d-3d0c-496a-a035-dfc94ed68911	18	Not Applicable	638	Not Available	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	325	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2544	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	Not Available	Alive	2010	2008
TCGA-25-1317	66	FEMALE	61	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	61			Not Available		66	Bilateral	TCGA-25-1317	78777a80-cc6c-46c9-a14a-837ac7943719	27	-24199	61	0	Not Available	TCGA-25-1317-D26653;TCGA-25-1317-D26652	0b21e1d6-b7d7-4509-84fd-30a3a6f2ba0c;4415066a-d41d-4847-b874-98a231029cf3	Not Available;Not Available	27;27	31;31	0;0	Carboplatin;Taxol	Not Available;Not Available	3;3	1;1	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1317-F26651	72ae7e80-c25a-4051-86da-8d77657354e5	27	61	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1317	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	Not Available	Ovary	Not Available	Dead	2009	2000
TCGA-13-2066	49	FEMALE	2133	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	1028.0			TUMOR FREE		49	Bilateral	TCGA-13-2066	bcb87812-94e3-4dc0-867e-d049b44a2690	1	-18170	Not Applicable	0	295	TCGA-13-2066-D25019;TCGA-13-2066-D25020	1fd48297-038d-468d-a6e2-b749ef1fa449;81c7a339-e58c-460a-82de-70cc361da73e	Not Available;Not Available	1;1	169;169	61;61	Carboplatin;Paclitaxel	Not Available;Not Available	2;2	6;6	Not Available;Not Available	AUC;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	6;Not Available	AUC;mg/m2	Not Available;Not Available	2010;2010	Not Available	HISPANIC OR LATINO	TCGA-13-2066-F25018;TCGA-13-2066-F72687	da230e2d-a08b-4cf3-8411-47128770411c;CC936079-881B-4171-9229-AE0FB1D1AAAF	1;31	Not Applicable;2133	295;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;1028	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2010;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	80	Not Available	2	G3									Not Available	Not Available	2066	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2010	2009
TCGA-24-0982	77	FEMALE	679	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	153.0		Recurrence	WITH TUMOR		77	Bilateral	TCGA-24-0982	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	10	-28201	679	0	679	TCGA-24-0982-D25905;TCGA-24-0982-D25902;TCGA-24-0982-D25901;TCGA-24-0982-D25906;TCGA-24-0982-D25904;TCGA-24-0982-D25903;TCGA-24-0982-D25907;TCGA-24-0982-D25908	912d8e00-f08e-482d-bb62-634b415019cc;86c8e150-07cf-4e9e-83d9-e57f33818e05;09307e85-1a95-410e-96db-c9761556f6fb;52092e56-744b-43f4-8bda-609e63790207;8070fa1e-6749-46b8-af00-245149e18154;ef503cec-e161-41bd-85a3-8bb01f6b1328;ce37916d-d891-424a-bc45-12e3cb0755f6;8e3d7162-d3b2-4f32-b3a8-948be3ee41ab	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;10;10;10;10;29;29	474;125;125;474;321;321;615;615	341;13;13;341;251;251;488;488	Gemzar;Paclitaxel;Carboplatin;Doxil;Navelbine;Topotecan;Taxol;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;1;1	5;6;06;5;4;04;7;7	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg	PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	24798;1966;4090;388;390;39;2276;3800	mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2010;2010	Not Available	Not Available	TCGA-24-0982-F25900	ac8e6667-9f37-442b-9a6e-6497824d60a9	10	679	679	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	153	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0982	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-04-1654	69	FEMALE	1451	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	808.0		Recurrence	Not Available		69	Bilateral	TCGA-04-1654	ff33db70-91d4-4dbb-a4fc-d81a128d0f32	2	-25387	1451	0	Not Available	TCGA-04-1654-D24186;TCGA-04-1654-D24187;TCGA-04-1654-D24189;TCGA-04-1654-D24188	b19aeaef-1ab3-44b8-a588-2040992cf2eb;328766be-9ea1-4360-b816-10dd79d46bb5;1247ef93-1e2d-450c-9cde-a787b06e0ab3;31686ad3-5c2c-4d51-aede-07dc220a29ab	Not Available;Not Available;Not Available;Not Available	9;9;9;9	Not Available;52;Not Available;52	877;31;877;31	Carboplatin;Cisplatin;Taxol;Taxol	Not Available;Not Available;Not Available;Not Available	11;11;11;11	Not Available;02;Not Available;02	Not Available;Not Available;Not Available;Not Available	Not Available;mg;Not Available;mg	PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;IP;IV;Not Available;IP;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;280;Not Available;380	Not Available;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	0	Not Available	TCGA-04-1654-F24185	a39da768-d60a-4a09-aab6-9a21b6ff50c2	2	1451	Not Available	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	808	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1654	Pre-Adjuvant Therapy	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-04-1357	52	FEMALE		Serous Cystadenocarcinoma	Ovary		Stage IIIB	G3	0				Not Available		52	Not Available	TCGA-04-1357	feda41d8-ca56-425d-b149-4d5485328107	26	-18999	Not Applicable	0	Not Available																								Not Available	Not Available	TCGA-04-1357-F24009	111f374e-4892-4400-8dd3-60c2e3d4f213	26	Not Applicable	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Not Available	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1357	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	Not Available	Ovary	Not Available	Alive	2009	2005
TCGA-24-2298	55	FEMALE	1620	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	469.0		Recurrence	WITH TUMOR		55	Bilateral	TCGA-24-2298	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	16	-20453	1620	0	1620	TCGA-24-2298-D26624;TCGA-24-2298-D26619;TCGA-24-2298-D26620;TCGA-24-2298-D26618;TCGA-24-2298-D26622;TCGA-24-2298-D26617;TCGA-24-2298-D26621;TCGA-24-2298-D26623	364cb2f7-17b3-4ba1-9c59-a3d286407790;213e17eb-ff72-482a-b2f0-1bd215af56c4;66801fd9-77b5-4227-aed6-30f08f29ad7f;fe77059f-2f22-47c8-9eaa-bf0724926c0f;14a42edb-bca3-40f7-aeb5-d55e4146512a;4027e5e5-c127-453d-b1cd-fed38de4e230;0d6bb242-0d31-4085-9602-963c9791488c;f2aedc57-777a-4a52-a35c-d6cb5de91ee1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16;16;16;16	1568;726;Discrepancy;218;1328;218;817;1328	1454;474;474;12;986;12;762;986	Doxil;Carboplatin;Taxol;Cytoxan;Carboplatin;Carboplatin;Topotecan;Navelbine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3	05;12;12;08;13;08;02;13	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg	PROGRESSION;RECURRENCE;RECURRENCE;ADJUVANT;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	308;2477;1984;5830;424;3605;27.7;731	mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2298-F26616	7d8007b6-ce25-4492-aaf7-bea05f783983	16	1620	1620	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	469	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2298	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1993
TCGA-30-1892	52	FEMALE	1484	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	253.0		Recurrence	WITH TUMOR		52	Left	TCGA-30-1892	a09f0626-002a-48fd-8b2d-c66b8285cf23	2	-19256	1484	0	1484	TCGA-30-1892-D27657;TCGA-30-1892-D27662;TCGA-30-1892-D27661;TCGA-30-1892-D27655;TCGA-30-1892-D27659;TCGA-30-1892-D27663;TCGA-30-1892-D27660;TCGA-30-1892-D27664;TCGA-30-1892-D27656;TCGA-30-1892-D27658;TCGA-30-1892-D27665;TCGA-30-1892-D27666	15b4f156-d559-4a4c-a41e-4f580ece69c1;bca6db49-eba4-482d-b1b7-38025d302b3a;86024c3e-d6d1-4070-b455-2802e60f49cb;8613c854-9f6d-47d0-82ed-0e350279b555;4ac6ea86-5442-489f-b149-c59fd9bf4337;19c74bf7-d4e0-4ed9-bb80-9ae383b30f63;a87f93b1-bdb0-4f71-8935-83676e4ed831;7a5870a1-c1e0-40f5-bbd4-40f24bf5b58c;2ac4a1ea-4121-4873-8a86-65f2bbcc6841;06790c50-25b2-4844-acd8-09bc85d7380d;ac5780c2-338d-43f3-bba7-da96287273e4;ef88b090-ede2-43bf-b637-d824c853ef5c	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	28;28;28;28;28;28;28;28;28;28;28;28	132;1197;Not Available;419;754;1258;Not Available;1384;132;573;1449;1197	10;1113;862;253;601;1197;Not Available;1265;10;428;1428;1134	Carboplatin;Cytoxin;Altima;Doxil;Carboplatin;Taxol;Topotecan;Carboplatin;Taxol;Gemcitabine;Catumaxumab;Avastin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12;12;12	06;Not Available;Not Available;05;Not Available;Not Available;Not Available;06;06;Not Available;04;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	AUC;mg;Not Available;Not Available;Not Available;mg/m2;Not Available;AUC;Not Available;Not Available;ug;mg/kg	ADJUVANT;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;PO;IV;IV;Not Available;IV;IV;IV;IV;Not Available;IP;PO	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	6;50;Not Available;Not Available;Not Available;70;Not Available;5;Not Available;Not Available;10;15	AUC;mg;Not Available;Not Available;Not Available;mg/m2;Not Available;AUC;Not Available;Not Available;ug;mg/kg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1892-F27654	0aa2e64a-fe67-47a7-a99b-0bc5d07725b0	2	1484	1484	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	253	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1892	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	Not Available	Dead	2009	2004
TCGA-24-1434	59	FEMALE	568	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	337.0		Recurrence	WITH TUMOR		59	Bilateral	TCGA-24-1434	5503b3a1-7d03-41b2-9ec8-e478c5414d67	12	-21810	568	0	568	TCGA-24-1434-D25991;TCGA-24-1434-D25986;TCGA-24-1434-D25989;TCGA-24-1434-D25987;TCGA-24-1434-D25985;TCGA-24-1434-D25988;TCGA-24-1434-D25990	d5d87b8c-f2a7-4933-952a-d6d64697e9b0;7daf51fd-b9e9-40ab-8923-3827104240b3;d46e3ac3-da2a-4655-b0e8-04190ea91652;6114e4ae-ce79-42ec-a860-ff6e8be5c913;e6cc7a45-81ef-4091-9c90-12614add799c;dd5e3e6f-08f9-4449-8085-6d08ee8f8737;5335c47b-38e3-47d8-ba92-73a859a8d43b	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12	535;228;371;228;228;314;426	496;45;343;45;45;281;395	Taxol;Taxol;Doxil;Gemzet;Carboplatin;Topotecan;Etoposide	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5	02;08;02;08;08;02;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	PROGRESSION;ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;PO	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	756;1890;160;16000;284;24;4200	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1434-F25984	0e4f7bf8-affb-45c7-8d16-d2eb4a044257	12	568	568	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	337	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	5	G3									Not Available	Not Available	1434	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-29-1690	66	FEMALE	1448	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	0	1448			WITH TUMOR		66	Bilateral	TCGA-29-1690	6b06281b-d3a9-440e-a86c-ee7db003352a	2	-24319	1448	0	1360	TCGA-29-1690-D27146;TCGA-29-1690-D27143;TCGA-29-1690-D27145;TCGA-29-1690-D27144	9ffc6761-7c68-4a4c-ac9d-2cd3fe1748e7;0d7fdf72-7232-4393-8010-1726ecc18ae0;12b9fc4e-5a0b-44cd-98a4-73f1ff3cbff9;27a85986-1d9f-457a-b3ca-613d2b8873ee	Not Available;Not Available;Not Available;Not Available	16;16;16;16	Not Available;Not Available;Not Available;Not Available	91;8;91;8	Paclitaxel;Carboplatin;Cisplatin;Cytoxan	Not Available;Not Available;Not Available;Not Available	2;2;2;2	Not Available;03;Not Available;03	Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV;IP;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	175;350;75;500	mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	Not Available	TCGA-29-1690-F27142	6429b19f-5be1-4edf-9c06-a0a292dede40	2	1448	1360	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1690	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	11-20 mm	Ovary	Not Available	Dead	2009	1993
TCGA-13-1408	59	FEMALE	1680	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	765.0			WITH TUMOR		59	Not Available	TCGA-13-1408	8fac8e40-beac-4059-9d54-7ee530598cfd	20	-21635	Not Applicable	0	180	TCGA-13-1408-D24813;TCGA-13-1408-D24812;TCGA-13-1408-D24816;TCGA-13-1408-D24815;TCGA-13-1408-D24814	0bc7de2d-ef5a-46ab-b7cb-174b698af786;11c746b9-b132-422a-b4c5-f6389fe6c53b;91bf1c84-4812-4b16-a1f7-c1cf1042de3e;e315b96b-2868-4ae0-9096-6c62a57da9f1;4503cd88-2a47-4ced-af56-16b2b3a96bd3	Not Available;Not Available;Not Available;Not Available;Not Available	30;30;1;1;1	91;91;201;201;201	8;8;152;152;152	Paclitaxel;Carboplatin;Paclitaxel;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available	6;6;2;2;2	5;5;3;3;3	Not Available;Not Available;60;135;75	mg/m2;AUC;mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IP;IV;IP	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	175;5;Not Available;Not Available;Not Available	mg/m2;AUC;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1408-F24811;TCGA-13-1408-F72659	b5ebd8fe-77ce-48fc-b3de-f0ac628225e4;CBED0324-EF5A-4B27-AAAB-952D4B886443	20;31	Not Applicable;1680	180;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;765	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Partial Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	Not Available	3	G3									Not Available	Not Available	1408	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-29-1705	47	FEMALE	555	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	283.0		Recurrence	WITH TUMOR		47	Bilateral	TCGA-29-1705	f9c835db-2ab6-4bf5-826f-48723493c0ec	2	-17530	555	0	555	TCGA-29-1705-D27282;TCGA-29-1705-D27280;TCGA-29-1705-D27281;TCGA-29-1705-D27285;TCGA-29-1705-D27283;TCGA-29-1705-D27286;TCGA-29-1705-D27284	05836639-1a84-47c3-89c5-694b2a5435b3;12ace512-a8b1-4ed4-816f-77013d68ef1f;615621a7-8290-4dca-b679-0976af6b59a0;539804dc-173d-426d-b2ec-e4a1b4cdb703;5ed39f48-80a2-4a76-94a0-313bd99a7df8;eb8131b7-b5ed-4fb3-b08f-f744072602e0;4aeb20a4-d869-46cd-8c57-04ed761d6fb4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;15;15;15;15	118;167;55;524;356;356;489	76;13;13;524;287;287;416	Docetaxel;Carboplatin;paclitaxel;Carboplatin;Gemcitabine;Bevacizumab;Doxorubicin HCL	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;3;3;3;3	3;8;03;01;06;Not Available;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;RECURRENCE;RECURRENCE;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;Not Available;IV	NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	450;4905;1050;725;2000;990;80	mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2010;2010;2010;2010	0	Not Available	TCGA-29-1705-F27279	1fe3bcd4-e15d-4d28-a88d-81ce50f34996	2	555	555	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;434	283;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1705	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Dead	2009	2005
TCGA-61-2111	61	FEMALE	3825	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	1	2205.0		Recurrence	WITH TUMOR		61	Left	TCGA-61-2111	91a17d40-c8cb-4cce-b306-966382a8fe4a	7	-22517	Not Applicable	0	3825	TCGA-61-2111-D28474;TCGA-61-2111-D28468;TCGA-61-2111-D28476;TCGA-61-2111-D28473;TCGA-61-2111-D28469;TCGA-61-2111-D28471;TCGA-61-2111-D28470;TCGA-61-2111-D28472;TCGA-61-2111-D28475;TCGA-61-2111-D28477	15db7502-ada4-472f-9061-ef9ea6087a00;5cf77f39-17b0-4d14-8ea3-ea290c63b199;a363d2df-0d8e-45e5-8faa-c9bbfb618a20;6cda5c22-d228-450b-8486-fb10316b9cf7;acfa69b3-3faa-4a7d-9a8d-b719408b3bf9;92211853-fa2a-4218-a96b-db3d1db39268;ab138666-d4a6-45cd-bb67-a74d0a8c97dd;1f0c6548-7a9f-44a1-ac71-91c393f297a4;bb037fb1-3dfc-476d-a329-f46e33afc260;82428555-0922-4f7b-a9ca-780dd852553d	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7;7;7;7	Not Available;133;Not Available;3165;133;2373;2373;3165;Not Available;Not Available	3808;29;Not Available;3079;29;2268;2268;3079;3808;Not Available	Cytoxan;Carboplatin;Megace;Cytoxan;Taxol;Taxol;Carboplatin;Cisplatin;Avastin;Provera	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12	Not Available;Not Available;Not Available;04;Not Available;06;06;04;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/day;mg;Not Available;mg;mg;Not Available;Not Available;mg;mg/m2/wk;Not Available	RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;IV;Not Available;IV;IV;Not Available;Not Available;IV;Not Available;Not Available	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;3400;Not Available;4000;1500;Not Available;Not Available;512;Not Available;Not Available	mg/day;mg;Not Available;mg;mg;Not Available;Not Available;mg;mg/m2/wk;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2111-F28467	273e554f-1bb2-4549-a9b8-c642b76e2458	7	Not Applicable	3825	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES;YES	NO;NO	Not Available;2232	2205;Not Available	Recurrence;Metastatic	Not Available;YES	Other Method;Other Method	Core biopsy;Core biopsy	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	12	G3									Not Available	Not Available	2111	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	Not Available	Alive	2009	1998
TCGA-30-1891	61	FEMALE	914	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	181.0		Recurrence	WITH TUMOR		61	Bilateral	TCGA-30-1891	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	2	-22344	914	0	914	TCGA-30-1891-D27643;TCGA-30-1891-D27646;TCGA-30-1891-D27647;TCGA-30-1891-D27641;TCGA-30-1891-D27648;TCGA-30-1891-D27650;TCGA-30-1891-D27642;TCGA-30-1891-D27644;TCGA-30-1891-D27651;TCGA-30-1891-D27645;TCGA-30-1891-D27649;TCGA-30-1891-D27652	2c926101-6d5b-42b0-8452-bd5074d5c811;d5f3bf0d-8d21-4914-88a2-107de938f057;ef980ca7-1da5-42fc-85e7-525fe996afd6;99ab0f66-db33-4c20-9813-a34ce14f25d6;a2090fb3-e9be-4240-9b2a-17011087a3de;cd524283-81d7-4569-8af9-8bae2aa59655;cbedad2d-cf2a-4f75-b280-dfa270d0b918;ebea0ddd-3575-40ef-843f-5007f3fde1d6;c5a7f0b8-9eba-4728-9684-dfe16a36d94a;fd0a5766-c375-4546-8acd-af9b0cb09e93;f3619476-e2c4-4284-9f6a-0ac66cec5f6c;9ada3d87-0c7b-450a-8c0e-0577b7ea4a49	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	21;21;21;21;21;21;21;21;21;21;21;27	141;526;526;330;638;890;141;386;890;453;694;386	15;460;460;189;554;701;15;358;855;400;666;358	Taxol;Gemcitabine;Carboplatin;Doxil;Cisplatin;Topotecan;Carboplatin;Cytoxan;Navelbine;Gemcitabine;Taxol;Avastin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12;12;1	07;04;04;06;05;12;07;02;06;05;04;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;AUC;mg/m2;mg/m2;mg/m2;AUC;mg;mg/m2;mg/m2;mg/m2;mg/kg	ADJUVANT;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IP;IV;IV;PO;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	175;700;5;40;75;3;5;50;25;700;80;10	mg/m2;mg/m2;AUC;mg/m2;mg/m2;mg/m2;AUC;mg;mg/m2;mg/m2;mg/m2;mg/kg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1891-F27640	8fdc5769-4e01-4a6e-b84d-79e1d6447711	2	914	914	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;536	181;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	NO	6	G2									Not Available	Not Available	1891	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	NO	Dead	2009	2004
TCGA-24-2036	50	FEMALE	1947	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIA	G3	1	914.0		Recurrence	WITH TUMOR		50	Not Available	TCGA-24-2036	c9226204-cb61-40b8-8a94-a7e71c14ea3a	19	-18582	1947	0	1947	TCGA-24-2036-D26507;TCGA-24-2036-D26511;TCGA-24-2036-D26514;TCGA-24-2036-D26506;TCGA-24-2036-D26508;TCGA-24-2036-D26515;TCGA-24-2036-D26513;TCGA-24-2036-D26512;TCGA-24-2036-D26509;TCGA-24-2036-D26510	ee86ed68-4a7a-4351-91fd-30b88a37e9e1;14225659-0bd5-4f58-a64d-dc0ea9287d74;c7f4e305-74e3-4c1b-9f9c-c33e1ff66512;9ad91411-5ada-42b1-8c1b-3cecf1c8b3b4;11db3802-3c6e-43cf-9b7f-6b6c52a8fa85;0d178a19-0839-48c5-92bb-9d47ac316742;b4e39ce6-689b-42ed-8318-45fc53d4696b;c4ede41b-9b04-4c0d-a118-e94eb903797c;bc14658b-86a2-4a1f-870a-341bd741fbb8;52ed5c3b-9463-4989-be52-0f43c0a1647d	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	19;19;19;19;19;19;19;19;19;19	153;Not Available;Not Available;153;638;Not Available;Not Available;Not Available;638;Not Available	Not Available;1156;1855;Not Available;592;1064;1454;1430;592;1156	Taxol;Taxol;Taxol;Carboplatin;Cisplatin;Tamoxifen;Mitomycin C;Doxil;Topotecan;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2;2;2;2	07;05;Not Available;07;03;Not Available;03;01;03;05	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;PROGRESSION;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IP;IV;Not Available;IV;IV;IP;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-24-2036-F26505	18df747d-b014-45a6-a225-5400d8ac2b53	19	1947	1947	0	Not Available	Not Available	Not Available	Not Available	2	YES;YES	YES;YES	Not Available;579	914;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Physical Examination;Physical Examination	Not Applicable;Not Applicable	Not Available	Other	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	2036	Other	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Local Recurrence	TCGA-24-2036-R26516	0acdc2d2-f778-4746-98db-4a2989285077	Not Available	19	1916	1897	Not Available	2	14	35	NO	EXTERNAL BEAM	Not Applicable	RECURRENCE	Not Available	cGy	2010	Not Available	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	1996
TCGA-59-2363	40	FEMALE	165	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIA	G3	0	165			TUMOR FREE		40	Bilateral	TCGA-59-2363	f4d95c8e-fb84-46ca-acc0-827015cc9d0a	12	Not Available	Not Applicable	0	165	TCGA-59-2363-D28116;TCGA-59-2363-D28117	370376ef-e337-4f4a-99e9-1946fb317d53;3947e570-c2af-4b0d-8d63-fb7eb1a976ca	Not Available;Not Available	15;15	Not Available;Not Available	Not Available;Not Available	carbopaltin;Taxol	Not Available;Not Available	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-59-2363-F28115	b9fa6c71-a686-47cc-8b85-ba5cca27a399	12	Not Applicable	165	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	2	G3									Not Available	Not Available	2363	Not Available	TUMOR FREE	Not Available	Not Available	ASIAN	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	59	No Macroscopic disease	Ovary	NO	Alive	2010	2007
TCGA-61-1743	53	FEMALE	1329	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIC	G2	1	809.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-61-1743	a3e26259-732b-49fb-bc95-2f0ec7a0494e	2	-19365	1329	0	1329	TCGA-61-1743-D28211;TCGA-61-1743-D28210	90ea70e1-cefe-4bee-b0bb-c04b6269d3a3;030502fa-6d42-4a5a-a3af-eedba0383040	Not Available;Not Available	30;30	172;172	40;40	Carboplatin;Taxol	Not Available;Not Available	11;11	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1743-F28209	b213f402-12f7-443a-bce1-f344086505fb	2	1329	1329	Not Available	Not Available	Not Available	Not Available	Not Available	6	Not Available;Not Available	NO;NO	Not Available;829	809;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1743	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	Not Available	Dead	2009	2004
TCGA-13-0762	65	FEMALE	3400	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1003.0			TUMOR FREE		65	Bilateral	TCGA-13-0762	6485b68f-caa7-45cd-9bc5-78c2add8191d	24	-23960	Not Applicable	0	981	TCGA-13-0762-D24550;TCGA-13-0762-D24551;TCGA-13-0762-D24552	55ae7407-0449-4ebf-bbdb-234a9b82628c;83cbff94-94d3-48a7-b33a-4271d6aef3f5;93f06508-dccf-4618-83f4-c16fd7ac7e53	Not Available;Not Available;Not Available	17;17;17	141;141;141	28;28;28	Cisplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;135;60	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0762-F24549;TCGA-13-0762-F72597	42abf706-0f37-4c0a-944b-88df5792202d;0773DF26-639F-47D0-9ED2-1F03EDCD08DE	24;30	Not Applicable;Not Applicable	981;3400	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;1003	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	80	Not Available	2	G3									Not Available	Not Available	0762	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2006
TCGA-42-2593	67	FEMALE	45	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	45			WITH TUMOR		67	Bilateral	TCGA-42-2593	3db7ecdd-315f-4475-a375-f6044a4b0070	19	-24823	45	0	Not Available																								4	NOT HISPANIC OR LATINO	TCGA-42-2593-F39341	56EC3E81-18F8-4A94-8F7A-B5CCD891144C	17	45	Not Available	Not Available	Scheduled Follow-up Submission	Not Applicable	Not Available	NO	1									NO	Not Available	WITH TUMOR	NO	Not Applicable	NO	Dead	2013	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	7	G3									Not Available	Not Available	2593	Other	WITH TUMOR	Not Available	Not Available	AMERICAN INDIAN OR ALASKA NATIVE	Not Available																			R2	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	YES	NO	42	>20 mm	Ovary	YES	Dead	2010	2009
TCGA-59-2352	78	FEMALE	286	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	286			WITH TUMOR		78	Right	TCGA-59-2352	758e6b52-062e-4ca0-84d1-ea38477414ac	29	Not Available	286	0	Not Available																								Not Available	NOT HISPANIC OR LATINO																												FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2352	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	59	Not Available	Ovary	Not Available	Dead	2010	2002
TCGA-13-0768	73	FEMALE	1784	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	398.0			TUMOR FREE		73	Bilateral	TCGA-13-0768	e732f81c-9b7d-44bd-a905-ff53fbed5009	24	-26999	Not Applicable	0	257	TCGA-13-0768-D24576;TCGA-13-0768-D24577;TCGA-13-0768-D24575;TCGA-13-0768-D24573;TCGA-13-0768-D24574	bc1188fa-1bdd-4a7b-9857-005920b5ddf7;17b07201-3aff-475c-b83e-6497ed980195;7fb6b1aa-f42a-491c-a202-18df8a0d0f5f;57e7d052-fdbb-4d18-85e9-c79ba8256d7b;419fde28-a4fc-450e-9eea-2e2bfb358bda	Not Available;Not Available;Not Available;Not Available;Not Available	17;17;17;17;17	148;148;148;57;57	78;78;78;36;36	Paclitaxel;Paclitaxel;Cisplatin;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4	4;4;4;2;2	Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IP;IP;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	135;60;75;6;175	mg/m2;mg/m2;mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0768-F24572;TCGA-13-0768-F72603	3c46ff04-2725-424b-a388-c837eb62ceec;CE928BA8-361B-4259-AA02-36B2E94364D8	24;30	Not Applicable;1784	257;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;398	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	60	Not Available	2	G3									Not Available	Not Available	0768	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-24-1549	58	FEMALE	1721	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G3	1	1042.0		Recurrence	WITH TUMOR		58	Bilateral	TCGA-24-1549	3b81ec7c-0934-4649-9231-9919dd26dd15	12	-21432	1721	0	1721	TCGA-24-1549-D26114;TCGA-24-1549-D26118;TCGA-24-1549-D26122;TCGA-24-1549-D26115;TCGA-24-1549-D26119;TCGA-24-1549-D26120;TCGA-24-1549-D26116;TCGA-24-1549-D26117;TCGA-24-1549-D26123;TCGA-24-1549-D26125;TCGA-24-1549-D26128;TCGA-24-1549-D26121;TCGA-24-1549-D26124;TCGA-24-1549-D26126;TCGA-24-1549-D26127	678cf3de-c647-4e78-b3d1-7540322bb15b;d80cf401-7c03-46d9-811a-35f6ca35de19;48e4085b-04cf-45c7-aa48-96f5b687e896;9b813b03-b91a-4d45-a2b3-3fb971350e7c;58e05d89-9a97-460f-ad0e-e15e4bfc2277;f0686f43-a6af-4c6c-8a21-ba3f086ff822;924adb2e-a095-4a4f-8783-fc6f490f2f3c;e6e97277-54e1-4889-9cfd-2defde4c7f2f;50c23ce7-dc88-463e-b3d3-46f14ecb21d9;dd2a3437-2db9-4766-a79d-c31bbbc85e04;c6fa6de4-b848-4745-9dd7-3f0fdad55379;91dafd17-6ac1-41ec-a1fa-16d7af1f1a24;b98c19e8-a11c-4161-9d42-53caa322ca87;1896232b-3242-4294-a28e-cb7b347ad760;eb07e660-7282-4a69-af97-edc6838f09b4	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12;12;12;12;12;12;12;12;12;12	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;1518;Not Available;Not Available;Not Available;Not Available;Not Available	Carboplatin;Toptecan;VP16;Taxol;Taxol;Gemzan;Carboplatin;Taxol;Carboplatin;Taxotere;Taxol;Doxil;Cisplatin;Xeloda;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;5;5;5;5;5	06;07;Not Available;06;Not Available;Not Available;06;06;Not Available;Not Available;Not Available;Not Available;Not Available;02;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;RECURRENCE;PROGRESSION;ADJUVANT;PROGRESSION;PROGRESSION;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;Not Available;IV;IV;IV;IV;IV;Not Available;IV;IV;IV;Not Available;PO;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1549-F26113	1c5bdf4e-cb21-4fd2-8079-c0390be43a7e	12	1721	1721	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES;YES	NO;NO	Not Available;1154	1042;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1549	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	Not Available	Ovary	Not Available	Dead	2009	1997
TCGA-25-1628	67	FEMALE	627	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	287.0		Recurrence	WITH TUMOR		67	Not Available	TCGA-25-1628	3f917550-89a6-404b-94df-938c99121411	2	-24488	627	0	627	TCGA-25-1628-D26726;TCGA-25-1628-D26727;TCGA-25-1628-D26725	3ec7e384-43ab-4947-a08c-80b115ff8ef0;6b515f85-0f51-40e8-a3c8-80ce274d199e;60320a2a-a599-48c4-ba83-457f94d9c083	Not Available;Not Available;Not Available	17;17;17	182;350;182	35;299;35	Carboplatin;Gemcitabine;Taxol	Not Available;Not Available;Not Available	6;6;6	08;02;08	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1628-F26724	50828490-96eb-46a5-9103-3b979676fea8	2	627	627	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;483	287;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1628	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-10-0938	80	FEMALE	636	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	362.0		Progression of Disease	WITH TUMOR		80	Bilateral	TCGA-10-0938	7ca97692-0bf5-4bbd-81ce-10a051d04bd5	6	-29558	636	0	604	TCGA-10-0938-D24487;TCGA-10-0938-D24486;TCGA-10-0938-D24485;TCGA-10-0938-D24484	c66f69b0-dcca-4e31-a97d-f082c418b72e;10f1ac83-b3d8-4d46-8f20-0375c6e60795;4ec299a4-7ca0-401b-a821-eb152b0bdb5e;23a9ca35-0862-46fa-a079-8d3834f1178c	Not Available;Not Available;Not Available;Not Available	18;18;18;18	153;148;188;188	30;30;41;41	Lupron;Letrozole;Taxotere;Carboplatin	Not Available;Not Available;Not Available;Not Available	3;3;3;3	Not Available;Not Available;06;06	Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2	OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Adjuvant and Progression;Adjuvant and Progression;Adjuvant and Progression;Adjuvant and Progression	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Hormone Therapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	3.75;225;960;3150	mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	2	Not Available	TCGA-10-0938-F24483	18a036e5-6796-4246-8bb6-2f23e0727ca7	6	636	604	2	Not Available	Not Available	Not Available	Not Available	3	Not Available;Not Available	Not Available;Not Available	Not Available;362	362;Not Available	Progression of Disease;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Not Available	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0938	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	>20 mm	Ovary	Not Available	Dead	2009	2002
TCGA-24-2026	79	FEMALE	1059	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1059			Not Available		79	Bilateral	TCGA-24-2026	2517ca7a-6057-4c19-b7e1-f6d078e9881a	15	-29050	1059	0	1059	TCGA-24-2026-D26457;TCGA-24-2026-D26458	f88ee7b6-f4e7-481c-9ef4-5fd54df656e6;ea8accae-d7ca-4fd7-ad89-da2f1cc2e415	Not Available;Not Available	15;15	Not Available;Not Available	23;23	Taxol;Cisplatin	Not Available;Not Available	3;3	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-24-2026-F26456	69ced7f3-1e11-4515-89e8-2e5e148f5271	15	1059	1059	Not Available	Not Available	Not Available	Not Available	Not Available	3									Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	3	G3									Not Available	Not Available	2026	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1995
TCGA-23-1809	63	FEMALE	16	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G3	0	16			Not Available		63	Right	TCGA-23-1809	bc3e0b74-ea09-46a5-9f61-16bd15ffd883	2	-23111	Not Applicable	0	16	TCGA-23-1809-D25754;TCGA-23-1809-D25755	548a5293-e55f-4f0d-aea8-880f79908766;6dab45bd-9189-4f7a-a844-85635ed7cbf7	Not Available;Not Available	9;9	107;107	24;24	Paclitaxel;Carboplatin	Not Available;Not Available	12;12	05;05	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1495;1898	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1809-F25753	834f38af-e051-41c8-aae9-1f2ff067b02e	2	Not Applicable	16	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1809	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	NO	Alive	2009	2009
TCGA-24-1560	51	FEMALE	1341	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G4	1	143.0		Recurrence	WITH TUMOR		51	Left	TCGA-24-1560	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	2	-18671	1341	0	1341	TCGA-24-1560-D26225;TCGA-24-1560-D26228;TCGA-24-1560-D26231;TCGA-24-1560-D26229;TCGA-24-1560-D26223;TCGA-24-1560-D26227;TCGA-24-1560-D26235;TCGA-24-1560-D26226;TCGA-24-1560-D26224;TCGA-24-1560-D26232;TCGA-24-1560-D26222;TCGA-24-1560-D26230;TCGA-24-1560-D26233;TCGA-24-1560-D26234	519de3c8-57e8-4eff-b384-e6009fef6629;187361ca-a5d7-4c06-9f76-a4e679d45120;bfb5f291-5d88-41ff-b188-cd65f7d75f9d;f16bdc03-c3a6-4145-b549-b96b1f1ed982;6a13deac-102e-4729-9d5d-1f596ff8ddbd;38a5fbe9-e640-4d56-b32b-034b72d65f5f;c351ac0b-9b82-4bb8-805d-fa9600249741;f6f38be5-a3cf-4506-8aff-4ba14246fdc2;c4244ff8-464e-4aca-994a-e9ba64291b6b;7b14e46a-8a83-4fc5-b3ca-f941f72a255a;b3f798db-b752-4079-b430-8d7d3cea945c;a5d8710d-3672-4dda-b17b-f73e9e9c6238;eaaa368c-902a-4b74-8d3a-8f1c52f88526;4cc322ae-a086-4db1-9219-ea8fd592c0b2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27;27;27;27;27;27;27;27;27	481;614;901;726;117;614;1258;614;481;901;117;726;1015;1189	398;509;757;635;15;509;1216;509;398;757;15;635;931;1043	Topotecan;Carboplatin;Carboplatin;Gemzar;Carboplatin;Taxol;Carboplatin;Amitostin;Topotecan;Etopside;Taxol;Doxil;Xeloda;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;7;7;7;7;7;7;7;7;7;7;7;7;7	05;06;06;03;06;06;03;06;05;06;06;03;05;05	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;PROGRESSION;RECURRENCE;RECURRENCE;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;Other (specify below);IV;IV;IV;IV;IV;IV;Other (specify below);IV;IV;PO;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	48;3100;2875;15000;4620;1730;1640;7220;48;4650;1620;200;210000;2730	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1560-F26221	f5657f7d-8bbe-49b7-875c-32d3c45a6b02	2	1341	1341	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	143	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G4									Not Available	Not Available	1560	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1999
TCGA-61-1916	53	FEMALE	475	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	326.0		Recurrence	Not Available		53	Bilateral	TCGA-61-1916	b25b3379-df8f-4900-9bce-0f8df50f549b	26	-19463	475	0	475	TCGA-61-1916-D28286;TCGA-61-1916-D28287;TCGA-61-1916-D28285;TCGA-61-1916-D28288	e5b625fa-134d-465f-b7c8-424ba5a72067;598ec300-0689-445d-8bf0-36cb29f5a1b8;24ff60f6-90b7-445c-ad89-3ccb0e5e15ba;5e8b3d4e-c2e0-42c2-b5e8-a398b22b2443	Not Available;Not Available;Not Available;Not Available	26;26;26;26	Not Available;Not Available;Not Available;Not Available	37;142;37;142	Carboplatin;Taxol;Topotecan;Carboplatin	Not Available;Not Available;Not Available;Not Available	2;2;2;2	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1916-F28284	bdb38e81-b854-4e27-b784-47790d09af9d	26	475	475	Not Available	Not Available	Not Available	Not Available	Not Available	2	Not Available;Not Available	Not Available;Not Available	Not Available;367	326;Not Available	Recurrence;Metastatic	Not Available;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8461/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	2	G2									Not Available	Not Available	1916	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Dead	2010	2002
TCGA-59-2348	59	FEMALE	5481	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	5481			TUMOR FREE		59	Bilateral	TCGA-59-2348	20cf00ea-d7da-42bb-bce7-f005f0b952eb	29	Not Available	Not Applicable	0	5481																								Not Available	NOT HISPANIC OR LATINO	TCGA-59-2348-F28098	46960c42-55ef-44c0-8839-18409aac5337	29	Not Applicable	5481	Not Available	Not Available	Not Available	Not Available	Not Available	1									Not Available	Not Available	TUMOR FREE	Not Available	Complete Remission/Response	Not Available	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2348	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	59	Not Available	Ovary	Not Available	Alive	2010	1994
TCGA-61-1728	59	FEMALE	848	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	1	533.0		Recurrence	TUMOR FREE		59	Bilateral	TCGA-61-1728	07fbdb3c-8337-4319-8255-f2363f8a031e	2	-21582	Not Applicable	0	848	TCGA-61-1728-D28158;TCGA-61-1728-D28157;TCGA-61-1728-D28159	f040590a-48e8-4891-9aff-f2534f18ff54;f38cdfc3-7031-4308-ad4e-4dc2ee43c0d7;c225c5ce-5c01-4ae5-b74f-a6e2034824bf	Not Available;Not Available;Not Available	30;30;30	204;848;204	43;246;43	Carboplatin;SNS 595;Taxol	Not Available;Not Available;Not Available	11;11;11	08;20;08	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	5280;1920;2000	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1728-F28156	16d97d30-b99b-4b12-9913-cf03f002008d	2	Not Applicable	848	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;533	533;Not Available	Recurrence;Metastatic	Not Available;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1728	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	NO	Alive	2009	2007
TCGA-13-1403	48	FEMALE	2345	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	418.0			TUMOR FREE		48	Left	TCGA-13-1403	0d5e232d-5aa2-4f6f-be58-ffd5f15ee0b8	20	-17697	Not Applicable	0	331	TCGA-13-1403-D24794;TCGA-13-1403-D24795;TCGA-13-1403-D24796	f08d91eb-9a00-43ad-89ce-b0780a1d9bf4;904c042a-d9f6-41fa-a753-91928f69b54d;5e06e147-2f73-44ea-b089-fd40985fc5f4	Not Available;Not Available;Not Available	30;30;30	142;142;142	27;27;27	Cisplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available	6;6;6	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	75;135;60	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1403-F24793;TCGA-13-1403-F72653	1b8ebf1f-79f6-4198-ad79-00cec38ef301;324D70B6-1848-46CD-9E8F-798C5937E1FA	20;31	Not Applicable;2345	331;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;418	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1403	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2008
TCGA-13-0887	42	FEMALE	2028	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	514.0		Recurrence	WITH TUMOR		42	Bilateral	TCGA-13-0887	14c58def-60ee-48e0-a74b-da4eb77ef344	25	-15669	2028	0	2028	TCGA-13-0887-D24669;TCGA-13-0887-D24671;TCGA-13-0887-D24670	36a82010-4db9-46e7-9ff5-8fb49a5d51ff;f8042e57-3947-4ac3-ac85-7c47074317e3;c463c28f-e65d-4bb2-a88a-9550f415cdd9	Not Available;Not Available;Not Available	15;15;15	114;268;114	7;184;7	Carboplatin;Cisplatin;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	6;4;6	Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0887-F24668	5db4b8a6-caf0-4a60-9eb5-01711d0b7af9	25	2028	2028	Not Available	Not Available	Not Available	80	Not Available	2	YES	NO	Not Available	514	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	80	Not Available	2	G3									Not Available	Not Available	0887	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-61-2008	40	FEMALE	932	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G2	1	818.0		Recurrence	WITH TUMOR		40	Bilateral	TCGA-61-2008	3ac45a71-c463-4f0f-b030-58c475a34418	8	-14791	Not Applicable	0	932	TCGA-61-2008-D28339;TCGA-61-2008-D28336;TCGA-61-2008-D28338;TCGA-61-2008-D28337;TCGA-61-2008-D28335	f5583f7b-a50c-4bf5-a9c9-11a8333d4781;d05da628-44eb-4405-8981-f0723b085b60;5258713d-41d6-476f-9869-3f98a9284455;e3ffc3a5-5a6b-4053-a5c4-3a61628c98ce;aae34ce1-d57d-4c05-924f-9c8a7cbc4f8f	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	979;149;979;979;149	861;29;861;861;29	Taxol;Taxotere;Cisplatin;Taxol;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	06;06;06;06;06	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg	RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IP;IV;IP;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	372;690;702;1260;3600	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2008-F28334	f45f3fe2-1f97-4e6f-afc7-d3abf0f3311a	8	Not Applicable	932	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES;YES	NO;NO	Not Available;828	818;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	12	G2									Not Available	Not Available	2008	Not Available	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	YES	Alive	2009	2007
TCGA-10-0931	44	FEMALE	1000	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	300.0		Recurrence	WITH TUMOR		44	Bilateral	TCGA-10-0931	e07a61e2-bcd2-4a96-80df-97e04aafbd32	6	-16262	1000	0	982	TCGA-10-0931-D24445;TCGA-10-0931-D24443;TCGA-10-0931-D24442;TCGA-10-0931-D24452;TCGA-10-0931-D24446;TCGA-10-0931-D24448;TCGA-10-0931-D24451;TCGA-10-0931-D24444;TCGA-10-0931-D24450;TCGA-10-0931-D24447;TCGA-10-0931-D24441;TCGA-10-0931-D24449	9c1c5ddc-68bf-48fb-8cae-507131f94067;44b0875b-a102-42e4-a61f-abfce289b500;dfdc84f0-c615-4da5-b487-34e7f9691adc;bffe9f9b-5c33-4340-b4d7-14f05b68f15f;392d5262-c107-42a2-b5a5-b33725bc6c95;e771584c-41ce-4c1b-a77f-01e3c8fe3d4b;8e89e478-3caf-4f3c-9f7d-6beb6d51b978;fdaa015f-c778-4f16-8461-faa4255fc6c0;8bd774bd-af1c-42d9-9e7f-5b3af5ba9fab;6f5f2462-b8d3-41a1-a759-bd6620dbea7a;9c726295-8f59-46f7-8c2b-82ffb7160c98;473285f6-556e-4b10-b85c-03b35b3fd7c6	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;18;18;18;18;18;18;18;18;18;18	509;124;124;848;666;666;383;509;932;666;124;848	386;19;19;792;538;538;335;386;876;538;19;792	Carboplatin;Herceptin;Carboplatin;Irressa;Carboplatin;Taxotere;Tamoxifen;Taxol;Doxil;Taxotere;Taxol;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3;3;3;3	06;06;06;Not Available;8;06;Not Available;06;3;4;06;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;Not Available;mg/m2;mg/m2;mg;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;Not Available;Not Available;Not Available;NO;Not Available;NO;NO;NO;NO;Not Available;NO	Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3240;2268;Not Available;14000;1840;420;1880;1632;231;440;2430;23.78	mg/m2;mg/m2;Not Available;mg/m2;mg/m2;mg;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	1	Not Available	TCGA-10-0931-F24440	c2b9ac2e-f094-4664-81f1-ba7e9a64ca33	6	1000	982	1	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	300	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0931	Preoperative	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	10	1-10 mm	Ovary	NO	Dead	2009	2002
TCGA-13-1407	51	FEMALE	2534	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1333.0			TUMOR FREE		51	Bilateral	TCGA-13-1407	f2dcf4cc-609d-4532-a90d-6ae2bbb53365	20	-18896	Not Applicable	0	184	TCGA-13-1407-D24808;TCGA-13-1407-D24809	4cd8eaeb-42d7-43f3-b626-83394aa6a3f9;8ada4cc3-f455-4065-9def-1341957f353d	Not Available;Not Available	30;30	184;184	42;42	Carboplatin;Paclitaxel	Not Available;Not Available	6;6	7;7	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1407-F24807;TCGA-13-1407-F72657	019f9660-f6a5-40c5-a156-998044af77a1;067C0773-1144-4C81-9A42-015B11AF1692	20;31	Not Applicable;Not Applicable	184;2534	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	Not Available;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;1333	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Not Available;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1407	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2008
TCGA-24-1603	53	FEMALE	2742	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G3	1	992.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-24-1603	19427350-619b-4b9c-a3ba-37f667bb2843	13	-19681	2742	0	2742	TCGA-24-1603-D26288;TCGA-24-1603-D26296;TCGA-24-1603-D26289;TCGA-24-1603-D26294;TCGA-24-1603-D26295;TCGA-24-1603-D26287;TCGA-24-1603-D26292;TCGA-24-1603-D26290;TCGA-24-1603-D26286;TCGA-24-1603-D26285;TCGA-24-1603-D26293;TCGA-24-1603-D26297;TCGA-24-1603-D26291	5d9979f4-99a7-405a-93ed-dabecce5eacd;d4130ac0-ad5f-40f4-bc29-77b8a859e40b;6d56fba5-bc5f-4161-b73f-5a4fa8ee9809;040db0b8-aff7-4a23-91e1-26379fb0e44c;38ef06ab-1145-47bd-b309-658243311e65;faecc8ec-f46c-4ea3-a013-3370d0692293;087cc90f-f414-4d12-b7a8-7c94798e1b4c;931b22e6-c6ab-4846-b1a4-4a22273d74c1;3dcddc28-0f92-48c0-81ee-683913402b4d;29019868-73c5-442e-93bb-8e83ea1504ae;8366500b-f54e-499d-98e4-e46780890b36;8f14e722-33d5-4063-9ffc-83a6ed940314;f52b3576-79f5-4a6e-917a-2e7962393f43	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13;13;13;13;13;13;13;13	1181;2629;1516;2203;2448;1181;1991;1516;Not Available;Not Available;1991;2629;1853	1107;2568;1356;2022;2234;1107;1899;1356;Not Available;Not Available;1899;2629;Not Available	Taxol;Topotecan;Carboplatin;Taxol;Carboplatin;Carboplatin;Gemzar;Taxol;Carboplatin;Taxol;Doxil;Taxotere;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;5;5;5	06;Not Available;08;28;9;06;09;08;06;06;09;01;09	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	RECURRENCE;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;RECURRENCE;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;Not Available;Not Available;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1603-F26284	7aa0d9f9-ecbe-4159-89a9-08c599697834	13	2742	2742	Not Available	Not Available	Not Available	Not Available	Not Available	5	YES	NO	Not Available	992	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1603	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	Not Available	Ovary	Not Available	Dead	2009	1996
TCGA-20-0991	78	FEMALE	797	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIB	G3	0	797			TUMOR FREE		78	Right	TCGA-20-0991	36595b52-2b5f-4e87-80eb-37c29109e92a	23	-28694	Not Applicable	0	797	TCGA-20-0991-D25531	8a48bcf0-7943-48da-89c6-1831cbe9da03	Not Available	16	Not Available	71	Carboplatin	Not Available	3	03	Not Available	mg/m2	ADJUVANT	Not Applicable	Not Available	IV	Not Available	Chemotherapy	Not Available	425	mg/m2	Not Available	2009	0	NOT HISPANIC OR LATINO	TCGA-20-0991-F25530	974f709b-2b9a-4a59-86a5-15974cdd107b	23	Not Applicable	797	0	Not Available	Not Available	Not Available	Not Available	2									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0991	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	20	No Macroscopic disease	Ovary	Not Available	Alive	2009	2006
TCGA-13-0904	63	FEMALE	1532	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	330.0		Progression of Disease	WITH TUMOR		63	Bilateral	TCGA-13-0904	0b519c08-9f23-4ceb-9a13-e16509ca55d7	25	-23278	Not Applicable	0	1470	TCGA-13-0904-D24724;TCGA-13-0904-D24725;TCGA-13-0904-D24727;TCGA-13-0904-D24726	19a07949-eb4b-4ca2-a6e4-dbcaa275a295;0dfb4665-f7e4-48fa-a171-2ca620eb578c;a552a880-bcd5-438e-9595-7eea9cc4ab4b;df387235-8141-4dd9-bcf3-500fb9ffaece	Not Available;Not Available;Not Available;Not Available	15;15;16;16	84;84;251;251	63;63;105;105	Carboplatin;Paclitaxel;Docetaxel;Carboplatin	Not Available;Not Available;Not Available;Not Available	4;4;4;4	2;2;6;6	Not Available;Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;Not Available	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;175;Not Available;Not Available	Not Available;mg/m2;mg/m2;Not Available	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0904-F24723;TCGA-13-0904-F72625	ab164d3c-baee-40a5-b0fd-dbb870fa1f3b;175A1E0A-A381-4E59-94A3-D5DA40149A80	25;30	Not Applicable;1532	1470;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	YES;Not Available	NO;Not Available	Not Available;Not Available	330;330	Progression of Disease;Unknown	Not Available;Not Available	Imaging Study;Not Available	Not Applicable;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	WITH TUMOR;WITH TUMOR	YES;Not Available	Partial Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	80	Not Available	2	G3									Not Available	Not Available	0904	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Alive	2009	2004
TCGA-36-2549	54	FEMALE	184	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G3	0	184			TUMOR FREE		54	Bilateral	TCGA-36-2549	9815ab87-454d-4dfc-8b3d-4b35af32d764	18	-20076	Not Applicable	0	184	TCGA-36-2549-D27967;TCGA-36-2549-D27968	45c7c8d0-307f-4398-800e-680320d860a1;5a6c332e-d031-47ff-8289-63c802a63356	Not Available;Not Available	18;18	181;181	41;41	Carboplatin;Paclitaxel	Not Available;Not Available	8;8	06;06	710;309	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	4400;1854	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-36-2549-F27966	6c2295e6-1597-4bc3-b5a4-18a051398009	18	Not Applicable	184	Not Available	Not Available	Not Available	Not Available	Not Available	8									Not Available	Not Available	TUMOR FREE	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2549	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	No Macroscopic disease	Ovary	Not Available	Alive	2010	2008
TCGA-23-1122	53	FEMALE	1189	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	447.0		Recurrence	WITH TUMOR		53	Left	TCGA-23-1122	d2c0d320-d1c5-4eed-af4f-15540e60db0b	19	-19537	1189	0	Not Available	TCGA-23-1122-D25729;TCGA-23-1122-D25730;TCGA-23-1122-D25726;TCGA-23-1122-D25725;TCGA-23-1122-D25727;TCGA-23-1122-D25728	75bcf34f-515a-4ada-aca8-b0e8548a4a67;5b6a82d6-b750-44e9-b52f-c8ce5cd84a75;9be1fb51-4bb5-4ad9-8bdd-d26152e731aa;948c7d43-3dbd-4e69-b81b-ba635e818523;5490f2a7-3eb4-4529-b556-001c0b298aaf;d4bbd55b-fc97-42f6-bb91-518b51ae30d0	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27	1031;1089;686;244;754;859	921;1054;501;27;707;775	Ifosfamide;Cisplatin;Gemcitabine;Carboplatin;Gemzar;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	6;6;20;8;5;9	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES;RECURRENCE;ADJUVANT;RECURRENCE;OTHER, SPECIFY IN NOTES	"Persistence";Persistence;Not Applicable;Not Applicable;Not Applicable;"Persistence"	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	72;240;15900;4200;3500;5900	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-23-1122-F25724	835873b9-9590-4af3-b5ac-33688f902940	19	1189	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES;YES	YES;YES	Not Available;470	447;Not Available	Recurrence;Metastatic	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	2	G3									Not Available	Not Available	1122	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-23-1122-R25731	bbcfcd21-0ecd-4b31-afe0-3287ce3c3b97	Not Available	19	1089	1054	Not Available	2	29	14290	NO	EXTERNAL BEAM	Not Applicable	PROGRESSION	Not Available	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	Not Available	Dead	2009	1998
TCGA-36-2551	57	FEMALE	492	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	338.0		Recurrence	WITH TUMOR		57	Bilateral	TCGA-36-2551	9f096022-e3ec-4f63-8c52-03ef24c018f3	18	-21045	Not Applicable	0	492	TCGA-36-2551-D27973;TCGA-36-2551-D27972;TCGA-36-2551-D27974;TCGA-36-2551-D27971	c5bf7b9a-ad76-474f-9a4c-47d768c31c8c;d1503daa-5943-43ab-bce9-9e6c09b8eab5;0ca9fe75-fd2c-420d-9ba2-b0f3b63798df;21e402db-38f5-420a-be93-d6c90b1b5f97	Not Available;Not Available;Not Available;Not Available	18;18;18;18	Not Available;163;Not Available;198	346;38;346;16	Carboplatin;Paclitaxel;Liposomal Doxorubicin;Carboplatin	Not Available;Not Available;Not Available;Not Available	8;8;8;8	6;06;Not Available;08	555;243;55;650	mg;mg;mg;mg	RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	YES;NO;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	Not Available;1602;Not Available;6340	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-36-2551-F27970	87bc498f-d002-429f-a48a-47c19dff4fae	18	Not Applicable	492	Not Available	Not Available	Not Available	Not Available	Not Available	8	YES	NO	Not Available	338	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	NO	8	G3									Not Available	Not Available	2551	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	Not Available	Alive	2010	2009
TCGA-29-1766	74	FEMALE	1199	Serous Cystadenocarcinoma	Peritoneum ovary	Dead	Stage IIIC	G2	1	672.0		Recurrence	WITH TUMOR		74	Right	TCGA-29-1766	01ea6354-137b-47f3-9021-a01a382b1147	2	-27359	1199	0	1190	TCGA-29-1766-D27351;TCGA-29-1766-D27352;TCGA-29-1766-D27356;TCGA-29-1766-D27354;TCGA-29-1766-D27355;TCGA-29-1766-D27353	ef80a8af-4328-4fe3-8e92-d75f92c1b8f2;85e08cba-87ad-4cd9-a99a-e7e8ebce3b30;af7205f0-a192-41e7-b706-5f49b22dc251;0abcc6b0-9996-4a86-8660-099bc0af0f02;bbd623cf-b7e5-418b-92c9-bf283a3e5baa;28d919af-cf13-4344-82b0-4b3bf6086ddb	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10;10;26;26;26;26	196;189;1112;727;909;406	39;98;1084;685;825;224	Gemcitabine;Carboplatin;Topotecan;Carboplatin;Doxil;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;4;4;4;4	11;04;04;03;04;09	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;AUC;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	19590;1580;5.4;6;75;320	mg;mg;mg;AUC;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010;2010	0	Not Available	TCGA-29-1766-F27350	043a6f1d-d0c2-411a-937d-9e5c790ed4ad	2	1199	1190	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	672	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C48.2	8441/3	C48.2	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1766	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	11-20 mm	Peritoneum ovary	Not Available	Dead	2009	2006
TCGA-61-1730	78	FEMALE	132	Serous Cystadenocarcinoma	Ovary	Dead	Stage IC	G3	0	132			WITH TUMOR		78	Left	TCGA-61-1730	107bd8af-13e6-4c6a-9bdc-83c08eaaff90	2	-28508	132	0	132																								Not Available	Not Available	TCGA-61-1730-F28161	92566454-18d4-4cca-a334-0485b15866f2	2	132	132	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	NO	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1730	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	NO	Dead	2009	2007
TCGA-25-2401	64	FEMALE	90	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	90			Not Available		64	Bilateral	TCGA-25-2401	3bc8a74f-49bd-46b6-a3a4-68ca838e83c6	5	-23711	90	0	90																								Not Available	NOT HISPANIC OR LATINO	TCGA-25-2401-F26829	94ff5853-4598-4507-831f-006d4aef14e2	5	90	90	Not Available	Not Available	Not Available	Not Available	Not Available	1									Not Available	Not Available	Not Available	Not Available	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2401	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2010	2004
TCGA-36-1578	63	FEMALE	847	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G3	1	310.0		Recurrence	WITH TUMOR		63	Not Available	TCGA-36-1578	f65f2e78-c001-4ef3-ae88-3e4f83c7aceb	2	-23329	Not Applicable	0	847	TCGA-36-1578-D27887;TCGA-36-1578-D27885;TCGA-36-1578-D27886	67ff741a-20f6-473c-93bf-60dc4e5ef139;72c7d40a-c4da-405a-8c98-02ff8c7b4036;f8bb0861-fe1f-4810-b9ca-bbfb06383418	Not Available;Not Available;Not Available	17;17;17	345;212;212	321;15;15	Liposomal Doxorubicin;Carboplatin;Paclitaxel	Not Available;Not Available;Not Available	2;2;2	02;11;9	Not Available;Not Available;Not Available	mg;mg;mg	PROGRESSION;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	136;4830;2013	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	0	NOT HISPANIC OR LATINO	TCGA-36-1578-F27884	35caaae5-e969-4b89-bba6-dfc7859ae181	2	Not Applicable	847	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	310	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Preoperative	WITH TUMOR	YES	Not Available	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1578	Preoperative	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	>20 mm	Ovary	NO	Alive	2009	2007
TCGA-36-1577	43	FEMALE	783	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G2	0	783			TUMOR FREE		43	Bilateral	TCGA-36-1577	e294b940-2828-499c-be24-47ef6c2e9035	2	-15804	Not Applicable	0	783	TCGA-36-1577-D27879;TCGA-36-1577-D27880	983593fc-3f1f-42ad-b8ae-4c4868fc29b6;1cf4b2f0-97fd-4253-9c7c-3486f0010871	Not Available;Not Available	18;18	84;84	28;28	Carboplatin;Paclitaxel	Not Available;Not Available	8;8	03;03	611;248	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1833;744	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-36-1577-F27878	210fbda1-7211-4d2b-9eea-f48f0d3f8567	2	Not Applicable	783	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	YES	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1577	Not Available	TUMOR FREE	Not Available	Not Available	ASIAN	Not Available	Primary Tumor Field;Primary Tumor Field	TCGA-36-1577-R27881;TCGA-36-1577-R27882	026101b1-4770-4f24-9ad1-2d5e6463ff14;126c8f98-b503-4cff-ae77-232b4ee73e54	Not Available;Not Available	18;18	156;156	111;111	Not Available;Not Available	8;8	11;22	2250;2250	NO;NO	EXTERNAL BEAM;EXTERNAL BEAM	Not Applicable;Not Applicable	ADJUVANT;ADJUVANT	Not Available;Not Available	cGy;cGy	2010;2010	Not Available	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	No Macroscopic disease	Ovary	Not Available	Alive	2009	2007
TCGA-24-1427	58	FEMALE	147	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	147			WITH TUMOR		58	Bilateral	TCGA-24-1427	02d9aa2e-b16a-48ea-a420-5daed9fd51a6	15	-21423	Not Applicable	0	147	TCGA-24-1427-D25958;TCGA-24-1427-D25957	f0961ad4-f0c1-406c-ae2d-9d44d6118237;c30b8039-7ef8-495e-954e-b0985c302c10	Not Available;Not Available	16;16	147;147	14;14	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3848;1996	mg;mg	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-24-1427-F25956	d5a10323-1f25-4c1f-9f25-44f6a2648a1d	15	Not Applicable	147	Not Available	Not Available	Not Available	Not Available	Not Available	4									Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	4	G3									Not Available	Not Available	1427	Not Available	WITH TUMOR	Not Available	Not Available	Not Available	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-24-2271	55	FEMALE	962	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	827.0		Recurrence	WITH TUMOR		55	Bilateral	TCGA-24-2271	a8c4a333-6b67-44c8-9000-516f8ccea788	5	-20399	962	0	962	TCGA-24-2271-D26559;TCGA-24-2271-D26558	6efd5855-3b58-4628-9e62-c993e2ad5554;9cc98084-f3e0-467d-aac7-d99952fa1fc1	Not Available;Not Available	25;25	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	6;6	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	RECURRENCE;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-24-2271-F26557	fd661ea5-f3fd-4b72-a100-02bd5ce517dc	5	962	962	Not Available	Not Available	Not Available	Not Available	Not Available	4	YES;YES	NO;NO	Not Available;22	827;Not Available	Recurrence;Metastatic	Not Available;YES	Physical Examination;Physical Examination	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	4	G3									Not Available	Not Available	2271	Not Available	WITH TUMOR	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	YES	Dead	2010	1999
TCGA-13-0886	67	FEMALE	4665	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	4665			TUMOR FREE		67	Bilateral	TCGA-13-0886	91de8a74-a1e6-46b6-a06e-70aedf2c3eaf	25	-24724	Not Applicable	0	2259	TCGA-13-0886-D24664;TCGA-13-0886-D24665;TCGA-13-0886-D24666	806d8340-5dbd-4b37-be0e-0a24f1819e6e;965956e2-03a9-4029-9a70-1be682b08540;189a2c96-a9c3-4a56-bbdb-12b6fd50f3fa	Not Available;Not Available;Not Available	15;15;15	132;132;263	12;12;221	Carboplatin;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available	4;4;4	6;6;3	Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0886-F24663;TCGA-13-0886-F72617	3e55773f-fd8a-4ea5-a2c0-b27dc4999829;8ECA3DB1-9337-4FA2-BA57-1A2C170B4BCD	25;30	Not Applicable;Not Applicable	2259;4665	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	Not Available;Not Available	Not Available;Not Available	2;7									Not Available;NO	Not Available;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0886	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2002
TCGA-36-2545	42	FEMALE	557	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIA	G3	0	557			TUMOR FREE		42	Bilateral	TCGA-36-2545	f3cd0ca3-8e5d-481b-b28c-619a4123dcd0	18	-15444	Not Applicable	0	557	TCGA-36-2545-D27955;TCGA-36-2545-D27956	f6ca9e7b-80f0-47bd-9a94-dad045441d16;f704b1b9-e697-44d8-9ce9-bd83bccb7ab4	Not Available;Not Available	18;18	145;152	19;19	Carboplatin;Paclitaxel	Not Available;Not Available	8;8	06;06	750;90	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IP;IP;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5450;2364	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-36-2545-F27954	9d76fdcd-128d-4287-8eb5-694eef3b5754	18	Not Applicable	557	Not Available	Not Available	Not Available	Not Available	Not Available	8									Not Available	Not Available	TUMOR FREE	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2545	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Stage IIIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	No Macroscopic disease	Ovary	Not Available	Alive	2010	2008
TCGA-24-0980	53	FEMALE	233	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	145.0		Recurrence	WITH TUMOR		53	Bilateral	TCGA-24-0980	d1eeaca3-52c0-4a0c-916a-fd64cec911d9	24	-19579	233	0	233	TCGA-24-0980-D25897;TCGA-24-0980-D25898	15cde1b3-b643-4d88-b4e5-6a05bfb9ab64;2f798bfb-2136-4d59-81f1-297bc7fbf831	Not Available;Not Available	27;27	178;178	77;77	paclitaxel;carboplatin	Not Available;Not Available	3;3	4;4	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	1265.5;2012	mg;mg	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-24-0980-F25896	01a4cffe-47b2-431f-8a34-e56b0f5fa229	24	233	233	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	145	Recurrence	Not Available	Other Method	patient did not complete adjuvant chemo. Druing her chemo there had been interval development of multiople bilaterl nodules and a new low attentuation legion in the spleen	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	YES	2	G3									Not Available	Not Available	0980	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2009	2003
TCGA-13-2059	50	FEMALE	2387	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	1005.0			TUMOR FREE		50	Bilateral	TCGA-13-2059	f4b56568-a74a-4a2e-89d9-11722ecf5948	1	-18449	Not Applicable	0	372	TCGA-13-2059-D24995;TCGA-13-2059-D24996;TCGA-13-2059-D24994	fcc5cdef-45eb-40d8-85c2-1b6517424003;47648d65-c903-46b2-9f45-69f99c62c6d9;ba631612-075c-4b0c-8da3-15387999edbf	Not Available;Not Available;Not Available	1;1;1	158;158;158	46;46;46	Paclitaxel;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available	2;2;2	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-13-2059-F24993;TCGA-13-2059-F72684	c56f861f-aa37-426d-968e-651e12e8c707;092F44C1-555D-4043-A5F5-331E09461C14	1;31	Not Applicable;Not Applicable	372;2387	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	80;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;1005	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2010;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	80	Not Available	2	G3									Not Available	Not Available	2059	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2010	2009
TCGA-13-0802	79	FEMALE	1552	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	510.0			TUMOR FREE		79	Bilateral	TCGA-13-0802	3c8b5986-f9d5-4e7e-9dd4-3ad301451279	25	-29075	Not Applicable	0	249	TCGA-13-0802-D24626;TCGA-13-0802-D24627	98c08254-9631-499e-b215-5c9c32eb8009;6327fc62-9594-4666-83cc-db0aed29baed	Not Available;Not Available	15;15	188;188	62;62	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	6;6	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0802-F24625;TCGA-13-0802-F72615	7d5cd3ae-c5d9-45a0-9372-c0cec72673e1;E5BF7B40-DC66-4D58-8072-2FAB2CEDE9CB	25;30	Not Applicable;1552	249;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	2;7	None;Not Available	None;Not Available	None;Not Available	None;510	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	60	Not Available	2	G3									Not Available	Not Available	0802	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	ASIAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	No Macroscopic disease	Ovary	Not Available	Alive	2009	2008
TCGA-25-2399	80	FEMALE	608	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	243.0		Recurrence	WITH TUMOR		80	Bilateral	TCGA-25-2399	ad2b1a0a-153f-483d-b228-5763eba3f6cc	5	-29373	608	0	608	TCGA-25-2399-D26820;TCGA-25-2399-D26819;TCGA-25-2399-D26821	2bdcf36c-2cf7-4179-8ba3-4fef5c34ce65;f67bbe0c-7be0-4fd0-9911-bdf622d7f6d3;9ca6cc56-eeb0-4463-8fad-adb07d1f9dae	Not Available;Not Available;Not Available	5;5;5	182;182;Discrepancy	61;61;Discrepancy	Taxol;Carboplatin;Doxil	Not Available;Not Available;Not Available	1;1;1	04;04;03	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	NOT HISPANIC OR LATINO	TCGA-25-2399-F26818	f2ca0f5d-438c-46cf-af2a-976cf4036f11	5	608	608	Not Available	Not Available	Not Available	Not Available	Not Available	1	YES	NO	Not Available	243	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2399	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	>20 mm	Ovary	Not Available	Dead	2010	2004
TCGA-24-1849	80	FEMALE	176	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	176			TUMOR FREE		80	Bilateral	TCGA-24-1849	94efd4f9-69b0-4efa-8a0c-61106e898fdd	2	-29555	Not Applicable	0	176	TCGA-24-1849-D26357;TCGA-24-1849-D26356	400d2f6c-3fea-402d-95b7-44939bd2741c;0521934a-f71f-4439-9f05-99c3eb435b47	Not Available;Not Available	24;24	141;141	36;36	Docetaxel;Carboplatin	Not Available;Not Available	8;8	06;06	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	696;3306	mg;mg	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-24-1849-F26355	f8e9aba6-d282-480f-bbee-d180107708b2	2	Not Applicable	176	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1849	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-09-2056	62	FEMALE	379	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	379			TUMOR FREE		62	Bilateral	TCGA-09-2056	ea6405c4-0fe4-4f37-bef2-275072f91e39	2	-22864	Not Applicable	0	379	TCGA-09-2056-D24401;TCGA-09-2056-D24400	83a5aabd-3f44-4398-9fd1-09ffac14acde;4782449f-9b8d-48f6-80e7-d05021eef896	Not Available;Not Available	2;2	147;147	25;25	Taxol;Carboplatin	Not Available;Not Available	11;11	6;6	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	HISPANIC OR LATINO	TCGA-09-2056-F24399	d88c100c-2a42-4ea1-8cf3-60def08194e0	2	Not Applicable	379	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	11	G3									Not Available	Not Available	2056	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2008
TCGA-13-0893	48	FEMALE	1319	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	461.0		Recurrence	WITH TUMOR		48	Bilateral	TCGA-13-0893	15170c7f-5880-4fb6-82ce-68d3df0dfb68	20	-17573	1319	0	1319	TCGA-13-0893-D24692;TCGA-13-0893-D24691;TCGA-13-0893-D24693	a48fb2d1-82b6-4f3b-b211-2319a0b329a7;79d5303d-f605-4215-ae23-86f9e3f1e193;5bdb21b9-a7f1-41eb-9eb0-ac3208afa81b	Not Available;Not Available;Not Available	30;30;30	284;284;566	80;80;340	Paciltaxel;Carboplatin;Femara	Not Available;Not Available;Not Available	6;6;6	8;8;Not Available	Not Available;Not Available;Not Available	mg/m2;Not Available;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available	175;5;2.5	mg/m2;Not Available;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0893-F24690	2e198688-0234-4ff0-bae5-0472ce5af182	20	1319	1319	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	461	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Partial Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	0893	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	11-20 mm	Ovary	Not Available	Dead	2009	2003
TCGA-59-2351	51	FEMALE	3532	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	2139.0		Progression of Disease	TUMOR FREE		51	Bilateral	TCGA-59-2351	16829472-5666-4fba-9bf9-360ec1689aa0	29	Not Available	Not Applicable	0	3532																								Not Available	NOT HISPANIC OR LATINO	TCGA-59-2351-F28104	714f1bfd-54f3-4a05-bbc7-3bc9bc5ace8e	29	Not Applicable	3532	Not Available	Not Available	Not Available	Not Available	Not Available	1	YES;YES	NO;NO	Not Available;2154	2139;Not Available	Progression of Disease;Both Locoregional and Distant Metastasis	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	TUMOR FREE	Not Available	Complete Remission/Response	Not Available	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	1	G3									Not Available	Not Available	2351	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	NO	YES	59	1-10 mm	Ovary	Not Available	Alive	2010	1999
TCGA-24-1419	62	FEMALE	239	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	239			TUMOR FREE		62	Bilateral	TCGA-24-1419	5e18b17d-4626-4b6d-8ac6-e560cee0376c	15	-22659	Not Applicable	0	239	TCGA-24-1419-D25931;TCGA-24-1419-D25930;TCGA-24-1419-D25932	fb686b35-70cb-45e0-991c-0169f28f0115;91f667fe-afb5-471d-af76-66b09ed65858;248762ea-e200-4742-b0f3-bcd821f96cf3	Not Available;Not Available;Not Available	15;15;24	Not Available;121;131	197;17;17	Pacitaxel;Carboplatin;Docetaxel	Not Available;Not Available;Not Available	4;4;4	02;06;6	Not Available;Not Available;Not Available	mg;mg;mg	OTHER, SPECIFY IN NOTES;ADJUVANT;ADJUVANT	Consolidation chemotherapy;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	YES;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	478;3882;806	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	Not Available	TCGA-24-1419-F25929	96d20828-bb11-4024-9701-2e35ab3fc712	15	Not Applicable	239	Not Available	Not Available	Not Available	Not Available	Not Available	4									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	4	G3									Not Available	Not Available	1419	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	11-20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-04-1516	48	FEMALE	1265	Serous Cystadenocarcinoma	Ovary	Alive	Stage IA	G3	0	1265			TUMOR FREE		48	Left	TCGA-04-1516	1c86e4e5-ecc9-4f6d-a557-77bf396a653b	25	-17768	Not Applicable	0	1265	TCGA-04-1516-D24090;TCGA-04-1516-D24089;TCGA-04-1516-D24088	c01ba4e5-6d06-430c-bed8-92b8566a1a2b;ad51a508-de7f-4d22-b4a2-a64aebe8ebb4;1cac7e12-6041-453f-bdcb-36d9023936fc	Not Available;Not Available;Not Available	25;25;25	157;157;Not Available	37;56;37	Carboplatin;Taxol;Taxotere	Not Available;Not Available;Not Available	6;6;6	6;05;01	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2010;2010;2010	0	Not Available	TCGA-04-1516-F24087	315cef90-6683-4c74-ae71-9888cc51cc33	25	Not Applicable	1265	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1516	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			R0	Not Applicable	Not Applicable	Stage IA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	04	No Macroscopic disease	Ovary	Not Available	Alive	2010	2006
TCGA-24-2289	68	FEMALE	2049	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	568.0		Recurrence	WITH TUMOR		68	Bilateral	TCGA-24-2289	b867e933-e3e3-4491-9bb6-b18c48d6f173	16	-25191	2049	0	2049	TCGA-24-2289-D26579;TCGA-24-2289-D26580;TCGA-24-2289-D26581	e30043ad-c281-46eb-9aa1-a49e87ab0647;586feb5d-42b7-4242-945c-dfdd16f8647e;09917dd3-3ce9-4899-8d93-69466b71bdb0	Not Available;Not Available;Not Available	16;16;16	183;183;708	4;4;598	Taxol;Cisplatin;Taxotere	Not Available;Not Available;Not Available	3;3;3	08;08;06	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	1735;645;957	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2010	Not Available	Not Available	TCGA-24-2289-F26578	1f1d7a75-371a-409e-abba-e228ad2397fc	16	2049	2049	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	568	Recurrence	Not Available	Molecular Markers	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2289	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1997
TCGA-09-2054	58	FEMALE	637	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	637			WITH TUMOR		58	Bilateral	TCGA-09-2054	cbd87697-7708-4b69-9e50-9ee474feabe1	2	-21285	637	0	637	TCGA-09-2054-D24389;TCGA-09-2054-D24391;TCGA-09-2054-D24393;TCGA-09-2054-D24390;TCGA-09-2054-D24392	5acfc9ba-d325-4e43-b8b4-154653154ad0;88f8d9fd-3a90-4644-abd7-48ee8c850bdf;d7d74c67-9d2c-43ce-8ccf-37ebb18b35fc;d033d1e2-585a-4515-a09c-3bb2ed9373f3;167ef959-4751-4101-9754-2e14e556f5d3	Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2	161;300;513;161;421	37;244;428;37;329	Carboplatin;Doxil;Gemzar;Taxol;Topotecan	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	6;3;3;6;3	Not Available;Not Available;Not Available;Not Available;Not Available	AUC;mg/m2;Not Available;mg/m2;Not Available	ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	6;50;Not Available;175;Not Available	AUC;mg/m2;Not Available;mg/m2;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-2054-F24388	2616c4a0-cee6-4a82-941f-c30445131b82	2	637	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	11									Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	11	G3									Not Available	Not Available	2054	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	1-10 mm	Ovary	YES	Dead	2009	2005
TCGA-13-1477	49	FEMALE	1662	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	1	235.0		Progression of Disease	WITH TUMOR		49	Bilateral	TCGA-13-1477	13f5814c-1f99-4ffa-84a4-3bbd8979faae	31	-18111	1662	0	1662	TCGA-13-1477-D24841;TCGA-13-1477-D24840	9c33a2aa-bca5-4b74-9eae-754de2f3b26b;c4ae4f9d-4ec7-47d4-92bd-82121c761ed6	Not Available;Not Available	30;30	206;206	57;57	Carboplatin;Paciltaxel	Not Available;Not Available	6;6	7;7	Not Available;Not Available	mg/m2;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	360;175	mg/m2;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1477-F24839	15ee294f-4702-4ca4-a8b5-3926ef50fb20	31	1662	1662	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	YES	Not Available	235	Progression of Disease	Not Available	Imaging Study	Not Applicable	Not Available	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Incisional Biopsy	Not Available	Not Available	Not Available	3	G2									Not Available	Not Available	1477	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Dead	2009	2000
TCGA-24-2260	74	FEMALE	1100	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIB	G3	1	667.0		Recurrence	WITH TUMOR		74	Bilateral	TCGA-24-2260	f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b	26	-27112	1100	0	1100	TCGA-24-2260-D26534;TCGA-24-2260-D26536;TCGA-24-2260-D26538;TCGA-24-2260-D26537;TCGA-24-2260-D26533;TCGA-24-2260-D26535	486ab8c1-e67a-4f02-84fc-9d4463840857;be9c03cb-0688-422d-bbba-c3b8ad80547d;ca2ff536-892b-4233-b660-b424a07d9133;68704d25-051a-471c-a28e-460d3f9e5802;0d57b63c-7817-41f7-ac60-a2bdb86ca7e3;e69ef23b-4fcd-426c-9680-aba7c3773664	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	26;26;26;26;26;26	135;849;1081;1009;135;849	24;682;1011;876;24;682	Cisplatin;Cytoxan;Chlorambucil;Hexalen;Taxol;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2	06;07;Not Available;Not Available;06;07	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;Not Available;Not Available;mg;mg	ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;PO;PO;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	727;5810;Not Available;Not Available;1110;2905	mg;mg;Not Available;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-2260-F26532	77d1bfaa-a99b-4154-a8c1-787c70df57da	26	1100	1100	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	667	Recurrence	Not Available	Physical Examination	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	2260	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2010	1992
TCGA-13-0807	54	FEMALE	414	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	414			Not Available		54	Not Available	TCGA-13-0807	067c5c61-d147-4b08-ab8a-32c30969d564	25	-19890	414	0	414	TCGA-13-0807-D24643;TCGA-13-0807-D24644	81a76588-bed5-4afc-b5ec-3a93daac9ead;1ecc3288-bfd8-444a-9231-b5aae9a6623d	Not Available;Not Available	16;16	Not Available;Not Available	Not Available;Not Available	Carboplatin;Paclitaxel	Not Available;Not Available	4;4	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0807-F24642	76c34f52-9a39-4378-9c5f-a27baccaac51	25	414	414	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	2	G3									Not Available	Not Available	0807	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	>20 mm	Ovary	Not Available	Dead	2009	2005
TCGA-24-1470	54	FEMALE	105	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIB	G3	0	105			TUMOR FREE		54	Bilateral	TCGA-24-1470	a3898640-0d85-441d-a000-b5b8ff857399	12	-20007	Not Applicable	0	105	TCGA-24-1470-D26065;TCGA-24-1470-D26066;TCGA-24-1470-D26067	521e955c-b121-4399-9a5b-4e665a6d8c53;c67a8709-2f8f-4d07-b3d0-548234c86b68;3285d027-0f38-45a6-807c-92ef0d27504d	Not Available;Not Available;Not Available	12;12;12	83;83;83	17;17;17	Docetaxel;Cisplatin;Paclitaxel	Not Available;Not Available;Not Available	5;5;5	04;04;04	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IP;IV;IP;IV;IP;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	475;593;110	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	1	Not Available	TCGA-24-1470-F26064	64784e56-eef8-4003-9cc8-7f8bc725b2bd	12	Not Applicable	105	1	Not Available	Not Available	Not Available	Not Available	5									Not Available	Other	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	5	G3									Not Available	Not Available	1470	Other	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIB	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2009	2009
TCGA-OY-A56Q	78	FEMALE	576	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIA	G3	0	576			TUMOR FREE		78	Left	TCGA-OY-A56Q	C7CF6755-8856-435B-A443-174B22A25B07	27	-28623	Not Applicable	0	190	TCGA-OY-A56Q-D40756;TCGA-OY-A56Q-D40757	E86F10BA-0449-406C-ABBE-AF17416539F6;4E265E98-8861-485E-A5C5-21CEDE8B7F99	Not Available;Not Available	27;27	128;128	23;23	Taxol;Carboplatin	Complete Response;Complete Response	2;2	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available;Not Available	Not Available;Not Available	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	NO;NO	2013;2013	Not Available	NOT HISPANIC OR LATINO	TCGA-OY-A56Q-F57585	9F8F69EC-4966-4E34-B5EE-5D8956F18154	17	Not Applicable	576	Not Available	Scheduled Follow-up Submission	Complete Remission/Response	Not Available	NO	3									NO	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2014	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	2	G3									NO	No	A56Q	Not Available	TUMOR FREE	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	Not Available																			RX	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	YES	NO	OY	No Macroscopic disease	Ovary	NO	Alive	2013	2012
TCGA-29-1770	54	FEMALE	741	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	1	377.0		Recurrence	WITH TUMOR		54	Bilateral	TCGA-29-1770	5abb6d80-fc39-49a4-8db5-3db24543feb6	2	-20015	Not Applicable	0	741	TCGA-29-1770-D27377;TCGA-29-1770-D27376;TCGA-29-1770-D27378;TCGA-29-1770-D27379;TCGA-29-1770-D27374;TCGA-29-1770-D27380;TCGA-29-1770-D27381;TCGA-29-1770-D27375	68258d53-863a-4fea-910f-39d19e435491;1d5ec102-18ba-4f80-9f5a-75392abd2a11;9f9ea9ab-d749-4426-8eca-5a68cfc3c54c;4fc81e28-e99d-4465-a5a8-ea8769a382d4;86b9066d-36b2-4f36-b460-71f470c4e95a;7ad46917-dc48-46d5-9e93-4f4dab7ff79d;ca385d1c-e8cd-4c8d-b8b6-e3f6342b9b43;1e51f5fb-e363-496b-ae43-0a814f064d15	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2;2;2;2	136;762;136;546;68;546;762;68	87;741;87;384;19;384;741;19	Docetaxel;Taxotere;Carboplatin;Carboplatin;Paciltaxel;Gemcitabine;Avastin;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11	03;02;03;06;03;06;Not Available;03	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;mg;mg;mg;mg;Not Available;mg	ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;Not Available;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	100;Not Available;690;650;300;1370;Not Available;630	mg;Not Available;mg;mg;mg;mg;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-29-1770-F27373	d7a26e91-ab1f-4ada-b736-84f1de3922b1	2	Not Applicable	741	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;432	377;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1770	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Alive	2009	2007
TCGA-61-2087	49	FEMALE	146	Serous Cystadenocarcinoma	Ovary	Alive	Stage IC	G3	0	146			TUMOR FREE		49	Left	TCGA-61-2087	be03bfec-5bb6-4cab-9dd2-bee590bd45f1	8	-18182	Not Applicable	0	146	TCGA-61-2087-D28374;TCGA-61-2087-D28373;TCGA-61-2087-D28375	4ae5fbbf-121c-45a8-8164-fb222d5e5605;ff89b35b-775d-4c23-a18c-aa0cfcd3e92e;e7f46eb7-164e-4af4-821e-a810016df63b	Not Available;Not Available;Not Available	8;8;8	Not Available;Not Available;Not Available	29;1;29	Taxol;Cisplatin;Carboplatin	Not Available;Not Available;Not Available	12;12;12	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2087-F28372	bc37cd71-1aa4-4e1e-9286-b1a9a766f05e	8	Not Applicable	146	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	12	G3									Not Available	Not Available	2087	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	NO	Alive	2009	2009
TCGA-25-2042	60	FEMALE	396	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1			Metastatic	WITH TUMOR		60	Bilateral	TCGA-25-2042	818dc159-aba4-46bc-a4ed-68ee0f8c4461	20	-22127	396	0	396	TCGA-25-2042-D26789;TCGA-25-2042-D26790;TCGA-25-2042-D26793;TCGA-25-2042-D26788;TCGA-25-2042-D26791;TCGA-25-2042-D26787;TCGA-25-2042-D26786;TCGA-25-2042-D26792	944d91a1-d9d3-42ea-839c-7bfac4d6e1bf;d2120dac-c367-4e8b-bf47-4defae73d882;5312bdff-a94c-42e6-9730-0eac4f016934;f51efcd0-d4f8-4952-8ded-9510e58c4648;21269f23-6d86-4696-9758-640be84884d1;36818245-ce52-4b65-a391-aaf7cdc2f464;404a7c2b-b98b-4746-8fd4-d6a9b2082d7c;3d6dee1b-1b8e-4505-8aeb-21d50754c68c	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	20;20;20;20;20;20;20;20	Not Available;Not Available;Not Available;Not Available;Not Available;123;123;Not Available	184;184;184;184;184;0;0;184	Carboplatin;Doxil;Topotecan;Taxol;Gemzar;Carboplatin;Taxol;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11;11;11	02;1;Not Available;02;02;06;06;02	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-2042-F26785	67cbdcbf-2e6a-4de9-9658-9bbd8ae0f47f	20	396	396	Not Available	Not Available	Not Available	Not Available	Not Available	11	YES	NO	123	Not Available	Metastatic	YES	First Seen At Further Surgery	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	11	G3									Not Available	Not Available	2042	Not Available	WITH TUMOR	Not Available	Not Available	AMERICAN INDIAN OR ALASKA NATIVE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	>20 mm	Ovary	Not Available	Dead	2009	2006
TCGA-36-2552	64	FEMALE	349	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIC	G3	0	349			TUMOR FREE		64	Bilateral	TCGA-36-2552	2d8b42fb-b12c-454e-a5a5-22c91913386f	18	-23379	Not Applicable	0	349	TCGA-36-2552-D27978;TCGA-36-2552-D27977	8a05a1cd-08bc-4e8a-b376-7580f51e54b5;9d94ac77-895f-4af1-9a46-8a1f6ca3fb17	Not Available;Not Available	18;18	121;121	15;15	Paclitaxel;Carboplatin	Not Available;Not Available	8;8	06;06	241;454	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	1449.5;2724	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-36-2552-F27976	f0f073e9-431f-4e1b-bcf4-92efb3848872	18	Not Applicable	349	Not Available	Not Available	Not Available	Not Available	Not Available	8									Not Available	Not Available	TUMOR FREE	YES	Not Available	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	8	G3									Not Available	Not Available	2552	Not Available	TUMOR FREE	Not Available	Not Available	Not Available	Not Available																			R0	Not Applicable	Not Applicable	Stage IIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	No Macroscopic disease	Ovary	Not Available	Alive	2010	2009
TCGA-61-1721	38	FEMALE	338	Serous Cystadenocarcinoma	Ovary	Alive	Stage IV	G1	0	338			TUMOR FREE		38	Bilateral	TCGA-61-1721	1c0318d9-0472-4840-add4-46bb9f914a30	2	-13894	Not Applicable	0	338	TCGA-61-1721-D28124;TCGA-61-1721-D28127;TCGA-61-1721-D28126;TCGA-61-1721-D28125	0b65dd59-5982-4c6e-bd9a-705298dcb9bd;d4666102-4b7e-48ee-80ae-e210b59c5590;88f75546-60dd-4748-83ef-3e287dfec167;be53f54f-26ff-45ce-8475-53ab28702ead	Not Available;Not Available;Not Available;Not Available	1;1;1;1	317;317;338;338	193;193;2;2	Oxaliplatin;Taxotere;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available	12;12;12;12	06;06;06;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;OTHER, SPECIFY IN NOTES;OTHER, SPECIFY IN NOTES	Not Applicable;Not Applicable;Neoadjuvant;Neoadjuvant	Not Available;Not Available;Not Available;Not Available	IP;IV;IP;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	528;786;3960;1782	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-1721-F28123	902be45d-0481-4e42-8dc7-10a185ca8ade	2	Not Applicable	338	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	Yes	C56.9	8441/3	C56.9	YES	Not Applicable	Excisional Biopsy	Not Available	Not Available	YES	6	G1									Not Available	Not Available	1721	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	Not Available	Ovary	YES	Alive	2009	2008
TCGA-09-1666	57	FEMALE	1752	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	480.0		Recurrence	WITH TUMOR		57	Bilateral	TCGA-09-1666	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	2	-21066	Not Applicable	0	1752	TCGA-09-1666-D24282;TCGA-09-1666-D24286;TCGA-09-1666-D24284;TCGA-09-1666-D24289;TCGA-09-1666-D24281;TCGA-09-1666-D24290;TCGA-09-1666-D24280;TCGA-09-1666-D24287;TCGA-09-1666-D24288;TCGA-09-1666-D24283;TCGA-09-1666-D24285	9ad3d880-56fd-4369-a662-6448ded41e23;7e32e0c6-f8ab-4cc8-944d-39c716db22fa;172437f0-7607-4941-bb7d-a1d174db12fa;201e8965-9390-427b-8279-89e17038f985;357d4b2b-6557-43ba-865b-6991025f5471;96136ebb-d42e-46e9-8ec0-5add836188f0;74931445-f83f-45dc-90a1-aecb7765fa41;51c24d42-2dab-4f27-b2ba-a0bda9af9e95;3380594f-d6ff-4fec-95a3-f50e8b444dd6;722d9fc6-ae4b-4953-a962-35ffe58712ca;b774aba5-d495-4fcc-a1dd-0f5f06ba1d9e	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	5;5;5;5;5;5;5;5;5;5;5	73;Not Available;708;1757;73;480;173;Not Available;1598;173;708	27;Not Available;616;1604;27;256;101;Not Available;1507;101;616	Taxol;Carboplatin;Carboplatin;Femara;Carboplatin;Oca Rex Oregovomab;Carboplatin;Taxotere;Doxil;Taxotere;Gemcitabine	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8;8;8;8;8;8;8	3;Not Available;5;Not Available;3;Not Available;5;Not Available;Not Available;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;Not Available;AUC;Not Available;AUC;mg;AUC;Not Available;Not Available;mg/m2;mg/m2	ADJUVANT;PROGRESSION;RECURRENCE;PROGRESSION;ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;Not Available;IV;Not Available;IV;Not Available;IV;Not Available;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Immunotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	135;Not Available;6;Not Available;6;2;6;Not Available;Not Available;60;1000	mg/m2;Not Available;AUC;Not Available;AUC;mg;AUC;Not Available;Not Available;mg/m2;mg/m2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-09-1666-F24279	f21016c7-5541-4378-869b-7dcadae9392c	2	Not Applicable	1752	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;568	480;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1666	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	09	No Macroscopic disease	Ovary	NO	Alive	2009	2003
TCGA-61-2098	62	FEMALE	1993	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	0	1993			TUMOR FREE		62	Bilateral	TCGA-61-2098	eb7c3b35-7a5e-4621-b31f-9775c51f9a23	8	-22876	Not Applicable	0	1993	TCGA-61-2098-D28419;TCGA-61-2098-D28420	e844b70b-eaae-45a1-98eb-911c6c63e56c;e06ba706-69b6-4c0a-a1d8-73d71b53a692	Not Available;Not Available	8;8	145;145	14;14	Taxol;Carboplatin	Not Available;Not Available	12;12	06;05	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-61-2098-F28418	0ed0fcad-6f61-425a-9057-ea887d6128ce	8	Not Applicable	1993	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	12	G2									Not Available	Not Available	2098	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	11-20 mm	Ovary	NO	Alive	2009	2003
TCGA-29-1768	50	FEMALE	952	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	547.0		Recurrence	WITH TUMOR		50	Bilateral	TCGA-29-1768	838693d5-1ae0-4d75-834b-e1b89b96b0ed	2	-18396	952	0	950	TCGA-29-1768-D27360;TCGA-29-1768-D27363;TCGA-29-1768-D27364;TCGA-29-1768-D27359;TCGA-29-1768-D27362;TCGA-29-1768-D27361	2c0ce251-f345-4a8a-aa00-e298dbc2b8c5;ed65a20a-8958-4fff-ba00-02ed6343c835;7b41d12a-5d40-47dc-95e1-2e6fe9230598;46ff17c1-0870-4b53-8e92-fcd7ccef6c0e;b4a10dad-0fcb-4aa0-a4a8-d8eb58d7cc56;76216199-6c74-4f8b-8259-3693f0df3818	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	13;13;13;13;13;13	124;915;252;103;719;719	19;827;40;19;551;551	Paciltaxel;Doxorubicin;Bevacizumab or placebo;Carboplatin;Gemcitabine;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11;11	06;03;Not Available;05;09;09	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	ADJUVANT;PROGRESSION;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;Not Available;IV;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	348;80;1493;816;1200;675	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	0	Not Available	TCGA-29-1768-F27358	d01ce2b3-4094-4593-84d7-6372bfb8657e	2	952	950	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	547	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1768	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Dead	2009	2006
TCGA-30-1718	44	FEMALE	1579	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	896.0		Recurrence	WITH TUMOR		44	Bilateral	TCGA-30-1718	ad2939e6-b8b8-475a-90e2-6a369c3d3167	2	-16400	1579	0	1579	TCGA-30-1718-D27537;TCGA-30-1718-D27535;TCGA-30-1718-D27536;TCGA-30-1718-D27540;TCGA-30-1718-D27538;TCGA-30-1718-D27539	ca71da11-843d-4468-988f-8a5f48ffbfb5;05090990-3b2e-4695-8640-d685a8dd5e38;49cdeed1-76cc-4608-aea3-af439a26c1e5;abea4d31-e57d-4f0f-b821-23a5d05123ec;c2fa4a73-8690-49e7-a1b7-cc0ec4f5d70e;0a8e0ead-87c1-40cb-a0a2-d7af833547a1	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;23;9;9	492;Not Available;178;896;Not Available;Not Available	206;Not Available;31;865;Not Available;Not Available	Taxol;Hexalin;Carboplatin;Tamoxifen;Carboplatin;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;12;12	11;Not Available;08;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;Not Available;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1718-F27534	634effee-a1bd-4dd7-a813-4f04f2c4a872	2	1579	1579	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	896	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1718	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	NO	Dead	2009	2002
TCGA-25-1627	73	FEMALE	394	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	394			Not Available		73	Bilateral	TCGA-25-1627	cbe3309e-9b7b-4f62-87b5-0f5ed4218ada	2	-26784	394	0	11																								Not Available	NOT HISPANIC OR LATINO	TCGA-25-1627-F26722	20c8251e-9302-47d0-b9fa-9e915447bc3d	2	394	11	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1627	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2003
TCGA-24-1105	36	FEMALE	1442	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	470.0		Recurrence	WITH TUMOR		36	Bilateral	TCGA-24-1105	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	9	-13187	1442	0	1442	TCGA-24-1105-D25847;TCGA-24-1105-D25850;TCGA-24-1105-D25852;TCGA-24-1105-D25851;TCGA-24-1105-D25858;TCGA-24-1105-D25845;TCGA-24-1105-D25848;TCGA-24-1105-D25846;TCGA-24-1105-D25849;TCGA-24-1105-D25854;TCGA-24-1105-D25855;TCGA-24-1105-D25853;TCGA-24-1105-D25857;TCGA-24-1105-D25856	f2b55619-c372-4f75-83ac-52dd647bcbf0;19208898-549c-4bec-9587-862255401569;666da692-65f8-4bad-ab2d-32179231bdbf;ddb1bcf5-8150-4936-9f35-65b161732d58;42d6f1c9-fe2e-40a1-8017-3c7fcbb35bb9;a5c72ec2-4288-4610-a12d-5a88be4834ee;6b4fe1cc-975c-40fb-8ba2-24ceed6eb1f4;ecff3707-6213-40e7-bfba-a2b87b1ac780;b0de8465-4152-4b3c-88e6-fc2adbdc54ed;1e77ffe6-2c69-45a6-8102-044a2aa42a6f;df0b4051-0453-488c-abe4-2edaeb0ec8c0;b73fda29-b8ca-47ae-9cb2-74fcbfeaa2b7;46f8c3f9-d453-4187-9a47-96a473ca8e76;b73f86c1-9dc1-4f86-b095-649ed53d41e2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9;9;9;1;1;1;10;10	860;1116;1375;1298;1298;178;860;178;1116;1340;1375;1200;584;584	724;1004;1368;1228;1228;25;724;25;1004;1313;1368;1130;486;486	Topotecan;Doxil;Cisplatin;Cytoxan;Avastin;Carboplatin;Navelbine;Taxol;Gemzar;Taxol;Gemzar;Carboplatin;Taxol;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3;2;2;2;3;3	6;4;01;Not Available;Not Available;6;6;6;4;02;01;04;06;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;PO;Not Available;IV;IV;IV;IV;IV;IV;IP;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	48.2;258;92;4500;2001;3410;486;1400;19320;975;1826;2275;1725;3360	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2010;2010;2010;2010;2010	Not Available	Not Available	TCGA-24-1105-F25844	da2b0e1e-ff62-4999-aa12-32768135104d	9	1442	1442	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	YES	Not Available	470	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	1105	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-24-1105-R25859	06461927-0e16-4d01-b765-c5f76574560d	Not Available	9	1285	1263	Not Available	3	28	7000	NO	EXTERNAL BEAM	Not Applicable	OTHER, SPECIFY IN NOTES	Progression, Recurrence	cGy	2009	Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	2001
TCGA-13-1507	77	FEMALE	1993	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	324.0			TUMOR FREE		77	Bilateral	TCGA-13-1507	502e8d02-2953-4514-a2e1-6179dd94da73	31	-28445	Not Applicable	0	145	TCGA-13-1507-D24954;TCGA-13-1507-D24955;TCGA-13-1507-D24953	36abb233-04b6-4ffa-be2f-1a6da2577bcf;e313f9e5-f3b1-48ae-a9e2-eb3ff4559fb1;e69faabb-e060-4871-b192-ff4af589b249	Not Available;Not Available;Not Available	1;1;1	166;166;166	54;54;54	Paclitaxel;Paclitaxel;Cisplatin	Not Available;Not Available;Not Available	2;2;2	6;6;6	135;60;37.5	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IP	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2010;2010;2010	1	NOT HISPANIC OR LATINO	TCGA-13-1507-F24952;TCGA-13-1507-F72677	211ff326-c0af-4317-8b10-c19cc527b139;E4C3C11E-4EDF-4FCF-B004-EADE9BBFACB2	31;31	Not Applicable;1993	145;Not Available	1;Not Available	Not Available;Not Available	Not Available;Progressive Disease	60;Not Available	Not Available;Not Available	3;7	None;Not Available	None;Not Available	None;Not Available	None;324	None;Unknown	None;Not Available	None;Not Available	None;Not Applicable	Not Available;YES	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;WITH TUMOR	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	60	Not Available	3	G3									Not Available	Not Available	1507	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2008
TCGA-42-2590	57	FEMALE	317	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G2	1	226.0		Progression of Disease	WITH TUMOR		57	Bilateral	TCGA-42-2590	2724109f-7d5a-402c-a915-741e43c6f7f9	3	-20965	Not Applicable	0	227	TCGA-42-2590-D28052;TCGA-42-2590-D28051;TCGA-42-2590-D28811	b71ee922-d388-4f5d-b45a-25f2f102aada;6706e8b9-0a34-469c-a95f-9bb26531c61e;ab3bd573-dcf1-44c5-8518-8d44a22e4b93	Not Available;Not Available;Not Available	3;3;18	Not Available;Not Available;269	31;38;249	Gemcitabine;Carboplatin;Taxotere	Not Available;Not Available;Not Available	6;6;5	5;5;02	1600;640;110	mg;mg;mg	ADJUVANT;ADJUVANT;PROGRESSION	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;02	IV;IV;IV	YES;YES;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	12100;2470;235	mg;mg;mg	Not Available;Not Available;Not Available	2010;2010;2011	1	NOT HISPANIC OR LATINO	TCGA-42-2590-F28050;TCGA-42-2590-F28809	34d12af0-1de3-4b9b-81c2-c18a4d27fb6e;180b4b5e-1924-4e63-a66b-e8fbafcdbe3d	3;18	Not Applicable;317	227;Not Available	1;1	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	6;5	YES;YES	NO;NO	Not Available;Not Available	226;226	Progression of Disease;Progression of Disease	Not Available;Not Available	Not Available;Imaging Study	Not Applicable;Not Applicable	Not Available;Not Available	Pre-Adjuvant Therapy;Post-Adjuvant Therapy	WITH TUMOR;WITH TUMOR	YES;YES	Progressive Disease;Progressive Disease	NO;NO	Alive;Dead	2010;2011	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	2590	Pre-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	42	>20 mm	Ovary	Not Available	Alive	2010	2009
TCGA-29-1703	56	FEMALE	1815	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	324.0		Recurrence	WITH TUMOR		56	Bilateral	TCGA-29-1703	b3511675-fd68-4745-8020-e290ca0fd115	2	-20622	1815	0	1815	TCGA-29-1703-D27256;TCGA-29-1703-D27257;TCGA-29-1703-D27261;TCGA-29-1703-D27264;TCGA-29-1703-D27266;TCGA-29-1703-D27259;TCGA-29-1703-D27263;TCGA-29-1703-D27262;TCGA-29-1703-D27260;TCGA-29-1703-D27265;TCGA-29-1703-D27267;TCGA-29-1703-D27258	14913535-e3ee-4b29-8485-5ef50b7c1123;299385fc-3e5b-4fd2-a656-6fdb78daa069;4c4f2cec-35a9-462b-bc94-0fb8506d93aa;53f8a8a1-9b2e-4469-9d98-66f1234ca04d;5a22c5fc-1192-4db9-86cb-84768e401698;7f6adfa1-73ce-46ec-b9ae-fdec4acedd2f;4d5bfe23-dd0f-43f5-8880-c91953ddc025;98b7f1cd-615d-4d0f-8e2d-ac2ababfc43d;48f028c2-6e0e-4b9a-a457-ab27cc986d53;7f78908a-4b31-41ff-9268-b209ed2e6c93;e56227e6-4d59-43d0-b3a9-8d0ba62a4731;8cb8447c-f35a-435e-9fb1-d51d74f152d2	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	18;18;26;26;26;26;26;26;26;26;26;26	163;163;1457;1753;946;651;1720;1667;946;470;1314;651	16;16;1317;1746;743;478;1720;1577;743;337;1030;478	Paclitaxel;Carboplatin;Doxorubicin HCL Liposomal -Doxil;Paclitaxel;Bevacizumab;Docetaxel;Carboplatin;Gemcitabine;Cytoxan;Tamoxifen;Amgen 706;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;4;4;4;4;4;4;4;4;4;4	06;06;06;02;Not Available;09;01;04;Not Available;Not Available;Not Available;09	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg/m2;mg;mg;mg;mg;mg;Not Available;Not Available;mg	ADJUVANT;ADJUVANT;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IP;IP;IV;IV;Not Available;IV;IV;IV;PO;Not Available;Not Available;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Targeted Molecular therapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1595;4081;70;80;800;55;390;1370;50;Not Available;Not Available;773	mg;mg;mg;mg/m2;mg;mg;mg;mg;mg;Not Available;Not Available;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-29-1703-F27255	aef081e4-4629-4f49-a25f-0787fe8e2ce5	2	1815	1815	0	Not Available	Not Available	Not Available	Not Available	6	YES	NO	Not Available	324	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1703	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Dead	2009	2005
TCGA-24-1546	46	FEMALE	1955	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1955			Not Available		46	Bilateral	TCGA-24-1546	9e7d3dea-5d81-4f10-819c-1c2a68ddd150	2	-17130	1955	0	1955	TCGA-24-1546-D26098;TCGA-24-1546-D26099	16c5f27e-162a-4104-9911-29d227cfd46c;2c1b2afb-5dba-4ecc-b390-b8169b0edfdb	Not Available;Not Available	24;24	Not Available;Not Available	Not Available;Not Available	Carboplatin;Taxol	Not Available;Not Available	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;Not Available	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-24-1546-F26097	0b61178a-f8fb-4a88-8c08-54ae6e0ab3f0	2	1955	1955	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Not Available	Not Available	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1546	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1997
TCGA-24-2281	68	FEMALE	1357	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIA	G3	0	1357			TUMOR FREE		68	Bilateral	TCGA-24-2281	59b3fbfe-0b7c-41e5-b756-ee7e23730df5	5	-25019	Not Applicable	0	1357	TCGA-24-2281-D26571;TCGA-24-2281-D26572	c3bc6bfa-aeaf-48c8-9afb-72f424b38730;15f30f01-7272-4617-84a1-8e94f86f6372	Not Available;Not Available	5;5	Not Available;Not Available	Not Available;Not Available	Carboplatin;Taxol	Not Available;Not Available	4;4	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	Not Available;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2010;2010	0	Not Available	TCGA-24-2281-F26570	5af8f13c-15ce-4bde-be6f-7adc93a93883	5	Not Applicable	1357	0	Not Available	Not Available	Not Available	Not Available	4									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	4	G3									Not Available	Not Available	2281	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIA	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Alive	2010	2006
TCGA-25-1630	73	FEMALE	1162	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	1162			Not Available		73	Bilateral	TCGA-25-1630	263e85e2-7b6f-453f-8fd0-e5ea1409fece	2	-27006	1162	0	239	TCGA-25-1630-D26731;TCGA-25-1630-D26730	9c32d4f7-8cc1-4b59-b283-5ddc42545296;94a3ddc3-9d4a-47a5-a36a-de3736298c44	Not Available;Not Available	17;17	Not Available;Not Available	33;33	Taxol;Carboplatin	Not Available;Not Available	6;6	06;06	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-25-1630-F26729	be6e817c-e570-43da-88b6-2a0d1b07d6b6	2	1162	239	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	Not Available	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G3									Not Available	Not Available	1630	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	25	1-10 mm	Ovary	Not Available	Dead	2009	2002
TCGA-29-1692	58	FEMALE	2872	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G2	1	544.0		Recurrence	WITH TUMOR		58	Right	TCGA-29-1692	92960f76-0242-4a1c-bf7d-014c2f720219	2	-21193	2872	0	2872	TCGA-29-1692-D27161;TCGA-29-1692-D27166;TCGA-29-1692-D27163;TCGA-29-1692-D27171;TCGA-29-1692-D27168;TCGA-29-1692-D27165;TCGA-29-1692-D27169;TCGA-29-1692-D27164;TCGA-29-1692-D27170;TCGA-29-1692-D27172;TCGA-29-1692-D27160;TCGA-29-1692-D27167;TCGA-29-1692-D27162	685c255e-2242-435e-b5d3-229453699a04;2438d130-a7cc-471c-8770-e9cab1a2f523;90600159-513c-457a-9f29-036530819aea;5190da4a-540d-4dd0-bf50-a58711ff9aea;f32e96f4-6144-4ed9-be21-ae2a8f6c0b8a;6a477a8e-e65c-467e-a25d-caae5486b693;92bc26a1-5bab-4fd2-858c-6f31f45e04e2;2917d0e8-ad7f-4643-8b76-7d5a97ff304d;642fd6be-d54d-4093-bfe4-f2a4bf2f939c;0ab57961-2afb-4492-b67e-51bdc6130ea7;5949a274-8f5b-4410-89b4-3d629590e929;fd9a3712-96c8-4b72-92fe-5432b346c056;9c687c7a-133d-404f-917c-d69210cd5624	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3;3;3;3;3	Not Available;2247;Not Available;2785;2521;Not Available;2577;694;2785;2125;Not Available;2247;Not Available	5;2120;544;2616;2278;1548;2556;Not Available;2616;1793;5;2120;544	Cisplatin;Carboplatin;Paclitaxel;Cisplatin;Cytoxan;Doxil;Paclitaxel;Topotecan;Gemcitabine;Tamoxifen;Taxol;Taxotere;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3;3;3;3;3;3;3;3	03;06;Not Available;06;Not Available;08;02;Not Available;06;Not Available;03;06;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	AUC;Not Available;Not Available;mg;Not Available;Not Available;mg;Not Available;mg;mg;mg/m2;Not Available;Not Available	ADJUVANT;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;PROGRESSION;ADJUVANT;PROGRESSION;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IP;IV;IV;IV;IV;IV;IV;IV;Not Available;IV;IV;IP;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	7;Not Available;Not Available;45;Not Available;Not Available;289;Not Available;1250;20;175;Not Available;Not Available	AUC;Not Available;Not Available;mg;Not Available;Not Available;mg;Not Available;mg;mg;mg/m2;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010;2010	0	Not Available	TCGA-29-1692-F27159	72f049e4-e0cc-44e8-9f54-5ba8e0acc565	2	2872	2872	0	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;2837	544;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1692	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			R1	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	11-20 mm	Ovary	Not Available	Dead	2009	1997
TCGA-13-1492	66	FEMALE	3819	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	3819			TUMOR FREE		66	Not Available	TCGA-13-1492	63c6a89b-b28c-434a-a632-5de6545db731	31	-24332	Not Applicable	0	2237	TCGA-13-1492-D24890;TCGA-13-1492-D24891	6f3448eb-dbbd-49e5-9a02-7d5951b8c588;c73b40ca-5b10-47a1-ac49-e4dd24db1e05	Not Available;Not Available	30;30	247;247	48;48	Carboplatin;Paclitaxel	Not Available;Not Available	6;6	7;7	Not Available;Not Available	Not Available;mg/m2	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	5;175	Not Available;mg/m2	Not Available;Not Available	2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-1492-F24889;TCGA-13-1492-F72643	62de4389-6bb4-42ff-84a9-3ab406e99c05;6A1E8C87-4A30-44E4-8289-0F4F8C092A75	31;31	Not Applicable;3819	2237;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	80;Not Available	Not Available;Not Available	3;7									Not Available;NO	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Dead	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Fine needle aspiration biopsy	Not Available	80	Not Available	3	G3									Not Available	Not Available	1492	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	Not Available	Ovary	Not Available	Alive	2009	2002
TCGA-57-1583	57	FEMALE	346	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	0	346			WITH TUMOR		57	Left	TCGA-57-1583	76cc2d21-eebc-4f09-9bc7-dbf7af0aafa8	2	-21167	346	0	346	TCGA-57-1583-D28069;TCGA-57-1583-D28070	fcaf527f-ac45-49ba-b12e-0898f26aa9fe;434279a5-98f5-4980-865b-49ce6f7f5e16	Not Available;Not Available	28;28	Not Available;Not Available	37;37	Carboplatin;Taxol	Not Available;Not Available	7;7	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	YES;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	Not Available;Not Available	2009;2009	Not Available	Not Available	TCGA-57-1583-F28068	226da9f5-f0ba-4f11-9c5e-1e1c53456ce7	2	346	346	Not Available	Not Available	Not Available	Not Available	Not Available	6									Not Available	Not Available	WITH TUMOR	YES	Not Available	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1583	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	57	No Macroscopic disease	Ovary	NO	Dead	2009	2006
TCGA-23-1027	48	FEMALE	976	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	114.0		Recurrence	Not Available		48	Right	TCGA-23-1027	c9e58844-9d61-44a2-aee6-1760bc19711b	24	-17588	976	0	966	TCGA-23-1027-D25621;TCGA-23-1027-D25620;TCGA-23-1027-D25617;TCGA-23-1027-D25619;TCGA-23-1027-D25622;TCGA-23-1027-D25618	bae3a196-ad8b-4c6e-baf3-cc6c49029a2f;a3e4c26f-59b6-4dfb-858b-dae3a7810a29;541ac876-abe8-4dfb-9330-f95da504b531;9aacdc7c-5ecf-49a8-9521-4decc19f0433;4c2c89ca-d46c-4f42-9b08-c66459b8189d;979a32c9-ef1b-4990-9f45-caaa8d702ca3	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	27;27;27;27;27;27	867;250;129;250;867;129	769;166;26;166;769;26	Gemcitabine;Docetaxel;Carboplatin;Cisplatin;Paclitaxel;Paclitaxel	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	3;3;3;3;3;3	5;5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg	PROGRESSION;ADJUVANT;ADJUVANT;ADJUVANT;PROGRESSION;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IP;IV;IV;IV;IV;IP;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	10932;360;2088;748;450;1281	mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-23-1027-F25616	517a109a-a6a8-4855-837c-b8d6a48412d3	24	976	966	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	114	Recurrence	Not Available	Not Available	Not Applicable	Not Available	Not Available	Not Available	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1027	Not Available	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	1-10 mm	Ovary	YES	Dead	2009	2005
TCGA-36-1569	52	FEMALE	885	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	885			Not Available		52	Bilateral	TCGA-36-1569	7d82ce56-32eb-4107-aa5c-c568764805c9	2	-19151	Not Applicable	0	885																								0	Not Available	TCGA-36-1569-F27855	770c209c-66ce-470e-a8fc-dabddcc580d7	2	Not Applicable	885	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Preoperative	Not Available	YES	Partial Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Cytology (e.g. Peritoneal or pleural fluid)	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1569	Preoperative	Not Available	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	36	1-10 mm	Ovary	Not Available	Alive	2009	2007
TCGA-13-0906	50	FEMALE	3619	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	3619			TUMOR FREE		50	Bilateral	TCGA-13-0906	e43d3769-e25f-4fb7-9080-ea26defaf094	25	-18383	Not Applicable	0	1367	TCGA-13-0906-D24736;TCGA-13-0906-D24735;TCGA-13-0906-D24737	30150f9a-7ff8-4c97-96a5-9450f584dd84;0f8f7b7a-2605-4d92-89cd-029df70ea38f;4648be54-8c2c-4fef-8fb0-fcb9d8ee65d2	Not Available;Not Available;Not Available	15;15;15	147;147;147	35;35;35	Paclitaxel;Cisplatin;Paclitaxel	Not Available;Not Available;Not Available	4;4;4	6;6;6	Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IP;IP	Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	135;75;60	mg/m2;mg/m2;mg/m2	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-13-0906-F24734;TCGA-13-0906-F72626	d883d22d-c87c-475b-8d85-05b7b688c3ef;C597761F-2106-4EEB-9505-99F2A208C4D4	25;30	Not Applicable;Not Applicable	1367;3619	Not Available;Not Available	Not Available;Not Available	Not Available;Complete Remission/Response	60;Not Available	Not Available;Not Available	2;7									Not Available;NO	Pre-Adjuvant Therapy;Not Available	TUMOR FREE;TUMOR FREE	YES;Not Available	Complete Remission/Response;Not Available	NO;Not Available	Alive;Alive	2009;2015	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	60	Not Available	2	G3									Not Available	Not Available	0906	Pre-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	13	1-10 mm	Ovary	Not Available	Alive	2009	2005
TCGA-29-1777	47	FEMALE	374	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G2	0	374			WITH TUMOR		47	Bilateral	TCGA-29-1777	5ced5b58-fab4-4bcd-b706-d6e49ce0cfc5	2	-17356	Not Applicable	0	374	TCGA-29-1777-D27418;TCGA-29-1777-D27416;TCGA-29-1777-D27417	c821d43b-cc39-4e8d-baef-20905b8795e5;2d46646d-aff6-454e-b00e-294b99ca71f9;b75caa77-a905-4a32-b84b-da1b1c8917a5	Not Available;Not Available;Not Available	26;26;26	346;303;325	346;87;325	Doxorubicin HCL;Carboplatin;Carboplatin	Not Available;Not Available;Not Available	10;10;10	01;06;01	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;IV	NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available	70;740;660	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	0	Not Available	TCGA-29-1777-F27415	26534f1e-ae94-44af-8630-10166f59e9a1	2	Not Applicable	374	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	6	G2									Not Available	Not Available	1777	Post-Adjuvant Therapy	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-61-2018	62	FEMALE	1381	Serous Cystadenocarcinoma	Ovary	Alive	Stage IC	G3	0	1381			TUMOR FREE		62	Bilateral	TCGA-61-2018	13d6c31a-6899-4119-a5c2-90adcb5bd20c	8	-22929	Not Applicable	0	1381	TCGA-61-2018-D28370;TCGA-61-2018-D28368;TCGA-61-2018-D28369;TCGA-61-2018-D28367	4af20208-1f14-49df-8e50-22ee1f341ab5;b98b71fc-711e-4226-b130-12e02b9eb2e1;c38fd237-8010-48ed-8dc4-1bae13e77bb3;77d725e0-430c-4c12-8d5e-4cae274cdd50	Not Available;Not Available;Not Available;Not Available	8;8;8;8	139;60;139;60	61;18;61;18	Carboplatin;Taxol;Taxotere;Carboplatin	Not Available;Not Available;Not Available;Not Available	12;12;12;12	04;03;04;03	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	1920;639;460;2010	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-61-2018-F28366	af1c06af-cd9a-4a86-9d96-ad8d83e3b9ff	8	Not Applicable	1381	Not Available	Not Available	Not Available	Not Available	Not Available	12									Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	12	G3									Not Available	Not Available	2018	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	No Macroscopic disease	Ovary	NO	Alive	2009	2005
TCGA-24-1467	51	FEMALE	3224	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	1253.0		Recurrence	WITH TUMOR		51	Right	TCGA-24-1467	34f545ab-d420-4dd2-8db4-3159896efd23	16	-18652	3224	0	3224	TCGA-24-1467-D26042;TCGA-24-1467-D26046;TCGA-24-1467-D26057;TCGA-24-1467-D26050;TCGA-24-1467-D26049;TCGA-24-1467-D26041;TCGA-24-1467-D26055;TCGA-24-1467-D26053;TCGA-24-1467-D26056;TCGA-24-1467-D26044;TCGA-24-1467-D26051;TCGA-24-1467-D26058;TCGA-24-1467-D26047;TCGA-24-1467-D26043;TCGA-24-1467-D26048;TCGA-24-1467-D26052;TCGA-24-1467-D26054;TCGA-24-1467-D26040;TCGA-24-1467-D26045	fb26dbaa-2ce9-4a77-94dd-c1e3a03fd281;b48c9b58-4f39-41a9-9475-781a87ef06c1;7e70652e-a5d0-4f50-9fc4-8343dabac54a;4599a840-cb0a-43d2-9461-c29b7c3f9a0b;27368d0d-fbd6-44f4-b65c-ac5ae2b8380a;79b8d114-bedd-4c6e-b9af-333a85dc5a85;7f1be972-6b5d-41cc-8707-73ef55706f5a;ec830e30-41a6-4b9d-bcf9-ab281700ff79;d9d6017a-251c-4150-b37a-91c584273b99;46af543c-9421-4864-823d-c9ad5d81850d;f10bb298-cef0-480a-a2aa-c2cfba674c88;faac15d8-07b9-42b6-908d-b0fbc92e4927;2b31a6de-3753-4ca2-91a0-03eb6c130d67;ed7b02b2-b81a-44b4-a476-72c61e8c5558;2789fe54-3b24-476b-bbaa-b6003d617c4d;0deb02e0-1be4-4b66-9b33-f2ab838a750e;a4acf824-ec0d-4ff6-a1e2-2e4dbe449d6a;03fc29d1-6abc-40fe-ace3-74f6a4214538;825e30c9-5a77-4cd9-8b02-62cb9cb2000f	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	16;16;16;16;16;16;16;16;16;16;16;16;16;16;16;16;16;16;16	1391;1909;2889;2737;2531;110;2458;3059;Not Available;1391;2737;3059;2296;1391;2296;2889;3101;110;1909	1277;1804;2819;2561;2476;6;2363;2989;2758;1277;2561;2989;2170;1277;2170;2819;3073;6;1804	Taxol;Cisplatin;Bevacizumab;Doxetaxel;Doxil;Carboplatin;Tamoxifen;Doxil;Tamoxifen;Cisplatin;Cisplatin;Bevacizumab;Topotecan;Carboplatin;Navelbine;Cytoxen;Topotecan;Taxol;Taxol	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4	06;06;Not Available;08;03;06;Not Available;03;Not Available;4;08;Not Available;06;2;06;Not Available;02;06;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	RECURRENCE;RECURRENCE;ADJUVANT;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE;PROGRESSION;PROGRESSION;RECURRENCE;PROGRESSION;PROGRESSION;RECURRENCE;RECURRENCE;RECURRENCE;PROGRESSION;PROGRESSION;ADJUVANT;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;PO;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV;IV	YES;YES;NO;YES;YES;YES;YES;YES;YES;YES;YES;NO;YES;YES;YES;YES;YES;NO;YES	Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy;Chemotherapy;Hormone Therapy;Chemotherapy;Chemotherapy;Targeted Molecular therapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	1780;600;3610;1350;240;4565;20;240;20;400;115;8871;60;1275;600;50;21;2650;1620	mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-24-1467-F26039	0b7db63c-a9e8-47c4-8459-b34e4260d092	16	3224	3224	Not Available	Not Available	Not Available	Not Available	Not Available	4	YES;YES	NO;NO	Not Available;1253	1253;Not Available	Recurrence;Metastatic	Not Available;YES	Molecular Markers;Molecular Markers	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	4	G3									Not Available	Not Available	1467	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	1-10 mm	Ovary	Not Available	Dead	2009	1998
TCGA-61-1738	60	FEMALE	1089	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	276.0		Recurrence	WITH TUMOR		60	Right	TCGA-61-1738	72c40fba-f502-489b-ad87-843f52655894	2	-21965	1089	0	1089	TCGA-61-1738-D28194;TCGA-61-1738-D28196;TCGA-61-1738-D28195;TCGA-61-1738-D28193;TCGA-61-1738-D28191;TCGA-61-1738-D28192	0008d328-4bb3-4d4a-b5d0-28d09f97d2c3;265b0571-09c1-4944-b6d1-b8f6b8c01b1c;5cae6b69-090f-47c8-8713-2eaa5c448e60;b26e2e7f-9a62-4f34-90d4-d3463baaab74;b8292746-a108-4445-8ef5-59cea4a9b2b0;f55cc532-8bdd-4cad-ad7b-e462a95f6c05	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	4;4;4;4;4;4	338;843;658;276;135;135	287;709;422;198;21;21	Doxil;Gemzar;Toptecan;Cisplatin;Taxol;Carboplatin	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12;12	03;06;29;04;06;06	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg/m2;mg;mg;mg;AUC	RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IP;IV;IV	NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	210;6200;191.4;364;2376;5	mg;mg/m2;mg;mg;mg;AUC	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-61-1738-F28190	8a114a36-f83c-41c5-9e9b-3f3e303592ca	2	1089	1089	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES;YES	NO;NO	Not Available;907	276;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Progressive Disease	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	6	G3									Not Available	Not Available	1738	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	YES	Dead	2009	2005
TCGA-24-2029	75	FEMALE	439	Serous Cystadenocarcinoma	Ovary	Dead	Stage IIIC	G3	1	372.0		Recurrence	WITH TUMOR		75	Bilateral	TCGA-24-2029	bbbf1184-1e19-479a-b31f-daa692d52e02	15	-27527	439	0	439	TCGA-24-2029-D26478;TCGA-24-2029-D26477	52b83717-b8f7-4848-add1-2b37c6de9dcb;541eb0c1-a2d4-464c-bdf3-8324f4bbff54	Not Available;Not Available	15;15	218;218	8;8	Carboplatin;Taxol	Not Available;Not Available	3;3	09;09	Not Available;Not Available	mg;mg	ADJUVANT;ADJUVANT	Not Applicable;Not Applicable	Not Available;Not Available	IV;IV	NO;NO	Chemotherapy;Chemotherapy	Not Available;Not Available	3773;1946	mg;mg	Not Available;Not Available	2010;2010	Not Available	Not Available	TCGA-24-2029-F26476	d10c3674-b9e5-422d-8989-85abed51bc3d	15	439	439	Not Available	Not Available	Not Available	Not Available	Not Available	3	YES	NO	Not Available	372	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2010	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	Not Available	3	G3									Not Available	Not Available	2029	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Dead	2010	1995
TCGA-61-2017	64	FEMALE	1398	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G1	1	1006.0		Recurrence	WITH TUMOR		64	Bilateral	TCGA-61-2017	f0ca8205-0754-4bd8-a6a8-31901040c5e7	8	-23509	Not Applicable	0	1398	TCGA-61-2017-D28364;TCGA-61-2017-D28361;TCGA-61-2017-D28360;TCGA-61-2017-D28363;TCGA-61-2017-D28362	d8e6f6d0-11e5-4857-9176-65b9fd0c367b;90f7abab-7512-4fca-acad-6e58dec64576;61c43bff-0d72-4d2c-922c-9694670bfceb;7c13d883-2763-4805-b918-f5c98710e43d;d69aaa81-29d1-4b99-baa8-5b5f7db327bb	Not Available;Not Available;Not Available;Not Available;Not Available	8;8;8;8;8	1186;Not Available;Not Available;1186;1186	1053;34;34;1053;1053	Taxol;Carboplatin;Taxol;Taxol;Cisplatin	Not Available;Not Available;Not Available;Not Available;Not Available	12;12;12;12;12	06;06;06;06;06	Not Available;Not Available;Not Available;Not Available;Not Available	mg;Not Available;Not Available;mg;mg	RECURRENCE;ADJUVANT;ADJUVANT;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IP;IV;IV;IV;IP;IV;IP;IV	NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	1206;Not Available;Not Available;456;618	mg;Not Available;Not Available;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	Not Available	Not Available	TCGA-61-2017-F28359	a1de5eb8-5151-4daa-aa00-cae596d21fa0	8	Not Applicable	1398	Not Available	Not Available	Not Available	Not Available	Not Available	12	YES;YES	NO;NO	Not Available;1033	1006;Not Available	Recurrence;Locoregional Disease	Not Available;YES	Imaging Study;Imaging Study	Not Applicable;Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	12	G1									Not Available	Not Available	2017	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	61	1-10 mm	Ovary	NO	Alive	2009	2005
TCGA-23-1110	42	FEMALE	1658	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	1	326.0		Recurrence	TUMOR FREE		42	Right	TCGA-23-1110	9fb1ba57-2007-4477-b000-2d36f163efd2	23	-15383	Not Applicable	0	1658	TCGA-23-1110-D25667;TCGA-23-1110-D25668;TCGA-23-1110-D25670;TCGA-23-1110-D25669	05f0a85e-8428-42e9-b8c6-79bf2d0eceed;b7078743-ae46-40f4-87e4-3e5d1e8873c7;b9882c4e-8bcd-42a7-baa4-a91102a3853a;58fe9851-57be-4df2-bd75-5e5dcbc2a094	Not Available;Not Available;Not Available;Not Available	14;14;14;14	375;110;235;110	333;6;179;6	Xeloda;Carboplatin;Ovarex/IND;Paclitaxel	Not Available;Not Available;Not Available;Not Available	12;12;12;12	04;06;03;06	Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg	RECURRENCE;ADJUVANT;OTHER, SPECIFY IN NOTES;ADJUVANT	Not Applicable;Not Applicable;Consolidation;Not Applicable	Not Available;Not Available;Not Available;Not Available	PO;IV;IV;IV	NO;NO;NO;NO	Chemotherapy;Chemotherapy;Immunotherapy;Chemotherapy	Not Available;Not Available;Not Available;Not Available	16800;1800;6;3960	mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009	Not Available	HISPANIC OR LATINO	TCGA-23-1110-F25666	412125d8-6e4b-4ece-9596-a1bb77f81e61	23	Not Applicable	1658	Not Available	Not Available	Not Available	Not Available	Not Available	2	YES	NO	Not Available	326	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	1110	Not Available	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	23	No Macroscopic disease	Ovary	YES	Alive	2009	2003
TCGA-29-1769	40	FEMALE	699	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	699			TUMOR FREE		40	Bilateral	TCGA-29-1769	94769f2c-b6fd-48ec-af34-b41165340b7c	2	-14754	Not Applicable	0	699	TCGA-29-1769-D27369;TCGA-29-1769-D27368;TCGA-29-1769-D27370;TCGA-29-1769-D27367;TCGA-29-1769-D27371	f005e844-c120-4a8d-9084-4363e2a321d1;44526a07-f299-45c9-bcb9-c9ffd10801e6;5d098ad8-d2fa-4557-9751-80e53c5f41c5;8825618c-518a-4baf-b858-9aab04f99db2;2fb6d93d-b53e-4aa6-aff1-90ff331b09d6	Not Available;Not Available;Not Available;Not Available;Not Available	2;2;2;2;2	150;20;150;20;Not Available	42;20;42;20;206	Paciltaxel;Carboplatin;Cisplatin;Paciltaxel;Abagovomab vs Placebo	Not Available;Not Available;Not Available;Not Available;Not Available	11;11;11;11;11	06;01;06;01;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available	mg;mg;mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available	IP;IV;IV;IP;IV;IV;Not Available	NO;NO;NO;NO;YES	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Immunotherapy	Not Available;Not Available;Not Available;Not Available;Not Available	300;870;130;318;2	mg;mg;mg;mg;mg	Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009	0	Not Available	TCGA-29-1769-F27366	b97223f7-bb76-4b6f-a938-a615aa68414a	2	Not Applicable	699	0	Not Available	Not Available	Not Available	Not Available	6									Not Available	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	NO	6	G3									Not Available	Not Available	1769	Post-Adjuvant Therapy	TUMOR FREE	Not Available	Not Available	WHITE	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	1-10 mm	Ovary	Not Available	Alive	2009	2007
TCGA-24-0966	78	FEMALE	232	Serous Cystadenocarcinoma	Ovary	Alive	Stage IIIC	G3	0	232			WITH TUMOR		78	Bilateral	TCGA-24-0966	fef1696c-a8f4-4db6-8615-e486522baaaa	24	-28529	Not Applicable	0	232	TCGA-24-0966-D25877;TCGA-24-0966-D25876;TCGA-24-0966-D25878	d59ae257-aaed-4b32-b2ee-4819c0c1f330;6e46e95c-59bd-4b05-aa53-4d4ab9726c05;b56ccf47-30cb-49bc-a45b-5d2c2d1617f1	Not Available;Not Available;Not Available	27;27;30	120;120;120	21;21;71	carboplatin;paclitaxel;Avastin/bevacizumab/placebo	Not Available;Not Available;Not Available	3;3;3	5;5;Not Available	Not Available;Not Available;Not Available	mg;mg;mg	ADJUVANT;ADJUVANT;ADJUVANT	Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available	IV;IV;Not Available	Not Available;Not Available;Not Available	Chemotherapy;Chemotherapy;Targeted Molecular therapy	Not Available;Not Available;Not Available	2456;1390;2457	mg;mg;mg	Not Available;Not Available;Not Available	2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-24-0966-F25875	23c1520b-680f-4177-ab0b-e2188bbe2e81	24	Not Applicable	232	Not Available	Not Available	Not Available	Not Available	Not Available	2									Not Available	Not Available	WITH TUMOR	YES	Stable Disease	NO	Alive	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	Not Available	Not Available	YES	2	G3									Not Available	Not Available	0966	Not Available	WITH TUMOR	Not Available	Not Available	BLACK OR AFRICAN AMERICAN	Not Available																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	24	>20 mm	Ovary	Not Available	Alive	2009	2008
TCGA-29-A5NZ	66	FEMALE	1088	Serous Cystadenocarcinoma	Omentum	Dead	Stage IIIC	G3	1	697.0		Recurrence	WITH TUMOR		66	Not Available	TCGA-29-A5NZ	F1CB3D48-1415-408D-89D1-DFDCC5924963	20	-24161	1088	0	Not Available	TCGA-29-A5NZ-D59533;TCGA-29-A5NZ-D59534;TCGA-29-A5NZ-D59535;TCGA-29-A5NZ-D59537;TCGA-29-A5NZ-D59532;TCGA-29-A5NZ-D59536	061ED9E3-C6F0-4348-9A32-9FAAD64DC411;2ABD0BB8-6960-48F8-B08D-28AB17CF9FE6;55F4F735-7B13-4FA5-8105-4B4D8480A870;F3B64637-8466-489E-AAE7-0CB2CD1E80C6;B8A9B895-3774-4B7A-8E4E-601BAEEB0C3B;F16C6D42-2092-4457-B4B5-D5F1169B78FD	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	14;14;14;14;14;14	151;543;543;Not Available;151;817	25;396;396;893;25;686	Paclitaxel;Carboplatin;Doxil;paclitaxel;Carboplatin;Gemzar	Complete Response;Partial Response;Partial Response;Not Applicable;Complete Response;Clinical Progressive Disease	5;5;5;5;5;5	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	NO;NO;NO;YES;NO;NO	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	YES;NO;NO;YES;YES;NO	2014;2014;2014;2014;2014;2014	Not Available	Not Available	TCGA-29-A5NZ-F59530;TCGA-29-A5NZ-F59529;TCGA-29-A5NZ-F59527	3BFD1FFC-178F-453E-9445-6C4AE268123F;3E121B6F-76A2-4617-ABF1-77F50BA1FD3A;B059FE0D-3A99-4FB1-AFEB-7E44CA131810	14;14;14	Not Applicable;1088;1088	984;Not Available;Not Available	Not Available;Not Available;Not Available	Additional New Tumor Event;Additional New Tumor Event;Scheduled Follow-up Submission	Not Applicable;Progressive Disease;Partial Remission/Response	Not Available;Not Available;Not Available	NO;NO;NO	5;5;5	YES;YES;YES;YES;YES;YES	NO;NO;NO;NO;NO;NO	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	879;879;697;697;396;396	Progression of Disease;Unknown;Recurrence;Unknown;Recurrence;Unknown	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	YES;YES;YES	Not Available;Not Available;Not Available	WITH TUMOR;WITH TUMOR;WITH TUMOR	YES;YES;YES	Not Applicable;Complete Remission/Response;Complete Remission/Response	NO;NO;NO	Alive;Dead;Dead	2014;2014;2014	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8460/3	C48.1	YES	Not Applicable	Not Available	Not Available	Not Available	Not Available	8	G3	YES;YES	NO;NO	Not Available;Not Available	704;358	Progression of Disease;Recurrence	Not Available;Not Available	Not Available;Not Available	Not Applicable;Not Applicable	Not Available	No	A5NZ	Not Available	WITH TUMOR	YES	Complete Remission/Response	BLACK OR AFRICAN AMERICAN	NO																			Not Available	Not Applicable	Not Applicable	Stage IIIC	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	29	Not Available	Omentum	Not Available	Dead	2013	2011
TCGA-30-1714	68	FEMALE	1158	Serous Cystadenocarcinoma	Ovary	Dead	Stage IV	G3	1	241.0		Recurrence	WITH TUMOR		68	Bilateral	TCGA-30-1714	09820a33-80b1-42d0-8366-a0ddaf94b122	2	-25032	1158	0	1158	TCGA-30-1714-D27523;TCGA-30-1714-D27525;TCGA-30-1714-D27522;TCGA-30-1714-D27527;TCGA-30-1714-D27520;TCGA-30-1714-D27528;TCGA-30-1714-D27519;TCGA-30-1714-D27529;TCGA-30-1714-D27526;TCGA-30-1714-D27521;TCGA-30-1714-D27524;TCGA-30-1714-D27530;TCGA-30-1714-D27531	96e20ade-957d-4325-bf8a-52bcf4a52c4a;d02262bf-8e14-4818-a03b-da6d5cc93714;5dcaa7ee-b212-4231-a324-aa6ce4fbc112;042e666e-6398-41eb-b4a7-a7c8f827113c;3b0d4be7-ecbf-4ea1-ad60-3f6e3b6fccad;e1b0dbd2-3f76-4035-bd5a-4d21fb2d5ead;0dfd75da-44eb-4094-886c-ea2ef1f0d39d;484b8f0c-dfc0-4609-8b68-bcb68ba7cfb0;229d1033-3c45-40c6-a9ff-3ac9a8dfcd07;cef80948-64c3-4608-b830-fc9ffb5114e7;c9389674-3b88-4809-aa7a-cba33bed3d60;994c0e08-62d3-4f19-b713-c74fad7d2a4f;ac3a5434-1fed-435f-8b81-48141e149b33	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	23;23;23;23;23;23;23;23;23;23;23;23;9	700;700;521;955;123;990;123;1075;955;417;700;1081;283	555;555;424;906;15;973;15;1002;906;314;555;1002;246	Carboplatin;Taxol;Topotecan;Taxotere;Carboplatin;VP 16;Taxol;Carboplatin;Gemcitabine;Doxil;Taxol;Taxol;Armidex	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	9;9;9;9;9;9;9;9;9;9;9;9;12	05;05;01;07;06;01;06;02;07;06;05;02;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	mg/m2;mg/m2;mg/m2;mg/m2;Not Available;mg;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;Not Available	RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;ADJUVANT;RECURRENCE;ADJUVANT;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE;RECURRENCE	Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable;Not Applicable	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	IV;IV;IV;IV;IV;PO;IV;IV;IV;IV;IV;IV;IV	NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO;NO	Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Chemotherapy;Hormone Therapy	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	343;278;3;30;5;50;175;343;700;40;175;135;Not Available	mg/m2;mg/m2;mg/m2;mg/m2;Not Available;mg;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;mg/m2;Not Available	Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available;Not Available	2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009;2009	Not Available	NOT HISPANIC OR LATINO	TCGA-30-1714-F27518	32baf547-650e-4412-8b72-977f2bfc79e6	2	1158	1158	Not Available	Not Available	Not Available	Not Available	Not Available	6	YES	YES	Not Available	241	Recurrence	Not Available	Imaging Study	Not Applicable	Not Available	Not Available	WITH TUMOR	YES	Complete Remission/Response	NO	Dead	2009	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Not Applicable	Tumor resection	ASHKENAZI	Not Available	YES	6	G3									Not Available	Not Available	1714	Not Available	WITH TUMOR	Not Available	Not Available	WHITE	Not Available	Distant Recurrence	TCGA-30-1714-R27532	a8b44ef4-48df-4042-8f23-7968857e10a0	Not Available	3	Not Available	777	Not Available	6	Not Available	Not Available	NO	EXTERNAL BEAM	Not Applicable	ADJUVANT	Not Available	Not Available	2009	Not Available	Not Applicable	Not Applicable	Stage IV	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Applicable	Not Available	Not Available	30	1-10 mm	Ovary	NO	Dead	2009	2001
